VAERS Reports #201A21A

VAERS 2728581

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: -
Alter: 68,0
Geschlecht: F
Eingang: 29.12.2023
Impfdatum: 08.04.2021
Beginn: 19.11.2023
Tage bis Beginn: 955,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute kidney injury Acute respiratory failure Asthenia Atelectasis Back pain Blood creatinine increased Brain natriuretic peptide increased COVID-19 Chest X-ray abnormal Chronic kidney disease Deep vein thrombosis Dizziness Escherichia test positive Fall Gastrooesophageal reflux disease Hyperkalaemia Hyperlipidaemia Lung disorder

Symptomtext

Patient is a 70 y.o. female patient of MD with history of IDDM2, HTN, HLD, CHFrEF, chronic pain syndrome, DVT, who presented to Hospital with weakness. UTI: Cefazolin Urine culture with E coli sensitive to cefazolin Will give keflex on discharge Covid-19 Virus Infection Acute hypoxemic respiratory failure: Date of onset of symptoms: 11/19/23 Symptoms present on admission: Dizziness, weakness Date of covid positive test: 11/19/23 Vaccination status: vaccinated Imaging: CXR with mild bibasilar atelectasis vs airspace disease Oxygen requirements on admission: 2 Lpm by NC Current oxygen requirements: 2 Lpm by NC Medical therapy: steroids; remdesivir started by ID Consultants following: ID Anticipated special isolation end date: 11/30/2023 AKI on chronic kidney disease: Hyperkalemia: Creatinine baseline approximately 1.4 Creatinine on admission was 2.17 Hold lasix and Entresto IVFs Back to baseline on 11/22 Generalized weakness Fall Acute on chronic back pain PT/OT Care management Fall precautions Thoracic lumbar and cervical x-rays-shows some severe degenerative ds Pt has seen Dr in past, will follow up with him as OP Chronic CHFrEF: HTN: Hold Lasix and Entresto elevated BNP to 2900 after fluids Toprol Stop IV fluids on 11/20 DVT: Warfarin per pharmacy HLD: Atovastatin Chronic pain syndrome: Continue home Butrans patch GERD: PPI IDDM2: Hold glipizide and metformin due to AKI Lantus and SSI

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 3,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2710743

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: TX
Alter: 54,0
Geschlecht: F
Eingang: 07.11.2023
Impfdatum: 07.08.2021
Beginn: 21.10.2021
Tage bis Beginn: 75,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Abdominal pain Acute respiratory failure COVID-19 pneumonia Cough Hypoxia Nausea Prone position Respiratory tract congestion Vomiting

Symptomtext

Admitted for Covid-19 PNA and acute hypoxemic resp failure. Presented with hypoxia, congestion, cough, abdominal pain, nausea, vomiting. She was treated with dexamethasone, remdesivir, tocilizumab, oxygen support, and prone positioning. She improved gradually with treatment and was stable for discharge home on day 8. She required oxygen supplement 2L with exertion on discharge.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 7,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2695518

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: TX
Alter: 71,0
Geschlecht: M
Eingang: 13.10.2023
Impfdatum: 11.04.2021
Beginn: 09.02.2022
Tage bis Beginn: 304,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure Anticoagulant therapy COVID-19 Dyspnoea Post-acute COVID-19 syndrome

Symptomtext

Presented wtih increasing SOB; dx with covid 1/22/23; Tx with Decadron, maxipime, heparin, eliquis, Rocephin, The pt was admitted to the hospital on 2/9/2022 because of acute hypoxic respiratory failure and post COVID syndrome. The patient was seen by Pulmonary. IV steroids increased. Eliquis was continued. Decadron 10 mg 3 times a day continued. Oxygen was gradually weaned. Patient on 3 L of oxygen now. Decadron to be slowly tapered 3-4 weeks per pulmonary recommendation.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 11,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2623154

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: -
Alter: 78,0
Geschlecht: F
Eingang: 28.04.2023
Impfdatum: 19.05.2021
Beginn: 31.05.2021
Tage bis Beginn: 12,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure Cardiac failure Carotid artery thrombosis Chest pain Coronary artery disease Hypoxia

Symptomtext

ACUTE HYPOXEMIC RESPIRATORY FAILURE 6/1/2021 THROMBOSIS OF LEFT INTERNAL CAROTID ARTERY HYPOXIA 7/9/2021 THROMBOSIS OF LEFT INTERNAL CAROTID ARTERY ACUTE HYPOXEMIC RESPIRATORY FAILURE 6/1/2021 CHEST PAIN HYPOXIA 7/9/2021 CHEST PAIN ACUTE HYPOXEMIC RESPIRATORY FAILURE 6/1/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA HYPOXIA 7/9/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA ACUTE HYPOXEMIC RESPIRATORY FAILURE 6/1/2021 HEART FAILURE W NORMAL LVEF >=50%, UNSPECIFIED ACUITY HYPOXIA 7/9/2021 HEART FAILURE W NORMAL LVEF >=50%, UNSPECIFIED ACUITY

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2600164

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: KY
Alter: 73,0
Geschlecht: M
Eingang: 21.03.2023
Impfdatum: 26.05.2021
Beginn: 18.01.2023
Tage bis Beginn: 602,0
Dosis: UNK
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death Endotracheal intubation Influenza Pneumonia SARS-CoV-2 test positive

Symptomtext

Had four vaccines for covid , one Janssen then three moderna. Had b cell lymphoma with metastatic cancer on chemotherapy and came to hospital 12-5-22 where he was subsequently intubated for flu and pneumonia and was Not covid + until 1-6-23. Later was transferred to hospice where he passed on 1-18-23. Complicated hospital course

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: b cell lymphoma with metastatic cancer, on chemotherapy, hyperlipidemia (not sure if this is all or not)
Andere Medikamente: -
Allergien: Penicillin allergy mild: rash
Vorherige Impfungen: -

VAERS 2584274

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: FL
Alter: 54,0
Geschlecht: M
Eingang: 20.02.2023
Impfdatum: 09.09.2021
Beginn: 01.04.2022
Tage bis Beginn: 204,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Bladder cancer stage IV Bladder neoplasm Bladder neoplasm surgery Blood bilirubin Blood test Blood urine present Computerised tomogram Cystoscopy abnormal Death Hepatic failure Jaundice Laboratory test Metastases to liver Metastatic carcinoma of the bladder Positron emission tomogram

Symptomtext

Shot mandated by employer or my husband would be fired from job. Patient got J&J death shot on 9/9/21 at local grocery store. April 2022 Patient had 1 episode of blood in urine. Could not get any appointment with Urologist any sooner. Patient saw a Urologist. He performed (weeks later due to no appointments available) a cystoscopy and saw 1 tumor in the bladder. Patient had outpatient surgery on 6/1/22 for tumor removal which was successful - only 1 tumor in there and he got it all. On 6/9/22 Patient was told that the tumor was the WORST type - very rare, very aggressive Stage 4 Bladder Cancer. Patient was sent to Oncology where that MD said due to type of cancer there was nothing they could do to cure this, they had only 2 platinum chemo agents available to offer in the hope to prolong his life. Oncology in gave 2nd opinion of the same thing as if reading from a script. Patient then researched the 2 platinum chemo agents and was horrified at the results - death as a side effect and complete loss of immune function. Patient sought treatment from a Cancer Center for 2 months out of pocket. His tests and labs showed promise. After returning, a few weeks into treatments, patient began to turn yellow (bilirubin/liverfailure). It was determined that the rare aggressive bladder cancer had overtaken his liver. Patient was hospitalized in September 2022 and not one employee told us what was going on wih him. My husband was given morphine and IV fluids and left in a bed. He was discharged after the hospitalist came into his room asking: "So what do you want us to do for you". He came home and we made arrangements for hospice. He was on hospice 2 weeks and died on 10/1/2022 from the death shot.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 2,0
Labordaten: It will take me having to research all this and provide exact dates. Here is a list of who treated patient and I have no doubt you can access all this and more: Outpatient Surgery Center Medical Center - CAT scans, PET scan Labs- blood draws Oncology Cancer Center
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: -
Allergien: none
Vorherige Impfungen: -

VAERS 2546415

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: CA
Alter: 31,0
Geschlecht: F
Eingang: 29.12.2022
Impfdatum: 01.08.2021
Beginn: 01.12.2021
Tage bis Beginn: 122,0
Dosis: 1
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Death of relative Exposure during pregnancy Foetal cardiac disorder Foetal heart rate decreased Hydrops foetalis Premature delivery Ultrasound antenatal screen abnormal Uterine contractions abnormal

Symptomtext

I was less than 12 weeks pregnant at the time that I received the vaccine. A few hours after the vaccine I had contractions on my lower belly for the rest of the day. In December (about 20 weeks pregnant) during a routine ultrasound they notice my baby had a very slow heart beat and I was send to a local Hospital. At the hospital they determined that indeed my baby?s heart rate was dropping to 40 beats per minute. I was then transferred to another Hospital for higher level of care. After a referral to a third hospital in another county with a fetal specialist it was determined that my baby in fact was suffering from a congenital complete heart block with hydrops with really poor outcomes. By baby was born at 29 weeks and was alive for less than 15 minutes. Prior to this pregnancy, I had 2 healthy pregnancy with healthy babies, my first child was born four years ago and my second child was born two years ago . Both of them are healthy and with no issues.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death of relative
Hospital-Tage: 2,0
Labordaten: -
Aktuelle Erkrankungen: No other illnesses at the time of vaccination.
Vorgeschichte: No chronic or long standing health conditions
Andere Medikamente: My baby was diagnosed with a congenital complete heart block and hydrops while I was pregnant, my baby only made it to 29 weeks in embryo, she was alive for less than 15minutes. My original due date was April 2022 but she was born and pass
Allergien: Allergic to bee stings
Vorherige Impfungen: -

VAERS 2487080

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: KY
Alter: 63,0
Geschlecht: M
Eingang: 24.10.2022
Impfdatum: 11.08.2021
Beginn: 01.12.2021
Tage bis Beginn: 112,0
Dosis: UNK
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Abdominal pain Anaemia COVID-19 Death Dizziness Haematemesis Nausea Pleural effusion SARS-CoV-2 test positive Vomiting

Symptomtext

presented to ER at Med Center with anemia, abd pain, hematemesis , nausea and vomiting and dizziness. Given IV zofran, promethazine, lorazepam, pantoprazole and IV NS boluses due to bp of 87/50. He was found to have pleural effusion as well on the right. Given IV piperacillin -tazobactam. Transferred to other med Center where he tested + for covid 11-30-2021. Expired 12-1-2021

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2450816

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: KY
Alter: 56,0
Geschlecht: F
Eingang: 19.09.2022
Impfdatum: 18.11.2021
Beginn: 24.08.2022
Tage bis Beginn: 279,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Acute respiratory failure Blood gases C-reactive protein COVID-19 COVID-19 pneumonia Chest X-ray abnormal Chills Chronic obstructive pulmonary disease Condition aggravated Dyspnoea Exposure to communicable disease Fibrin D dimer Haemoptysis Lung opacity Procalcitonin Productive cough SARS-CoV-2 test positive Sputum culture

Symptomtext

Patient presents to ED with a 3 day history of shortness of air and productive cough with blood tinged sputum. Pt reports her roommates have been treated for bronchitis this week, but she was not aware that any of them had tested positive for COVID. Pt does not use supplemental O2 at baseline. She endorses chills, but has not had fever. She denies any bright red blood in sputum, or large volume bleeding. Constitutional: Positive for chills. Negative for activity change, fatigue and fever. Respiratory: Positive for cough and shortness of breath. Negative for chest tightness and wheezing. Hospital course: #Acute hypoxic respiratory failure 2/2 SARS CoV2 pneumonia and COPD exacerbation - RESOLVED. - Pt. O2 sat stable on 2 liters NC. VBG 7.41/32/51/87. - CXR showing interval development of diffuse groundglass opacity through the left hemithorax and right lower lobe - Afebrile with WBC (10), procal minimally and CRP pending, d-dimer (1.18) PLAN: - sputum cx pending - 08/24: s/p solumedrol 125 mg IV x 1 in ED - 08/24: starting Remdesivir x 3 days and dexamethasone 6 mg PO daily x 10 days Discharge Disposition/Condition Disposition: Home Condition: Stable (s/sx potential problems absent or manageable)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 5,0
Labordaten: COVID PCR confirmed positive on 8/24/22
Aktuelle Erkrankungen: N/A
Vorgeschichte: Past Medical History: Pregnancy induced cardiomyopathy, HFpEF Opioid use disorder on suboxone COPD Anxiety/depression Hep C HLD Obesity GERD
Andere Medikamente: suboxone cholecalciferol multivitamin naloxone zofran miralax zocor detrol bupropion coreg duloxetine hydroxyzine lisinopril methocarbamol nortriptyline pantoprazole proair trazodone
Allergien: Penicillins
Vorherige Impfungen: -

VAERS 2347525

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: IL
Alter: 74,0
Geschlecht: M
Eingang: 30.08.2022
Impfdatum: 17.08.2021
Beginn: 03.02.2022
Tage bis Beginn: 170,0
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute respiratory failure Angiogram pulmonary abnormal Anticoagulant therapy Blood creatinine increased Blood lactic acid increased Angiogram pulmonary Blood creatinine Blood lactic acid COVID-19 COVID-19 pneumonia Cardiac disorder Chest discomfort Computerised tomogram Computerised tomogram thorax abnormal Decreased appetite Dyspnoea Dyspnoea exertional Echocardiogram normal

Symptomtext

ACUTE RESPIRATORY FAILURE; COVID-19 PNEUMONIA; BLOOD LACTIC ACID INCREASED; PNEUMONIA VIRAL; PRODUCTIVE COUGH; LACTIC ACIDOSIS; LEUKOCYTOSIS; PULMONARY EMBOLISM; SCAN WITH CONTRAST ABNORMAL; BLOOD CREATININE INCREASED; LACTIC ACIDOSIS; BLOOD LACTIC ACID INCREASED; PULMONARY EMBOLISM; DYSPNOEA EXERTIONAL; ECHOCARDIOGRAM NORMAL; EJECTION FRACTION NORMAL; FIBRIN D DIMER INCREASED; FULL BLOOD COUNT ABNORMAL; HYPERTRANSAMINASAEMIA; INFLAMMATORY MARKER INCREASED; INTENSIVE CARE; LEUKOCYTOSIS; LUNG INFILTRATION; LUNG INFILTRATION; MECHANICAL VENTILATION; MECHANICAL VENTILATION; PERIPHERAL ARTERY ANEURYSM; PERIPHERAL ARTERY ANEURYSM; POSITIVE AIRWAY PRESSURE THERAPY; POSITIVE AIRWAY PRESSURE THERAPY; PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED; CARDIAC DISORDER; COVID-19; CHEST DISCOMFORT; CARDIAC DISORDER; DECREASED APPETITE; SCAN WITH CONTRAST ABNORMAL; TACHYCARDIA; SHIFT TO THE LEFT; TROPONIN NORMAL; SPUTUM DISCOLOURED; ULTRASOUND DOPPLER ABNORMAL; TACHYCARDIA; WHEEZING; TROPONIN NORMAL; ANGIOGRAM PULMONARY ABNORMAL; ULTRASOUND DOPPLER ABNORMAL; ANTICOAGULANT THERAPY; PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED; SARS-COV-2 TEST POSITIVE; ANGIOGRAM PULMONARY ABNORMAL; COVID-19 PNEUMONIA; ANTICOAGULANT THERAPY; PNEUMONIA VIRAL; COMPUTERISED TOMOGRAM THORAX ABNORMAL; CHEST DISCOMFORT; PYREXIA; SHIFT TO THE LEFT; SARS-COV-2 TEST POSITIVE; SPUTUM DISCOLOURED; WHEEZING; COMPUTERISED TOMOGRAM THORAX ABNORMAL; DYSPNOEA; PRODUCTIVE COUGH; PYREXIA; COVID-19; BLOOD CREATININE INCREASED; This spontaneous report received from a health care professional by a Regulatory Authority VAERS (Vaccine Adverse Event Reporting System) (VAERS ID: 2347525) concerned a 74 year old male of unspecified race and ethnicity. The patient's height, and weight were not reported. The patient's past medical history included: covid-19 infection (2 Years ago), and concurrent conditions included: psoriasis, hypertension, dyslipidemia, tobacco abuse, alcohol use (was drinking up to half a pint of vodka at twice a week, His last drink was 12 days ago), poor appetite, High density lipoprotein, and other pre-existing medical conditions included: No history of alcohol withdrawal. Patient denied any sick contact in the recent past. The patient experienced heartburn when treated with ciprofloxacin. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 201A21A, expiry: unknown) dose was not reported, 1 total, administered on 17-AUG-2021 for an unspecified indication. Age at time of vaccination 74 years old. Concomitant medications included secukinumab for hypertension, amlodipine, atorvastatin, clobetasol, diazepam, escitalopram, salbutamol, tadalafil, and torasemide. On 03-FEB-2022, The patient presented to the hospital with shortness of breath (dyspnea), fever (pyrexia) and cough (productive cough). He was hypoxic and require initially BiPAP had bilateral wheezing his COVID-19 test was positive (covid-19) and (sars-cov-2 test positive). The patient was transferred from emergency department for management of acute hypoxic respiratory failure secondary to COVID-19 pneumonia and bilateral pulmonary embolism with signs of right heart strain. He presented emergency room with a complaint of shortness of breath. Patient was in relatively good state of health until 4 days ago when he started to had progressively worsening dyspnea worse with exertion. He also reported cough productive of yellowish sputum since 2 days ago. He reported right-sided chest heaviness. No palpitations, fever, chills or rigors. Patient denied any sick contact in the recent past. No report of nausea vomiting or diarrhea. Patient denied use of tobacco products. On 13-FEB-2022 Upon evaluation at the emergency room he was afebrile. He was hypoxic with oxygen saturation 86 percent on room air. He was tachycardic significant lab findings were creatinine of 1.31 which was close to his baseline and mild transaminitis. He was also noted to had lactic acidosis at 6.1 and proBNP of 1279, Lactic acid trended down to 2.6 after intravenous hydration. Complete blood count revealed leukocytosis at 19,000 with slight left shift D-dimer was significantly elevated more than 35 computed tomography, chest with intravenous contrast was obtained which revealed right-sided pulmonary thromboembolism involving right middle lower and lower lobes with some signs of right heart strain, However troponin was negative, computed tomography chills also revealed patchy multifocal bilateral infiltrates suggestive of viral pneumonitis. Nasopharyngeal swab was positive for COVID-19. At the referring facility emergency department patient was started with intravenous heparin drip. He also received intravenous Solu-Medrol DuoNeb nebulization and ceftriaxone intravenous. The patient had elevated inflammatory markers and elevated D-dimer, computerized tomography chest angiogram show bilateral multiple pulmonary embolism. Initially worrisome for submissive pulmonary embolism with right ventricular strain the patient placed on heparin drip and the cardiologist consulted and the patient had echocardiogram show EF (ejection fraction) 60% without signs of right ventricular strain. The cardiologist recommend on anticoagulation and no intervention the patient admitted to the intensive care unit and he require to be on noninvasive ventilator BiPAP and OptiFlow. He received decadron and remdesivir and antibiotics for possible secondary bacterial pneumonia. He was not candidate for Actemra because he was on immunosuppressive therapy for history assess. The patient had history of alcoholism but he did not develop any signs of alcohol withdrawal, history of hypertension dyslipidemia and were controlled. The patient did had lower limbs Doppler ultrasound show asymptomatic, popliteal aneurysm and no deep vein thrombosis. The patient off oxygen gradually and oxygen walking test done before the patient discharged and show the patient did not require oxygenation at rest and required 2 Liter of oxygen with activities discussed with the patient would discharge the patient home with home oxygen and continue tapered steroids. The patient hospitalized for 14 days The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from acute respiratory failure, angiogram pulmonary abnormal, anticoagulant therapy, blood creatinine increased, blood lactic acid increased, covid-19, covid-19 pneumonia, cardiac disorder, chest discomfort, computerised tomogram thorax abnormal, decreased appetite, dyspnoea, dyspnoea exertional, echocardiogram normal, ejection fraction normal, fibrin d dimer increased, full blood count abnormal, hypertransaminasaemia, inflammatory marker increased, intensive care, lactic acidosis, leukocytosis, lung infiltration, mechanical ventilation, peripheral artery aneurysm, pneumonia viral, positive airway pressure therapy, productive cough, prohormone brain natriuretic peptide increased, pulmonary embolism, pyrexia, sars-cov-2 test positive, scan with contrast abnormal, shift to the left, sputum discoloured, tachycardia, troponin normal, ultrasound doppler abnormal, and wheezing. This report was serious (Hospitalization Caused / Prolonged). This report was associated with a product quality complaint: 90000243179. The suspected product quality complaint has been confirmed to be the reported allegation could not be determined. A manufacturing related root cause could not be identified based on the PQC evaluation/investigation performed. Additional information received from central complaint vigilance department on 25-AUG-2022. The following information was updated and incorporated into the case narrative: Product quality complaint investigation result.; Sender's Comments: V1- This follow up adds information about Product quality complaint investigation result. This does not alter previous causality assessment of the reported events. 20220732778-covid-19 vaccine ad26.cov2.s- pulmonary embolism, angiogram pulmonary abnormal, anticoagulant therapy, computerised tomogram thorax abnormal. This event(s) is labeled per RSI and is therefore considered potentially related. 20220732778-covid-19 vaccine ad26.cov2.s-acute respiratory failure, blood creatinine increased, blood lactic acid increased, covid-19, covid-19 pneumonia, cardiac disorder, chest discomfort, decreased appetite, dyspnoea, dyspnoea exertional, echocardiogram normal, ejection fraction normal, fibrin d dimer increased, full blood count abnormal, hypertransaminasaemia, inflammatory marker increased, intensive care, lactic acidosis, leukocytosis, lung infiltration, mechanical ventilation, peripheral artery aneurysm, pneumonia viral, positive airway pressure therapy, productive cough, prohormone brain natriuretic peptide increased, pyrexia, sars-cov-2 test positive, scan with contrast abnormal, shift to the left, sputum discoloured, tachycardia, troponin normal, ultrasound doppler abnormal, and wheezing.. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered unassessable.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 14,0
Labordaten: Test Date: 20220203; Test Name: NASOPHARYNGEAL SWAB; Test Result: Positive ; Test Date: 20220213; Test Name: LOWER LIMBS DOPPLER ULTRASOUND; Result Unstructured Data: show asymptomatic popliteal aneurysm and no Deep vein thrombosis; Test Date: 20220213; Test Name: LACTIC ACID; Result Unstructured Data: 6.1; Test Date: 20220213; Test Name: PROHORMONE BRAIN NATRIURETIC PEPTIDE; Result Unstructured Data: 1279; Test Date: 20220213; Test Name: LACTIC ACID; Result Unstructured Data: down to 2.6; Test Date: 20220213; Test Name: COMPLETE BLOOD COUNT; Result Unstructured Data: revealed leukocytosis at 19 000 with slight left shift; Test Date: 20220213; Test Name: D-DIMER; Result Unstructured Data: significantly elevated more than 35; Test Date: 20220213; Test Name: CHEST COMPUTED TOMOGRAPHY; Result Unstructured Data: with Iodinated contrast was obtained which revealed right-sided pulmonary thromboembolism involving right middle lower and lower lobes with some signs of right heart strain; Test Date: 20220213; Test Name: TROPONIN; Test Result: Negative ; Test Date: 20220213; Test Name: COMPUTED TOMOGRAPHY CHILLS; Result Unstructured Data: revealed patchy multifocal bilateral infiltrates suggestive of viral pneumonitis; Test Date: 20220213; Test Name: INFLAMMATORY MARKERS; Result Unstructured Data: elevated; Test Date: 20220213; Test Name: CT CHEST ANGIOGRAM; Result Unstructured Data: show bilateral multiple pulmonary embolism; Test Date: 20220213; Test Name: ECHOCARDIOGRAM; Result Unstructured Data: show EF 60% without signs of RV strain; Test Date: 20220213; Test Name: OXYGEN SATURATION; Result Unstructured Data: 86 %; Test Date: 20220213; Test Name: CREATININE; Result Unstructured Data: 1.31 which was close to his baseline
Aktuelle Erkrankungen: Alcohol use (was drinking up to half a pint of vodka at twice a week, His last drink was 12 days ago); Decreased appetite; Dyslipidemia; High density lipoprotein; Hypertension; Psoriasis; Tobacco abuse
Vorgeschichte: Medical History/Concurrent Conditions: COVID-19 (2 Years ago); Comments: No history of alcohol withdrawal. Patient denied any sick contact in the recent past.
Andere Medikamente: ALBUTEROL [SALBUTAMOL]; AMLODIPINE; ATORVASTATIN; CLOBETASOL; DIAZEPAM; ESCITALOPRAM; SECUKINUMAB; TADALAFIL; TORSEMIDE; COSENTYX
Allergien: -
Vorherige Impfungen: -

VAERS 2347525

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: IL
Alter: 74,0
Geschlecht: M
Eingang: 30.08.2022
Impfdatum: 17.08.2021
Beginn: 03.02.2022
Tage bis Beginn: 170,0
Dosis: 1
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute respiratory failure Angiogram pulmonary abnormal Anticoagulant therapy Blood creatinine increased Blood lactic acid increased Angiogram pulmonary Blood creatinine Blood lactic acid COVID-19 COVID-19 pneumonia Cardiac disorder Chest discomfort Computerised tomogram Computerised tomogram thorax abnormal Decreased appetite Dyspnoea Dyspnoea exertional Echocardiogram normal

Symptomtext

ACUTE RESPIRATORY FAILURE; COVID-19 PNEUMONIA; BLOOD LACTIC ACID INCREASED; PNEUMONIA VIRAL; PRODUCTIVE COUGH; LACTIC ACIDOSIS; LEUKOCYTOSIS; PULMONARY EMBOLISM; SCAN WITH CONTRAST ABNORMAL; BLOOD CREATININE INCREASED; LACTIC ACIDOSIS; BLOOD LACTIC ACID INCREASED; PULMONARY EMBOLISM; DYSPNOEA EXERTIONAL; ECHOCARDIOGRAM NORMAL; EJECTION FRACTION NORMAL; FIBRIN D DIMER INCREASED; FULL BLOOD COUNT ABNORMAL; HYPERTRANSAMINASAEMIA; INFLAMMATORY MARKER INCREASED; INTENSIVE CARE; LEUKOCYTOSIS; LUNG INFILTRATION; LUNG INFILTRATION; MECHANICAL VENTILATION; MECHANICAL VENTILATION; PERIPHERAL ARTERY ANEURYSM; PERIPHERAL ARTERY ANEURYSM; POSITIVE AIRWAY PRESSURE THERAPY; POSITIVE AIRWAY PRESSURE THERAPY; PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED; CARDIAC DISORDER; COVID-19; CHEST DISCOMFORT; CARDIAC DISORDER; DECREASED APPETITE; SCAN WITH CONTRAST ABNORMAL; TACHYCARDIA; SHIFT TO THE LEFT; TROPONIN NORMAL; SPUTUM DISCOLOURED; ULTRASOUND DOPPLER ABNORMAL; TACHYCARDIA; WHEEZING; TROPONIN NORMAL; ANGIOGRAM PULMONARY ABNORMAL; ULTRASOUND DOPPLER ABNORMAL; ANTICOAGULANT THERAPY; PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED; SARS-COV-2 TEST POSITIVE; ANGIOGRAM PULMONARY ABNORMAL; COVID-19 PNEUMONIA; ANTICOAGULANT THERAPY; PNEUMONIA VIRAL; COMPUTERISED TOMOGRAM THORAX ABNORMAL; CHEST DISCOMFORT; PYREXIA; SHIFT TO THE LEFT; SARS-COV-2 TEST POSITIVE; SPUTUM DISCOLOURED; WHEEZING; COMPUTERISED TOMOGRAM THORAX ABNORMAL; DYSPNOEA; PRODUCTIVE COUGH; PYREXIA; COVID-19; BLOOD CREATININE INCREASED; This spontaneous report received from a health care professional by a Regulatory Authority VAERS (Vaccine Adverse Event Reporting System) (VAERS ID: 2347525) concerned a 74 year old male of unspecified race and ethnicity. The patient's height, and weight were not reported. The patient's past medical history included: covid-19 infection (2 Years ago), and concurrent conditions included: psoriasis, hypertension, dyslipidemia, tobacco abuse, alcohol use (was drinking up to half a pint of vodka at twice a week, His last drink was 12 days ago), poor appetite, High density lipoprotein, and other pre-existing medical conditions included: No history of alcohol withdrawal. Patient denied any sick contact in the recent past. The patient experienced heartburn when treated with ciprofloxacin. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 201A21A, expiry: unknown) dose was not reported, 1 total, administered on 17-AUG-2021 for an unspecified indication. Age at time of vaccination 74 years old. Concomitant medications included secukinumab for hypertension, amlodipine, atorvastatin, clobetasol, diazepam, escitalopram, salbutamol, tadalafil, and torasemide. On 03-FEB-2022, The patient presented to the hospital with shortness of breath (dyspnea), fever (pyrexia) and cough (productive cough). He was hypoxic and require initially BiPAP had bilateral wheezing his COVID-19 test was positive (covid-19) and (sars-cov-2 test positive). The patient was transferred from emergency department for management of acute hypoxic respiratory failure secondary to COVID-19 pneumonia and bilateral pulmonary embolism with signs of right heart strain. He presented emergency room with a complaint of shortness of breath. Patient was in relatively good state of health until 4 days ago when he started to had progressively worsening dyspnea worse with exertion. He also reported cough productive of yellowish sputum since 2 days ago. He reported right-sided chest heaviness. No palpitations, fever, chills or rigors. Patient denied any sick contact in the recent past. No report of nausea vomiting or diarrhea. Patient denied use of tobacco products. On 13-FEB-2022 Upon evaluation at the emergency room he was afebrile. He was hypoxic with oxygen saturation 86 percent on room air. He was tachycardic significant lab findings were creatinine of 1.31 which was close to his baseline and mild transaminitis. He was also noted to had lactic acidosis at 6.1 and proBNP of 1279, Lactic acid trended down to 2.6 after intravenous hydration. Complete blood count revealed leukocytosis at 19,000 with slight left shift D-dimer was significantly elevated more than 35 computed tomography, chest with intravenous contrast was obtained which revealed right-sided pulmonary thromboembolism involving right middle lower and lower lobes with some signs of right heart strain, However troponin was negative, computed tomography chills also revealed patchy multifocal bilateral infiltrates suggestive of viral pneumonitis. Nasopharyngeal swab was positive for COVID-19. At the referring facility emergency department patient was started with intravenous heparin drip. He also received intravenous Solu-Medrol DuoNeb nebulization and ceftriaxone intravenous. The patient had elevated inflammatory markers and elevated D-dimer, computerized tomography chest angiogram show bilateral multiple pulmonary embolism. Initially worrisome for submissive pulmonary embolism with right ventricular strain the patient placed on heparin drip and the cardiologist consulted and the patient had echocardiogram show EF (ejection fraction) 60% without signs of right ventricular strain. The cardiologist recommend on anticoagulation and no intervention the patient admitted to the intensive care unit and he require to be on noninvasive ventilator BiPAP and OptiFlow. He received decadron and remdesivir and antibiotics for possible secondary bacterial pneumonia. He was not candidate for Actemra because he was on immunosuppressive therapy for history assess. The patient had history of alcoholism but he did not develop any signs of alcohol withdrawal, history of hypertension dyslipidemia and were controlled. The patient did had lower limbs Doppler ultrasound show asymptomatic, popliteal aneurysm and no deep vein thrombosis. The patient off oxygen gradually and oxygen walking test done before the patient discharged and show the patient did not require oxygenation at rest and required 2 Liter of oxygen with activities discussed with the patient would discharge the patient home with home oxygen and continue tapered steroids. The patient hospitalized for 14 days The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from acute respiratory failure, angiogram pulmonary abnormal, anticoagulant therapy, blood creatinine increased, blood lactic acid increased, covid-19, covid-19 pneumonia, cardiac disorder, chest discomfort, computerised tomogram thorax abnormal, decreased appetite, dyspnoea, dyspnoea exertional, echocardiogram normal, ejection fraction normal, fibrin d dimer increased, full blood count abnormal, hypertransaminasaemia, inflammatory marker increased, intensive care, lactic acidosis, leukocytosis, lung infiltration, mechanical ventilation, peripheral artery aneurysm, pneumonia viral, positive airway pressure therapy, productive cough, prohormone brain natriuretic peptide increased, pulmonary embolism, pyrexia, sars-cov-2 test positive, scan with contrast abnormal, shift to the left, sputum discoloured, tachycardia, troponin normal, ultrasound doppler abnormal, and wheezing. This report was serious (Hospitalization Caused / Prolonged). This report was associated with a product quality complaint: 90000243179. The suspected product quality complaint has been confirmed to be the reported allegation could not be determined. A manufacturing related root cause could not be identified based on the PQC evaluation/investigation performed. Additional information received from central complaint vigilance department on 25-AUG-2022. The following information was updated and incorporated into the case narrative: Product quality complaint investigation result.; Sender's Comments: V1- This follow up adds information about Product quality complaint investigation result. This does not alter previous causality assessment of the reported events. 20220732778-covid-19 vaccine ad26.cov2.s- pulmonary embolism, angiogram pulmonary abnormal, anticoagulant therapy, computerised tomogram thorax abnormal. This event(s) is labeled per RSI and is therefore considered potentially related. 20220732778-covid-19 vaccine ad26.cov2.s-acute respiratory failure, blood creatinine increased, blood lactic acid increased, covid-19, covid-19 pneumonia, cardiac disorder, chest discomfort, decreased appetite, dyspnoea, dyspnoea exertional, echocardiogram normal, ejection fraction normal, fibrin d dimer increased, full blood count abnormal, hypertransaminasaemia, inflammatory marker increased, intensive care, lactic acidosis, leukocytosis, lung infiltration, mechanical ventilation, peripheral artery aneurysm, pneumonia viral, positive airway pressure therapy, productive cough, prohormone brain natriuretic peptide increased, pyrexia, sars-cov-2 test positive, scan with contrast abnormal, shift to the left, sputum discoloured, tachycardia, troponin normal, ultrasound doppler abnormal, and wheezing.. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered unassessable.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 14,0
Labordaten: Test Date: 20220203; Test Name: NASOPHARYNGEAL SWAB; Test Result: Positive ; Test Date: 20220213; Test Name: LOWER LIMBS DOPPLER ULTRASOUND; Result Unstructured Data: show asymptomatic popliteal aneurysm and no Deep vein thrombosis; Test Date: 20220213; Test Name: LACTIC ACID; Result Unstructured Data: 6.1; Test Date: 20220213; Test Name: PROHORMONE BRAIN NATRIURETIC PEPTIDE; Result Unstructured Data: 1279; Test Date: 20220213; Test Name: LACTIC ACID; Result Unstructured Data: down to 2.6; Test Date: 20220213; Test Name: COMPLETE BLOOD COUNT; Result Unstructured Data: revealed leukocytosis at 19 000 with slight left shift; Test Date: 20220213; Test Name: D-DIMER; Result Unstructured Data: significantly elevated more than 35; Test Date: 20220213; Test Name: CHEST COMPUTED TOMOGRAPHY; Result Unstructured Data: with Iodinated contrast was obtained which revealed right-sided pulmonary thromboembolism involving right middle lower and lower lobes with some signs of right heart strain; Test Date: 20220213; Test Name: TROPONIN; Test Result: Negative ; Test Date: 20220213; Test Name: COMPUTED TOMOGRAPHY CHILLS; Result Unstructured Data: revealed patchy multifocal bilateral infiltrates suggestive of viral pneumonitis; Test Date: 20220213; Test Name: INFLAMMATORY MARKERS; Result Unstructured Data: elevated; Test Date: 20220213; Test Name: CT CHEST ANGIOGRAM; Result Unstructured Data: show bilateral multiple pulmonary embolism; Test Date: 20220213; Test Name: ECHOCARDIOGRAM; Result Unstructured Data: show EF 60% without signs of RV strain; Test Date: 20220213; Test Name: OXYGEN SATURATION; Result Unstructured Data: 86 %; Test Date: 20220213; Test Name: CREATININE; Result Unstructured Data: 1.31 which was close to his baseline
Aktuelle Erkrankungen: Alcohol use (was drinking up to half a pint of vodka at twice a week, His last drink was 12 days ago); Decreased appetite; Dyslipidemia; High density lipoprotein; Hypertension; Psoriasis; Tobacco abuse
Vorgeschichte: Medical History/Concurrent Conditions: COVID-19 (2 Years ago); Comments: No history of alcohol withdrawal. Patient denied any sick contact in the recent past.
Andere Medikamente: ALBUTEROL [SALBUTAMOL]; AMLODIPINE; ATORVASTATIN; CLOBETASOL; DIAZEPAM; ESCITALOPRAM; SECUKINUMAB; TADALAFIL; TORSEMIDE; COSENTYX
Allergien: -
Vorherige Impfungen: -

VAERS 2411316

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: KY
Alter: 75,0
Geschlecht: M
Eingang: 15.08.2022
Impfdatum: 12.08.2021
Beginn: 07.08.2022
Tage bis Beginn: 360,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Acute respiratory failure Asthenia COVID-19 Condition aggravated Cough Diarrhoea Exposure to SARS-CoV-2 Fatigue Fluid intake reduced Hypertension Hypophagia Hyporesponsive to stimuli Hypovolaemia Laboratory test abnormal Loss of personal independence in daily activities SARS-CoV-2 test positive Somnolence

Symptomtext

present to ED due to generalized fatigue. Patient is disabled at baseline due to his prior neurologic injury and is cared for by his wife at home. Patient's wife reports the patient is becoming less responsive at home and is having difficulty with his ADLs. Patient is significantly weak and is sleeping most of the day. Patient's wife reports that he has been developing a cough over the last 4-5 days which is nonproductive as well as some nonbloody diarrhea for the past 2 days. Patient's wife denies any blood in the stool or any other significant changes. Patient's daughter recently tested positive for COVID and was last around patient about 7 days ago. Patient has been afebrile at home. Patient has not been eating or drinking over the last 24 hours. Patient is afebrile on arrival, normal vital signs, mild hypertension. Patient does appear to be significantly fatigued with a GCS of 13 patient will wake up and follow commands when prompted. Patient appears mildly volume depleted. Laboratory results demonstrated no significant abnormalities. Patient's COVID test is positive. ER gave IV fluids, IV Toradol, IV Zofran, oral Tylenol with minimal relief of symptoms. Patient is debilitated at baseline and patient's wife is concerned about his worsening status at home. Patient continues to saturate well on room air but is able to tolerate by mouth. Patient denies palpitations, chest pain, shortness of breath, decreased UOP or diarrhea. Patient admitted to hospital medicine for medical management in setting of COVID-19 infection, decreased PO intake and generalized weakness. Hospital course: Acute COVID-19 infection complicated by acute respiratory failure O2 saturation <94% on room air, required oxygen briefly meets criteria for dexamethasone and remdisivir. Started both 8/9 Continue supportive care with tylenol as needed Discharge Disposition/Condition Disposition: Home Condition: Stable (s/sx potential problems absent or manageable)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 6,0
Labordaten: COVID PCR confirmed positive on 8/7/22
Aktuelle Erkrankungen: N/A
Vorgeschichte: ? Chronic kidney disease ? Conversions - Other Cerumen Impaction ? Conversions - Other Dysphagia ? Disease of thyroid gland ? History of falling History of fall ? Hypertension ? Personal history of other diseases of the circulatory system History of hypertension ? Personal history of other endocrine, nutritional and metabolic disease History of diabetes mellitus ? Personal history of other endocrine, nutritional and metabolic disease History of high cholesterol ? Personal history of other endocrine, nutritional and metabolic disease History of hypothyroidism ? Stroke ? Type 2 diabetes mellitus ? Unspecified cataract Cataract, bilateral
Andere Medikamente: albuterol sulfate amoxicillin clavulanate atorvastatin cetirizine ciprofloxacin ferrous sulfate insulin Glargine insulin Lispro latanoprost levothyroxine metoprolol succinate nystatin promethazine-DM sitagliptin sulfamethoxazole-trimeth
Allergien: aspirin
Vorherige Impfungen: -

VAERS 2405991

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: TX
Alter: 49,0
Geschlecht: F
Eingang: 09.08.2022
Impfdatum: 08.04.2021
Beginn: 11.02.2022
Tage bis Beginn: 309,0
Dosis: 1
Route/Site: SC / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Aphasia Cerebrovascular accident Cognitive disorder Computerised tomogram thorax Dysgraphia Echocardiogram Hemiparesis Implantable cardiac monitor insertion Mental impairment Speech disorder Thrombectomy

Symptomtext

Stroke affecting speech & cognitive thinking. A Thrombectomy was performed by a doctor at hospital. I was not able to speak, write, or type in any way that was understandable by anyone. I also had weakness on the right side of my body. After the procedure, I was kept in the hospital for 5 days to try determine the cause & to evaluate any necessary therapy needs.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 5,0
Labordaten: ECHO: 2/14/2022 CT of the Heart: 2/15/2022 Insertion of Heart Loop Recorder: 2/16/2022
Aktuelle Erkrankungen: None
Vorgeschichte: Hypertension Pre-diabetic Pain conditions
Andere Medikamente: Lisinopril Celecoxib Metformin Gabapentin Zanaflex Baclofen Xyzal
Allergien: None
Vorherige Impfungen: -

VAERS 2267338

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: IA
Alter: 58,0
Geschlecht: M
Eingang: 09.05.2022
Impfdatum: 04.05.2021
Beginn: 18.11.2021
Tage bis Beginn: 198,0
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure Anaemia Atelectasis Blood glucose normal Blood lactic acid Blood magnesium decreased Blood sodium decreased COVID-19 Cardiomegaly Chest X-ray abnormal Chest discomfort Decreased appetite Dyspnoea Hyperglycaemia Hypomagnesaemia Hyponatraemia Hypophagia Laboratory test abnormal

Symptomtext

COVID Vaccine Breakthrough Case J&J Dose 5/4/21 (201A21A COVID Positive 11/21/21 11/21/21: Patient is a 59 year old male presented to ED via EMS from a facility with reports of shortness of breath. The patient has felt unwell for the past 3 days. He has had body aches, productive, wheezes, shortness of breath and decreased appetite and oral intake. He was recently started on a course Azithromycin and albuterol but has not had no improvements in his symptoms. He developed increased shortness of breath today and is reported to ED for further evaluation. He denies any abdominal pain, nausea vomiting or diarrhea. He does endorse some chest tightness especially with inspiration. He was COVID vaccinated with Johnson and Johnson approximately 6 months ago. He has a past medical history significant for hypertension, morbid obesity, type 2 diabetes mellitus, asthma and coronary artery disease status post stenting & CABG. On arrival to ED patient was febrile 101.2 saturating at 95% on 2 L NC. Laboratory findings were significant for hyponatremia 132. Hypomagnesemia 1.2. Lactic acidosis 4.9. ProBNP 491. Anemia 11.4. Hyperglycemia 196. Rapid COVID positive. Chest x-ray showed cardiomegaly and pulmonary vascular congestion. Patchy bibasilar airspace disease could represent atelectasis versus infiltrates. Levaquin was initiated in ED. Patient received DuoNeb treatment and Solu-Medrol, as well as acetaminophen in ER. IV hydration was given with NS 0.9% 2 L bolus. 11/30/21: Patient is a 59 year old male presented to EDwith reports of shortness of breath. The patient has felt unwell for the past 3 days. He has had body aches, productive, wheezes, shortness of breath and decreased appetite and oral intake. He was recently started on a course Azithromycin and albuterol but has not had no improvements in his symptoms. He developed increased shortness of breath today and is reported to ED for further evaluation. He denies any abdominal pain, nausea vomiting or diarrhea. He does endorse some chest tightness especially with inspiration. He was COVID vaccinated with Johnson and Johnson approximately 6 months ago. He has a past medical history significant for hypertension, morbid obesity, type 2 diabetes mellitus, asthma and coronary artery disease status post stenting & CABG. On arrival to ED patient was febrile 101.2 saturating at 95% on 2 L NC. Laboratory findings were significant for hyponatremia 132. Hypomagnesemia 1.2. Lactic acidosis 4.9. ProBNP 491. Anemia 11.4. Hyperglycemia 196. Rapid COVID positive. Chest x-ray showed cardiomegaly and pulmonary vascular congestion. Patchy bibasilar airspace disease could represent atelectasis versus infiltrates. Levaquin was initiated in ED. Patient received DuoNeb treatment and Solu-Medrol, as well as acetaminophen in ER. IV hydration was given with NS 0.9% 2 L bolus. The patient was treated for acute hypoxemic respiratory failure due to COVID-19 infection and symptoms have improved Patient will be discharged to original facility and he will continue his home medications. We recommend him to see his primary care provider in 3-5 days

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 10,0
Labordaten: -
Aktuelle Erkrankungen: anemia CAD DM obesity HTN asthma COPD nonsmoker
Vorgeschichte: anemia CAD DM obesity HTN asthma COPD nonsmoker
Andere Medikamente: acetaminophen 1000 mg PO BID amitriptyline 100 mg PO HS aspirin 81 mg PO QD atorvastatin 80 mg PO HS clopidogrel 75 mg PO QD ergocalcifero l50,000 units PO QSu gabapentin 900 mg PO BID hydroxyzine 50 mg PO QD insulin glargine 20 units SQ HS
Allergien: lisinopril - cough contrast dye - anaphylaxis
Vorherige Impfungen: -

VAERS 2231498

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201a21a

kritisch

Staat: CA
Alter: 43,0
Geschlecht: F
Eingang: 13.04.2022
Impfdatum: 09.04.2021
Beginn: 12.04.2021
Tage bis Beginn: 3,0
Dosis: 1
Route/Site: SYR / -

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Anticoagulant therapy Cardiac operation Cerebral thrombosis Cerebrovascular accident

Symptomtext

blood clot in brain a, stroke, open heart surgery. On blood thinner now

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 17,0
Labordaten: -
Aktuelle Erkrankungen: asthma
Vorgeschichte: after vaccine had a blood clot in my brain, then I have open heart surgery
Andere Medikamente: seasonique lo (biryh control) , multi vitamins
Allergien: none
Vorherige Impfungen: -

VAERS 2201741

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: KY
Alter: 70,0
Geschlecht: M
Eingang: 28.03.2022
Impfdatum: 08.06.2021
Beginn: 09.02.2022
Tage bis Beginn: 246,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Acute respiratory failure Asthenia COVID-19 Chest X-ray abnormal Chills Chronic obstructive pulmonary disease Condition aggravated Decreased activity Decreased appetite Dyspnoea Dysuria Emphysema Lung disorder Lung opacity Nausea Pallor Pneumonia Respiratory tract congestion

Symptomtext

Patient presents to the ER on 2/9 with c/o shortness of breath x3 days requiring increased use of his inhaler without improved dyspnea. Review of Systems: Review of Systems Constitutional: Positive for activity change, appetite change and chills. HENT: Positive for congestion. Respiratory: Positive for shortness of breath. Negative for cough (productive). Gastrointestinal: Positive for nausea. Genitourinary: Positive for difficulty urinating. Skin: Positive for pallor. Neurological: Positive for weakness. Hospital course: Acute on chronic resp failure - resolved -Etiology: COVID superimposed on terminal COPD -COVID positive on 2/9/22 -CXR: Emphysematous lung disease with mild opacity in LL lung -Started on Decadron 6mg daily (equivlaent to prednisone 40 mg that will help with COPD too) and Remdesivir -Breathing treatment QID scheduled plus PRN - Continue Dulera, home inhaler, switch to Trelegy on discharge - s/p 5 days of ceftriaxone (dual coverage for pneumonia and UTI) 02/09-02/13 azithromycin (3 times weekly) Continue baseline oxygen 3-4L NC Discharge Disposition/Condition Disposition: Rehab facility (specify) Condition: Stable (s/sx potential problems absent or manageable)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 15,0
Labordaten: COVID PCR confirmed positive on 2/9/22
Aktuelle Erkrankungen: N/A
Vorgeschichte: Past Medical History: Diagnosis Date ? Conversions - Other Arthritis Of Shoulder ? Conversions - Other Chronic Kidney Disease, Stage 3 ? Conversions - Other Feeling Weak ? Conversions - Other Gout ? Conversions - Other Native Coronary Artery Stenosis ? Conversions - Other Overweight ? Conversions - Other Stroke Syndrome ? Conversions - Other Urinary Tract Infection ? COPD (chronic obstructive pulmonary disease) (CMS/HCC) ? CVA (cerebral vascular accident) (CMS/HCC) x 5 ? Diabetes mellitus (CMS/HCC) ? Encounter for screening for depression Negative depression screening
Andere Medikamente: albuterol budesonide-formoterol lactulose lisinopril hydrochlorothiazide metformin oxycodone
Allergien: ampicillin morphine
Vorherige Impfungen: -

VAERS 2200832

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: TX
Alter: 61,0
Geschlecht: F
Eingang: 27.03.2022
Impfdatum: 07.04.2021
Beginn: 17.06.2021
Tage bis Beginn: 71,0
Dosis: 1
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Carotid artery thrombosis Cerebrovascular accident Hypoaesthesia Intensive care Laboratory test Thrombolysis

Symptomtext

I received the vaccine at the Pharmacy on 4/7/21. On June 17th, I had a stroke and was taken by ambulance to hospital. At hospital they discovered I had a blood clot on my right carotid artery and that what was caused my right arm to go numb. They then transported me by ambulance to another medical facility's ICU, where they began to try and dissolve the blood clot. I am going to physician for my follow up. I got the actual vaccine at pharmacy.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 3,0
Labordaten: All of the Tests were at a medical facility's ICU.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: -
Allergien: None that I am aware of.
Vorherige Impfungen: -

VAERS 2188827

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: CO
Alter: 46,0
Geschlecht: M
Eingang: 19.03.2022
Impfdatum: -
Beginn: 18.04.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Angiogram Anticoagulant therapy Blood electrolytes Blood electrolytes normal Blood fibrinogen Blood fibrinogen normal Blood glucose Brain natriuretic peptide Chest discomfort Chills Computerised tomogram head Deep vein thrombosis Electrocardiogram Electrocardiogram normal Erythema Fatigue Fibrin D dimer increased Full blood count

Symptomtext

This spontaneous report received from a patient via Regulatory Authority the Vaccine Adverse Event Reporting System (VAERS) concerned a 46 year old white non Hispanic or Latino male via literature: Persistence of Ad26.COV2.S-associated VITT and specific detection of VITT antibodies. Local Journal of Hematology 2022. The objective of this study was to study COVID-19 vaccinated individuals develop anti-platelet factor 4 (PF4) antibodies that cause thrombocytopenia and thrombotic complications, a syndrome referred to as vaccine induced immune thrombotic thrombocytopenia (VITT). The patient's height and weight were not reported. The patient's pre-existing medical conditions included he had no known allergies to medications, food or other products. He had no history of cellulitis, gout, deep vein thrombosis (DVT) or pulmonary embolism (PE). He had no photophobia, no altered mental status, no ataxia, no meningismus. He had no chest pain or shortness of breath, had no cough and no other complaint. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 201A21A and expiry: unknown) dose was not reported, 01 total administered in arm on 08-APR-2021 for prophylactic vaccination. Concomitant medications included Singulair (montelukast sodium) and Ventolin (salbutamol). On 18-APR-2021, the patient experienced pain in right posterior thigh, popliteal fossa and calf which appeared on contralateral side/pain and tenderness over left calf extending down into ankle and dorsum of foot/body aches. On 19-APR-2021, the patient experienced deep vein thrombosis, pulmonary embolism, thrombocytopenia, peripheral swelling, vaccination complication, erythema and warmth, generalized chest discomfort, chills, fatigue, fever and headache (throughout this course he had a significant headache which was described as bitemporal, positional, and worse when bent over and better when upright and it was mild to moderate). Laboratory data included: Blood electrolytes (NR: not provided) Within normal ranges, complete blood count (CBC) (NR: not provided) Not Reported, Electrocardiogram (ECG) (NR: not provided) Normal sinus rhythm, Fibrin D Dimer abnormal (NR: not provided) 28980 FEU, Fibrinogen (NR: not provided) 200 mg/dL, Hematocrit (NR: not provided) 41.1 %, Hemoglobin (NR: not provided) 14.7 g/dL, Heparin-induced thrombocytopenia test (NR: not provided) Positive, Immunology test (NR: not provided) Not Reported, Platelet count (NR: not provided) 54 10*9/L, and White blood cells (WBC) (NR: not provided) 12.3 10*9/L. On 22-APR-2021, Laboratory data included: Diagnostic ultrasound (NR: not provided) Negative bilateral lower extremity ultrasound, enzyme-linked immunoassay (ELISA) (NR: not provided) 3.016 OD, Head Computerised tomogram (CT) (NR: not provided) non-contrast; no results provided, and Heparin-induced thrombocytopenia test (NR: not provided) Negative. On 24-APR-2021, Laboratory data included: Angiogram (NR: not provided) chest; bilateral PE, possible lingular infiltrate vs infarct, Brain natriuretic peptide (NR: not provided) negative, Comprehensive metabolic panel (NR: not provided) Glucose of 121, otherwise negative, Diagnostic ultrasound (NR: not provided) left DVT from popliteal vein through ankle, Glucose (NR: not provided) 121, 138, 138, INR (NR: not provided) 1.3, Platelet count (NR: not provided) thrombocytopenia with count 25, Platelet factor 4 (NR: not provided) 2.407 (Ag detected by ELISA), Prothrombin time (NR: not provided) 14.7, Troponin (NR: not provided) undetectable and Venogram (NR: not provided) no acute thrombus or other process noted. On an unspecified date, the patient experienced vaccine induced thrombotic thrombocytopenia. Laboratory data (dates unspecified) included: Serotonin release assay (NR: not provided) Not Reported. Treatment medications (dates unspecified) included: bivalirudin, prednisone and apixaban with direct oral anticoagulants. He was also given high dose intravenous immunoglobulin G. On an unspecified date, the patient was hospitalized. The number of days hospitalized was 3 days and the discharge information was not reported. He had visited the physician's office and emergency room. The action taken With covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from platelet count decreased, had not recovered from deep vein thrombosis, headache, heparin-induced thrombocytopenia test positive, peripheral swelling, pulmonary embolism, vaccination complication, white blood cell count increased, anticoagulant therapy, blood electrolytes normal, blood fibrinogen normal, electrocardiogram normal, fibrin d dimer increased, full blood count, haematocrit normal, haemoglobin normal, immunoglobulin therapy, and immunology test, and the outcome of thrombocytopenia, pain in right posterior thigh, popliteal fossa and calf which appeared on contralateral side/pain and tenderness over left calf extending down into ankle and dorsum of foot/body aches, erythema and warmth, chills, fatigue, fever, generalized chest discomfort and vaccine induced thrombotic thrombocytopenia was not reported. The authors emphasized that the associated VITT antibodies persisted for greater than 5 months in platelet factor 4 (PF4) polyanion enzyme linked immunosorbent assays (ELISA) while the PEA became negative earlier. Thus, it was concluded that the patients with VITT demonstrate long term ELISA positivity, although functional assays become seronegative earlier during the course of recovery. The data suggest that the uncomplexed PF4 ELISA is sensitive and significantly more specific for the detection of VITT than currently available tests. This report was serious (Hospitalization Caused / Prolonged). This case is a duplicate of 20220237634. This case, from the same reporter is linked to 20210448310, 20210444498, 20210415297, 20220249472, 20220249398, 20220249417, 20220249503 and 20220249430. Following receipt of additional information from other health professional via literature on 10-MAR-2022. It was determined that nullification and deletion was required for 20220237634 as it was duplicate of 20210515201. All relevant information regarding 20220237634 will be submitted under 20210515201. The following information was updated and incorporated into the case narrative: Reporters, events (vaccine induced thrombotic thrombocytopenia), lab data (Immunology test, Heparin-induced thrombocytopenia test, PF4 polyanion enzyme linked immunosorbent assays, serotonin release assay), treatment medications was added. Upon review following information was amended: Patient's medical history, events (erythema and warmth, generalized chest discomfort, chills, fatigue and fever), lab dates were updated. Sender's Comments: V3.The version updates update: Reporter, events (vaccine induced thrombotic thrombocytopenia),lab data, VAERS ID, patients medical history, MAC updated. 20210515201-Covid-19 vaccine ad26.cov2.s -vaccine induced thrombotic thrombocytopenia. This event(s) is labeled per RSI and is therefore considered potentially related. This spontaneous report concerns a 46- year- old white male (non-Hispanic/Latino) who was hospitalized for deep vein thrombosis(DVT) & pulmonary embolism(PE) 16 days after COVID-19 Ad26.COV2.S vaccine. The patient denies prior history of cellulitis, gout, DVT, PE, and allergies. Symptoms reported were right leg swelling and bi-temporal headache that prompted urgent care consultation. Emergency department(ED) consultation 16 days after vaccination, where it was found that a few days prior there was some transient pain in his right posterior thigh, popliteal fossa & calf that extended to the ankle and dorsum of the foot; that also appeared on the right. The patient complained of chills, fatigue, fever(unknown temperature) & body aches; vague and intermittent generalized chest discomfort. The patient was diagnosed with left lower extremity DVT & bilateral PE & was transferred to a hospital for management including anticoagulation with a direct thrombin inhibitor and intravenous immune globulin (IVIG).Laboratory/diagnostic test results: platelet count (PC) 25 and (54 on repeat);INR 1.3;PT 14.7;PF-4 Assay 2.407(ELISA);HIT ELISA 3.016 OD;DVT on left from popliteal vein through ankle on ultrasound; bilateral pulmonary emboli, possible lingular infiltrate versus infarct on chest CTA chest; no acute thrombus noted on head CT venogram. The patient had not recovered. Based on the evolving knowledge of Thrombosis with Thrombocytopenia Syndrome (TTS, per definition from Brighton Collaboration - BC) & considering the low platelet count and temporal relationship to vaccination (BC Criteria level 2), the events are assessed to have a plausible relationship with vaccination.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: Test Date: 20210419; Test Name: Heparin-induced thrombocytopenia test; Result Unstructured Data: Positive; Test Date: 20210419; Test Name: CBC; Result Unstructured Data: Not Reported; Test Date: 20210419; Test Name: Immunology test; Result Unstructured Data: Not Reported; Test Date: 20210419; Test Name: Fibrin D dimer abnormal; Result Unstructured Data: 28980 FEU; Comments: Reference range was less than 500 ng/mL; Test Date: 20210419; Test Name: Fibrinogen; Result Unstructured Data: 200 mg/dL, Normal; Test Date: 20210419; Test Name: WBC; Result Unstructured Data: 12.3 10*9/L, Increased; Test Date: 20210419; Test Name: Blood electrolytes; Result Unstructured Data: Within normal ranges; Test Date: 20210419; Test Name: ECG; Result Unstructured Data: Normal sinus rhythm; Test Date: 20210419; Test Name: Platelet count; Result Unstructured Data: 54 10*9/L, Decreased; Test Date: 20210419; Test Name: Hematocrit; Result Unstructured Data: 41.1 %, Normal; Test Date: 20210419; Test Name: Hemoglobin; Result Unstructured Data: 14.7 g/dL, Normal; Test Date: 20210422; Test Name: Heparin-induced thrombocytopenia test; Result Unstructured Data: Negative; Test Date: 20210422; Test Name: ELISA; Result Unstructured Data: 3.016 OD; Test Date: 20210422; Test Name: Diagnostic ultrasound; Result Unstructured Data: Negative; Test Date: 20210422; Test Name: Head CT; Result Unstructured Data: non-contrast; no results provided; Test Date: 20210424; Test Name: Comprehensive metabolic panel; Result Unstructured Data: Glucose of 121, otherwise negative; Test Date: 20210424; Test Name: Glucose; Result Unstructured Data: 121; Test Date: 20210424; Test Name: Glucose; Result Unstructured Data: 138; Test Date: 20210424; Test Name: Platelet factor 4; Result Unstructured Data: 2.407 (Ag detected by ELISA); Comments: PF4 POLYANION ENZYME LINKED IMMUNOSORBENT ASSAYS Positive; Test Date: 20210424; Test Name: Venogram; Result Unstructured Data: no acute thrombus; Comments: discussed with the reading neuroradiologist at time of dictation; Test Date: 20210424; Test Name: Angiogram; Result Unstructured Data: bilateral PE; Comments: possible lingular infiltrate vs infarct; Test Date: 20210424; Test Name: Diagnostic ultrasound; Result Unstructured Data: left DVT from popliteal vein; Test Date: 20210424; Test Name: Brain natriuretic peptide; Result Unstructured Data: negative; Test Date: 20210424; Test Name: Troponin; Result Unstructured Data: undetectable; Test Date: 20210424; Test Name: Prothrombin time; Result Unstructured Data: 14.7; Test Date: 20210424; Test Name: Glucose; Result Unstructured Data: 138; Test Date: 20210424; Test Name: Platelet count; Result Unstructured Data: thrombocytopenia with count 25; Test Date: 20210424; Test Name: INR; Result Unstructured Data: 1.3; Test Name: Serotonin release assay; Result Unstructured Data: Not Reported; Comments: Normal Range -Less than 20 percent release
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: The patient had no known allergies to medications, food or other products. He had no history of cellulitis, gout, deep vein thrombosis (DVT) or pulmonary embolism (PE). He had no photophobia, no altered mental status, no ataxia, no meningismus. He had no chest pain or shortness of breath, had no cough and no other complaint.
Andere Medikamente: Singulair; Ventolin [Salbutamol]
Allergien: -
Vorherige Impfungen: -

VAERS 1540417

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: -
Alter: -
Geschlecht: U
Eingang: 16.03.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Abdominal pain Anticoagulant therapy Anxiety Back pain Blood pressure increased Arthralgia Chills Computerised tomogram thorax abnormal Condition aggravated Computerised tomogram Deep vein thrombosis Malaise Platelet count decreased Abnormal faeces Antiphospholipid antibodies Blood pressure measurement Body temperature Adverse reaction

Symptomtext

This spontaneous report received from a patient via a company representative from social media concerned a patient of unspecified age, sex, race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, 1 total start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. It was reported that "hopefully he contacts people like me that had major adverse reactions from the jab and have been diagnosed with vaccine induced thrombotic thrombocytopenia (VITT) and currently dealing with blocked splenic vein". The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from blocked splenic vein, and the outcome of vaccine induced thrombotic thrombocytopenia and major adverse reactions from the jab was not reported. This report was serious (Other Medically Important Condition). Version created to amend previously reported information on 03-MAR-2022. Upon review following information was amended the case validity was updated from invalid to valid. Sender's Comments: V1: This Version is created to amend previously reported information on 03-MAR-2022. Upon review following information was amended the case validity was updated from invalid to valid. This updated information does not alter the company causality of previously reported events. 20220311052-Covid-19 vaccine ad26.cov2.s -vaccine induced thrombotic thrombocytopenia ,Blocked splenic vein. This event(s) is labeled per RA and is therefore considered potentially related.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1540417

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: -
Alter: -
Geschlecht: U
Eingang: 16.03.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Abdominal pain Anticoagulant therapy Anxiety Back pain Blood pressure increased Arthralgia Chills Computerised tomogram thorax abnormal Condition aggravated Computerised tomogram Deep vein thrombosis Malaise Platelet count decreased Abnormal faeces Antiphospholipid antibodies Blood pressure measurement Body temperature Adverse reaction

Symptomtext

This spontaneous report received from a patient via a company representative from social media concerned a patient of unspecified age, sex, race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, 1 total start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. It was reported that "hopefully he contacts people like me that had major adverse reactions from the jab and have been diagnosed with vaccine induced thrombotic thrombocytopenia (VITT) and currently dealing with blocked splenic vein". The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from blocked splenic vein, and the outcome of vaccine induced thrombotic thrombocytopenia and major adverse reactions from the jab was not reported. This report was serious (Other Medically Important Condition). Version created to amend previously reported information on 03-MAR-2022. Upon review following information was amended the case validity was updated from invalid to valid. Sender's Comments: V1: This Version is created to amend previously reported information on 03-MAR-2022. Upon review following information was amended the case validity was updated from invalid to valid. This updated information does not alter the company causality of previously reported events. 20220311052-Covid-19 vaccine ad26.cov2.s -vaccine induced thrombotic thrombocytopenia ,Blocked splenic vein. This event(s) is labeled per RA and is therefore considered potentially related.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2110045

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: TX
Alter: 72,0
Geschlecht: F
Eingang: 09.03.2022
Impfdatum: 08.04.2021
Beginn: 18.01.2022
Tage bis Beginn: 285,0
Dosis: 1
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute respiratory failure Blood creatine phosphokinase increased Brain natriuretic peptide increased COVID-19 COVID-19 pneumonia Blood creatine phosphokinase Brain natriuretic peptide Death Fall Hypoxia Liver function test increased SARS-CoV-2 test positive Liver function test SARS-CoV-2 test

Symptomtext

DEATH; ACUTE RESPIRATORY FAILURE; COVID-19 PNEUMONIA; HYPOXIA; FALL; BLOOD CREATINE PHOSPHOKINASE INCREASED; BRAIN NATRIURETIC PEPTIDE INCREASED; LIVER FUNCTION TEST INCREASED; SARS-COV-2 TEST POSITIVE; COVID-19; This spontaneous report received from a health care professional by a Regulatory Authority Vaccine Adverse Event Reporting System (VAERS) concerned a 72 year old female of an unspecified race and ethnicity. The patient's height, and weight were not reported. The patient's concurrent conditions included: PAF (paroxysmal atrial fibrillation), stage 3 severe COPD (chronic obstructive pulmonary disease), CAD (coronary artery disease), HLD (hyperlipidemia), drug allergy to isoflurane and codeine, and penicillin allergy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 201A21A expiry: UNKNOWN) dose was not reported, 1 total administered on 08-APR-2021 to right arm for an unspecified indication. The drug start period (latency) was 298 days. Concomitant medications included oxygen for stage 3 severe COPD, amitriptyline, azithromycin, bismuth subsalicylate (Pepto bismol), budesonide, diltiazem, ezetimibe (Zetia), fluticasone, formoterol, furosemide, gabapentin, glycopyrronium bromide (Glycopyrrolate), ipratropium, methocarbamol, ondansetron, prednisone, rosuvastatin, salbutamol (albuterol), and tizanidine. On 18-JAN-2022, Laboratory data included: COVID-19 virus test (NR: not provided) positive. The sample was analyzed using the Roche LIAT SARS (severe acute respiratory syndrome) assay platform using PCR (polymerase chain reaction) or equivalent NAA (nucleic acid amplification technology). The patient had experienced covid-19. On 22-JAN-2022, the patient had presented to the emergency department after falling out of bed and was found down without oxygen (hypoxia). The patient was admitted for acute hypoxemic respiratory failure and covid-19 pneumonia complicated by elevated liver function test (LFT), troponin brain natriuretic peptide (BNP) and creatine kinase (CK). The patient was placed on 2 liter nasal cannula oxygen (O2). The hypoxia had worsened throughout admission. The patient was treated with Paxloid, methylprednisolone sodium succinate (Solumedrol) and remdesivir. The patient was transitioned to comfort care. On 31-JAN-2022, Laboratory data included: Blood creatine phosphokinase (NR: not provided) Increased, Brain natriuretic peptide (NR: not provided) Increased, Liver function test (NR: not provided) Increased, and SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) test (NR: not provided) Positive. On 31-JAN-2022, the patient died from an unknown cause of death. It was unknown if an autopsy was performed. The patient was hospitalized for 9 days. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient died of death, acute respiratory failure, covid-19 pneumonia, hypoxia, covid-19, fall, blood creatine phosphokinase increased, brain natriuretic peptide increased, liver function test increased and sars-cov-2 test positive on 31-JAN-2022. This report was serious (Death, and Hospitalization Caused / Prolonged). This report was associated with product quality complaint: 90000219432. The suspected product quality complaint has been confirmed to be the reported allegation could not be determined. A manufacturing related root cause could not be identified based on the PQC evaluation/investigation performed. Additional information received from Central Complaint Vigilance department on 04-MAR-2022. The following information was updated and incorporated into the case narrative: Product quality complaint investigation result.; Sender's Comments: V2: This follow up version was created to update following information: Product quality complaint investigation result. This added information does not alter the causality of previous reported event. 20220258559-COVID-19 VACCINE AD26.COV2.S-death, acute respiratory failure, covid-19 pneumonia, hypoxia, covid-19, fall, blood creatine phosphokinase increased, brain natriuretic peptide increased, liver function test increased and sars-cov-2 test positive. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered unassessable.; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 9,0
Labordaten: Test Date: 20220118; Test Name: COVID-19 virus test; Result Unstructured Data: positive; Test Date: 20220122; Test Name: Brain natriuretic peptide; Result Unstructured Data: elevated; Test Date: 20220122; Test Name: Liver function test; Result Unstructured Data: elevated; Test Date: 20220122; Test Name: CK; Result Unstructured Data: elevated; Test Date: 20220131; Test Name: Liver function test; Result Unstructured Data: Increased; Test Date: 20220131; Test Name: Brain natriuretic peptide; Result Unstructured Data: Increased; Test Date: 20220131; Test Name: Blood creatine phosphokinase; Result Unstructured Data: Increased; Test Date: 20220131; Test Name: SARS-CoV-2 test; Result Unstructured Data: Positive
Aktuelle Erkrankungen: COPD (on 2L O2); Coronary artery disease; Drug allergy (Isoflurane and codeine); Hyperlipidemia; Paroxysmal atrial fibrillation; Penicillin allergy
Vorgeschichte: Comments: Unknown
Andere Medikamente: PREDNISONE; ALBUTEROL [SALBUTAMOL]; AMITRIPTYLINE; AZITHROMYCIN; PEPTO BISMOL [BISMUTH SUBSALICYLATE]; BUDESONIDE; GLYCOPYRROLATE [GLYCOPYRRONIUM BROMIDE]; FORMOTEROL; DILTIAZEM; ZETIA; FLUTICASONE; FUROSEMIDE; GABAPENTIN; IPRATROPIUM; METH
Allergien: -
Vorherige Impfungen: -

VAERS 2110045

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: TX
Alter: 72,0
Geschlecht: F
Eingang: 09.03.2022
Impfdatum: 08.04.2021
Beginn: 18.01.2022
Tage bis Beginn: 285,0
Dosis: 1
Route/Site: OT / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute respiratory failure Blood creatine phosphokinase increased Brain natriuretic peptide increased COVID-19 COVID-19 pneumonia Blood creatine phosphokinase Brain natriuretic peptide Death Fall Hypoxia Liver function test increased SARS-CoV-2 test positive Liver function test SARS-CoV-2 test

Symptomtext

DEATH; ACUTE RESPIRATORY FAILURE; COVID-19 PNEUMONIA; HYPOXIA; FALL; BLOOD CREATINE PHOSPHOKINASE INCREASED; BRAIN NATRIURETIC PEPTIDE INCREASED; LIVER FUNCTION TEST INCREASED; SARS-COV-2 TEST POSITIVE; COVID-19; This spontaneous report received from a health care professional by a Regulatory Authority Vaccine Adverse Event Reporting System (VAERS) concerned a 72 year old female of an unspecified race and ethnicity. The patient's height, and weight were not reported. The patient's concurrent conditions included: PAF (paroxysmal atrial fibrillation), stage 3 severe COPD (chronic obstructive pulmonary disease), CAD (coronary artery disease), HLD (hyperlipidemia), drug allergy to isoflurane and codeine, and penicillin allergy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 201A21A expiry: UNKNOWN) dose was not reported, 1 total administered on 08-APR-2021 to right arm for an unspecified indication. The drug start period (latency) was 298 days. Concomitant medications included oxygen for stage 3 severe COPD, amitriptyline, azithromycin, bismuth subsalicylate (Pepto bismol), budesonide, diltiazem, ezetimibe (Zetia), fluticasone, formoterol, furosemide, gabapentin, glycopyrronium bromide (Glycopyrrolate), ipratropium, methocarbamol, ondansetron, prednisone, rosuvastatin, salbutamol (albuterol), and tizanidine. On 18-JAN-2022, Laboratory data included: COVID-19 virus test (NR: not provided) positive. The sample was analyzed using the Roche LIAT SARS (severe acute respiratory syndrome) assay platform using PCR (polymerase chain reaction) or equivalent NAA (nucleic acid amplification technology). The patient had experienced covid-19. On 22-JAN-2022, the patient had presented to the emergency department after falling out of bed and was found down without oxygen (hypoxia). The patient was admitted for acute hypoxemic respiratory failure and covid-19 pneumonia complicated by elevated liver function test (LFT), troponin brain natriuretic peptide (BNP) and creatine kinase (CK). The patient was placed on 2 liter nasal cannula oxygen (O2). The hypoxia had worsened throughout admission. The patient was treated with Paxloid, methylprednisolone sodium succinate (Solumedrol) and remdesivir. The patient was transitioned to comfort care. On 31-JAN-2022, Laboratory data included: Blood creatine phosphokinase (NR: not provided) Increased, Brain natriuretic peptide (NR: not provided) Increased, Liver function test (NR: not provided) Increased, and SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) test (NR: not provided) Positive. On 31-JAN-2022, the patient died from an unknown cause of death. It was unknown if an autopsy was performed. The patient was hospitalized for 9 days. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient died of death, acute respiratory failure, covid-19 pneumonia, hypoxia, covid-19, fall, blood creatine phosphokinase increased, brain natriuretic peptide increased, liver function test increased and sars-cov-2 test positive on 31-JAN-2022. This report was serious (Death, and Hospitalization Caused / Prolonged). This report was associated with product quality complaint: 90000219432. The suspected product quality complaint has been confirmed to be the reported allegation could not be determined. A manufacturing related root cause could not be identified based on the PQC evaluation/investigation performed. Additional information received from Central Complaint Vigilance department on 04-MAR-2022. The following information was updated and incorporated into the case narrative: Product quality complaint investigation result.; Sender's Comments: V2: This follow up version was created to update following information: Product quality complaint investigation result. This added information does not alter the causality of previous reported event. 20220258559-COVID-19 VACCINE AD26.COV2.S-death, acute respiratory failure, covid-19 pneumonia, hypoxia, covid-19, fall, blood creatine phosphokinase increased, brain natriuretic peptide increased, liver function test increased and sars-cov-2 test positive. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered unassessable.; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 9,0
Labordaten: Test Date: 20220118; Test Name: COVID-19 virus test; Result Unstructured Data: positive; Test Date: 20220122; Test Name: Brain natriuretic peptide; Result Unstructured Data: elevated; Test Date: 20220122; Test Name: Liver function test; Result Unstructured Data: elevated; Test Date: 20220122; Test Name: CK; Result Unstructured Data: elevated; Test Date: 20220131; Test Name: Liver function test; Result Unstructured Data: Increased; Test Date: 20220131; Test Name: Brain natriuretic peptide; Result Unstructured Data: Increased; Test Date: 20220131; Test Name: Blood creatine phosphokinase; Result Unstructured Data: Increased; Test Date: 20220131; Test Name: SARS-CoV-2 test; Result Unstructured Data: Positive
Aktuelle Erkrankungen: COPD (on 2L O2); Coronary artery disease; Drug allergy (Isoflurane and codeine); Hyperlipidemia; Paroxysmal atrial fibrillation; Penicillin allergy
Vorgeschichte: Comments: Unknown
Andere Medikamente: PREDNISONE; ALBUTEROL [SALBUTAMOL]; AMITRIPTYLINE; AZITHROMYCIN; PEPTO BISMOL [BISMUTH SUBSALICYLATE]; BUDESONIDE; GLYCOPYRROLATE [GLYCOPYRRONIUM BROMIDE]; FORMOTEROL; DILTIAZEM; ZETIA; FLUTICASONE; FUROSEMIDE; GABAPENTIN; IPRATROPIUM; METH
Allergien: -
Vorherige Impfungen: -

VAERS 2137090

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: KY
Alter: 62,0
Geschlecht: F
Eingang: 24.02.2022
Impfdatum: 15.09.2021
Beginn: 12.02.2022
Tage bis Beginn: 150,0
Dosis: 1
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure Anaemia Anticoagulant therapy Atrial fibrillation COVID-19 Computerised tomogram thorax Condition aggravated Death Dialysis Dyspnoea End stage renal disease Hypertension Oxygen saturation decreased Positive airway pressure therapy Respiratory failure

Symptomtext

Principal Dx/ Final Dx: Acute hypoxemic respiratory failure due to COVID-19 Relevant Inpt Dx: Principal Problem: Acute hypoxemic respiratory failure due to COVID-19 Active Problems: HTN (hypertension) Anemia End stage renal disease on dialysis PAF (paroxysmal atrial fibrillation) HPI: Hospital Course: patient was admitted with anemia. Was seen by GI. She did not require endoscopy during this admission. She has esrd and was seen by nephrology for dialysis She also was seen by cardiology about anticoagulation and PAF. She has chronic hypoxic respiratory failure and was on oxygen at home. She had covid in January. She had worsening of her oxygenation during this stay and was seen by pulmonary. She progressed to bipap. CT chest did not show PE. She continued to struggle with her breathing. She had decided on DNR status previously and she decided to pursue comfort care. She expired at 1847

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 10,0
Labordaten: -
Aktuelle Erkrankungen: Acute Renal failure
Vorgeschichte: HTN, PAF, End stage renal disease,
Andere Medikamente: unable to ascertain
Allergien: PCN, macrodantin, eggs, oats, rice, wheat
Vorherige Impfungen: -

VAERS 2110044

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: KY
Alter: 56,0
Geschlecht: M
Eingang: 14.02.2022
Impfdatum: 22.07.2021
Beginn: 10.02.2022
Tage bis Beginn: 203,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute coronary syndrome Acute myocardial infarction COVID-19 Cardiac stress test abnormal Catheterisation cardiac abnormal Chest pain Coronary arterial stent insertion Coronary artery occlusion Ex-tobacco user Ischaemic cardiomyopathy SARS-CoV-2 test positive

Symptomtext

Admitted with chest pain, known ACS and abnormal stress test. cardiolgoy consulted and performed LHC. LHC with Ischemic cardiomyopathy, patient LIMA to LAD, patient stents, CTO of the RCA. Recommended aggressive RF modification, tobacco cessation, medical management. Medically stable for discharge home. F/u with PCP and cardiology. * Precordial chest pain NSTEMI - cardiology consult, performed LHC which recommended medical management, no stents placed. F/u with cardiology as outpatient. Covid positive 1/22/2022 - no hypoxia.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: 3,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Cardiomyopathy, CAD, CHF, Type 2 DM, BKA
Andere Medikamente: Norvasc
Allergien: shrimp, fish products, Penicillins
Vorherige Impfungen: -

VAERS 2092726

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: WA
Alter: 30,0
Geschlecht: M
Eingang: 07.02.2022
Impfdatum: 28.06.2021
Beginn: 28.06.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: unbekannt Erholt: nein

Angiogram pulmonary abnormal Anticoagulant therapy Antiphospholipid antibodies positive Cardiac disorder Chest pain Coagulation test Cough Echocardiogram abnormal Ejection fraction normal Hypercoagulation Intensive care Mitral valve incompetence Pain in extremity Pulmonary embolism Pulmonary valve incompetence Right ventricular systolic pressure Tricuspid valve incompetence Ultrasound Doppler abnormal

Symptomtext

30 y/o M with hx of pulmonary embolism presents to discuss referral potnetially to pulmonology as he was seeing one in country this past fall when he was diagnosed with an acute sub-massive 'unprovoked' PE. Diagnosed with submassive pulmonary embolism in July with evidence of R heart strain, although he states that he had been having L lower calf pain for a few days prior. Ultrasound showed potential sequelea of DVT however without confirmation or presence at that time. Hypercoagulable workup sent which did show elevated lupus anti- coagulant but in the setting of already initiated anticoagulation, it was non diagnostic at that time for underlying hypercoagulability. endorses that he continues to have mild chest pain and cough, and wants a renewal of his profile. 2 months after his PE, he did have an echo that showed: Adequate study with NSR RA/RV: Normal LA: Normal LV: Chamber size & wall thickness: Normal Systolic function: Normal with EF of 65 % Diastolic function: Normal RWMA: None Mitral Valve: Minimal MR. No MS Aortic Valve: Normal Tri-leaflet AV. No AS or AR Tricuspid Valve: Minimal TR with normal est RVSP (28 mm Hg). No TS Pulmonic Valve: Minimal PR. No PSFull Echo report will be in the system a repeat CTPA which showed bilateral subsegmental and segmental pulmonary emboli, although with decreased clot burden from prior. He continues to have mild chest pain, but notes that it is improving. he spent 3 days in the ICU on a drip, and was initiated on anticoagulation at the time of diagnosis. He has continued on apixiban for anticoagulation.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 3,0
Labordaten: 2 months after his PE, he did have an echo that showed: Adequate study with NSR RA/RV: Normal LA: Normal LV: Chamber size & wall thickness: Normal Systolic function: Normal with EF of 65 % Diastolic function: Normal RWMA: None Mitral Valve: Minimal MR. No MS Aortic Valve: Normal Tri-leaflet AV. No AS or AR Tricuspid Valve: Minimal TR with normal est RVSP (28 mm Hg). No TS Pulmonic Valve: Minimal PR. No PSFull Echo report will be in the system
Aktuelle Erkrankungen: Acid reflux
Vorgeschichte: Tobacco use, acid reflux
Andere Medikamente: Prilosec, ketoconazole
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2082692

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: KY
Alter: 67,0
Geschlecht: M
Eingang: 02.02.2022
Impfdatum: 26.05.2021
Beginn: 06.01.2022
Tage bis Beginn: 225,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

No adverse reactions at the time

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: COPD, Diabeties, Hypertension, CAD, Liver Cancer
Andere Medikamente: unknown
Allergien: unknown
Vorherige Impfungen: -

VAERS 2079210

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: -
Alter: 67,0
Geschlecht: M
Eingang: 01.02.2022
Impfdatum: 14.08.2021
Beginn: 20.01.2022
Tage bis Beginn: 159,0
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute respiratory failure Agitation Anaemia Angiogram pulmonary abnormal Anion gap Anticoagulant therapy Anxiety Aortic aneurysm Arterial catheterisation Atelectasis Bladder catheterisation Blood bicarbonate normal Blood calcium decreased Blood chloride normal Blood creatinine decreased Blood glucose normal Blood magnesium normal Blood phosphorus

Symptomtext

Hospitalized (1.20.22 - still admitted currently); COVID-19 positive (1.20.22); Fully vaccinated -J&J x1 1/31/22 Medical Critical Care progress note: ADMISSION DATE: 1/20/2022 PRESENTING PROBLEM:Respiratory failure Acute respiratory failure with hypoxia COVID-19 Active Hospital Problems Diagnosis Date Noted POA ? Co-morbid condition 01/30/2022 Unknown ? Anxiety 01/28/2022 Unknown ? Goals of care, counseling/discussion 01/28/2022 Unknown ? Anemia 01/25/2022 Unknown ? Abdominal aortic aneurysm (AAA) 3.0 cm to 5.5 cm in diameter in male 01/25/2022 Unknown ? Pneumonia of left lower lobe due to Pseudomonas species 01/24/2022 Unknown ? Peripheral vascular disease 01/24/2022 Unknown ? Acute respiratory failure with hypoxia 01/20/2022 Unknown ? Shock 01/20/2022 Unknown ? COVID-19 01/20/2022 Unknown ? Acute pulmonary embolism without acute cor pulmonale 01/20/2022 Unknown ? Pericardial effusion 01/20/2022 Unknown ? OSA (obstructive sleep apnea) 03/09/2016 Yes ? COPD (chronic obstructive pulmonary disease) 01/20/2011 Yes ? HTN (hypertension) 01/20/2011 Yes ? DM (diabetes mellitus) 01/20/2011 Yes ? Dyslipidemia 01/20/2011 Yes ? Seizure REASON FOR TRANSFER: Clinical improvement, no longer requiring ICU level care DATE OF TRANSFER: 1/31/2022 TRANSFER DESTINATION: w/ tele BRIEF SUMMARY OF CARE: 68 year old male history of seizure disorder, COPD (2L O2 dependent), CAD, DM2, HTN, HPL, PAD presented via EMS to the ED 1/20 with altered mental status. He was found down 1/20 next to his bed by EMS laying on his oxygen tubing and was hypoxic at 60%. He was placed on a NRB. He was disoriented and incomprehensible. In the ED he was found to have respiratory acidosis thus he was intubated. Shortly after intubation he had a brady PEA cardiac arrest (2 rounds CPR with 1 epi given). CXR noted no PTX. COVID PCR +. CTA revealed moderate segmental and subsegmental PE and significant left lower lobe pneumonia that has grown Pseudomonas, on Zosyn. Head CT was negative. He was on escalating vasopressors thus was transferred to the MICU for further monitoring. Failed trial extubation and ultimately re-intubated on 1/27 due to hypoxia and agitation. Vent settings stable and he passed SBT 1/30 and was extubated to BiPAP. Palliative continues to follow, patient plans to sign onto Hospice. Transferred to the hospitalist service as arrangements are made for discharge home per the patient's wishes. Spke with doctor who accepted the patient for transfer. CONSULTS: IP CONSULT TO SPIRITUAL CARE IP CONSULT TO NUTRITION IP CONSULT TO NUTRITION IP CONSULT TO NUTRITION SUPPORT (PHYSICIAN CONSULT) IP CONSULT TO SOCIAL WORK IP CONSULT TO PSYCHIATRY IP CONSULT TO PALLIATIVE CARE PROCEDURES PERFORMED: -1/20: Intubation / 1/20: R femoral arterial line / 1/20: R femoral CVC / 1/20: EEG 1/21: Bronchoscopy / 1/21: Corpak 1/22: Left radial arterial line / 1/22: Left IJ CVC 1/27: Intubation RECOMMENDATIONS AT TRANSFER: Acute on chronic hypoxemic respiratory failure Has baseline emphysema that is oxygen dependent. ETT 1/20-1/25; 1/27-1/30 Bronchoscopy culture from 1/21 +Pseudomonas resulted as pansensitive, Sedation: Fentanyl, Preceded Diuresis: Lasix 20mg BID 1/30: Plan for one way extubation to BiPAP while on precedex. Patient in agreement as well as family. All with the understanding that he may not tolerate extubation in which case they would proceed with comfort care. Palliative care at bedside during conversation - will continue to follow. 1/31: Stable off BiPAP, will use for naps / night. Precedex weaned off Moderate Segmental/subsegmental PE Therapeutic Lovenox -COVID pneumonia - Remdesivir course 1/20-1/24 Solumedrol 1/20-1/22 40mg BID, 1/23-1/25 30mg BID, 1/26-1/29 20mg BID, 1/30- 20mg QD -Pseudomonas pneumonia -+ culture from BAL 1/21 Abx below -Hypotension, resolved In-hospital arrest on day of admission: CTA +PE, ECHO 1/20 showed EF of 55%, small pericardial effusion, normal RV function without evidence of strain. Head CT with no acute findings. S/p NE for MAP goal >/=65mmHg -CAD -HPL -Peripheral arterial disease -H/o HTN Infrarenal abdominal aortic aneurysm, 3.6cm CT A/P revealed high grade stenosis left common iliac artery. Holding home clopidogrel currently as it is unclear if he will end up needing a tracheostomy. Consider value of adding clopidogrel daily in the context of tracheostomy requirement, while continuing heparin infusion. ASA, statin Catapres restarted 1/31 Amlodipine held -Chronic pancreatitis CT A/P chronic calcification causing obstructive dilation of pancreatic duct Appears stable, not trending pancreatic labs. -Anemia -Borderline Hgb - no indication for emergent transfusion at this time -Altered mental status, resolved -Seizure history -Head CT with no acute findings EEG 1/20 with severe diffuse slowing without seizure Continue home phenytoin. Phenytoin level low at 1.2 on 1/24. -Agitation/anxiety Following extubation was anxious, hyperventilating, and agitated which contributed to reintubation Seroquel 25 mg bid Clonazepam 0.25 mg bid -Psych consulted on 1/28 -BPH - Hold proscar Foley -Diabetes mellitus type 2 hgb a1c 7.3 stress hyperglycemia, basal bolus insulin in context of tube feeds -DVT prophylaxis Therapeutic Lovenox -GI prophylaxis Protonix Code status: DNR/DNI Lines: Right femoral CVC 1/20-22 / Right femoral arterial line 1/20-22 / Left IJ CVC 1/22-1/31 / L radial A line 1/22-1/31 Drains: Corpak 1/21 / Foley Airways: ETT 1/20-1/25; 1/27-1/30 Antibiotics: Zosyn 1/20, 1/22-1/24 / Ceftazidime 1/24-2/2 / Ceftriaxone 1/20-1/22 / Azithro 1/20-1/22 / Vanco 1/20-1/22 CONDITION AT TRANSFER: stable

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 12,0
Labordaten: DR CHEST SINGLE VIEW Resulted: 02/01/22 0738 Order Status: Completed Updated: 02/01/22 0740 Narrative: EXAMINATION: Single View Chest EXAM DATE: 2/1/2022 6:49 AM TECHNIQUE: Single view chest INDICATION: hypoxic respiratory failure COMPARISON: 1/31/2022 ENCOUNTER: Not applicable _________________________ FINDINGS: No definite change in support devices. Heart size is normal. No other mediastinal pathology. Progression of moderate airspace disease of the left lower lung including obscuration of the left heart border. Increase in mild atelectasis of the right lung base. No pneumothorax. Probable small bilateral pleural effusions. _________________________ Impression: Progression of moderate airspace disease of the left lower lung and of mild atelectasis of the right lung base. Phosphorus, Blood Level (Normal) Collected: 02/01/22 0357 Order Status: Completed Specimen: Blood, Venous Updated: 02/01/22 0547 Phosphorus Level 3.1 2.5 - 4.5 mg/dL Magnesium, Blood Level (Normal) Collected: 02/01/22 0357 Order Status: Completed Specimen: Blood, Venous Updated: 02/01/22 0547 Magnesium Level 1.8 1.6 - 2.5 mg/dL Basic Metabolic Panel (BMP) (Abnormal) Collected: 02/01/22 0357 Order Status: Completed Specimen: Blood, Venous Updated: 02/01/22 0547 Sodium Level 142 134 - 146 mmol/L Potassium Level 3.5 3.4 - 5.0 mmol/L Chloride 101 98 - 112 mmol/L HCO3 38 High 21 - 29 mmol/L Anion Gap 3 Low 9 - 18 mmol/L Glucose Level 73 70 - 99 mg/dL Blood Urea Nitrogen 21 High 8 - 20 mg/dL Creatinine 0.47 Low 0.60 - 1.30 mg/dL MDRD eGFR >60 >=60 mL/min/1.73 m2 CG eCrCl 160 mL/min/1.73 m2 Calcium Level Total 8.6 8.6 - 10.4 mg/dL
Aktuelle Erkrankungen: -
Vorgeschichte: Past Medical History: Diagnosis Date ? COPD (chronic obstructive pulmonary disease) ? Coronary artery disease ? Diabetes ? HTN (hypertension) ? Hyperlipemia ? Hyperlipidemia ? Hypertension ? PAD (peripheral artery disease) ? Peripheral vascular disease ? Peripheral vascular disease, unspecified ? Seizure ? Tobacco use disor
Andere Medikamente: Alfuzosin HCl 10 mg Oral Daily, Take with food. Aspirin 81 mg Oral Every morning Clopidogrel Bisulfate 75 mg Oral Every morning Finasteride 5 mg Oral Daily Ipratropium-Albuterol 0.5-2.5 (3) MG/3ML 3 mL Nebulization Every 4 hours PRN Losarta
Allergien: No known allergies
Vorherige Impfungen: -

VAERS 2068759

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: IL
Alter: 88,0
Geschlecht: M
Eingang: 27.01.2022
Impfdatum: 08.04.2021
Beginn: 08.11.2021
Tage bis Beginn: 214,0
Dosis: UNK
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure Anticoagulant therapy Blood thyroid stimulating hormone decreased Bradycardia COVID-19 COVID-19 pneumonia Echocardiogram normal Ejection fraction normal Epistaxis Euthyroid sick syndrome Haemorrhage Thyroxine free normal Troponin increased

Symptomtext

CONTRACTED covid-19 and required hospitilization

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 12,0
Labordaten: Hospital Course This is a 89 yo M with extensive history who was admitted to local HCF on 11/16/21 for acute hypoxic respiratory failure 2/2 covid 19 pneumonia. ID and Pulmonology was consulted. Patient was initially placed on high flow oxygen. He was placed on dexamethasone and did not qualify for Remdesevir due to onsent of symptoms. He received a dose of Actemra on 11/19 and placed on prophylactic acyclovir thru 12/17/21. Patient's troponin was noted to be elevated on admission, Cardiology was consulted and had Echocardiogram which noted EF 50-55%. He was also noted to have abnormal TSH level of 0.15 with normal fT4 and was likely 2/2 sick euthyroid syndrome and was recommended repeat TSH level in 4-6 weeks. He has history of atrial fibrillation and was noted to have episodes of bradycardia, patient was evaluated by Cardiologist and metoprolol and amlodipine was discontinued. During the course of hospital stay patient had developed an episode of epistaxis which did require his Eliquis to be on hold for 24 hrs. His bleeding did stop without intervention and was resumed on his AC with no further bleeding noted. Patient was evaluated by PT/OT who recommended rehab placement. He was able to be weaned off high flow oxygen, but remained between 2-3 liters. He was accepted at another facility, cleared by all speciality and discharged in stable condition. All other chronic conditions remained stable and no further interventions warranted.
Aktuelle Erkrankungen: unknown
Vorgeschichte: Past medical history coronary artery disease, CVA, hypertension, dyslipidemia, A. fib
Andere Medikamente: unknown
Allergien: strawberries
Vorherige Impfungen: -

VAERS 2054543

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: TX
Alter: 62,0
Geschlecht: F
Eingang: 21.01.2022
Impfdatum: 03.06.2021
Beginn: 04.01.2022
Tage bis Beginn: 215,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute respiratory failure COVID-19 Chills Death Dyspnoea Endotracheal intubation General physical health deterioration Intensive care Pain Pyrexia SARS-CoV-2 test positive

Symptomtext

Janssen COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Janssen Vaccine on 6/3/2021. Presented to ED on 1/4/2022 with symptoms of shortness of breath, fevers, chills, body aches for the past 5 days. Admitted for acute hypoxemic respiratory failure due to Covid19 c/b CKD3, HTN, CHF DM2. Intubated and admitted to ICU. Despite therapy with dexamethsaone and baricitinib, patient decompensated and expired 1/12/22.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 8,0
Labordaten: COVID-19 Positive on 1/4/2022 using the test method platform
Aktuelle Erkrankungen: -
Vorgeschichte: Anemia of chronic disease, Asthma, ASCVD, CKD, Degenerative arthropathy, Depression, Hypertension, Gout, Obesity, hyperlipidemia, Hypothyroidism, osteoarthritis, peripheral neuropathy, Type 2 DM.
Andere Medikamente: Albuterol, Benzonatate, Peridex, Febuxostat, Advair, Flonase, Furosemide, Gabapentin, Levothyroxine, Linagliptin, Loratadine, Methocarbamol, Metoprolol, Nystatin, Olopatadine, Pravastatin, Triamcinolone cream.
Allergien: Kiwi fruit, Morphine, Povodone iodine
Vorherige Impfungen: -

VAERS 2042950

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: KY
Alter: 74,0
Geschlecht: M
Eingang: 18.01.2022
Impfdatum: 06.07.2021
Beginn: 16.01.2022
Tage bis Beginn: 194,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death

Symptomtext

PT DIED AFTER CONTRACTING COVID-19

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 1,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: COPD
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1916075

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: KY
Alter: 76,0
Geschlecht: F
Eingang: 05.01.2022
Impfdatum: 03.09.2021
Beginn: 23.12.2021
Tage bis Beginn: 111,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 pneumonia Death COVID-19 Chest X-ray abnormal Cough Dyspnoea Lung disorder SARS-CoV-2 test positive

Symptomtext

pt developed covid pneumonia and passed after hospitalization

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: covid pneumonia
Vorgeschichte: hypothyroidism, gout, mobid obesity
Andere Medikamente: unknown
Allergien: unknown
Vorherige Impfungen: -

VAERS 1988866

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: TX
Alter: 64,0
Geschlecht: M
Eingang: 29.12.2021
Impfdatum: 09.04.2021
Beginn: 01.12.2021
Tage bis Beginn: 236,0
Dosis: 1
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute kidney injury Acute respiratory failure Anaemia COVID-19 COVID-19 pneumonia Death Dyspnoea Influenza Metabolic acidosis Positive airway pressure therapy SARS-CoV-2 test positive Thrombocytopenia

Symptomtext

Janssen COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Janssen Vaccine on 4/9/2021. Presented to ED on 12/1/21 c/o SOB and flu sx's x10 days. PMHx chronic Hep B, liver cirrhosis, IDDM and HTN admitted for acute respiratory failure with hypoxia 2/2 Covid PNA. Tx'd w/remdesivir, Vit C, steroids, and zinc. Developed acute renal failure and metabolic acidosis, anemia and thrombocytopenia. Started on Baricitinib but d/c'd due to abnormal liver function. Remained on BiPAP 2/2 DNAR status. Expired 12/17/21.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 16,0
Labordaten: Positive COVID-19 on 12/1/2021 using the Roche LIAT SARS assay platform using PCR or equivalent Nucleic Acid Amplification (NAA) technology
Aktuelle Erkrankungen: -
Vorgeschichte: Chronic hepatitis B with cirrhosis, Hypertension, cardiac murmur, diabetic necrobiosis lipoidica.
Andere Medikamente: Carvedilol 12.5 mg QD, Lotrimin Cream BID, Glyburide 5 mg QD, Insulin degludec 35 units QD.
Allergien: Codeine, Metformin
Vorherige Impfungen: -

VAERS 1407614

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: MI
Alter: 74,0
Geschlecht: M
Eingang: 27.12.2021
Impfdatum: 16.06.2021
Beginn: 24.12.2021
Tage bis Beginn: 191,0
Dosis: 1
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Death Pneumonia bacterial SARS-CoV-2 test positive Sepsis Interchange of vaccine products No adverse event

Symptomtext

Patient was admitted with sepsis and bacterial pneumonia on 12/17/2021. Patient had a COVID test on 12/24 for placement to Hospice and it was positive. Patient passed on 12/25.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1407614

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: MI
Alter: 74,0
Geschlecht: M
Eingang: 27.12.2021
Impfdatum: 16.06.2021
Beginn: 24.12.2021
Tage bis Beginn: 191,0
Dosis: UNK
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Death Pneumonia bacterial SARS-CoV-2 test positive Sepsis Interchange of vaccine products No adverse event

Symptomtext

Patient was admitted with sepsis and bacterial pneumonia on 12/17/2021. Patient had a COVID test on 12/24 for placement to Hospice and it was positive. Patient passed on 12/25.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2565104

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: -
Alter: 70,0
Geschlecht: M
Eingang: 04.12.2021
Impfdatum: 25.06.2021
Beginn: 25.06.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Cerebrovascular accident Confusional state Haemorrhagic stroke

Symptomtext

Narrative: Per Patient's Spouse was at PCP visit 6/25, patient received J&J vaccine on same, 5days later 6/30/21 dx with Hemorrhagic stroke, was transferred to MED CENTER-DISCHARGE SUMMARY-6/29/21-07/05/2021. Case reported to this writer on 7/23/21 during post d/c follow-up. Per spouse unsure if J&J vaccine caused recent CVA -given patient had had a previous stroke. However, says timing concerning.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: Per Spouse Patient was his usual self on 6/25/21 at PCP visit- where they requested and was given the J & J vaccine- 5days later on 6/30/21 patient reported with confusion -EMS called and taken to medical center for evaluation- Was ruled out for another stroke.
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1897686

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: IL
Alter: 65,0
Geschlecht: M
Eingang: 24.11.2021
Impfdatum: 12.04.2021
Beginn: 22.11.2021
Tage bis Beginn: 224,0
Dosis: 1
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

COVID-19 COVID-19 pneumonia Chest X-ray abnormal Death Hypoxia Intensive care Respiratory failure SARS-CoV-2 test positive

Symptomtext

Patient tested positive for COVID on 11/8/2021 Developed severe respiratory syndrome 2ndary to COVID pneumonia required up to 50L heated high flow oxygen due to respiratory failure Received remdesivir, dexamethasone Was in the ICU. Patient's wishes were to be DNR. Patient placed on comfort care and subsequently died on 11/22/2021

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 9,0
Labordaten: COVID19 test not performed at hospital, done outside. Positive PCR on 11/8/2021 11/17/2021 CXR done due to worsening hypoxia. Impression: slightly increasing, suspicious for pneumonia in this COVID19 positive patient.
Aktuelle Erkrankungen: -
Vorgeschichte: Atrial fibrillation CABG - Coronary artery bypass graft CAD - Coronary artery disease COPD Cardiomyopathy Coronary artery disease Dementia.... Depression Diabetes mellitus Dysphagia GERD - Gastro-esophageal reflux disease Hemiparesis (weakness on one side) Hemiplegia Hypercholesterolemia Hypertension Incontinence Insomnia Pacemaker catheter, device Stroke Urinary tract infection
Andere Medikamente: acetaminophen 325 mg oral tablet, 650 mg= 2 TAB, PO, Q4H (Every 4 hours), PRN acetaminophen 325 mg oral tablet, 650 mg= 2 TAB, PO, Q4H (Every 4 hours), PRN aspirin 81 mg oral delayed release tablet, 81 mg= 1 TAB, PO, Daily atorvastatin 4
Allergien: Ace inhibitors, codeine, lisinopril
Vorherige Impfungen: -

VAERS 1868193

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: MD
Alter: 77,0
Geschlecht: F
Eingang: 14.11.2021
Impfdatum: 08.04.2021
Beginn: 10.06.2021
Tage bis Beginn: 63,0
Dosis: N/A
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia Cerebral haemorrhage Death Headache Heart valve incompetence Hypervolaemia Platelet count decreased Platelet transfusion Pneumonia Renal failure

Symptomtext

Adverse event started w/ c/o headache and extreme progressive weakness. Treated at Hospital Center briefly. Diagnosis Low platelets 28k, cerebral hemorrhage, and pneumonia. Transferred Hospital . Received multiple platelet transfusions (5 I believe), and treated w/ IV ABT. Pneumonia "resolved" only to return within a week. During hospital stay patient experienced fluid overload, kidney failure, and heart valve failure of replaced heart valve. Lengthy hospital stay ultimately ended with transfer to hospice and death.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebral haemorrhage
Hospital-Tage: 22,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: DM type 2 Hypothyroidism A. Fib CHF GERD History of Heart valve replacement COPD
Andere Medikamente: Lasix KCl Spironolactone Multivitamin Carafate Tylenol Advair Iron Metoprolol Metformin Lipitor Eliquis Jardance
Allergien: Bactrim DS
Vorherige Impfungen: -

VAERS 2600544

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: -
Alter: 41,0
Geschlecht: M
Eingang: 01.11.2021
Impfdatum: 07.06.2021
Beginn: 28.08.2021
Tage bis Beginn: 82,0
Dosis: UNK
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute respiratory failure COVID-19 Chest X-ray abnormal Dyspnoea Lung disorder Pyrexia SARS-CoV-2 test positive

Symptomtext

Narrative: Full vaccinated patient admitted 8/28/2021 for acute hypoxic respiratory failure secondary to COVID-19. Positive COVID test 8/23. Presented 8/28 with O2 sat of 85% at night, fevers (103.4) and SOB. Received dexamethasone and remdesivir. Empirically treated with ceftriaxone and azithromycin. Initially on 3L oxygen and saturating > 90%. On day of discharge, on 2L. NO SOB at rest or when walking. Discharged on 9/1 in stable condition.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: COVID-19 positive: 8/23/2021 Chest x-ray = vague haziness throughout the left greater than right lung concerning for infiltrates
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1825546

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: IL
Alter: 59,0
Geschlecht: M
Eingang: 28.10.2021
Impfdatum: 11.04.2021
Beginn: 08.10.2021
Tage bis Beginn: 180,0
Dosis: UNK
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure Back pain COVID-19 Cough Decreased appetite Diarrhoea Exposure to SARS-CoV-2 Nausea Pain Pneumonia Pyrexia

Symptomtext

Chief Complaint This patient is a pleasant 59-year-old man with no significant past medical history and has been adequately immunized with a Johnson & Johnson Covid vaccine March 2021 has been admitted for multifocal pneumonia and acute hypoxic respiratory failure due to COVID-19. Duration of symptom is almost 2 weeks and has 2 other family members sick with Covid 19 History of Present Illness This patient is a pleasant 59-year-old man who works as a painter. He stated that he has been having unhygienic workplace and may have caught infection somewhere at workplace. He became acutely aware and symptomatic with cough fever body aches nausea loss of appetite and diarrhea about 2 weeks ago. He has been living and household consist of his daughter wife who is been sick with similar cough and congestive symptoms but improved not needing any hospitalization. Patient himself has been awake alert oriented x4 sitting upright using supplemental oxygen by nasal cannula and does not show any signs of distress or toxicity/resting comfortably. Earlier had some back pain and intractable cough low appetite into loose stool. He has been brought in and does not qualify for remdesivir, steroid therapy has been initiated supplemental oxygen as well as antitussive therapy advised and infectious disease service requested to see the patient.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 10,0
Labordaten: -
Aktuelle Erkrankungen: unknown
Vorgeschichte: Past Medical History: Obesity BMI of 33.6 Hyperglycemia
Andere Medikamente: unknown
Allergien: no known drug allergy
Vorherige Impfungen: -

VAERS 1804677

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: KY
Alter: 71,0
Geschlecht: M
Eingang: 21.10.2021
Impfdatum: 12.05.2021
Beginn: 25.09.2021
Tage bis Beginn: 136,0
Dosis: 1
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

COVID-19 Death SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Had breakthrough infection and deceased.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 10,0
Labordaten: Positive laboratory test: 9/15/2021
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Coronary artery disease, hypertension, obstructive sleep apnea, diabetes mellitus,
Andere Medikamente: Unknown
Allergien: Unknown
Vorherige Impfungen: -

VAERS 1801203

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: KY
Alter: 86,0
Geschlecht: F
Eingang: 20.10.2021
Impfdatum: 21.07.2021
Beginn: 08.10.2021
Tage bis Beginn: 79,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Body temperature decreased Chills Death Pulse absent Resuscitation

Symptomtext

Patient from the nursing home arrived DOA. She was down for an unknown period of time no less than 70 minutes (another note said at least 20 min) before nursing home found her. When she was found at the nursing home the patient had no pulse and she had no pulse during any resuscitation efforts. Core temperature 95.9. She is developing rigors.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Dementia, Parkinson's
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1783028

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: GA
Alter: 79,0
Geschlecht: M
Eingang: 13.10.2021
Impfdatum: 07.04.2021
Beginn: 07.09.2021
Tage bis Beginn: 153,0
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death

Symptomtext

Patient fully vaccinated and died due to Covid related causes

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1641676

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: KY
Alter: 57,0
Geschlecht: M
Eingang: 06.10.2021
Impfdatum: 07.04.2021
Beginn: 25.07.2021
Tage bis Beginn: 109,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute psychosis Acute respiratory failure Amnesia COVID-19 COVID-19 pneumonia Chills Cognitive disorder Chest X-ray abnormal Dyspnoea Encephalitis Exposure to SARS-CoV-2 Fatigue Hypophagia Laboratory test Infection Lung disorder Magnetic resonance imaging head normal Myalgia

Symptomtext

Patient is a 57 y.o. male with past medical history most significant for diabetes who presents to ED for shortness of breath. Patient reports she is getting exposed to someone who tested positive for COVID 2 weeks ago. Since the exposure, patient has had constitutional symptoms in form of fevers chills and poor by mouth intake. Of late, he has developed shortness of breath and cough with cough producing a yellow color sputum which continued to worsen prompting the hospital visit. He has not had any concurrent GI symptoms. Constitutional: Positive for activity change, chills, fatigue and fever. Eyes: Negative. Respiratory: Positive for cough and shortness of breath. Negative for wheezing. Hypoxic respiratory failure 2/2 COVID PNA Symptom onset 13-14 days ago. NO signs of CHF. Troponin x 2 -ve -Start dexamethasone 6mg qday + remdesivir per protocol -Consider descalating antibiotics based on Procalcitonin. Currently on Azithromycin. -ID for delta variant testing, vaccination failure -Self Proning advised -Incentive spirometry Discharge summary: Chief Concern, Brief History of Present Illness, and Hospital Course 57 y.o. male with past medical history most significant for diabetes admitted for symptomatic COVID. # Acute hypoxic respiratory failure 2/2 SARS-COV 2 viral PNA; improved - continue dexamethasone x 10 days - Completed remdesevir - State Lab to ID if it is delta variant. Turnaround time is approx. 10 days. - Janssen Vaccine 1 dose taken on 04/07 PLAN: O2 weaned off and ambulatory pulse ox noted and doing well. Plan to discharge to home to resume prior regimen and to follow with PCP regarding his diabetes and cognitive decline. Discharge Disposition/Condition Disposition: Home Condition: Stable (s/sx potential problems absent or manageable)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 15,0
Labordaten: COVID PCR positive on 07/25/21
Aktuelle Erkrankungen: N/A
Vorgeschichte: H/o T2DM, insulin dependent H/O HTN GERD
Andere Medikamente: atorvastatin (Lipitor) 20 MG tablet empagliflozin (Jardiance) 25 MG metFORMIN XR (Glucophage-XR) 500 MG 24 hr tablet naproxen (EC Naprosyn) 500 MG EC tablet neomycin-bacitracin-polymyxin-hydrocortisone (Cortisporin) 1 % ophthalmic ointment
Allergien: Cephalexin Hives, Rash Medium Allergy 12/28/2006 Codeine Codeine Rash Medium Allergy 2/3/2011 Lisinopril Unknown Reaction Low Allergy 5/25/2021 Oxycodone-acetaminophen Rash Low Allergy 2/1/2011
Vorherige Impfungen: -

VAERS 1641676

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: KY
Alter: 57,0
Geschlecht: M
Eingang: 06.10.2021
Impfdatum: 07.04.2021
Beginn: 25.07.2021
Tage bis Beginn: 109,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute psychosis Acute respiratory failure Amnesia COVID-19 COVID-19 pneumonia Chills Cognitive disorder Chest X-ray abnormal Dyspnoea Encephalitis Exposure to SARS-CoV-2 Fatigue Hypophagia Laboratory test Infection Lung disorder Magnetic resonance imaging head normal Myalgia

Symptomtext

Patient is a 57 y.o. male with past medical history most significant for diabetes who presents to ED for shortness of breath. Patient reports she is getting exposed to someone who tested positive for COVID 2 weeks ago. Since the exposure, patient has had constitutional symptoms in form of fevers chills and poor by mouth intake. Of late, he has developed shortness of breath and cough with cough producing a yellow color sputum which continued to worsen prompting the hospital visit. He has not had any concurrent GI symptoms. Constitutional: Positive for activity change, chills, fatigue and fever. Eyes: Negative. Respiratory: Positive for cough and shortness of breath. Negative for wheezing. Hypoxic respiratory failure 2/2 COVID PNA Symptom onset 13-14 days ago. NO signs of CHF. Troponin x 2 -ve -Start dexamethasone 6mg qday + remdesivir per protocol -Consider descalating antibiotics based on Procalcitonin. Currently on Azithromycin. -ID for delta variant testing, vaccination failure -Self Proning advised -Incentive spirometry Discharge summary: Chief Concern, Brief History of Present Illness, and Hospital Course 57 y.o. male with past medical history most significant for diabetes admitted for symptomatic COVID. # Acute hypoxic respiratory failure 2/2 SARS-COV 2 viral PNA; improved - continue dexamethasone x 10 days - Completed remdesevir - State Lab to ID if it is delta variant. Turnaround time is approx. 10 days. - Janssen Vaccine 1 dose taken on 04/07 PLAN: O2 weaned off and ambulatory pulse ox noted and doing well. Plan to discharge to home to resume prior regimen and to follow with PCP regarding his diabetes and cognitive decline. Discharge Disposition/Condition Disposition: Home Condition: Stable (s/sx potential problems absent or manageable)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 15,0
Labordaten: COVID PCR positive on 07/25/21
Aktuelle Erkrankungen: N/A
Vorgeschichte: H/o T2DM, insulin dependent H/O HTN GERD
Andere Medikamente: atorvastatin (Lipitor) 20 MG tablet empagliflozin (Jardiance) 25 MG metFORMIN XR (Glucophage-XR) 500 MG 24 hr tablet naproxen (EC Naprosyn) 500 MG EC tablet neomycin-bacitracin-polymyxin-hydrocortisone (Cortisporin) 1 % ophthalmic ointment
Allergien: Cephalexin Hives, Rash Medium Allergy 12/28/2006 Codeine Codeine Rash Medium Allergy 2/3/2011 Lisinopril Unknown Reaction Low Allergy 5/25/2021 Oxycodone-acetaminophen Rash Low Allergy 2/1/2011
Vorherige Impfungen: -

VAERS 1762080

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: MO
Alter: 73,0
Geschlecht: F
Eingang: 05.10.2021
Impfdatum: 25.07.2021
Beginn: 28.09.2021
Tage bis Beginn: 65,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure Angiogram pulmonary abnormal Arteriosclerosis coronary artery Chest pain Computerised tomogram abnormal Diarrhoea Dyspnoea Electrocardiogram QRS complex Electrocardiogram QT interval Electrocardiogram ST-T segment abnormal Electrocardiogram abnormal Exposure to SARS-CoV-2 Intensive care Laboratory test normal Lung opacity Oropharyngeal pain Osteoarthritis Oxygen saturation abnormal

Symptomtext

presented to ER on 9/28 with dyspnea. EMS noted a SP02 of low 80's on room air. On arrival, vitals wnl except for Sp02 of 86% on room air and tachypnea to 24. Patient was started on bipap 55% Fio2 with an improvement in Sp02 to 91%. CTPE performed which showed no evidence of PE, but multifocal pneumonia. Rapid COVID was negative. Labs were unremarkable. Pulmonary consulted and accepted admission to ICU for bipap therapy for AHRF. Patient reports that her nurses aide tested positive for Covid recently. Patient reports onset of sore throat starting 2 weeks ago. She also endorses a cough productive with "green gobs " which also started 2 weeks ago. Few days later she developed vomiting and diarrhea, which have now resolved. Starting 1 week ago patient developed shortness of breath and chest pain. She endorses some mild rhinorrhea as well.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: Diagnostic Results Measurements Intervals Axis Rate: 67 P: 42 PR: 212 QRS: 14 QRSD: 81 T: 70 QT: 418 QTc: 433 Interpretive Statements SINUS RHYTHM WITH FIRST DEGREE AV BLOCK NONSPECIFIC ST & T-WAVE ABNORMALITY Compared to ECG 09/06/2019 10:13:57 T-wave abnormality now present Sinus bradycardia no longer present Electronically Signed On 9-28-2021 22:03:21 [1] (09/28/2021 20:43 CT Chest PE Protocol) FINDINGS: VASCULAR: The study is diagnostic to the level of the subsegmental pulmonary arteries. PULMONARY ARTERIES: No evidence of acute or chronic pulmonary embolism. The pulmonary arteries are normal in size. THORACIC AORTA: Normal in size. PULMONARY VEINS: Normal drainage into the left atrium. CORONARY ARTERIES: Moderate calcified coronary atherosclerosis. SYSTEMIC VEINS: Within normal limits. HEART: The heart is normal in size. No pericardial effusion. CHEST: LUNGS/PLEURA: Bilateral multifocal groundglass and consolidative airspace opacities. No suspicious pulmonary nodules are visualized. No pleural effusion or focal pleural lesion. MEDIASTINUM: No pathologic mediastinal or hilar adenopathy. The visualized thyroid and the esophagus are unremarkable. AXILLA/SOFT TISSUE: No supraclavicular or axillary adenopathy. Regional soft tissues are within normal limits. UPPER ABDOMEN: The gallbladder is surgically absent. Similar appearance of a calcified splenic artery aneurysm measuring 1.5 cm in diameter, unchanged dating back to CT abdomen/pelvis dated 1/26/2017. BONES: No evidence of acute fractures or aggressive osseous lesions. Multilevel degenerative changes of the spine. Bilateral shoulder joint osteoarthrosis. IMPRESSION: VASCULAR: No CT evidence of pulmonary embolism. CHEST: Bilateral multifocal groundglass and consolidative airspace opacities. Findings are consistent with multifocal pneumonia. Consider laboratory evaluation for Covid-19.
Aktuelle Erkrankungen: unknown
Vorgeschichte: pmhx of CAD w/o stents, fibromyalgia, hypothyroidism, obesity, lymphedema, Hx seizures, anxiety, depression, Hx of decompensated cirrhosis with HE, HCV s/p treatment and SVR
Andere Medikamente: unknown
Allergien: haloperidol (pressure in head) phenobarbital (HALLUCINATIONS) No Known Latex Allergy Thorazine Wellbutrin (anxiety) allopurinol (headache)
Vorherige Impfungen: -

VAERS 1761370

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: CO
Alter: 40,0
Geschlecht: M
Eingang: 05.10.2021
Impfdatum: 16.09.2021
Beginn: 16.09.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Cardiomegaly Death Influenza like illness Malaise Chest discomfort Fatigue Feeling abnormal Influenza Loss of consciousness Nausea Pain Sensory disturbance Overweight Skin warm Somnolence

Symptomtext

SEPT. 16TH NIGHT - FELT WEIRD TO TOUCH "FEVER SKIN", FLU SYMPTOMS, JOINTS HURT, ACHEY, FATIGUE 17TH - FATIGUE AND SLEPT ALL DAY, SAME SYMPTOMS AS BEFORE 18TH - STILL FEELING BAD, BUT STARTING TO FEEL BETTER 19TH - 26TH - MUCH BETTER, NO COMPLAINTS MADE AND USUAL SELF 27TH NIGHT - JOINTS HURT, STERNUM FELT WEIRD, ACHEY, ARMS FELT WEIRD, FELT "WEIRD" , TOOK 2 ASPIRINS 27TH - 8:50PM WAS HEADING TO ER AND HE NEEDED TO VOMIT BUT WAS UNCONCIOUS IN THE DRIVEWAY, PARAMEDICS WORKED ON HIM FOR 45 MINUTES AND WAS 9:55PM DECLARED DEAD

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: NONE
Aktuelle Erkrankungen: NONE
Vorgeschichte: ACID REFLUX AND KIDNEY STONES SINCE AGE 12
Andere Medikamente: PROTONIX 40MG ONCE DAILY
Allergien: NONE
Vorherige Impfungen: -

VAERS 1740968

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: KY
Alter: 43,0
Geschlecht: F
Eingang: 28.09.2021
Impfdatum: 03.05.2021
Beginn: 07.05.2021
Tage bis Beginn: 4,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Cerebrovascular accident

Symptomtext

Patient presented to the ED at Hospital on 5/7/21. Patient presented with signs of a stroke. Patient was transferred to another hospital to receive a higher level of care.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: Dexamethasone and IV contrast dye
Vorherige Impfungen: -

VAERS 1735739

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: CA
Alter: 34,0
Geschlecht: M
Eingang: 26.09.2021
Impfdatum: 30.08.2021
Beginn: 30.08.2021
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Acute myocardial infarction Allergy to vaccine Differential white blood cell count Dizziness Electrocardiogram abnormal Full blood count Hyperhidrosis Metabolic function test Seizure like phenomena Syncope Troponin I

Symptomtext

Janssen COVID-19 Vaccine EUA. 0900: patient reports dizziness 0903: BP 97/58, HR- 44, 02 RA 99%. syncopal episode occur. S/SX seizure/posture (15 seconds), diaphoretic. DOD aware, paramedics called 0905: AxOx4. BP 98/60, HR 60, O2 98% 0905: medics arrive to vaccine clinic. EKG done + STEMI. Patient transferred via gurney to ambulance for higher level of care, Allergy to COVID-19 vaccine documented in Allergies activity, Patient advised to discuss second dose considerations with a clinician Patient transferred via ambulance to ER 0940: patient arrival at ER. BMP, CBC w/auto Diff, Troponin I, ED EKG-CernerCV, Diagnosis: Syncope, Patient advised to follow up with primary care physician within 1-2 days

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Atopic Dermatitis
Vorgeschichte: -
Andere Medikamente: Triamcinolone Acetonide (TRIDERM) 0.5 % Top Cream
Allergien: None
Vorherige Impfungen: -

VAERS 1731741

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: CA
Alter: 64,0
Geschlecht: M
Eingang: 24.09.2021
Impfdatum: 17.05.2021
Beginn: 01.06.2021
Tage bis Beginn: 15,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Cerebrovascular accident

Symptomtext

Suffered a stroke, hospitalized for 2 weeks.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 14,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: COPD
Andere Medikamente: Vitamins.
Allergien: None.
Vorherige Impfungen: -

VAERS 1727359

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: CA
Alter: 39,0
Geschlecht: M
Eingang: 23.09.2021
Impfdatum: 26.08.2021
Beginn: 15.09.2021
Tage bis Beginn: 20,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute myocardial infarction Anticoagulant therapy Blood test Cardiac stress test Echocardiogram Electrocardiogram ST segment elevation Fatigue Mobility decreased Palpitations

Symptomtext

Three days after the vaccine I started to have extreme fatigue. One week after that I started to have heart palpitations and I called my doctor. I went to the ER and I had ST elevations in my Stemi. I was in the hospital one night. I was given a Heparin drip and aspirin. I was discharged with an unexplained ST elevation and MI. I normally run Marathons and I have been having a lot of problems since the vaccine. I had extreme fatigue two weeks after the shot and I was unable to get out of bed. I am still having Palpitations every day intermittently after three weeks. I am still extremely fatigued. When I was getting the scans I could hear my arm vibrating.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: 1,0
Labordaten: Echocardiogram, Stress Test, Blood Test
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 1641053

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: KY
Alter: 76,0
Geschlecht: M
Eingang: 20.09.2021
Impfdatum: 18.08.2021
Beginn: 23.08.2021
Tage bis Beginn: 5,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Abdominal discomfort Abdominal distension Agitation Anuria Blood bicarbonate increased Blood creatinine increased Blood pressure decreased Blood urea increased COVID-19 Chills Chronic lymphocytic leukaemia Computerised tomogram abdomen Computerised tomogram abdomen abnormal Confusional state Cough Death Dyspnoea Endotracheal intubation

Symptomtext

Patient presented to urgent care on 8/23/21 with c/o exposure to COVID illness at church, cough, fever, shortness of breath and chills. Subsequently presented to BHL 8/26/2021 with worsening dyspnea, tested positive for COVID-19, and was noted to have bilateral pulmonary infiltrates and significant hypoxemia. Was admitted to the floor and received Decadron, Remdesivir, Actemra, and broad-spectrum empiric antibiotics. Despite therapy developed progressive hypoxemic respiratory failure requiring transfer to the ICU and intubation 9/3/2021. Seem to improve on mechanical ventilation and passed a pressure support trial at which point he was extubated 9/12/2021. Unfortunately the morning of 9/13/2029 he became increasingly confused, agitated, and could not keep his mask on. Attempts at Precedex and Haldol were not successful so he was reintubated and placed back on ventilatory support 9/13/2021 (has been on ventilator a total of 15 days now). WBC was noted to jump to 47.41 at the same time as above event despite being on linezolid, Merrem, and micafungin (although was on Solu-Medrol). There was noted to be gastric distention and an NG tube was placed with resolution of distention. By 9/16/2021 patient had improved and had had good UOP after Lasix with no decrement in renal function. Was essentially afebrile off all antibiotics although WBC remained persistently elevated at 21,000 (presumably secondary to CLL). In addition procalcitonin was only 0.04. Patient tolerated pressure support/CPAP (although pressure support was 15). Plans were to proceed with respiratory mechanics 9/17/2021 and again attempt to wean and extubate. Unfortunately patient dropped his blood pressure 9/16/21 without obvious GI losses and required volume and pressors. At 3:20 AM hematocrit was checked and had dropped from 40 yesterday morning, to 22. Had complaints of abdominal discomfort and underwent a CT scan which revealed large acute bilateral retroperitoneal hematomas right greater than left (13 x 9 x 8 cm). Blood was ordered but after 3 units hematocrit had only gone from 22, to 23. CT angiogram was then performed revealing 3 separate sites of active arterial extravasation which short interval enlargement of the previously noted bilateral large retroperitoneal hematomas. Areas of active extravasation or along the left psoas musculature at the level of L3 and bilaterally within iliac musculature. Additional 3 units of blood were ordered as well as 2 L of normal saline infused and situation discussed with interventional radiology who indicated that they could attempt to proceed with angiogram and attempted ablation. Unfortunately patient was now totally anuric with a jump in his BUN to 49 and 1.41 creatinine with serum bicarb of 16. In addition was developing increasing hypoxemia with all the fluids. Interventional radiology indicated the they would place a dialysis catheter at the time of his angiogram. Situation discussed with wife who indicated that he had discussed the situation with her before and would not wish to be on dialysis. At this point in time the patient was made a DNR and family had accepted the fact that he would not recover. Comfort care was initiated per family wishes. Following comfort medication administration, the patient was palliative extubated. He was pronounced deceased at 1511 on 9/17/21 by Hospital Supervisor.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 23,0
Labordaten: -
Aktuelle Erkrankungen: AKI, Anxiety, CAD, CHF, chronic Afib, Chronic lymphocytic leukemia, diverticulitis, dupuytren contracture, enlarged prostate, GERD, gout, HTN, HLD, mass of right elbow, osteoarthritis both hands, PPM, sleep apnea, SSS.
Vorgeschichte: see above
Andere Medikamente: Albuterol inhaler, Allopurinol, Alprazolam, ASA, Cetirizine, Doxycycline, Ergocalciferol, Evolocumab, Furosemide, Gabapentin, Glimepiride, Losartan potassium, Nitroglycerin prn, Ondansetron HCl prn, Pantoprazole sodium, Potassium chloride,
Allergien: Azithromycin
Vorherige Impfungen: -

VAERS 1704505

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201a21a

kritisch

Staat: KY
Alter: 67,0
Geschlecht: M
Eingang: 16.09.2021
Impfdatum: 01.07.2021
Beginn: 27.08.2021
Tage bis Beginn: 57,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 pneumonia Death

Symptomtext

Patient died 8/27/2021 at the Hospital with diagnosis of Pnuemonia caused by SARS-CoV-2

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: unknown
Vorgeschichte: unknown
Andere Medikamente: unknown
Allergien: NKA
Vorherige Impfungen: -

VAERS 1689743

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: CA
Alter: 50,0
Geschlecht: M
Eingang: 16.09.2021
Impfdatum: 16.08.2021
Beginn: 26.08.2021
Tage bis Beginn: 10,0
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: ja Erholt: nein

Angiogram cerebral Antinuclear antibody Antiphospholipid antibodies Antithrombin III Aspartate aminotransferase Balance disorder Beta-2 glycoprotein antibody Blood creatinine Blood electrolytes Blood fibrinogen Blood glucose Blood grouping Blood magnesium Blood urea Cardiolipin antibody Blood test normal Cerebellar stroke Coordination abnormal

Symptomtext

Pt is a 50 year old male with hypertension and hyperlipidemia who was admitted on 9/2/2021 for ACUTE STROKE, UNSPECIFIED TYPE AND ARTERY. Following admission, the patient was found to have head CT c/f L cerebellar ischemic stroke. `. Of note, he had the Johnson & Johnson Covid-19 vaccine 8/16/21. Eval in hospital. Negative eval for causes. Cryptogentic stroke. Pt with classic symptoms and signs of lateral medullary syndrome, with crossed sensory impairment of ipsilateral face and contralateral arm, vertigo, nausea, dysarthria and incoordination

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 2,0
Labordaten: MRI showed left cerebellar DWI acute stroke with suggestion of L lateral medullary involvement and nonspecific white matter disease; symptoms were c/w lateral medullary syndrome c/f PICA stroke. TTE showed normal LVEF and no thrombus, and carotid duplex was negative. Of note, he had the Johnson & Johnson Covid-19 vaccine 8/16/21. Hypercoag work up negative. Eval for thromocytopenia was negative.
Aktuelle Erkrankungen: None
Vorgeschichte: None.
Andere Medikamente: Truvada 1 tab daily, Atenolol 50 mg daily,
Allergien: none
Vorherige Impfungen: -

VAERS 1696266

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: OH
Alter: 58,0
Geschlecht: F
Eingang: 14.09.2021
Impfdatum: 28.07.2021
Beginn: 10.09.2021
Tage bis Beginn: 44,0
Dosis: N/A
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure COVID-19 pneumonia SARS-CoV-2 test positive

Symptomtext

Patient presented to ED 9/10/21 and was admitted for acute hypoxic respiratory failure secondary to COVID-19 pneumonia. COVID antigen test was positive 9/10/21. Patient was discharged to home 9/13/21.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: COVID antigen test 9/10/21- POSITIVE
Aktuelle Erkrankungen: unknown
Vorgeschichte: type II diabetes, asthma, CKD stage IIIa, history of DVT, hypothyroidism, obstructive sleep apnea, morbid obesity
Andere Medikamente: acetaminophen, albuterol sulfate inhaler, apixaban, vit D3, cyclobenaprine, folic acid, gabapentin, levothyroxine, metformin, metoprolol, prednisone, sitagliptin, warfarin
Allergien: vicodin, ibuprofen
Vorherige Impfungen: -

VAERS 1689462

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: IL
Alter: 55,0
Geschlecht: M
Eingang: 10.09.2021
Impfdatum: 07.04.2021
Beginn: 08.09.2021
Tage bis Beginn: 154,0
Dosis: UNK
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute respiratory failure COVID-19 COVID-19 pneumonia Chest X-ray normal Chills Cough Dyspnoea Fatigue Malaise Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

Patient received Janssen vaccine on 4/7/21. Started having symptoms approx Labor Day weekend (9/4/21). Started with chills and malaise and progressed over the next few days with cough, runny nose, mild SOB, and fatigue. Presented to ED 9/7, COVID PCR via NP was sampled 9/7 and positive 9/8, transferred to Hospital for admit to IMC unit on 9/8/21. Remains in hospital at time of submission with primary diagnosis of acute hypoxic respiratory failure secondary to COVID pneumonia.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 3,0
Labordaten: COVID PCR via nasopharyngeal swab, positive 9/8 Chest XR 9/8, cardiomediastinal contours and pulmonary vasculature within normal limits. No confluent consolidation, pneumothorax or pleural effusion
Aktuelle Erkrankungen: Coronary artery disease (post stenting on 2020) with stable angina for "last few months."
Vorgeschichte: COPD, hyperlipidemia, sleep apnea, obesity without diabetes, hypertension.
Andere Medikamente: Aspirin, clopidogrel (Plavix), lovastatin (mevacor), meloxicam (mobic), metoprolol tartrate (lopressor), fish oil, oxycodone (roxicodone), excedrin, sildenafil (revatio)
Allergien: Atorvastatin, codeine
Vorherige Impfungen: -

VAERS 1666115

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: KY
Alter: 58,0
Geschlecht: F
Eingang: 02.09.2021
Impfdatum: 09.06.2021
Beginn: 05.08.2021
Tage bis Beginn: 57,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure Adenocarcinoma metastatic Back pain Bacterial test Bacterial test positive Bilirubin urine present Biopsy breast Bladder catheterisation Blood cholesterol increased Blood glucose increased Blood lactic acid normal Blood pressure normal Body fluid analysis Breast cancer female Breast mass C-reactive protein increased COVID-19 Cancer pain

Symptomtext

Patient received COVID vaccine on 6/9/21, tested COVID positive 8/6/21 (tested negative for COVID on 7/2/21, 8/16/21, and 8/17/21) 8/5/21: Patient is a 59 y.o. female with past medical history significant for Type II diabetes mellitus, essential hypertension, and known spinal lytic lesions who presented to the ED yesterday for chief complaint of worsening lower back pain. She reports that her pain has progressively impeded her ability to ambulate and complete simple ADL's in the past few weeks. She reports new numbness to her right hip, however denies loss of bladder or bowel control, recent falls, or any other acute complaints today. Of note, the patient was admitted on 7/16 with concern for spinal lesion found. An MR spine was completed, showing 10mm nodule in right superior medial posterior breast and lytic destructive lesion within the L1 vertebral body, right superior portion of T12, as well as large omental deposit. An MRI showed cord and thecal sac compression at this time, prompting ortho, neurosurgery, and IR guided biopsy that was significant for malignant metastatic adenocarcinoma with high suspicion of breast primary site. She was subsequently discharged and mammography guided biopsy of her left breast was completed on 7/28 with pathologic results pending. Workup thus far in the ED has been significant for UTI, elevated CRP, sed rate, MRI with stable findings with exception of re-demonstration of L1 lytic lesion with worsening wedge deformity suggestive of new pathologic fracture. There is additional extensive enhancement throughout the subdural space throughout the thoracic spine, resulting in mass-effect and deformity of portions of the spinal cord. Hospital medicine has thus been consulted for admission of this patient for further management of her symptoms. Patient is a 59 y.o. female with past medical history significant for Type II diabetes mellitus, essential hypertension, and known spinal lytic lesions who presented to the ED yesterday for chief complaint of worsening lower back pain. 1. L1 lytic lesion concerning for malignant metastases with suspected breast primary malignancy - FNA of lumbar spine lesion last month significant for malignant metastatic adenocarcinoma with high suspicion of breast primary site - CT spine shows stable 9mm lytic lesion in T12 vertebral body with no new acute pathologic fracture seen. Extensive multilevel degenerative changes with prominent endplate and similar appearing Schmorl's nodes - Re-demonstration of L1 2.4 cm lytic lesion with worsening wedge deformity suggestive of new pathologic fracture. No acute lytic lesion or fracture identified within the remaining lumbar vertebrae - Extensive enhancement throughout the subdural space throughout the thoracic spine, resulting in mass-effect and deformity of portions of the spinal cord. - Dermatome pattern of numbness consistent with L1 involvement - Mammogram completed on 7/28 with results significant for right breast Bi-RADS 4 suspicious finding. Biopsy results pending. - ED has consulted ortho spine with recommendations pending PLAN - Follow up on ortho spine recommendations - Will initiate dexamethasone 4mg Q6 hours for symptomatic relief - Pain control with oxycodone, PRN morphine for now - PT/OT evaluation ordered and pending 2. Urinary tract infection - UA significant for 100 protein, small bilirubin, trace ketones, 2.0 urobilogen, trace leukocytes, negative nitrites, 6-10 WBC, calcium oxalate crystals, and present bacteria. - No evidence of renal calculi on CT abdomen - Sed rate >111, CRP 163.8, WBC: 10.84 - Patient denies current symptoms including dysuria, hematuria, or urinary frequency PLAN - Start empiric rocephin for now given signs of infection ; discontinue as indicated - Urine culture ordered and pending collection 3. Type II Diabetes Mellitus with hyperglycemia - Poorly controlled; patient A1C 1 month ago 7.8 - Home regimen includes metformin - High glucose today of 151 PLAN -FSBG ACHS -SSI not indicated at this time given stable BG; initiate if changes -Hold patient metformin, PO antihyperglycemic medications until discharge. 4. Essential hypertension - Patient has been normotensive while at the ED with high BP of 133/81 - Home medications include lisinopril-hctz PLAN - Continue to monitor vital signs and trend BP - Hold outpatient antihypertensives for now; restart as indicated - PRN IV antihypertensives for SBP sustained > 180 5. Hypercholesterolemia PLAN - Continue outpatient pravastatin 9. Morbid obesity (POA) - BMI on admission is: 40.72 - complicates multiple aspects of the patient's care PLAN - Diet and exercise counseling to be provided before discharge 8/28/21 Discharge Summary: Admission Date: 8/5/2021 Discharge Date: 08/29/21 Primary Discharge Diagnosis Spinal cord compression due to malignant neoplasm metastatic to spine (CMS/HCC) Secondary Discharge Diagnosis Patient Active Problem List Diagnosis ? Type 2 diabetes mellitus, without long-term current use of insulin (CMS/HCC) ? High cholesterol ? Metastasis to vertebral column of unknown origin (CMS/HCC) ? Closed fracture of first lumbar vertebra (CMS/HCC) ? Morbid obesity (CMS/HCC) ? Cancer associated pain ? Hypothyroidism ? Acute respiratory failure with hypoxia (CMS/HCC) ? Malignant ascites ? Urinary retention ? Spinal cord compression due to malignant neoplasm metastatic to spine (CMS/HCC) ? Peritoneal carcinomatosis (CMS/HCC) Discharge Disposition Home with home health vs. Hospice Outpatient Follow-Up Test Results Pending at Discharge Pending Labs Order Current Status Body Fluid Cell Count W/O Diff - Ascities Collected (08/26/21 1823) CBC and differential Collected (08/11/21 0544) Comprehensive metabolic panel Collected (08/11/21 0544) Fine needle aspiration - Core Biopsy Collected (08/26/21 1816) Cytology - Ascites In process Urine Culture In process AFB Culture, Non Respiratory Source and Acid Fast Stain Preliminary result Fungal Culture, Sterile Body Fluid (NOT CSF) and KOH Preliminary result DETAILS OF HOSPITAL STAY Presenting Problem/History of Present Illness Urinary retention [R33.9] Metastasis to vertebral column of unknown origin (CMS/HCC) [C79.51, C80.1] Closed fracture of first lumbar vertebra, unspecified fracture morphology, initial encounter (CMS/HCC) [S32.019A] Hospital Course Prior to this admission: Patient was admitted on 7/16/2021 with concern for spinal lesion found. An MR spine was completed, showing 10mm nodule in right superior medial posterior breast and lytic destructive lesion within the L1 vertebral body, right superior portion of T12, as well as large omental deposit. An MRI showed cord and thecal sac compression at this time, prompting ortho, neurosurgery, and IR guided biopsy of L7 that was significant for malignant metastatic adenocarcinoma with high suspicion of breast primary site as was ER+/PR+. She was subsequently discharged and mammography guided biopsy of her left breast was completed on 7/28/2021 showing fibroadenoma. Patient is a 59 y.o. female with history of T2DM, metatstatic carcinoma of unknown primary who presented to the emergency department on 8/6/2021 with progressive back pain and imaging concerning for progression of malignancy into spine, found to be COVID positive. On 8/6 she presented with new onset urinary retention with worsened lower back pain. MR of the L spine showed enhancement in the L1 vertebral body (concerning for metastatic disease) as well as compression on the thecal sac and cauda equina. She was admitted to medicine. Neurosurgery was consulted who had no acute surgical intervention to offer. Patient was initiated on dexamethasone as well as remdesivir for COVID-19 infection. Oncology was consulted on 8/10 and recommended initiation of anastrozole and continuation of dexamethasone for cord compression. Radiation oncology was consulted on 8/20 and performed palliative radiation therapy. Overall patient's functional status is very poor. Throughout her entire 23 day hospitalization she was unable to participate in care, unable to walk or urinate without a catheter secondary to her advanced disease. She was evaluated several times by physical therapy who recommended she be discharged to a rehabilitation facility, however she and her family declined. Patient and family's goal is to return home, however they were also not ready to make a transition to hospice prior to discharge until additional evaluation could be performed. Her symptoms are concerning for ongoing spinal cord compression, this was expressed to the patient and her family who still requested discharge home. Prior to discharge they planned to either follow-up with oncology in 1 week or transition to hospice once home. Resources provided for the hospice agency in their home county. Please see below for a problem based hospital course: Spinal Cord Compression secondary to metastatic malignancy Urinary Retention likely secondary to continued spinal cord compression - Presented with urinary retention, imaging with compression of cauda equina - Neurosurgery and ortho spine consulted, no operative management to offer - Foley placed on admission and treatment initiated for cord compression with dexamethasone, now status post palliative radiation - Voiding trial of 12hrs failed prior to discharge and foley was replaced. Discussed risks related to chronic indwelling foley catheter with patient and daughter as well as likely underlying cause. They requested discharge home. PLAN: - Discharged home with indwelling foley: If decision is made to transition to hospice, hospice will manage catheter. Will followup with PCP or oncology otherwise, daughter expressed understanding of etiology and plan - Dexamethasone 2mg daily continued at discharge Carcinoma metastatic to spine, axial skeleton and peritoneum (ER/PR positive AdenoCA) | Unproven primary - Biopsy at L7 (July 2021): metastatic carcinoma ER+/PR+ - Biopsy of breast mass (July 2021): fibroadenoma - Lumbar puncture with IR on 8/9/2021 without cells for cytology - Oncology consulted who recommended initiation of anastrozole, continuation of dexamethasone and further investigation for primary - CT A/P on 8/19 showed worsened peritoneal carcinomatosis. Surgical Oncology consulted for omental biopsy, however discussions with surgical oncology were discordant with conversations previously had with oncology regarding prognosis if this is truly metastatic breast cancer. If breast is true primary or if HER2 status can be delineated she would likely be candidate for hormonal therapy leading to improved quality of life. Surgical Oncology signed off. Planned to biopsy vertebral lesion 8/26 however patient did not tolerate positioning. PLAN: - Workup remaining includes obtaining tissue for HER2 testing, patient to followup with oncology if desired - Continue use of TSLO if attempts at ambulation made - Continuing anastrozole, dexamethasone Malignant Ascites - Required therapeutic paracentesis on 8/12, (4.9L removed, cytology positive for malignancy) and 8/26 (5.5L removed, cytology pending) PLAN: - Will need continued large volume paracentesis approximately every 2 weeks, will be set up via oncology or hospice (Patient to establish with Hospice, can perform in patient's home) Cancer-related pain - Patient underwent palliative radiation on 8/20, 8/21 - Palliative care consulted while inpatient to assist in pain regimen creation, prior to discharge adequate pain control had been achieved PLAN: - discharged with one week supply of Extended release morphine, 30mg BID, oxycodone 5mg q4 PRN and gabapentin - Hospice vs. Oncology will take responsibility of these medications Intermittent Hypotension - Patient had several episodes of asymptomatic, fluid responsive hypotension - Critical care consulted and recommended bolusing PRN - Lactate, urine output all within normal limits during these episodes - etiology could be secondary to progression of malignancy, infiltration of adrenal glands - patient declined invasive investigation or treatment that might delay her discharge home PLAN: - previous home antihypertensives held at discharge Depression - Psychiatry consulted during this admission PLAN: - continue venlafaxine at 75mg daily, mirtazapine 7.5mg at bedtime Acute respiratory failure with hypoxia | COVID-19: RESOLVED Bilateral pleural effusions in setting of malignant ascites - Patient COVID-19 Positive on admission, received dexamethasone and remdesivir PLAN: - will discharge home with supplemental oxygen Hyperlipidemia - Home statin continued during hospitalization and at discharge Hypothyroidism - Home levothyroxine continued during hospitalization and at discharge Type 2 DM [A1c 7.8%] - Patient received sliding scale insulin while inpatient, discharged to continue home metformin Operative Procedures Performed Lumbar Puncture 8/9/2021 Large Volume Paracentesis 8/12/2021 Large Volume Paracentesis 8/12/2021 Consults: Oncology, Palliative Care, Surgical Oncology, Critical Care, Psychiatry Physical Exam at Discharge Discharge Condition: poor Heart Rate: 101 Resp: 16 BP: 90/60 Temp: 36.3 ?C (97.3 ?F) SpO2: 90 % Weight: 108 kg (238 lb 1.6 oz) Gen: Asleep, in bed, wakes easily, in NAD CV: RRR, normal S1 and S2, no murmurs. Trace lower extremity edema to the level of the mid shin Respiratory: CTAB, no crackles or wheezes, asleep on nasal canula GI: Abdomen soft, nontender, non-distended GU: Foley catheter in place Integumentary: Warm, dry. Psych: Tired appearing this morning

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 25,0
Labordaten: tested COVID positive 8/6/21 (tested negative for COVID on 7/2/21, 8/16/21, and 8/17/21)
Aktuelle Erkrankungen: -
Vorgeschichte: Type II diabetes mellitus, essential hypertension, and known spinal lytic lesions
Andere Medikamente: amlodipine, aspirin, calcium carbonate, fluticasone nasal spray, levothyroxine, lisinopril-hydrochlorothiazide, melatonin, pravastatin, gabapentin, oxycodone, paroxetine, omeprazole, metformin
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1656135

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: GA
Alter: 57,0
Geschlecht: F
Eingang: 30.08.2021
Impfdatum: 10.08.2021
Beginn: 24.08.2021
Tage bis Beginn: 14,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Angiogram Chest X-ray Electrocardiogram Pulmonary embolism

Symptomtext

PT ADMITTED TO MEDICAL CENTER FOR PE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: HOSPITAL ADMISSION WITH EKG, CTA, XR CHEST AND ICR VASUCLAR TRANSCATHER INFUSION 8/29/21 CURRENTLY INHOUSE AND UNDER TREATMENT
Aktuelle Erkrankungen: HYPERTENSION, HYPERLIPIDEMA, PERIPHERAL NEUROPATHY,
Vorgeschichte: -
Andere Medikamente: ALLPURINOL, ASPIRIN, ATORVASTATIN, COREG CR, LASIX, LOSARTIN, NITROGLYCERIN PRN, OMEGA 3S, KCL10MeQ, TRILIPIX, B12, VIT D
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1602859

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: CO
Alter: 23,0
Geschlecht: M
Eingang: 21.08.2021
Impfdatum: 13.08.2021
Beginn: 14.08.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Blood test Body temperature decreased Cardiac function test Disorientation General physical health deterioration Hyperhidrosis Hypothermia Musculoskeletal disorder Near death experience Pulmonary function test Shock

Symptomtext

profuse sweating, loss of use of limbs, disoriented, temp drop to 85 degrees. Body started to shut down. Hypothermia, shock near death! by minutes if my son didn't get to the hospital exactly when he did! This was a nightmare and no one could explain it.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Near death experience
Hospital-Tage: 2,0
Labordaten: many blood tests for everything imaginable and heart and lung test.
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: at age 18 he had diarrhea and vomiting from flu shot

VAERS 1594386

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: CA
Alter: 62,0
Geschlecht: M
Eingang: 21.08.2021
Impfdatum: -
Beginn: 01.07.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute kidney injury COVID-19 pneumonia Coma Dehydration Multiple organ dysfunction syndrome Oxygen saturation SARS-CoV-2 test Sepsis Severe acute respiratory syndrome Suspected COVID-19 Thrombocytopenia

Symptomtext

COMA; COVID-19 RELATED PNEUMONIA; SEVERE SEPSIS; ACUTE RESPIRATORY SYNDROME; MULTIPLE ORGAN FAILURE; SUSPECTED COVID-19; ACUTE KIDNEY INJURY; THROMBOCYTOPENIA; SEVERELY DEHYDRATED; This spontaneous report received from a consumer concerned a 62 year old White, Not Hispanic or Latino male. The patient's height, and weight were not reported. The patient's concurrent conditions included: rheumatoid arthritis, non-smoker, and non alcohol user. The patient had no known allergies and no drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 201A21A expiry: UNKNOWN) dose was not reported, 1 total administered on 26-MAY-2021 for prophylactic vaccination. Concomitant medications included etanercept for rheumatoid arthritis. On 17-JUL-2021, the patient started feeling chills, fever and throwing up. The oximeter showed that his oxygen levels were low. On The patient was admitted to the hospital and on 18-JUL-2021 the patient was diagnosed with covid-19 related pneumonia. On an unspecified date in JUL-2021, it was reported that the patient was severely dehydrated and had an intravenous (IV), had thrombocytopenia and acute kidney injury. The reporter (spouse) stated that the patient was given 4 liters of oxygen but was not getting better, and hence was put on the ventilator. On JUL-2021, the patient experienced suspected covid-19, multiple organ failure. Laboratory data included: covid-19 antigen test (NR: not provided) positive to Covid-19. On an unspecified date, the patient experienced coma. On 25-JUL-2021, the patient died from covid-19 related pneumonia, severe sepsis, acute respiratory syndrome, suspected covid-19, and multiple organ failure. An autopsy was not performed. The duration of hospitalization was unspecified. The death certificate of the patient had severe sepsis, acute respiratory syndrome and covid-19 related pneumonia. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from coma, thrombocytopenia, acute kidney injury, and severely dehydrated. This report was serious (Death and Hospitalization Caused / Prolonged). This case is associated with a Product Quality Complaint.; Sender's Comments: V0;20210834830; Covid-19 vaccine ad26.cov2. s, Suspected covid-19, Covid-19 related pneumonia, Acute respiratory syndrome, Severe sepsis, Coma, Thrombocytopenia, Multiple organ failure, Acute kidney injury and Severely dehydrated. This events are considered unassessable. The events have a compatible/suggestive temporal relationship, is unlabeled, and have unknown scientific plausibility. There is no information on any other factors potentially associated with the events.; Reported Cause(s) of Death: COVID-19 RELATED PNEUMONIA; SEVERE SEPSIS; ACUTE RESPIRATORY SYNDROME; SUSPECTED COVID-19; MULTIPLE ORGAN FAILURE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Coma
Hospital-Tage: -
Labordaten: Test Date: 202107; Test Name: COVID-19 antigen test; Result Unstructured Data: positive to Covid-19; Test Date: 20210717; Test Name: Oxygen saturation; Result Unstructured Data: low.
Aktuelle Erkrankungen: Abstains from alcohol; Non-smoker; Rheumatoid arthritis (Enbrel).
Vorgeschichte: Comments: Patient had no known allergies and no drug abuse or illicit drug usage.
Andere Medikamente: ENBREL
Allergien: -
Vorherige Impfungen: -

VAERS 1263940

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: CO
Alter: 46,0
Geschlecht: M
Eingang: 18.08.2021
Impfdatum: 08.04.2021
Beginn: 19.04.2021
Tage bis Beginn: 11,0
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Activated partial thromboplastin time Angiogram pulmonary abnormal Arthralgia Arthritis bacterial Blood fibrinogen Angiogram Blood count Computerised tomogram head normal Computerised tomogram thorax abnormal Deep vein thrombosis Anticoagulant therapy Blood electrolytes normal Blood fibrinogen normal Electrocardiogram normal Blood glucose normal Brain natriuretic peptide normal Cellulitis Chest discomfort

Symptomtext

Im healthy 46 yo man who received the J&J vaccine for COVID19 on 4/8/2021. Thereafter, I had low grade subjective fevers, aching, and fatigue. I eventually also noticed headache and RLE discomfort. I went to a free-standing ER on 4/22/2021. My left leg was swollen and I have had pain in there. I returned to the ER on 4/24/2021 with LLE pain and swelling, as well as ongoing headaches. CT venogram was negative for cerebral sinus thrombosis, but LE dopplers showed a DVT(popliteal vein left leg) and CTA showed PE(thrombus in right lower lobe and segmental pulmonary arteries, on the left thrombus is in the distal main pulmonary artery with extension in to the upper and lower lobes). D dimer was 28,000. I had no prior history of VTE. I was transferred , steroids, IVIG, and bivalirudin were started.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 4,0
Labordaten: multiple complete blood counts D dimer
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 1263940

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: CO
Alter: 46,0
Geschlecht: M
Eingang: 18.08.2021
Impfdatum: 08.04.2021
Beginn: 19.04.2021
Tage bis Beginn: 11,0
Dosis: 1
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Activated partial thromboplastin time Angiogram pulmonary abnormal Arthralgia Arthritis bacterial Blood fibrinogen Angiogram Blood count Computerised tomogram head normal Computerised tomogram thorax abnormal Deep vein thrombosis Anticoagulant therapy Blood electrolytes normal Blood fibrinogen normal Electrocardiogram normal Blood glucose normal Brain natriuretic peptide normal Cellulitis Chest discomfort

Symptomtext

Im healthy 46 yo man who received the J&J vaccine for COVID19 on 4/8/2021. Thereafter, I had low grade subjective fevers, aching, and fatigue. I eventually also noticed headache and RLE discomfort. I went to a free-standing ER on 4/22/2021. My left leg was swollen and I have had pain in there. I returned to the ER on 4/24/2021 with LLE pain and swelling, as well as ongoing headaches. CT venogram was negative for cerebral sinus thrombosis, but LE dopplers showed a DVT(popliteal vein left leg) and CTA showed PE(thrombus in right lower lobe and segmental pulmonary arteries, on the left thrombus is in the distal main pulmonary artery with extension in to the upper and lower lobes). D dimer was 28,000. I had no prior history of VTE. I was transferred , steroids, IVIG, and bivalirudin were started.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 4,0
Labordaten: multiple complete blood counts D dimer
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 1559265

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: -
Alter: 89,0
Geschlecht: F
Eingang: 15.08.2021
Impfdatum: 09.08.2021
Beginn: 10.08.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death Headache

Symptomtext

Patient c/o sudden onset of headache to family and suddenly passed away immediately following statement made that she had a headache

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: none per family request
Aktuelle Erkrankungen: pneumonia
Vorgeschichte: Primary Diagnosis is: PNEUMONIA, UNSPECIFIED ORGANISM, ACUTE ON CHRONIC SYSTOLIC (CONGESTIVE) HEART FAILURE, PULMONARY FIBROSIS, UNSPECIFIED, ACUTE AND CHRONIC RESPIRATORY FAILURE, UNSPECIFIED WHETHER WITH HYPOXIA OR HYPERCAPNIA, HYPOTHYROIDISM, UNSPECIFIED, TYPE 2 DIABETES MELLITUS WITHOUT COMPLICATIONS, UNSPECIFIED ATRIAL FIBRILLATION, CHRONIC KIDNEY DISEASE, UNSPECIFIED, DIVERTICULOSIS OF INTESTINE, PART UNSPECIFIED, WITHOUT PERFORATION OR ABSCESS WITHOUT BLEEDING CHF Diabetes
Andere Medikamente: Allopurinol 100 MG, Anastrazole 1mg, atorvastatin 20mg, vitamin D, Lasix 20mg, lantus, Levaquin 500mg, synthroid 25mg, melatonin 5mg, omeprazole 20mg, trugenta, coreg, Eliquis 2.5mg, glipizide, iron 325mg
Allergien: none
Vorherige Impfungen: -

VAERS 1545944

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: FL
Alter: 64,0
Geschlecht: F
Eingang: 11.08.2021
Impfdatum: 21.05.2021
Beginn: 18.07.2021
Tage bis Beginn: 58,0
Dosis: 1
Route/Site: SYR / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure Arthralgia COVID-19 Condition aggravated Dyspnoea Essential hypertension Infection Oedema peripheral Pain SARS-CoV-2 test positive Ultrasound Doppler normal

Symptomtext

Patient required hospitalization due to breakthrough infection. She received JnJ vaccine on 05/21/21. Hospitalized from 07/18/21 - 07/26/21. Below is copied from discharge summary: Hospital Course: This is a 64-year-old female with past medical history of morbid obesity/arthralgias, presents with lower extremity edema and pain along with shortness of breath after testing positive for COVID-19. Patient has been vaccinated withJ&J vaccine last month. Acute hypoxic respiratory failure secondary to COVID 19 Better, tolerating nasal cannula Completed remdesivir. Continue decadron Keep PRN albuterol inhlaer Muccinex PRN D/c to a facility. Essential hypertension / NIDDM Resume outpatient medications Bilateral lower extremity arthritic pain Continue p.r.n. pain medications US neg for DVT Seizure disorder - stable continue Trileptal

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 8,0
Labordaten: SARS-COV-2, NAA, Detected on 07/25/21
Aktuelle Erkrankungen: -
Vorgeschichte: ? Arthritis ? BPPV (benign paroxysmal positional vertigo) ? Diabetes mellitus ? Gastric acidity ? Hypertension ? Seizures (CMS-HCC: 79) last 1980
Andere Medikamente: benazepril (LOTENSIN) 40 MG Tablet Take 40 mg by mouth daily. 10/12/17 Yes Information, Historical hydroCHLOROthiazide (HYDRODIURIL) 25 MG Tablet Take 25 mg by mouth daily. 10/12/17 Yes Information, Historical metFORMIN (GLUCOPHAGE-XR
Allergien: NKA
Vorherige Impfungen: -

VAERS 1532021

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: TX
Alter: 62,0
Geschlecht: F
Eingang: 06.08.2021
Impfdatum: 30.04.2021
Beginn: 26.05.2021
Tage bis Beginn: 26,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

COVID-19 pneumonia Death Dyspnoea Endotracheal intubation Mental status changes Respiratory failure SARS-CoV-2 test positive

Symptomtext

Janssen COVID-19 Vaccine EUA Patient received Janssen Vaccine on 4/30/2021. Presented to ED on 7/9/2021 with Altered Mental Status and Shortness of Breath. Admitted with Respiratory failure. Patient admitted 7/9/21 for COVID-19 pneumonia. Intubated 7/10 and completed treatment with decadron and remdesivir daily (7/9 - 7/13). Treated with ceftriaxone and azithromycin. Patient expired on 7/26/2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 18,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Type 2 diabetes, Stage 3 CKD, BMI 40.0-44.9
Andere Medikamente: Benefiber QD, Lovastatin 20 mg QD, Meloxicam 15 mg QD, MVI,
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1529248

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: FL
Alter: 43,0
Geschlecht: M
Eingang: 05.08.2021
Impfdatum: 04.08.2021
Beginn: 05.08.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Cardiac arrest Death

Symptomtext

Patient presented to the emergency room one day following being vaccinated in cardiac arrest. Patient is deceased.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Patient had cold symptoms for 1 week prior to vaccination
Vorgeschichte: None
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 1515554

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: -
Alter: -
Geschlecht: U
Eingang: 30.07.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure Arthralgia COVID-19 Condition aggravated Dyspnoea Essential hypertension Infection Oedema peripheral Pain in extremity SARS-CoV-2 test positive Ultrasound scan normal

Symptomtext

Patient hospitalized for breakthrough infection from 07/18/21 - 07/26/21. Patient received J&J vaccine on 05/21/21. The below information is copied from the patients discharge summary: This is a 64-year-old female with past medical history of morbid obesity/arthralgias, presents with lower extremity edema and pain along with shortness of breath after testing positive for COVID-19. Patient has been vaccinated with J&J vaccine last month. Patient BMI is 38. Acute hypoxic respiratory failure secondary to COVID 19 Better, tolerating nasal cannula Completed remdesivir. Continue decadron Keep PRN albuterol inhlaer Muccinex PRN D/c to SNF Essential hypertension / NIDDM Resume outpatient medications Bilateral lower extremity arthritic pain Continue p.r.n. pain medications US neg for DVT Seizure disorder - stable continue Trileptal

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 7,0
Labordaten: CORONAVIRUS (COVID-19), NAA Detected 07/25/21
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1514397

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: TX
Alter: 35,0
Geschlecht: F
Eingang: 30.07.2021
Impfdatum: -
Beginn: 05.06.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Atrial septal defect COVID-19 Cerebral artery occlusion Cerebrovascular accident Chills Fatigue Headache SARS-CoV-2 test SARS-CoV-2 test positive Thrombectomy Vaccination failure

Symptomtext

CEREBRAL ARTERY OCCLUSION; CEREBROVASCULAR ACCIDENT; ATRIAL SEPTAL DEFECT; THROMBECTOMY; CONFIRMED COVID-19 INFECTION; SARS-COV-2 TEST POSITIVE; CHILLS; FATIGUE; HEADACHE; CONFIRMED CLINICAL VACCINATION FAILURE; This spontaneous report received from a health care professional via a Regulatory Authority Vaccine Adverse Event Reporting System (VAERS ID: 1463769), concerned a 35 year old female patient of unspecified race and ethnic origin. The patient's height, and weight were not reported. The patient's concurrent condition included antiphospholipid syndrome. The patient had no allergies reported. On 14-JAN-2021, the patient was tested positive for coronavirus disease (COVID-19) via the COVID-19 polymerase chain reaction (PCR) test. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration was not reported, batch number: 201A21A and expiry: unknown) dose was not reported, 1 total, administered on 08-APR-2021 for prophylactic vaccination. Concomitant medication included Xarelto (rivaroxaban). On 05-JUN-2021, the patient experienced onset of chills, fatigue, headache and was tested positive for COVID-19 via COVID-19 PCR test [severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) test positive, confirmed covid-19 infection and confirmed clinical vaccination failure]. The patient went to emergency room visit and was hospitalized (date unspecified in report). On 05-JUN-2021, she had acute right middle cerebral artery (R MCA) ischemic stroke (cerebrovascular accident), 2/2 M1 occlusion (cerebral artery occlusion) status post (S/P) thrombectomy '(HCC)' (as reported), and had atrial septal defect [patent foramen ovale (PFO)]. On 12-JUN-2021, she was discharged to inpatient rehabilitation. The patient was hospitalized for 8 days. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the atrial septal defect, cerebral artery occlusion, cerebrovascular accident, chills, confirmed covid-19 infection, fatigue, headache, thrombectomy, SARS-COV-2 test positive and confirmed clinical vaccination failure was not reported. This report was serious (Hospitalization Caused / Prolonged, Other Medically Important Condition, Life Threatening, and Disability Or Permanent Damage). This report was associated with product quality complaint : 90000187446. Version created to amend previously reported information on 23-JUL-2021. Upon review following information amended. Event chills, fatigue and headache were updated from labeled to unlabeled. Additional information received from Consumer Complaint Vigilance Organization on 27-JUL-2021. The following information updated and incorporated into the case narrative. product quality complaint number was added.; Sender's Comments: V1: Follow-up information updates the labeling and adds a product quality complaint number; this does not change the previous assessment. This spontaneous report received from a Regulatory Authority [VAERS ID: 1463769] concerns a 35-year-old female patient of unspecified ethnicity who had an acute right middle cerebral artery (R MCA) ischemic stroke with cerebral artery occlusion and was hospitalized 58 days after receiving the Janssen Covid-19 vaccine. Concurrent condition included antiphospholipid syndrome. The patient was previously COVID-19 polymerase chain reaction (PCR) test positive 3 month prior to vaccination. On the day of hospitalization, the patient noted chills, fatigue, headache; COVID-19 PCR test was positive. The patient underwent thrombectomy "HCC"; atrial septal defect was noted. The subject's anti-phospholipid syndrome and SARS-COV-2 infection may have increased the risk for the events to occur. However, considering the temporal relationship with vaccination, a relationship with Janssen Covid-19 vaccine cannot be ruled out. Therefore, the relationship is considered indeterminate.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 8,0
Labordaten: Test Date: 20210114; Test Name: COVID-19 PCR test; Result Unstructured Data: Positive; Test Date: 20210605; Test Name: SARS-CoV-2 test; Result Unstructured Data: Positive PCR; Comments: PCR test
Aktuelle Erkrankungen: Antiphospholipid syndrome
Vorgeschichte: Comments: The patient had no allergies reported.
Andere Medikamente: XARELTO
Allergien: -
Vorherige Impfungen: -

VAERS 1474601

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: UT
Alter: 81,0
Geschlecht: F
Eingang: 15.07.2021
Impfdatum: 10.04.2021
Beginn: 14.07.2021
Tage bis Beginn: 95,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Angiogram pulmonary abnormal Deep vein thrombosis Pulmonary embolism

Symptomtext

Left leg DVT and Pulmonary Emboli developed 07/14/2021

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 1,0
Labordaten: CTPA 07/14/2021
Aktuelle Erkrankungen: n/a
Vorgeschichte: Actinic keratosis Ankle sprain Anxiety Arthritis Bilateral hand pain Calcium pyrophosphate arthropathy Chronic low back pain Chronic, continuous use of opioids Compression fracture COPD type A DDD (degenerative disc disease), lumbar Fall risk Fracture GERD (gastroesophageal reflux disease) Greater trochanteric bursitis H/O squamous cell carcinoma Heartburn History of skin cancer Hyperglycemia Hypertension Hypothyroidism Hypoxemia Irritable bowel syndrome Lactose intolerance Left lateral epicondylitis Left shoulder pain Long-term use of immunosuppressant medication Low back pain Low back strain Lumbar compression fracture Lumbar scoliosis Lumbar spondylosis with myelopathy Miscarriage NSAID long-term use Obstructive sleep apnea syndrome Osteoarthritis of both knees Osteoporosis Primary Osteoarthritis Psoriasis Psoriatic arthritis Squamous cell carcinoma Ureteral stone Vertigo Vitamin D deficiency
Andere Medikamente: folic acid 1 mg oral tablet, 1 mg= 1 tabs, Oral, Daily, 3 refills folic acid 1 mg oral tablet, 1 mg= 1 tabs, Oral, Daily Lidoderm 5% topical film, 1 patches, Topical, Daily meloxicam 15 mg oral tablet, 15 mg= 1 tabs, Oral, Daily, 3 refil
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1394032

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: TX
Alter: 35,0
Geschlecht: F
Eingang: 12.07.2021
Impfdatum: 08.04.2021
Beginn: 05.06.2021
Tage bis Beginn: 58,0
Dosis: 1
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Atrial septal defect COVID-19 Cerebral artery occlusion Cerebrovascular accident Chills Migraine Thrombosis Fatigue Headache SARS-CoV-2 test positive Thrombectomy

Symptomtext

6/5/2021 Positive PCR for COVID-19 and onset of chills, fatigue, headache (had a previous COVID-19 positive PCR 1/14/2021) 6/5/2021 Acute R MCA ischemic stroke 2/2 M1 occlusion s/p thrombectomy (HCC) PFO (patent foramen ovale) 6/12/2021 Discharged to inpatient rehabilitation

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 8,0
Labordaten: -
Aktuelle Erkrankungen: antiphospholipid syndrome
Vorgeschichte: antiphospholipid syndrome
Andere Medikamente: Xarelto
Allergien: None reported
Vorherige Impfungen: -

VAERS 1463752

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: -
Alter: 30,0
Geschlecht: M
Eingang: 11.07.2021
Impfdatum: 28.06.2021
Beginn: 10.07.2021
Tage bis Beginn: 12,0
Dosis: 1
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Angiogram pulmonary abnormal Anticoagulant therapy Chest pain Dyspnoea Dyspnoea exertional Fibrin D dimer Myocardial strain Pulmonary embolism

Symptomtext

About 12 days following vaccination, patient developed chest pain and shortness of breath. He went to the ED and was found to have multiple bilateral pulmonary emboli with signs of right heart strain. It is not clear if the vaccine was the cause of the embolism, but there are no other provoking factors that could be identified. He has been started on anticoagulants with improvement in symptoms, but he has persistent dyspnea with exertion.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 3,0
Labordaten: D-dimer 10-July CT Pulmonary Angiogram 10July
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1457398

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: CA
Alter: 45,0
Geschlecht: M
Eingang: 08.07.2021
Impfdatum: 10.04.2021
Beginn: 29.06.2021
Tage bis Beginn: 80,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Chest X-ray Chest pain Computerised tomogram thorax abnormal Fibrin D dimer increased Full blood count Metabolic function test Pulmonary embolism Troponin

Symptomtext

Chest pain began 6/28 and thought to be muscular in etiology but increased on 7/3 and was seen in ER and found to have elevated d dimer and CT showed multiple R sided PE.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: 7/4/21--d dimer, cbc, bmp, troponin, CXR, CT of chest
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 1264060

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: -
Alter: 48,0
Geschlecht: M
Eingang: 02.07.2021
Impfdatum: -
Beginn: 01.04.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Activated partial thromboplastin time shortened Angiogram pulmonary abnormal Anticoagulant therapy Antiphospholipid antibodies Antithrombin III Activated partial thromboplastin time Angiogram Beta-2 glycoprotein antibody Blood fibrinogen Chest discomfort Deep vein thrombosis Heparin-induced thrombocytopenia test positive Immunoglobulin therapy Blood homocysteine normal Blood smear test C-reactive protein increased Chest pain Coagulation test normal

Symptomtext

BILATERAL LOWER EXTREMITY PAIN; MULTIPLE ACUTE BILATERAL PULMONARY EMBOLI; PLATELET COUNT DECREASED; DEEP VEIN THROMBOSIS; VACCINE INDUCED THROMBOTIC THROMBOCYTOPENIA; ULTRASOUND DOPPLER ABNORMAL; FULL BLOOD COUNT; METABOLIC FUNCTION TESTS; MUSCLE SPAMS; SWELLING; MILD HEADACHE; This spontaneous report was received from a health care professional via a Regulatory Authority and from literature and concerned a 48 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included exercise induced asthma, and no tobacco use (both current and historically), and other pre-existing medical conditions included the patient had no known allergies. The patient was not obese, denied recent procedures, prolonged immobility, family history of bleeding or clotting disease, etc. The patient was up to date on cancer screenings based on age/family history. He was reported as being an unusually physically active and fit 48 year-old male who has enjoyed good health and exercised regularly. In 2019, his platelet count was 177 10*9/L. The patient reported flying out of town and back on 30-MAR-2021 and 04-APR-2021 respectively with the longest continuous flight lasting around 4 hours. The patient at age 48, received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 201A21A, expiry: UNKNOWN) dose was not reported, 1 total administered on 07-APR-2021 for prophylactic vaccination. Concomitant medications included finasteride, and salbutamol. On an unspecified date in APR-2021, the patient experienced mild headache. On 18-APR-2021, 11 days after receiving the vaccine, the patient experienced deep vein thrombosis, vaccine induced thrombotic thrombocytopenia; new pain in his big toe, bilateral leg cramping (muscle spasm), bilateral lower extremity pain, and swelling. The patient attributed soreness in the large muscle groups of his thighs to Peloton riding and exercise. The patient travelled again via airplane to an unspecified location 22-APR-2021 and 25-APR-2021 (both1 hr long flights). The patient administered Advil for the leg pain when he returned on an unspecified date. On an unspecified date he felt a leg vessel that "didn't seem right." On 26-APR-2021 the patient went to emergency department for evaluation presenting with leg pain and chest discomfort. He had normal vital signs and oxygen saturation. Additional laboratory results: Platelet count (NR 140-440 K/uL) 74; fibrinogen (NR 150-430 mg/dL) of 254; D-dimer (NR 0-499 ng/mL FEU) 15,109 ng/mL FEU; activated partial thromboplastin time (aPTT) (NR 25.1-36.5 s) 31.8. Venous duplex ultrasound of the lower extremities revealed non-occlusive DVT in the bilateral popliteal veins extending to the gastrocnemius veins, an occlusive DVT of the left posterior tibial vein, as well as occlusive superficial venous thrombosis in the bilateral saphenous veins. The patient was discharged from the emergency room on rivaroxaban 15 mg twice daily with two-day follow-up with his primary care physician. He had no known exposure to heparin before the onset of symptoms and no exposure during his emergency room visit. On 28-APR-2021 (also reported as the next day), the patient complained of a new onset of chest pain (pleuritic) and presented again to the emergency room. Chest CT showed presence of acute pulmonary embolism, with emboli present in segmental and more proximal arteries. He had already taken his rivaroxaban for the night (1800). The patient was hospitalized for further evaluation and work up. A peripheral smear showed thrombocytopenia without schistocytes. The hematology service was consulted, and a presumptive diagnosis of VITT (vaccine induced thrombotic thrombocytopenia) was made. His anti-PF4 enzyme-linked immunosorbent assay (ELISA) (LIFECODES PF4 IgG), performed on a sample collected prior to initiating IVIG therapy, demonstrated a strongly positive result of 3.323 optical density (OD) units (reference interval < 0.399), consistent with a diagnosis of VITT. The patient was immediately treated with 1 g/kg of intravenous immunoglobulins (IVIG) for 2 days, 1 mg/kg of prednisone, and switched from rivaroxaban to an intravenous argatroban infusion drip, during which he achieved therapeutic aPTT levels between 44 - 50 sec. The patient was also treated with apixaban. Other studies included: Magnetic resonance venography (MRV) and angiography (MRA) of the brain, performed due to symptoms of mild headaches, were unremarkable. Platelet factor 4 (NR: not provided) strong positive at 2.9 OD; Prothrombin mutation G20210A not detected, Red blood cell count (NR: 3.98 - 5.98) 5.07 M/ microliter, Red blood cell sedimentation rate (NR: not provided) Normal, SARS-CoV-2 test was negative, Serotonin release assay was positive, and WBC (NR: 3.2 - 10.6) 5.8 K/microliter. Anticardiolipin antibodies (NR: not provided) 5 GPL, Beta-2 glycoprotein 1 antibodies (NR: 0 - 20) 0 SGU, 5 SMU, Blood homocysteine (NR: not provided) 13.4 nml (normal), C-reactive protein (NR: not provided) 2.6, Cardiolipin immunoglobulin G (NR: 0 - 12) 6 MPL, Cell marker increased was positive, EKG (NR: not provided) Normal, Hematocrit (NR: 36.9 - 52.1) 42.2 %, Hemoglobin (NR: 2.5 - 18.0) 15.0 g/dL, Lupus anticoagulant (NR: not provided) not detected, MCHC (NR: 33.4 - 35.3) 35.5 g/dL, MCV (NR: 80.6 - 97.6) 83.2 fL. On an unspecified date the serotonin release assay was no longer positive. Within a week post-discharge, the patient developed recurrent thrombocytopenia, with a platelet count that down trended to 107 10*9/L His thrombocytopenia appeared to somewhat correlate with prednisone dose adjustments, suggesting an autoimmune-driven process, although it did not respond to repeat IVIG administration. Due to the normalized D-Dimer levels and negative SRA, it was assumed that there was no further ongoing platelet activation. The authors stated the patient had no prior risk factors for thrombosis other than the 2 recent 4-hour flights. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from bilateral lower extremity pain, was recovering from deep vein thrombosis, vaccine induced thrombotic thrombocytopenia, platelet count decreased, swelling, full blood count, metabolic function tests, muscle spasms, ultrasound doppler abnormal, and multiple acute bilateral pulmonary emboli, and the outcome of mild headache was not reported. This report was serious (Hospitalization Caused / Prolonged). This case is a duplicate of 20210642952. Additional information was received from literature article on 19-JUN-2021. The following information was updated and incorporated into the case narrative: literature reference information, additional reporters, laboratory data, updated events. It has been determined that Manufacture Report Number 20210514958 is a duplicate of deleted case 20210642952. All relevant information from Manufacture Report Number 20210642952 will be reported in this case 20210514958.; Sender's Comments: V2: Follow up consisted of a literature citation, presenting this case as a case report. This does not change the previous assessment. This case obtained via VAERS (ID 1264060) concerns a 48-year-old male who developed symptoms of bilateral lower extremity deep vein thromboses (DVT) and thrombocytopenia 11 days after receiving Janssen Covid-19 vaccine. Concurrent conditions included exercise induced asthma. Patient was not obese, did not smoke, denied recent procedures, family history of bleeding/clotting disease & was physically active. He was up to date on cancer screenings based on age/family history. He had taken two 1-hour long flights 15 days and 18 days post-vaccination. Concomitant medications included finasteride & salbutamol. After 1 week of bilateral leg cramping & swelling which began 11 days post-vaccination, he presented to emergency department (ED) where complete blood count showed platelets 74 k/uL, peripheral smear with giant platelets, and d-Dimer 15K. Venous duplex ultrasound showed nonocclusive DVT in the bilateral popliteal veins extending to the gastrocnemius veins, occlusive superficial vein thrombosis in the bilateral saphenous veins, and occlusive DVT of the left posterior tibial vein. He was started on rivaroxaban & was not hospitalized. Two days later, he developed new chest pain & returned to ED, where CT chest showed numerous bilateral pulmonary emboli. He was hospitalized; empiric treatment for vaccine-induced immune thrombotic thrombocytopenia was started: IVIG, steroids, & argatroban. Anti-PF4 resulted as OD=2.9 and 3.323 (strong positive), confirming diagnosis. The patient was recovering from the events. Based on evolving knowledge of Thrombosis with Thrombocytopenia Syndrome (TTS, per definition from Brighton Collaboration), low platelet count & temporal relationship to vaccination, the events are assessed to have a plausible relationship with vaccination.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: Test Date: 2019; Test Name: Platelet count; Result Unstructured Data: 177 10*9/L; Test Date: 20210426; Test Name: Factor V Leiden heterozygote; Result Unstructured Data: Negative; Test Date: 20210426; Test Name: Fibrinogen; Result Unstructured Data: 254 mg/dL; Test Date: 20210426; Test Name: Activated partial thromboplastin time; Result Unstructured Data: 31.8 s; Test Date: 20210426; Test Name: Oxygen saturation; Result Unstructured Data: Normal; Test Date: 20210426; Test Name: Vital signs measurement; Result Unstructured Data: Normal; Test Date: 20210426; Test Name: Complete blood count; Result Unstructured Data: Not reported; Test Date: 20210426; Test Name: Fibrin D dimer; Result Unstructured Data: 15 109 ng/mL; Test Date: 20210426; Test Name: Hypercoagulability; Result Unstructured Data: no abnormality; Test Date: 20210426; Test Name: Smear; Result Unstructured Data: Peripheral Smear - thrombocytopenia without schistocytes; Test Date: 20210426; Test Name: Basic metabolic panel; Result Unstructured Data: Normal; Test Date: 20210426; Test Name: Magnesium; Result Unstructured Data: within normal limits; Test Date: 20210426; Test Name: Platelet count; Result Unstructured Data: 150 10*9/L, 159 10*9/L, 74 10*9/L; Comments: Giant platelets; Test Date: 20210426; Test Name: Ultrasound Doppler; Result Unstructured Data: Nonocclusive deep vein thrombosis; Comments: Non occlusive deep vein thrombosis within the right popliteal vein extending to the gastrocnemius veins. Occlusive SVT of the right lesser saphenous vein. Nonocclusive DVT of the left popliteal vein extending into the gastrocnemius veins. Occlusive DVT of the left posterior tibial veins. Occlusive SVT of the greater saphenous vein.; Test Date: 20210426; Test Name: Prothrombin; Result Unstructured Data: Factor II PCR Negative; Test Date: 20210428; Test Name: Chest CT; Result Unstructured Data: Acute pulmonary embolism. Emboli in segmental and proximal arteries; Test Name: MCV; Result Unstructured Data: 83.2 fL; Test Name: Nuclear magnetic resonance angiography brain; Result Unstructured Data: mild headaches; Test Name: Nuclear magnetic resonance imaging brain; Result Unstructured Data: mild headaches; Test Name: Prothrombin mutation G20210A; Result Unstructured Data: not detected; Test Name: Red blood cell count; Result Unstructured Data: 5.07 M/ microliter; Test Name: Serotonin release assay; Result Unstructured Data: positive; Test Name: SARS-CoV-2 test; Result Unstructured Data: negative; Test Name: White blood cells; Result Unstructured Data: 5.8 K/microliter; Test Name: MRI brain; Result Unstructured Data: unremarkable; Test Name: Angiography; Result Unstructured Data: unremarkable; Test Name: Serotonin release assay; Result Unstructured Data: No longer positive; Test Name: MCHC; Result Unstructured Data: 35.5 g/dL; Test Name: Lupus anticoagulant; Result Unstructured Data: not detected; Test Name: Hemoglobin; Result Unstructured Data: 15.0 g/dL; Test Name: Hematocrit; Result Unstructured Data: 42.2 %; Test Name: Platelet factor 4; Result Unstructured Data: 3.323 optical density, thrombotic thrombocytopenia; Test Name: Cell marker increased; Result Unstructured Data: positive; Test Name: Platelet count; Result Unstructured Data: 107 10*9/L; Test Name: Beta-2 glycoprotein 1 antibodies; Result Unstructured Data: 0 SGU, 5 SMU; Test Name: Anticardiolipin antibodies; Result Unstructured Data: 5 GPL; Test Name: Activated partial thromboplastin time; Result Unstructured Data: 44-50 sec; Test Name: Red blood cell sedimentation rate; Result Unstructured Data: Normal; Test Name: Blood homocysteine; Result Unstructured Data: 13.4 nml (normal); Test Name: EKG; Result Unstructured Data: Normal; Test Name: Platelet factor 4; Result Unstructured Data: 2.9 Strong positive; Test Name: C-reactive protein; Result Unstructured Data: 2.6; Test Name: APTT; Result Unstructured Data: 31.8; Test Name: Cardiolipin immunoglobulin G; Result Unstructured Data: 6 MPL
Aktuelle Erkrankungen: Exercise induced asthma; Non-smoker
Vorgeschichte: Comments: The patient had no known allergies. The patient was not obese, recent procedures, prolonged immobility, family history of bleeding or clotting disease, etc. He is up to date on cancer screenings based on age/family history. Recent air travel (date and destination unspecified)
Andere Medikamente: FINASTERIDE; ALBUTEROL [SALBUTAMOL]
Allergien: -
Vorherige Impfungen: -

VAERS 1264060

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: -
Alter: 48,0
Geschlecht: M
Eingang: 02.07.2021
Impfdatum: -
Beginn: 01.04.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Activated partial thromboplastin time shortened Angiogram pulmonary abnormal Anticoagulant therapy Antiphospholipid antibodies Antithrombin III Activated partial thromboplastin time Angiogram Beta-2 glycoprotein antibody Blood fibrinogen Chest discomfort Deep vein thrombosis Heparin-induced thrombocytopenia test positive Immunoglobulin therapy Blood homocysteine normal Blood smear test C-reactive protein increased Chest pain Coagulation test normal

Symptomtext

BILATERAL LOWER EXTREMITY PAIN; MULTIPLE ACUTE BILATERAL PULMONARY EMBOLI; PLATELET COUNT DECREASED; DEEP VEIN THROMBOSIS; VACCINE INDUCED THROMBOTIC THROMBOCYTOPENIA; ULTRASOUND DOPPLER ABNORMAL; FULL BLOOD COUNT; METABOLIC FUNCTION TESTS; MUSCLE SPAMS; SWELLING; MILD HEADACHE; This spontaneous report was received from a health care professional via a Regulatory Authority and from literature and concerned a 48 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included exercise induced asthma, and no tobacco use (both current and historically), and other pre-existing medical conditions included the patient had no known allergies. The patient was not obese, denied recent procedures, prolonged immobility, family history of bleeding or clotting disease, etc. The patient was up to date on cancer screenings based on age/family history. He was reported as being an unusually physically active and fit 48 year-old male who has enjoyed good health and exercised regularly. In 2019, his platelet count was 177 10*9/L. The patient reported flying out of town and back on 30-MAR-2021 and 04-APR-2021 respectively with the longest continuous flight lasting around 4 hours. The patient at age 48, received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 201A21A, expiry: UNKNOWN) dose was not reported, 1 total administered on 07-APR-2021 for prophylactic vaccination. Concomitant medications included finasteride, and salbutamol. On an unspecified date in APR-2021, the patient experienced mild headache. On 18-APR-2021, 11 days after receiving the vaccine, the patient experienced deep vein thrombosis, vaccine induced thrombotic thrombocytopenia; new pain in his big toe, bilateral leg cramping (muscle spasm), bilateral lower extremity pain, and swelling. The patient attributed soreness in the large muscle groups of his thighs to Peloton riding and exercise. The patient travelled again via airplane to an unspecified location 22-APR-2021 and 25-APR-2021 (both1 hr long flights). The patient administered Advil for the leg pain when he returned on an unspecified date. On an unspecified date he felt a leg vessel that "didn't seem right." On 26-APR-2021 the patient went to emergency department for evaluation presenting with leg pain and chest discomfort. He had normal vital signs and oxygen saturation. Additional laboratory results: Platelet count (NR 140-440 K/uL) 74; fibrinogen (NR 150-430 mg/dL) of 254; D-dimer (NR 0-499 ng/mL FEU) 15,109 ng/mL FEU; activated partial thromboplastin time (aPTT) (NR 25.1-36.5 s) 31.8. Venous duplex ultrasound of the lower extremities revealed non-occlusive DVT in the bilateral popliteal veins extending to the gastrocnemius veins, an occlusive DVT of the left posterior tibial vein, as well as occlusive superficial venous thrombosis in the bilateral saphenous veins. The patient was discharged from the emergency room on rivaroxaban 15 mg twice daily with two-day follow-up with his primary care physician. He had no known exposure to heparin before the onset of symptoms and no exposure during his emergency room visit. On 28-APR-2021 (also reported as the next day), the patient complained of a new onset of chest pain (pleuritic) and presented again to the emergency room. Chest CT showed presence of acute pulmonary embolism, with emboli present in segmental and more proximal arteries. He had already taken his rivaroxaban for the night (1800). The patient was hospitalized for further evaluation and work up. A peripheral smear showed thrombocytopenia without schistocytes. The hematology service was consulted, and a presumptive diagnosis of VITT (vaccine induced thrombotic thrombocytopenia) was made. His anti-PF4 enzyme-linked immunosorbent assay (ELISA) (LIFECODES PF4 IgG), performed on a sample collected prior to initiating IVIG therapy, demonstrated a strongly positive result of 3.323 optical density (OD) units (reference interval < 0.399), consistent with a diagnosis of VITT. The patient was immediately treated with 1 g/kg of intravenous immunoglobulins (IVIG) for 2 days, 1 mg/kg of prednisone, and switched from rivaroxaban to an intravenous argatroban infusion drip, during which he achieved therapeutic aPTT levels between 44 - 50 sec. The patient was also treated with apixaban. Other studies included: Magnetic resonance venography (MRV) and angiography (MRA) of the brain, performed due to symptoms of mild headaches, were unremarkable. Platelet factor 4 (NR: not provided) strong positive at 2.9 OD; Prothrombin mutation G20210A not detected, Red blood cell count (NR: 3.98 - 5.98) 5.07 M/ microliter, Red blood cell sedimentation rate (NR: not provided) Normal, SARS-CoV-2 test was negative, Serotonin release assay was positive, and WBC (NR: 3.2 - 10.6) 5.8 K/microliter. Anticardiolipin antibodies (NR: not provided) 5 GPL, Beta-2 glycoprotein 1 antibodies (NR: 0 - 20) 0 SGU, 5 SMU, Blood homocysteine (NR: not provided) 13.4 nml (normal), C-reactive protein (NR: not provided) 2.6, Cardiolipin immunoglobulin G (NR: 0 - 12) 6 MPL, Cell marker increased was positive, EKG (NR: not provided) Normal, Hematocrit (NR: 36.9 - 52.1) 42.2 %, Hemoglobin (NR: 2.5 - 18.0) 15.0 g/dL, Lupus anticoagulant (NR: not provided) not detected, MCHC (NR: 33.4 - 35.3) 35.5 g/dL, MCV (NR: 80.6 - 97.6) 83.2 fL. On an unspecified date the serotonin release assay was no longer positive. Within a week post-discharge, the patient developed recurrent thrombocytopenia, with a platelet count that down trended to 107 10*9/L His thrombocytopenia appeared to somewhat correlate with prednisone dose adjustments, suggesting an autoimmune-driven process, although it did not respond to repeat IVIG administration. Due to the normalized D-Dimer levels and negative SRA, it was assumed that there was no further ongoing platelet activation. The authors stated the patient had no prior risk factors for thrombosis other than the 2 recent 4-hour flights. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from bilateral lower extremity pain, was recovering from deep vein thrombosis, vaccine induced thrombotic thrombocytopenia, platelet count decreased, swelling, full blood count, metabolic function tests, muscle spasms, ultrasound doppler abnormal, and multiple acute bilateral pulmonary emboli, and the outcome of mild headache was not reported. This report was serious (Hospitalization Caused / Prolonged). This case is a duplicate of 20210642952. Additional information was received from literature article on 19-JUN-2021. The following information was updated and incorporated into the case narrative: literature reference information, additional reporters, laboratory data, updated events. It has been determined that Manufacture Report Number 20210514958 is a duplicate of deleted case 20210642952. All relevant information from Manufacture Report Number 20210642952 will be reported in this case 20210514958.; Sender's Comments: V2: Follow up consisted of a literature citation, presenting this case as a case report. This does not change the previous assessment. This case obtained via VAERS (ID 1264060) concerns a 48-year-old male who developed symptoms of bilateral lower extremity deep vein thromboses (DVT) and thrombocytopenia 11 days after receiving Janssen Covid-19 vaccine. Concurrent conditions included exercise induced asthma. Patient was not obese, did not smoke, denied recent procedures, family history of bleeding/clotting disease & was physically active. He was up to date on cancer screenings based on age/family history. He had taken two 1-hour long flights 15 days and 18 days post-vaccination. Concomitant medications included finasteride & salbutamol. After 1 week of bilateral leg cramping & swelling which began 11 days post-vaccination, he presented to emergency department (ED) where complete blood count showed platelets 74 k/uL, peripheral smear with giant platelets, and d-Dimer 15K. Venous duplex ultrasound showed nonocclusive DVT in the bilateral popliteal veins extending to the gastrocnemius veins, occlusive superficial vein thrombosis in the bilateral saphenous veins, and occlusive DVT of the left posterior tibial vein. He was started on rivaroxaban & was not hospitalized. Two days later, he developed new chest pain & returned to ED, where CT chest showed numerous bilateral pulmonary emboli. He was hospitalized; empiric treatment for vaccine-induced immune thrombotic thrombocytopenia was started: IVIG, steroids, & argatroban. Anti-PF4 resulted as OD=2.9 and 3.323 (strong positive), confirming diagnosis. The patient was recovering from the events. Based on evolving knowledge of Thrombosis with Thrombocytopenia Syndrome (TTS, per definition from Brighton Collaboration), low platelet count & temporal relationship to vaccination, the events are assessed to have a plausible relationship with vaccination.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: Test Date: 2019; Test Name: Platelet count; Result Unstructured Data: 177 10*9/L; Test Date: 20210426; Test Name: Factor V Leiden heterozygote; Result Unstructured Data: Negative; Test Date: 20210426; Test Name: Fibrinogen; Result Unstructured Data: 254 mg/dL; Test Date: 20210426; Test Name: Activated partial thromboplastin time; Result Unstructured Data: 31.8 s; Test Date: 20210426; Test Name: Oxygen saturation; Result Unstructured Data: Normal; Test Date: 20210426; Test Name: Vital signs measurement; Result Unstructured Data: Normal; Test Date: 20210426; Test Name: Complete blood count; Result Unstructured Data: Not reported; Test Date: 20210426; Test Name: Fibrin D dimer; Result Unstructured Data: 15 109 ng/mL; Test Date: 20210426; Test Name: Hypercoagulability; Result Unstructured Data: no abnormality; Test Date: 20210426; Test Name: Smear; Result Unstructured Data: Peripheral Smear - thrombocytopenia without schistocytes; Test Date: 20210426; Test Name: Basic metabolic panel; Result Unstructured Data: Normal; Test Date: 20210426; Test Name: Magnesium; Result Unstructured Data: within normal limits; Test Date: 20210426; Test Name: Platelet count; Result Unstructured Data: 150 10*9/L, 159 10*9/L, 74 10*9/L; Comments: Giant platelets; Test Date: 20210426; Test Name: Ultrasound Doppler; Result Unstructured Data: Nonocclusive deep vein thrombosis; Comments: Non occlusive deep vein thrombosis within the right popliteal vein extending to the gastrocnemius veins. Occlusive SVT of the right lesser saphenous vein. Nonocclusive DVT of the left popliteal vein extending into the gastrocnemius veins. Occlusive DVT of the left posterior tibial veins. Occlusive SVT of the greater saphenous vein.; Test Date: 20210426; Test Name: Prothrombin; Result Unstructured Data: Factor II PCR Negative; Test Date: 20210428; Test Name: Chest CT; Result Unstructured Data: Acute pulmonary embolism. Emboli in segmental and proximal arteries; Test Name: MCV; Result Unstructured Data: 83.2 fL; Test Name: Nuclear magnetic resonance angiography brain; Result Unstructured Data: mild headaches; Test Name: Nuclear magnetic resonance imaging brain; Result Unstructured Data: mild headaches; Test Name: Prothrombin mutation G20210A; Result Unstructured Data: not detected; Test Name: Red blood cell count; Result Unstructured Data: 5.07 M/ microliter; Test Name: Serotonin release assay; Result Unstructured Data: positive; Test Name: SARS-CoV-2 test; Result Unstructured Data: negative; Test Name: White blood cells; Result Unstructured Data: 5.8 K/microliter; Test Name: MRI brain; Result Unstructured Data: unremarkable; Test Name: Angiography; Result Unstructured Data: unremarkable; Test Name: Serotonin release assay; Result Unstructured Data: No longer positive; Test Name: MCHC; Result Unstructured Data: 35.5 g/dL; Test Name: Lupus anticoagulant; Result Unstructured Data: not detected; Test Name: Hemoglobin; Result Unstructured Data: 15.0 g/dL; Test Name: Hematocrit; Result Unstructured Data: 42.2 %; Test Name: Platelet factor 4; Result Unstructured Data: 3.323 optical density, thrombotic thrombocytopenia; Test Name: Cell marker increased; Result Unstructured Data: positive; Test Name: Platelet count; Result Unstructured Data: 107 10*9/L; Test Name: Beta-2 glycoprotein 1 antibodies; Result Unstructured Data: 0 SGU, 5 SMU; Test Name: Anticardiolipin antibodies; Result Unstructured Data: 5 GPL; Test Name: Activated partial thromboplastin time; Result Unstructured Data: 44-50 sec; Test Name: Red blood cell sedimentation rate; Result Unstructured Data: Normal; Test Name: Blood homocysteine; Result Unstructured Data: 13.4 nml (normal); Test Name: EKG; Result Unstructured Data: Normal; Test Name: Platelet factor 4; Result Unstructured Data: 2.9 Strong positive; Test Name: C-reactive protein; Result Unstructured Data: 2.6; Test Name: APTT; Result Unstructured Data: 31.8; Test Name: Cardiolipin immunoglobulin G; Result Unstructured Data: 6 MPL
Aktuelle Erkrankungen: Exercise induced asthma; Non-smoker
Vorgeschichte: Comments: The patient had no known allergies. The patient was not obese, recent procedures, prolonged immobility, family history of bleeding or clotting disease, etc. He is up to date on cancer screenings based on age/family history. Recent air travel (date and destination unspecified)
Andere Medikamente: FINASTERIDE; ALBUTEROL [SALBUTAMOL]
Allergien: -
Vorherige Impfungen: -

VAERS 1264060

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: -
Alter: 48,0
Geschlecht: M
Eingang: 02.07.2021
Impfdatum: -
Beginn: 01.04.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Activated partial thromboplastin time shortened Angiogram pulmonary abnormal Anticoagulant therapy Antiphospholipid antibodies Antithrombin III Activated partial thromboplastin time Angiogram Beta-2 glycoprotein antibody Blood fibrinogen Chest discomfort Deep vein thrombosis Heparin-induced thrombocytopenia test positive Immunoglobulin therapy Blood homocysteine normal Blood smear test C-reactive protein increased Chest pain Coagulation test normal

Symptomtext

BILATERAL LOWER EXTREMITY PAIN; MULTIPLE ACUTE BILATERAL PULMONARY EMBOLI; PLATELET COUNT DECREASED; DEEP VEIN THROMBOSIS; VACCINE INDUCED THROMBOTIC THROMBOCYTOPENIA; ULTRASOUND DOPPLER ABNORMAL; FULL BLOOD COUNT; METABOLIC FUNCTION TESTS; MUSCLE SPAMS; SWELLING; MILD HEADACHE; This spontaneous report was received from a health care professional via a Regulatory Authority and from literature and concerned a 48 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included exercise induced asthma, and no tobacco use (both current and historically), and other pre-existing medical conditions included the patient had no known allergies. The patient was not obese, denied recent procedures, prolonged immobility, family history of bleeding or clotting disease, etc. The patient was up to date on cancer screenings based on age/family history. He was reported as being an unusually physically active and fit 48 year-old male who has enjoyed good health and exercised regularly. In 2019, his platelet count was 177 10*9/L. The patient reported flying out of town and back on 30-MAR-2021 and 04-APR-2021 respectively with the longest continuous flight lasting around 4 hours. The patient at age 48, received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 201A21A, expiry: UNKNOWN) dose was not reported, 1 total administered on 07-APR-2021 for prophylactic vaccination. Concomitant medications included finasteride, and salbutamol. On an unspecified date in APR-2021, the patient experienced mild headache. On 18-APR-2021, 11 days after receiving the vaccine, the patient experienced deep vein thrombosis, vaccine induced thrombotic thrombocytopenia; new pain in his big toe, bilateral leg cramping (muscle spasm), bilateral lower extremity pain, and swelling. The patient attributed soreness in the large muscle groups of his thighs to Peloton riding and exercise. The patient travelled again via airplane to an unspecified location 22-APR-2021 and 25-APR-2021 (both1 hr long flights). The patient administered Advil for the leg pain when he returned on an unspecified date. On an unspecified date he felt a leg vessel that "didn't seem right." On 26-APR-2021 the patient went to emergency department for evaluation presenting with leg pain and chest discomfort. He had normal vital signs and oxygen saturation. Additional laboratory results: Platelet count (NR 140-440 K/uL) 74; fibrinogen (NR 150-430 mg/dL) of 254; D-dimer (NR 0-499 ng/mL FEU) 15,109 ng/mL FEU; activated partial thromboplastin time (aPTT) (NR 25.1-36.5 s) 31.8. Venous duplex ultrasound of the lower extremities revealed non-occlusive DVT in the bilateral popliteal veins extending to the gastrocnemius veins, an occlusive DVT of the left posterior tibial vein, as well as occlusive superficial venous thrombosis in the bilateral saphenous veins. The patient was discharged from the emergency room on rivaroxaban 15 mg twice daily with two-day follow-up with his primary care physician. He had no known exposure to heparin before the onset of symptoms and no exposure during his emergency room visit. On 28-APR-2021 (also reported as the next day), the patient complained of a new onset of chest pain (pleuritic) and presented again to the emergency room. Chest CT showed presence of acute pulmonary embolism, with emboli present in segmental and more proximal arteries. He had already taken his rivaroxaban for the night (1800). The patient was hospitalized for further evaluation and work up. A peripheral smear showed thrombocytopenia without schistocytes. The hematology service was consulted, and a presumptive diagnosis of VITT (vaccine induced thrombotic thrombocytopenia) was made. His anti-PF4 enzyme-linked immunosorbent assay (ELISA) (LIFECODES PF4 IgG), performed on a sample collected prior to initiating IVIG therapy, demonstrated a strongly positive result of 3.323 optical density (OD) units (reference interval < 0.399), consistent with a diagnosis of VITT. The patient was immediately treated with 1 g/kg of intravenous immunoglobulins (IVIG) for 2 days, 1 mg/kg of prednisone, and switched from rivaroxaban to an intravenous argatroban infusion drip, during which he achieved therapeutic aPTT levels between 44 - 50 sec. The patient was also treated with apixaban. Other studies included: Magnetic resonance venography (MRV) and angiography (MRA) of the brain, performed due to symptoms of mild headaches, were unremarkable. Platelet factor 4 (NR: not provided) strong positive at 2.9 OD; Prothrombin mutation G20210A not detected, Red blood cell count (NR: 3.98 - 5.98) 5.07 M/ microliter, Red blood cell sedimentation rate (NR: not provided) Normal, SARS-CoV-2 test was negative, Serotonin release assay was positive, and WBC (NR: 3.2 - 10.6) 5.8 K/microliter. Anticardiolipin antibodies (NR: not provided) 5 GPL, Beta-2 glycoprotein 1 antibodies (NR: 0 - 20) 0 SGU, 5 SMU, Blood homocysteine (NR: not provided) 13.4 nml (normal), C-reactive protein (NR: not provided) 2.6, Cardiolipin immunoglobulin G (NR: 0 - 12) 6 MPL, Cell marker increased was positive, EKG (NR: not provided) Normal, Hematocrit (NR: 36.9 - 52.1) 42.2 %, Hemoglobin (NR: 2.5 - 18.0) 15.0 g/dL, Lupus anticoagulant (NR: not provided) not detected, MCHC (NR: 33.4 - 35.3) 35.5 g/dL, MCV (NR: 80.6 - 97.6) 83.2 fL. On an unspecified date the serotonin release assay was no longer positive. Within a week post-discharge, the patient developed recurrent thrombocytopenia, with a platelet count that down trended to 107 10*9/L His thrombocytopenia appeared to somewhat correlate with prednisone dose adjustments, suggesting an autoimmune-driven process, although it did not respond to repeat IVIG administration. Due to the normalized D-Dimer levels and negative SRA, it was assumed that there was no further ongoing platelet activation. The authors stated the patient had no prior risk factors for thrombosis other than the 2 recent 4-hour flights. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from bilateral lower extremity pain, was recovering from deep vein thrombosis, vaccine induced thrombotic thrombocytopenia, platelet count decreased, swelling, full blood count, metabolic function tests, muscle spasms, ultrasound doppler abnormal, and multiple acute bilateral pulmonary emboli, and the outcome of mild headache was not reported. This report was serious (Hospitalization Caused / Prolonged). This case is a duplicate of 20210642952. Additional information was received from literature article on 19-JUN-2021. The following information was updated and incorporated into the case narrative: literature reference information, additional reporters, laboratory data, updated events. It has been determined that Manufacture Report Number 20210514958 is a duplicate of deleted case 20210642952. All relevant information from Manufacture Report Number 20210642952 will be reported in this case 20210514958.; Sender's Comments: V2: Follow up consisted of a literature citation, presenting this case as a case report. This does not change the previous assessment. This case obtained via VAERS (ID 1264060) concerns a 48-year-old male who developed symptoms of bilateral lower extremity deep vein thromboses (DVT) and thrombocytopenia 11 days after receiving Janssen Covid-19 vaccine. Concurrent conditions included exercise induced asthma. Patient was not obese, did not smoke, denied recent procedures, family history of bleeding/clotting disease & was physically active. He was up to date on cancer screenings based on age/family history. He had taken two 1-hour long flights 15 days and 18 days post-vaccination. Concomitant medications included finasteride & salbutamol. After 1 week of bilateral leg cramping & swelling which began 11 days post-vaccination, he presented to emergency department (ED) where complete blood count showed platelets 74 k/uL, peripheral smear with giant platelets, and d-Dimer 15K. Venous duplex ultrasound showed nonocclusive DVT in the bilateral popliteal veins extending to the gastrocnemius veins, occlusive superficial vein thrombosis in the bilateral saphenous veins, and occlusive DVT of the left posterior tibial vein. He was started on rivaroxaban & was not hospitalized. Two days later, he developed new chest pain & returned to ED, where CT chest showed numerous bilateral pulmonary emboli. He was hospitalized; empiric treatment for vaccine-induced immune thrombotic thrombocytopenia was started: IVIG, steroids, & argatroban. Anti-PF4 resulted as OD=2.9 and 3.323 (strong positive), confirming diagnosis. The patient was recovering from the events. Based on evolving knowledge of Thrombosis with Thrombocytopenia Syndrome (TTS, per definition from Brighton Collaboration), low platelet count & temporal relationship to vaccination, the events are assessed to have a plausible relationship with vaccination.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: Test Date: 2019; Test Name: Platelet count; Result Unstructured Data: 177 10*9/L; Test Date: 20210426; Test Name: Factor V Leiden heterozygote; Result Unstructured Data: Negative; Test Date: 20210426; Test Name: Fibrinogen; Result Unstructured Data: 254 mg/dL; Test Date: 20210426; Test Name: Activated partial thromboplastin time; Result Unstructured Data: 31.8 s; Test Date: 20210426; Test Name: Oxygen saturation; Result Unstructured Data: Normal; Test Date: 20210426; Test Name: Vital signs measurement; Result Unstructured Data: Normal; Test Date: 20210426; Test Name: Complete blood count; Result Unstructured Data: Not reported; Test Date: 20210426; Test Name: Fibrin D dimer; Result Unstructured Data: 15 109 ng/mL; Test Date: 20210426; Test Name: Hypercoagulability; Result Unstructured Data: no abnormality; Test Date: 20210426; Test Name: Smear; Result Unstructured Data: Peripheral Smear - thrombocytopenia without schistocytes; Test Date: 20210426; Test Name: Basic metabolic panel; Result Unstructured Data: Normal; Test Date: 20210426; Test Name: Magnesium; Result Unstructured Data: within normal limits; Test Date: 20210426; Test Name: Platelet count; Result Unstructured Data: 150 10*9/L, 159 10*9/L, 74 10*9/L; Comments: Giant platelets; Test Date: 20210426; Test Name: Ultrasound Doppler; Result Unstructured Data: Nonocclusive deep vein thrombosis; Comments: Non occlusive deep vein thrombosis within the right popliteal vein extending to the gastrocnemius veins. Occlusive SVT of the right lesser saphenous vein. Nonocclusive DVT of the left popliteal vein extending into the gastrocnemius veins. Occlusive DVT of the left posterior tibial veins. Occlusive SVT of the greater saphenous vein.; Test Date: 20210426; Test Name: Prothrombin; Result Unstructured Data: Factor II PCR Negative; Test Date: 20210428; Test Name: Chest CT; Result Unstructured Data: Acute pulmonary embolism. Emboli in segmental and proximal arteries; Test Name: MCV; Result Unstructured Data: 83.2 fL; Test Name: Nuclear magnetic resonance angiography brain; Result Unstructured Data: mild headaches; Test Name: Nuclear magnetic resonance imaging brain; Result Unstructured Data: mild headaches; Test Name: Prothrombin mutation G20210A; Result Unstructured Data: not detected; Test Name: Red blood cell count; Result Unstructured Data: 5.07 M/ microliter; Test Name: Serotonin release assay; Result Unstructured Data: positive; Test Name: SARS-CoV-2 test; Result Unstructured Data: negative; Test Name: White blood cells; Result Unstructured Data: 5.8 K/microliter; Test Name: MRI brain; Result Unstructured Data: unremarkable; Test Name: Angiography; Result Unstructured Data: unremarkable; Test Name: Serotonin release assay; Result Unstructured Data: No longer positive; Test Name: MCHC; Result Unstructured Data: 35.5 g/dL; Test Name: Lupus anticoagulant; Result Unstructured Data: not detected; Test Name: Hemoglobin; Result Unstructured Data: 15.0 g/dL; Test Name: Hematocrit; Result Unstructured Data: 42.2 %; Test Name: Platelet factor 4; Result Unstructured Data: 3.323 optical density, thrombotic thrombocytopenia; Test Name: Cell marker increased; Result Unstructured Data: positive; Test Name: Platelet count; Result Unstructured Data: 107 10*9/L; Test Name: Beta-2 glycoprotein 1 antibodies; Result Unstructured Data: 0 SGU, 5 SMU; Test Name: Anticardiolipin antibodies; Result Unstructured Data: 5 GPL; Test Name: Activated partial thromboplastin time; Result Unstructured Data: 44-50 sec; Test Name: Red blood cell sedimentation rate; Result Unstructured Data: Normal; Test Name: Blood homocysteine; Result Unstructured Data: 13.4 nml (normal); Test Name: EKG; Result Unstructured Data: Normal; Test Name: Platelet factor 4; Result Unstructured Data: 2.9 Strong positive; Test Name: C-reactive protein; Result Unstructured Data: 2.6; Test Name: APTT; Result Unstructured Data: 31.8; Test Name: Cardiolipin immunoglobulin G; Result Unstructured Data: 6 MPL
Aktuelle Erkrankungen: Exercise induced asthma; Non-smoker
Vorgeschichte: Comments: The patient had no known allergies. The patient was not obese, recent procedures, prolonged immobility, family history of bleeding or clotting disease, etc. He is up to date on cancer screenings based on age/family history. Recent air travel (date and destination unspecified)
Andere Medikamente: FINASTERIDE; ALBUTEROL [SALBUTAMOL]
Allergien: -
Vorherige Impfungen: -

VAERS 1396391

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: CA
Alter: 73,0
Geschlecht: M
Eingang: 22.06.2021
Impfdatum: 26.05.2021
Beginn: 27.05.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death Malaise

Symptomtext

Pt had vaccine on 5/26, died (found down, no autopsy yet) on 6/3/21, last seen alive on 6/2/21

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: None - pt was found down
Aktuelle Erkrankungen: COPD HTN Prostate Cancer Hypercholesterolemia
Vorgeschichte: COPD HTN Prostate Cancer Hypercholesterolemia
Andere Medikamente: albuterol, amlodipine, aotrvastatin, bicalutamide, calcium, fluticason, folic acid, gabapentin, hydrochlorothiazine, hydrocodone-acetaminophen, incruse ellipta, melatonin, pantoprazole, senna, sertraline, tamsulsoin, tiotropium, trazodone
Allergien: NDKA
Vorherige Impfungen: -

VAERS 1413535

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: AR
Alter: 65,0
Geschlecht: M
Eingang: 21.06.2021
Impfdatum: 28.05.2021
Beginn: 06.06.2021
Tage bis Beginn: 9,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Acute respiratory failure Aphasia Aspiration Blood test Brain stem stroke Antiphospholipid antibodies Blood homocysteine normal Coagulation test normal Dysphagia Echocardiogram Cerebral thrombosis Computerised tomogram Depressed level of consciousness Feeling abnormal Ejection fraction Facial paralysis Factor II mutation Gastrostomy

Symptomtext

June 6 my husband got sick with a severe headache, fever and was a little unstable on his feet. He had previously had a few UTIs and kidney stones so I thought he had some type of infection. On June 7 I took him to the urgent care, they did a Covid test, flu test which came back negative. On June 7 they took him to ER by ambulance where he was admitted later that day. CT scan and MRI bloodwork x-rays were all done June 7, 8. June 9 in the morning the doctor came in and said he had a blood clot that went to his brain and caused him to have mini stroke. At this time we were at the hospital. Since there was not a neurologist at the hospital we had him med-flighted that evening to a different hospital. He arrived by helicopter on June 9 around 8:30 PM. June 10 at 3 AM in the morning he started to aspirate and have an acute respiratory failure with hypoxia which put him on life-support and later a feeding tube.June 21 he is still in ICU.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 14,0
Labordaten: Neurologist and I see you confirm that he had a brainstem stroke on the left side of his brain. He currently cannot swallow does not have the ability to talk and his conscious level has been affected. Sometimes he knows where he is and who I am, and sometimes he doesn?t. On June 17 they did a Tracheotomy and put a permanent feeding tube in his stomach.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Multivitamin, vitamin C, D3
Allergien: Sulfamethoxazole Clindamycin
Vorherige Impfungen: -

VAERS 1413535

UNKNOWN MANUFACTURER · COVID19 (COVID19 (UNKNOWN)) · Charge 201A21A

kritisch

Staat: AR
Alter: 65,0
Geschlecht: M
Eingang: 21.06.2021
Impfdatum: 28.05.2021
Beginn: 06.06.2021
Tage bis Beginn: 9,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Acute respiratory failure Aphasia Aspiration Blood test Brain stem stroke Antiphospholipid antibodies Blood homocysteine normal Coagulation test normal Dysphagia Echocardiogram Cerebral thrombosis Computerised tomogram Depressed level of consciousness Feeling abnormal Ejection fraction Facial paralysis Factor II mutation Gastrostomy

Symptomtext

June 6 my husband got sick with a severe headache, fever and was a little unstable on his feet. He had previously had a few UTIs and kidney stones so I thought he had some type of infection. On June 7 I took him to the urgent care, they did a Covid test, flu test which came back negative. On June 7 they took him to ER by ambulance where he was admitted later that day. CT scan and MRI bloodwork x-rays were all done June 7, 8. June 9 in the morning the doctor came in and said he had a blood clot that went to his brain and caused him to have mini stroke. At this time we were at the hospital. Since there was not a neurologist at the hospital we had him med-flighted that evening to a different hospital. He arrived by helicopter on June 9 around 8:30 PM. June 10 at 3 AM in the morning he started to aspirate and have an acute respiratory failure with hypoxia which put him on life-support and later a feeding tube.June 21 he is still in ICU.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 14,0
Labordaten: Neurologist and I see you confirm that he had a brainstem stroke on the left side of his brain. He currently cannot swallow does not have the ability to talk and his conscious level has been affected. Sometimes he knows where he is and who I am, and sometimes he doesn?t. On June 17 they did a Tracheotomy and put a permanent feeding tube in his stomach.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Multivitamin, vitamin C, D3
Allergien: Sulfamethoxazole Clindamycin
Vorherige Impfungen: -

VAERS 1371381

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: TX
Alter: 21,0
Geschlecht: F
Eingang: 14.06.2021
Impfdatum: 09.04.2021
Beginn: 25.05.2021
Tage bis Beginn: 46,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Angiogram pulmonary abnormal Anticoagulant therapy Asymptomatic COVID-19 Cardiac monitoring Electrocardiogram COVID-19 Fibrin D dimer increased Hypoxia Heart rate Odynophagia Pulmonary embolism Pulmonary pain SARS-CoV-2 test positive X-ray

Symptomtext

where she tested positive for COVID_19 and was also found to have pulmonary embolism. She was hospitalized for two days for acute pulmonary embolism. She had an episode of hypixia while in the hospital and needed oxygen. However she did not need ICU care. Her discharge medications were: acetaminophen 325 mg oral tablet 650 mg, PRN, PO q4h; apixaban 5 mg oral tablet; dextromethorphan-guaiFENesin 10 mg-100 mg/5 mL oral liquid 10 mL, PRN, q4h; dicyclomine 10 mg oral capsule 10 mg = 1 capsule qidACbedtime; methocarbamol 750 mg oral tablet 750 mg = 1 tab(s), PRN, PO; ondansetron 4 mg oral tablet, disintegrating 4 mg = 1 tab(s), PRN, PO (oral), q4h sertraline 150 mg, PO (oral), qDay traMADol 50 mg oral tablet 50 mg = 1 tab(s), PRN, PO (oral), q4h Vyvanse 30 mg, PO (oral), qAM

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 3,0
Labordaten: CT Angiography: mild pulmonary embolism involving the RLL pulmonary artery branch - 05/26/2021 Positive SARS COVID-19 nasal swab ABN - 05/26/2021 D-dimer: 1,371 (05/26/2021)
Aktuelle Erkrankungen: No
Vorgeschichte: ADHD/ Depression
Andere Medikamente: Vyvanse and Sertraline
Allergien: No
Vorherige Impfungen: -

VAERS 1365733

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: CA
Alter: 50,0
Geschlecht: F
Eingang: 01.06.2021
Impfdatum: 10.04.2021
Beginn: 24.05.2021
Tage bis Beginn: 44,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Anticoagulant therapy Chest pain Dyspnoea Pulmonary embolism

Symptomtext

Pulmoary Embolism - Chest Pain, Shortness of Breath Hospitalization of 3 days Treatment of blood thinners

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 3,0
Labordaten: -
Aktuelle Erkrankungen: Sjogrens, SLE
Vorgeschichte: -
Andere Medikamente: amplodipine, amoxicillin
Allergien: none
Vorherige Impfungen: -

VAERS 1356076

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: TN
Alter: 56,0
Geschlecht: F
Eingang: 27.05.2021
Impfdatum: 08.04.2021
Beginn: 14.04.2021
Tage bis Beginn: 6,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Computerised tomogram Laboratory test Migraine Pulmonary embolism

Symptomtext

migraine headaches Pulmonary Embolism

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: doctor visit. labwork multiple. CT SCANS multiple
Aktuelle Erkrankungen: none
Vorgeschichte: ideopathic neuropathy
Andere Medikamente: none
Allergien: slight milk
Vorherige Impfungen: -

VAERS 1354490

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: IL
Alter: 85,0
Geschlecht: M
Eingang: 27.05.2021
Impfdatum: 25.05.2021
Beginn: 27.05.2021
Tage bis Beginn: 2,0
Dosis: 1
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

Was found deceased in bed this morning

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: None known
Aktuelle Erkrankungen: Memory loss
Vorgeschichte: Smoker
Andere Medikamente: Unknown
Allergien: NKA
Vorherige Impfungen: -

VAERS 1354359

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: IL
Alter: 76,0
Geschlecht: M
Eingang: 27.05.2021
Impfdatum: 07.04.2021
Beginn: 12.05.2021
Tage bis Beginn: 35,0
Dosis: UNK
Route/Site: IM / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Acute kidney injury Acute respiratory distress syndrome Acute respiratory failure COVID-19 pneumonia Chronic kidney disease Condition aggravated Death Endotracheal intubation Intensive care Pneumothorax Septic shock

Symptomtext

Patient presented to this facility on 5/12/21 as transfer from hospital for treatment of acute hypoxic respiratory failure secondary to COVID pneumonia requiring intensive care unit treatment. Patient did receive a J&J COVID vaccine on 4/7/21. Patient was intubated on arrival. Patient was treated with remdesivir, tocilizumab, steroids, and antibiotics. Patient's ARDS progressed. He developed septic shock, recurrent pneumothoraces, and acute kidney injury on chronic kidney disease. Patient did not improve. Patient was transitioned to comfort care on 5/23/21 and patient expired.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: morbid obesity, coronary artery disease, chronic kidney disease
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1354152

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: TX
Alter: 79,0
Geschlecht: F
Eingang: 27.05.2021
Impfdatum: 06.04.2021
Beginn: 17.04.2021
Tage bis Beginn: 11,0
Dosis: UNK
Route/Site: SYR / AR

Tod: ja Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Apallic syndrome Aphasia Autoimmune disorder Back pain Computerised tomogram Contusion Death Dialysis Discomfort Dyskinesia Dysstasia Electroencephalogram Endotracheal intubation Fall Fatigue Fine motor skill dysfunction Gastrointestinal tube insertion General physical health deterioration

Symptomtext

Eleven days after getting the shot, my mother in law was experiencing severe back pain and was not able to get comfortable or sleep at night. Before we could take her to see a doctor, she fell while trying to get out of bed at 7am the next morning. She had trouble getting up and exerted a lot of energy trying on her own. She called for my husband and I to help her get up. I grabbed her around the waist and my husband held her walker for her as support. Upon rising (mostly of her own ability) she was so exhausted that we had her sit on her walker and rest a moment. My husband went to check on her twice over the next 15-20 minutes, but when he returned again she was showing classic stroke signs and EMS was called. They arrived quickly and agreed. She was taken immediately to the ER, where they also agreed that it looked like a stroke. She was admitted as they continued to run tests, but she continued to decline more and more each day at the hospital losing motor skills and ability to speak. She was not able to move her right side at all and the left side was fidgety and had uncontrollably flailing that left her bruises on her arm and leg. She was also excessively sleepy. After loads of testings and images, the MRIs finally showed that the brain stem was extremely inflamed and it was an auto-immune response. By this time, she was already a vegetable in the ICU ward under incubation, IVs and a feeding tube. They continued to run more tests and brought in infectious diseases, but they ultimately said her body was fighting an infection that she did not have. They attempted a hemoglobin treatment with an oncologist to shut down her immune system but never consulted with her renal doctor, even through they were very concerned about renal failure. She could not complete the treatment and only received 4 out of the 5 doses they wanted to give her because of her kidney counts. They said that the auto-immune attack was very aggressive and they could not shut it down. In the early morning of 4/28/21, they finally contacted her kidney doctor and she was put on dialysis as a last effort to try to save her, but it was too late and all her organs were failing. She passed at 1:56 pm. Patient was homebound during the pandemic and did not leave the house unless she was visiting her doctor's office. My husband and I have limited contact at our jobs, as we work in small offices, and our children (that also lived with her) were being schooled virtually. There is nothing that I know that could have caused her immune system to go into overdrive, except for the vaccine that was administered less than 2 weeks (which is considered the time frame for vaccine immunity) prior to her symptoms.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 11,0
Labordaten: Admitted to Hospital from 4/18/21 - 4/28/21. Several tests, MRIs, CTs, EEGs, etc. taken.
Aktuelle Erkrankungen: Recent checkups showed good health prior to vaccination.
Vorgeschichte: Pulmonary, Cardiac, and Kidney doctors said all her tests and checkups over the last 6 months were in good health.
Andere Medikamente: Albuterol Inhaler, Eliquis 5mg, Amiodarone 200mg, Aspirin 81mg, Wellbutrin 300mg, Centrum Silver, Colace 250 mg twice daily, Gabapentin 600mg twice daily, Losartan 50mg, Mirtazapine 7.5 mg, Simvastin 40mg, Tiotropium 18mg, Toviaz 4mg and Vi
Allergien: No Food or Medication Allergies
Vorherige Impfungen: Tetnus shot when she was younger. She told HCP but they still administered COVID vaccine because she still received the flu shot

VAERS 1346602

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: MD
Alter: 71,0
Geschlecht: F
Eingang: 25.05.2021
Impfdatum: 10.04.2021
Beginn: 04.05.2021
Tage bis Beginn: 24,0
Dosis: UNK
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Cerebrovascular accident Fall Peroneal nerve palsy Transient ischaemic attack

Symptomtext

Patient's daughter, called and states she is her mom's POA and she stated that she was with her mom when she got the vaccine in the parking lot. About 3 weeks ago her mom started dragging her foot and fell twice, she went to a facility and then was sent to hospital and was hospitalized for about 3 weeks, she has had two mini strokes, she is currently at nursing home. She also provided the name of her mom's PCP.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: unknown
Aktuelle Erkrankungen: unknown
Vorgeschichte: unknown
Andere Medikamente: unknown
Allergien: unknown
Vorherige Impfungen: -

VAERS 1327596

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: OH
Alter: 70,0
Geschlecht: M
Eingang: 25.05.2021
Impfdatum: -
Beginn: 08.05.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Myocardial infarction

Symptomtext

MAJOR HEART ATTACK, GOT PLACED WITH A STENT; This spontaneous report received from a patient concerned a 70-year-old male. The patient's weight, height, and medical history were not reported. Prior to the vaccination, patient was never on any medication. Patient had no pre-existing conditions. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, expiry: not reported) dose was not reported, 1 total administered on 04-MAY-2021 at 15:00 to left arm as prophylactic vaccination. No concomitant medications were reported. On 08-MAY-2021, four days after vaccination, the patient experienced major heart attack due to which he went in an ambulance (his spouse called 911) and was hospitalized on the same day. Patient was placed in ICU (intensive care unit) and got step down. On 10-MAY-2021, patient was discharged and he went home with a life vest. Patient was hospitalized for 3 days. No other side effects were reported. Patient got placed with a stent. Patient was discharged with Treatment medications (dates unspecified): lipitor 80 mg, losartan potassium 25 mg, plavix 75 mg, metoprolol succinate extended release 50mg, and baby aspirin 81 mg. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from major heart attack on 17-MAY-2021. This report was serious (Hospitalization).; Sender's Comments: V0; 20210535227 -covid-19 vaccine ad26.cov2. s major heart attack. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocardial infarction
Hospital-Tage: 3,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Prior to the vaccination, patient was never on any medication. Patient had no pre-existing conditions.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1327596

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: OH
Alter: 70,0
Geschlecht: M
Eingang: 25.05.2021
Impfdatum: -
Beginn: 08.05.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Myocardial infarction

Symptomtext

MAJOR HEART ATTACK, GOT PLACED WITH A STENT; This spontaneous report received from a patient concerned a 70-year-old male. The patient's weight, height, and medical history were not reported. Prior to the vaccination, patient was never on any medication. Patient had no pre-existing conditions. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, expiry: not reported) dose was not reported, 1 total administered on 04-MAY-2021 at 15:00 to left arm as prophylactic vaccination. No concomitant medications were reported. On 08-MAY-2021, four days after vaccination, the patient experienced major heart attack due to which he went in an ambulance (his spouse called 911) and was hospitalized on the same day. Patient was placed in ICU (intensive care unit) and got step down. On 10-MAY-2021, patient was discharged and he went home with a life vest. Patient was hospitalized for 3 days. No other side effects were reported. Patient got placed with a stent. Patient was discharged with Treatment medications (dates unspecified): lipitor 80 mg, losartan potassium 25 mg, plavix 75 mg, metoprolol succinate extended release 50mg, and baby aspirin 81 mg. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from major heart attack on 17-MAY-2021. This report was serious (Hospitalization).; Sender's Comments: V0; 20210535227 -covid-19 vaccine ad26.cov2. s major heart attack. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocardial infarction
Hospital-Tage: 3,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Prior to the vaccination, patient was never on any medication. Patient had no pre-existing conditions.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1323773

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: TX
Alter: 46,0
Geschlecht: F
Eingang: 17.05.2021
Impfdatum: 10.04.2021
Beginn: 16.04.2021
Tage bis Beginn: 6,0
Dosis: 1
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Anticoagulant therapy Catheter placement Pulmonary embolism

Symptomtext

Admitted with bilateral pulmonary emboli. Treated with anticoagulation via pulmonary catheter

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 3,0
Labordaten: -
Aktuelle Erkrankungen: unknown
Vorgeschichte: HTN, DM
Andere Medikamente: unknown
Allergien: Tramadol
Vorherige Impfungen: -

VAERS 1206380

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: TX
Alter: 19,0
Geschlecht: F
Eingang: 14.05.2021
Impfdatum: 08.04.2021
Beginn: 11.04.2021
Tage bis Beginn: 3,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Angiogram pulmonary abnormal Dyspnoea Dyspnoea exertional Magnetic resonance imaging head normal Pulmonary embolism Chest X-ray Computerised tomogram thorax Headache Magnetic resonance imaging Thrombosis Venogram normal

Symptomtext

3 days after vaccine given, developed DOE/DOB. Worsened, so 4/13/21, went to ER. Diagnosis with Pulmonary Embolism (right Main Pulmonary Art.) Had MRI of brain with venogram-normal.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: CTA Lungs -PE of right main pulm. artery MRI brain with venogram-Normal #item 20 below is improving
Aktuelle Erkrankungen: left ankle sprain, wearing a walking boot
Vorgeschichte: none
Andere Medikamente: Estrarylla
Allergien: no known
Vorherige Impfungen: -

VAERS 1273483

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: CA
Alter: 60,0
Geschlecht: M
Eingang: 07.05.2021
Impfdatum: 07.04.2021
Beginn: 10.04.2021
Tage bis Beginn: 3,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Apnoea Breath sounds absent Cardiac arrest Death Electrocardiogram abnormal Heart sounds abnormal Muscle rigidity Pulse absent Pupil fixed Unresponsive to stimuli

Symptomtext

Death

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: Cholesterol & High Blood Pressure
Andere Medikamente: Omeprazole, Atorvastatin, Losartan Potassium, Aspirin
Allergien: N/A
Vorherige Impfungen: -

VAERS 1273483

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: CA
Alter: 60,0
Geschlecht: M
Eingang: 07.05.2021
Impfdatum: 07.04.2021
Beginn: 10.04.2021
Tage bis Beginn: 3,0
Dosis: 1
Route/Site: SYR / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Apnoea Breath sounds absent Cardiac arrest Death Electrocardiogram abnormal Heart sounds abnormal Muscle rigidity Pulse absent Pupil fixed Unresponsive to stimuli

Symptomtext

Death

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: Cholesterol & High Blood Pressure
Andere Medikamente: Omeprazole, Atorvastatin, Losartan Potassium, Aspirin
Allergien: N/A
Vorherige Impfungen: -

VAERS 1288955

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: OH
Alter: 51,0
Geschlecht: M
Eingang: 05.05.2021
Impfdatum: 08.04.2021
Beginn: 20.04.2021
Tage bis Beginn: 12,0
Dosis: 1
Route/Site: SYR / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Autopsy Cardiac arrest Computerised tomogram Death Debridement Diarrhoea Dyspnoea Haemodialysis Hepatic failure Hypotension Influenza like illness Multiple organ dysfunction syndrome Necrotising fasciitis Pain in extremity Renal failure Sepsis Surgery Ultrasound scan

Symptomtext

Exactly 11 days after receiving the J&J vaccine my husband developed leg pain in his right lower inner leg, he was taken to the hospital on 04/20/2021 which a ultrasound was completed but resulted no blood clots, no other labs or treatment was performed that day, the next day he developed severe diarrhea and flu like symptoms with continued leg pain and difficulty breathing, He was then rushed to the hospital by ambulance where he was suffering from very low BP 41/31 was the lowest, a line was placed and he was put on pressors to increase his BP. He was transferred to the hospital where he was diagnosed with a flesh eating bacteria in the right leg where the pain was at and Sepsis. He was taken to surgery to debride the right leg and was started on CVVHD because his new kidney was now failing, he eventually was started back on Hemodialysis and taken to surgery 2 more times where he cardiac arrested on the table in surgery and died. A private autopsy is being performed but the preliminary results shows he had multi-system organ failure, including his liver which was NEVER a problem in the past.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: -
Labordaten: Autopsy, US, CT scan at the hospital
Aktuelle Erkrankungen: None
Vorgeschichte: Diabetes, HTN, Cholesterol, Kidney Transplant, Bilateral Knee amputee
Andere Medikamente: Coreg, Gabapentin, Atorvastain, Humalog, Tacrolimus, Prednisone, Aspirin, Sensipar
Allergien: Seasonal
Vorherige Impfungen: -

VAERS 1260946

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: IL
Alter: 54,0
Geschlecht: F
Eingang: 27.04.2021
Impfdatum: 10.04.2021
Beginn: 26.04.2021
Tage bis Beginn: 16,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Angiogram cerebral abnormal Computerised tomogram head abnormal Deep vein thrombosis Dizziness Dyspnoea Anticoagulant therapy Fibrin D dimer increased Head injury Myocardial strain Peripheral swelling Pulmonary embolism Skin laceration Syncope Ultrasound Doppler abnormal Ventricular septal defect

Symptomtext

Patient developed DVT post vaccination and was put on Eliquis

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 2,0
Labordaten: -
Aktuelle Erkrankungen: Patient had Covid-19 in February 2021
Vorgeschichte: Hypertension Hypothyroidism Depression
Andere Medikamente: Enalapril-HCTZ 10-25mg tabs Levothyroxine 200 mcg tabs Sertraline 50 mg tabs Apixaban 5 mg tabs
Allergien: No other allergies noted
Vorherige Impfungen: -

VAERS 1238499

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: GA
Alter: 67,0
Geschlecht: F
Eingang: 27.04.2021
Impfdatum: -
Beginn: 01.04.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cerebral haemorrhage Cerebrovascular accident Hypoaesthesia Computerised tomogram Magnetic resonance imaging

Symptomtext

BLOOD CLOTS IN LEFT TEMPORAL LOBE/BRAIN; STROKE; LEFT SIDE FACIAL NUMBNESS; This spontaneous report received from a patient concerned a 67 year old African American, not Hispanic or Latino female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient was not pregnant at time of reporting. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 201A21A, expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 in left arm for prophylactic vaccination. No concomitant medications were reported. On 12-APR-2021, the patient experienced blood clots in her left temporal lobe/brain that lead to stroke. On an unknown date APR/2021, she occasionally had left side facial numbness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the blood clots in left temporal lobe/brain, stroke and left side facial numbness was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: This 67-year-old African American (non-Hispanic/Latino) female was found to have "blood clots in left temporal lobe/brain that lead to stroke" 5 days after receiving Janssen COVID-19 vaccine for the prevention of symptomatic SARS-CoV-2 virus infection. No other details was reported. The information available precludes a complete and meaningful assessment. However, considering the temporal relationship and recently evolving theories in the literature about COVID infections and vaccinations, potential vaccine contribution cannot be excluded. Additional information as requested.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: The patient was not pregnant at time of reporting.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1238499

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: GA
Alter: 67,0
Geschlecht: F
Eingang: 27.04.2021
Impfdatum: -
Beginn: 01.04.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cerebral haemorrhage Cerebrovascular accident Hypoaesthesia Computerised tomogram Magnetic resonance imaging

Symptomtext

BLOOD CLOTS IN LEFT TEMPORAL LOBE/BRAIN; STROKE; LEFT SIDE FACIAL NUMBNESS; This spontaneous report received from a patient concerned a 67 year old African American, not Hispanic or Latino female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient was not pregnant at time of reporting. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 201A21A, expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 in left arm for prophylactic vaccination. No concomitant medications were reported. On 12-APR-2021, the patient experienced blood clots in her left temporal lobe/brain that lead to stroke. On an unknown date APR/2021, she occasionally had left side facial numbness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the blood clots in left temporal lobe/brain, stroke and left side facial numbness was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: This 67-year-old African American (non-Hispanic/Latino) female was found to have "blood clots in left temporal lobe/brain that lead to stroke" 5 days after receiving Janssen COVID-19 vaccine for the prevention of symptomatic SARS-CoV-2 virus infection. No other details was reported. The information available precludes a complete and meaningful assessment. However, considering the temporal relationship and recently evolving theories in the literature about COVID infections and vaccinations, potential vaccine contribution cannot be excluded. Additional information as requested.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: The patient was not pregnant at time of reporting.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1249792

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: CA
Alter: 84,0
Geschlecht: F
Eingang: 24.04.2021
Impfdatum: 10.04.2021
Beginn: 17.04.2021
Tage bis Beginn: 7,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Atrial fibrillation Cerebrovascular accident Disorientation Electrocardiogram abnormal Feeling abnormal Illiteracy Impaired driving ability Magnetic resonance imaging abnormal Visual impairment

Symptomtext

Patient complained of not being able to read 1 week after vaccine. 1 week and one day, became very disoriented. Taken to ER on 1 week and 2 days after the shot and diagnosed with a stroke in the left occipital lobe of brain. Also diagnosed with atrial fibrillation same day. (for first time.). Patient had no history of blood clotting disorders nor heart problems. This stroke rendered patient with restricted vision. She is now unable to drive, and still quite foggy, though she is likely to recover almost fully.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 2,0
Labordaten: MRI revealed stroke. EKG revealed AFib.
Aktuelle Erkrankungen: None, But did have Covid in 1/2021
Vorgeschichte: Knee replacement 12/20
Andere Medikamente: Lipitor, Calciuma, Vitamin C, Vitamin D
Allergien: None
Vorherige Impfungen: -

VAERS 1225917

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: FL
Alter: 61,0
Geschlecht: F
Eingang: 18.04.2021
Impfdatum: 08.04.2021
Beginn: 10.04.2021
Tage bis Beginn: 2,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Angiogram abnormal Brain natriuretic peptide increased Chest pain Deep vein thrombosis Dyspnoea Echocardiogram abnormal Pulmonary embolism Pulmonary hypertension Tachycardia Troponin

Symptomtext

Bilateral pulmonary embolism. She had chest pain, SOB, tachycardia in 130s. . Presented to ED. CTA positive for bilateral PE with Left popliteal DVT. She was treated with systemic TPA and heparin. She is still hospitalized.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 3,0
Labordaten: CTA 4/17/21 - Bilateral pulmonary emboli U/s 4/17/21 Nonocclusive DVT Left popliteal, occlusive DVT left peroneal vein Echo - EF 60-65%. severe pulmonary HTN >70 mm Hg. No obvious right heart strain. BNP 104 troponin 0.13
Aktuelle Erkrankungen: Skin cancer removal 4/5/21
Vorgeschichte: HTN, GERD, Asthma., chronic pain
Andere Medikamente: Lasix 40 mg po daily Albuterol 1 inhalation qid losartan 50 mg po daily methocarbamol 750 mg po daily montelukast 10 mg po daily. omprezole 40 mg po daily percocet q6 hours prn
Allergien: Morphine - pruritis
Vorherige Impfungen: -

VAERS 1222886

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: MD
Alter: 56,0
Geschlecht: M
Eingang: 17.04.2021
Impfdatum: 08.04.2021
Beginn: 15.04.2021
Tage bis Beginn: 7,0
Dosis: 1
Route/Site: SYR / AR

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Aneurysm Computerised tomogram Death

Symptomtext

Massive aneurysm - deceased 04-15-2021

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: CT Scan 04-15-2021
Aktuelle Erkrankungen: -
Vorgeschichte: HIV
Andere Medikamente: ODEFSEY 25 MG
Allergien: N/A
Vorherige Impfungen: -

VAERS 1221298

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: CA
Alter: 57,0
Geschlecht: F
Eingang: 16.04.2021
Impfdatum: 07.04.2021
Beginn: 15.04.2021
Tage bis Beginn: 8,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Angiogram pulmonary abnormal Fibrin D dimer increased Pulmonary embolism Ultrasound Doppler

Symptomtext

Large saddle pulmonary embolism. No DVT. Patient stable, hospitalized. Form competed upon admission, unknown duration of hospitalization at this time

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 1,0
Labordaten: CT angio: + PE LE Duplex US: negative D-dimer: positive
Aktuelle Erkrankungen: None
Vorgeschichte: hypothyroidisim
Andere Medikamente: NP thyroid 60mg progesterone/estrogen unknown dose
Allergien: penicillin, tetracycline, erythromycin
Vorherige Impfungen: -

VAERS 1213958

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: NC
Alter: 69,0
Geschlecht: M
Eingang: 15.04.2021
Impfdatum: 12.04.2021
Beginn: 15.04.2021
Tage bis Beginn: 3,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blood calcium normal Blood chloride normal Blood creatinine normal Blood magnesium normal Blood thyroid stimulating hormone normal Chest X-ray normal Chest discomfort Death Discomfort Electrocardiogram normal Full blood count normal Gastrointestinal pathogen panel Glycosylated haemoglobin Lipids normal Troponin normal

Symptomtext

PATIENT PRESENTED TO CLINIC FOR ANNUAL WELLNESS VISIT ON 4/12/2021 AND RECEIVED THE JANSSEN COVID-19 VACCINE FOLLOWING HIS VISIT. ON 4/14/2021 PATIENT CALLED EMS FOR C/O CHEST TIGHTNESS. DISCOMFORT HAD RESOLVED BY THE TIME EMS ARRIVED. PATIENT WAS TAKEN TO ER FOR FURTHER EVALUATION. PATIENT REMIANED FREE OF CHEST TIGHTNESS/DISCOMFORT THROUGHOUT THE VISIT AND CARDIAC WORK-UP AT THE ER WAS ESSENTIALLY NORMAL. PATIENT WAS DISCHARGED HOME WITH F/U INSTRUCTIONS. ON 4/15/21 RN RECEIVED A CALL FROM THE COUNTY MEDICAL EXAMINER STATING THAT PATIENT WAS FOUND DECEASED IN HIS DRIVEWAY THIS MORNING AT AROUND 09:41 AM. THERE WERE NO SIGNS OF FOUL PLAY AT THE SCENE. PATIENT'S RECENT PHYSICAL AND LAB WORK WITH HIS PROVIDER ON 4/12/2021 SHOWED NO FINDINGS OF CONCERN. PATIENT HAD NO CHRONIC ILLNESSES, WAS ACTIVE, AND OFFERED NO MEDICAL CONCERNS AT HIS VISIT ON 4/12/2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: 4/12/21 - Hgb A1c 5.4% 4/12/21 - Chem7/Ca++, Gi Panel, Magnesium, Tsh, Lipid Profile (non-fasting) - all results within normal/acceptable range 4/14/21 - CBC, Chemistry Panel, CR/CL, Trop - all results within normal/acceptable range 4/14/21 - Portable upright AP chest x-ray - normal 4:14/21 - EKG - no abnormal findings or changes
Aktuelle Erkrankungen: NONE
Vorgeschichte: NICOTINE DEPENDENCE OSTEOARTHRITIS
Andere Medikamente: HYDROCHLOROTHIAZIDE 25MG CALCIUM CARBONATE 1500MG
Allergien: NO KNOWN ALLERGIES
Vorherige Impfungen: -

VAERS 1212295

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: KY
Alter: 50,0
Geschlecht: F
Eingang: 15.04.2021
Impfdatum: 06.04.2021
Beginn: 07.04.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chills Death Disorganised speech Headache Musculoskeletal stiffness Neck pain Pain in extremity Pyrexia Resuscitation Unresponsive to stimuli

Symptomtext

Patients mom states 12 hours after vaccination dev: fever, chills, stiff neck. Symptoms got progressively worse throughout the day. on the evening of 4/8/21 patients mom describes patient talking "out of her head", fever, chills, leg pain, "bad" headache. On 4/9/21 patient woke up around 5:30 AM, sister helped to bathroom. reported leg pain, neck pain, headache. Laid back down. Sister found patient unresponsive around 9:00 AM. Sister performed CPR. Pronounced dead at patient's home by EMS.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: None reported
Aktuelle Erkrankungen: None reported
Vorgeschichte: Gastroparesis, current smoker
Andere Medikamente: Unknown
Allergien: No
Vorherige Impfungen: -

VAERS 1193697

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: OH
Alter: 68,0
Geschlecht: M
Eingang: 13.04.2021
Impfdatum: 09.04.2021
Beginn: 10.04.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Blood pressure systolic increased Cerebral mass effect Confusional state Dizziness Endotracheal intubation Cerebrovascular accident Gait disturbance Headache Intensive care International normalised ratio increased Subdural haematoma Unresponsive to stimuli

Symptomtext

pt had a massive stroke

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 5,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1198464

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

kritisch

Staat: TX
Alter: 26,0
Geschlecht: M
Eingang: 12.04.2021
Impfdatum: 11.04.2021
Beginn: 11.04.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Circulatory collapse

Symptomtext

Patient collapsed to hands and knees a few minutes after vaccination. Did not require medical assistance. Was able to leave on his own afterwards

Weitere VAERSDATA-Felder

Praegender Schweregrund: Circulatory collapse
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2718396

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: TX
Alter: 63,0
Geschlecht: M
Eingang: 28.11.2023
Impfdatum: 08.04.2021
Beginn: 23.12.2021
Tage bis Beginn: 259,0
Dosis: 1
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Blood creatinine increased COVID-19 Fibrin D dimer increased Haemoglobin abnormal Haemorrhage Hypoxia Imaging procedure Lung infiltration Polyuria Presyncope Respiratory failure SARS-CoV-2 test positive

Symptomtext

Patient noted to have Covid 19 +ve with bilateral infiltrates but no symptoms. Doxycycline started. Patient noted to have elevated creatinine. Next morning had a large bleeding episode with near syncope when tried to stand after the bowel movement. Bleeding scan negative. Bleeding stopped, hemoglobin stabilized. Unfortunately patient then became hypoxic, possible fluid overload versus worsening COVID. He started on diuresis During that time his D-dimer also increase to greater than 20. As he had stopped bleeding and his D-dimer was going up in the setting of respiratory failure, he was started on Lovenox on 12/31/2021. Patient received antibiotics steroids Remdesivir. Symptoms improved patient is discharged

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: 13,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2679373

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CA
Alter: 58,0
Geschlecht: F
Eingang: 05.09.2023
Impfdatum: 29.06.2021
Beginn: 09.09.2021
Tage bis Beginn: 72,0
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: ja Erholt: unbekannt

Magnetic resonance imaging head abnormal Thalamic infarction Thalamic stroke

Symptomtext

Right thalamic stroke 9/9/21

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thalamic stroke
Hospital-Tage: 2,0
Labordaten: MRI 9/13/21 Diagnostic imaging 102416352 9/13/2021 4:29 PM M.D. Signed by (M.D.), MEDICAL DOCTOR on 09/13/21 at 1629 CLINICAL HISTORY: F/U OLIGODENDROGLIOMA TO BE DONE ON September 15, 2021 OR COUPLE OF DAYS BEFORE. Neuro-oncology Protocol for Brain MRI Scans Pre-contrast: Axial T1, Coronal Flair, Axial Flair, Axial T2 and Axial DWI Post-contrast: Axial T1 post, Axial post FSPGR if possible (if not possible) do Coronal T1 post and sagital T1 post, Coronal T2-flair 5 mm thick cuts with no skip Send the ima COMPARISON: 3/5/2021 TECHNIQUE: Study performed per protocol. CONTRAST: 7.0 milliliter of GADAVIST was given on 9/13/2021 4:14:00 PM by route: INTRAVENOUS RIGHT ANTECUBITAL FINDINGS: There is a new 2.0 cm anterior right thalamic area of diffusion restriction with associated increased T2 weighted signal and peripheral discontinuous faint rim-like enhancement. There is no midline shift or mass effect. Sequelae of a left frontal craniotomy with subjacent left frontal lobe volume loss and signal alteration are stable. No associated abnormal enhancement is identified. There is again patchy left greater than right matter T2 hyperintense signal. The posterior fossa structures are unremarkable as imaged. Normal flow-voids are seen in the major intracranial arteries. The sella and parasellar structures are unremarkable as visualized. There is normal orbital signal. The visualized paranasal sinuses and mastoid air cells are clear. There is normal calvarial marrow signal. The imaged portion of the cervical spine is limited in assessment but no significant abnormality is identified. IMPRESSION: 1. Right thalamic likely subacute infarct. Consider a follow-up MRI brain without and with contrast in several weeks to exclude other etiologies. 2. Stable postoperative/posttreatment findings. This report electronically signed by MD on 9/13/2021 4:23 PM Display only: Transcription (102416352) on 9/13/2021 4:29 PM by M.D.
Aktuelle Erkrankungen: -
Vorgeschichte: Left frontal oligodendroglioma S/P resection 12/20/11, treated with radiation and temozolomide. Temozolomide completed 12/4/12.
Andere Medikamente: Loratadine (ALLERGY RELIEF, LORATADINE,) 10 mg Oral Tab, Take 1 tablet by mouth daily as needed for allergy symptoms . Do not exceed 1 tablet in 24 hours LevETIRAcetam (KEPPRA) 500 mg Oral Tab, Take 2 tablets by mouth 2 times a day (to rep
Allergien: None
Vorherige Impfungen: -

VAERS 2450535

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CA
Alter: 56,0
Geschlecht: F
Eingang: 17.09.2022
Impfdatum: 21.08.2021
Beginn: 15.04.2022
Tage bis Beginn: 237,0
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Anticoagulant therapy Blood test Pain in extremity Peripheral swelling Skin discolouration Thrombosis Ultrasound Doppler abnormal

Symptomtext

On April 15 2022, , I was sent to have an ultra sound on my lower left leg as it was getting worse in the swelling, coloration and pain level. When it was completed and read by the dr I was told I had a blood clot and would need to go to the ER for evaluation. After a stay in the ER with blood work having been completed, I was started on Eliquis.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: -
Labordaten: On April 15 2022, I had an ultra sound done on my lower left leg, as well as blood work in the ER
Aktuelle Erkrankungen: Hypothyroidism Polycystic ovarian disease MPD Borderline Type 2 diabetic Failed back syndrome Migraines Degenerative bone/joint disease Ulcers Obesity Venous insufficiency lower left leg for many years IBS-C
Vorgeschichte: Hypothyroidism Polycystic ovarian disease MPD Borderline Type 2 diabetic Failed back syndrome Migraines Degenerative bone/joint disease Ulcers Obesity Venous insufficiency for many years IBS-C
Andere Medikamente: Amrix 15mg 1cap 1Xdy Amitiza 24mcg 1cap 2Xdy Cymbalta 60mg 1cap 1Xdy Dexilant 60mg 1cap 1Xdy Famotidine 20mg 1 tab 1Xdy Hydromorphone 2mg 1tab 2Xdy as needed Levothroxine 50mcg 1tab 1Xdy Metformin 500mg 1tab 1Xdy Montalucast 10mg 1tab 1
Allergien: PCN, sulfa, Wellbutrin, Lyrica, lg amounts of codeine, Demerol , morphine Anzamet
Vorherige Impfungen: -

VAERS 2429390

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: -
Alter: 51,0
Geschlecht: M
Eingang: 03.09.2022
Impfdatum: 10.04.2021
Beginn: 20.05.2021
Tage bis Beginn: 40,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Burning sensation Guillain-Barre syndrome Laboratory test normal

Symptomtext

Narrative: Pt reports that he started experiencing a constant burning sensation in bilateral legs from groin to ankles that started about 1 week after receiving the COVID-19 VACCINE (J&J) on 4/10/21. provider completed additional workup with labs to investigate but could not conclude anything. Per primary care provider note on 8/2/22, COVID-19 VACCINE resulted in Guillain-Barre syndrome. Pt still has the sensation to some extent but is it improved and denies any weakness.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Guillain-Barre syndrome
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2400504

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: UT
Alter: 22,0
Geschlecht: M
Eingang: 03.08.2022
Impfdatum: 09.07.2021
Beginn: 23.08.2021
Tage bis Beginn: 45,0
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Bell's palsy Dysphagia Eyelid function disorder Facial paresis Hypoaesthesia Mastication disorder Neurological symptom

Symptomtext

Patient received Janssen vaccine at the jail on 7/9/2021 and 2 weeks later he started having neurologic symptoms (could only smile on the L side of his lip, could not his eye on the R side, difficulty chewing and swallowing, and eventually the R side of his face became numb). He was subsequently diagnosed with Bells Palsy by the physician at the jail. He came to get booster doses for COVID and at the time of our visit he stated that he feels he has fully recovered except that he his R eye does not blink as often as the L eye. I told him to refer to his primary care provider and never to get the Janssen vaccine again--he confirmed understanding.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bell's palsy
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: general anxiety disorder, STDs substance abuse disorder depression suicidal ideation
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 2363811

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: IL
Alter: -
Geschlecht: F
Eingang: 09.07.2022
Impfdatum: 07.04.2021
Beginn: 07.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Bell's palsy Computerised tomogram Disability Feeling abnormal Headache Hypoaesthesia Lethargy Magnetic resonance imaging Meningioma Mobility decreased Presyncope Thrombosis

Symptomtext

SHORT TERM DISABILITY; VERY LETHARGIC; MENINGIOMA; CAN HARDLY MOVE/NOT HERSELF/COULD NOT GET OUT OF BED; BAD HEADACHE; MENTAL FOG; ALMOST PASSED OUT; BLOOD CLOTS IN NECK; SUSPECTED BELLS PALSY; NUMBNESS IN LEFT HAND, FINGERS AND UP FOREARM, REST OF LEFT SIDE; This spontaneous report received from a patient concerned a female of unspecified age, race and ethnicity. The patient's height, and weight were not reported. The patient's concurrent conditions included: drug allergy (prednisone and all type of blood pressure medications), food allergy (oranges), no alcohol use, non smoker, and high blood pressure (blood pressure medication Lucinapro, in conjunction with Zeratek over the counter - as reported), and other pre-existing medical conditions included: The patient did not have any drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A expiry: 23-JUN-2021) dose was not reported, 1 total, administered on 07-APR-2021 in left arm for prophylactic vaccination. Concomitant medications included ergocalciferol for drug used for unknown indication, cetirizine hydrochloride for high blood pressure, and lisinopril for high blood pressure. On 07-APR-2021, while waiting in obligatory 15 minutes after receiving vaccine the patient experienced numbness in left hand, fingers and up forearm, patient walked out into parking and numbness spread to face and the rest of left side. Patient experienced eye drooping and lip drooping (similar to physical signs of stroke). Patient went home and the next day on 08-APR-2021, patient saw physician who ran a few tests, suspected Bell's Palsy but did recommend patient to go back to work and asked to keep monitoring her symptoms. 09-APR-2021 patient almost passed out at work and felt that she was in a fog and felt out of it. On 10-APR-2021, patient could not get out of bed, she called the on call nurse who recommended emergency room if patients symptoms were to get worse. Patient still experience mental fog and could hardly move, she was very lethargic, and not herself. On 10-APR-2021, she had a very bad headache. On 11-APR-2021 symptoms stayed the same. On 12-APR-2021 patient called her doctor who stated that patient might have inflammation and wanted to give her a "cocktail" that included prednisone, which patient was allergic to, so they could not give that to the patient. On 13-APR-2021, patient visited primary care doctor and showed him her neck where she had found a new symptom, small fluid filled knot, similar to a blister, and as doctor listened to neck and heard a whooshing sound, then sent patient to the emergency room for urgent care. In the emergency room Computerised tomogram scan was performed and they found blood clots in the neck. Patient was put on blood thinners and anti-inflammatory drugs. On 14-APR-2021, patient was called by primary care doctor and changed the prescription to Eliquis drug. Due to the fact that patient could not take any medication with Heparin in it. Patient sought out a Hematologist for further testing. Patient had Magnetic resonance imaging (MRI) done after hospital to check whether she had had a stroke or Bell's Palsy. Patient was continuing to suffer with adverse symptoms and went on Family and Medical Leave (FMLA) and then was put on short term disability and then forced into early retirement in FEB-2022. Her doctor was now recommending experimental treatments for her active symptoms. On 12-JUL-2021, Laboratory data included: MRI to look at the meningioma. On 23-OCT-2021, Laboratory data included: CT scan confirmed blood clots in neck. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from blood clots in neck, mental fog, suspected bells palsy, can hardly move/not herself/could not get out of bed, very lethargic, bad headache, short term disability, and numbness in left hand, fingers and up forearm, rest of left side, and the outcome of almost passed out and meningioma was not reported. This report was serious (Other Medically Important Condition). This report was associated with product quality complaint: 90000240836; Sender's Comments: V0: 20220706864-covid-19 vaccine ad26.cov2.s-blood clots in neck, short term disability. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered unassessable. 20220706864-covid-19 vaccine ad26.cov2.s-meningioma. The event(s) shows an incompatible temporal relationship. Therefore, this event(s) is considered not related. 20220706864-covid-19 vaccine ad26.cov2.s-suspected bells palsy. This event(s) is labeled per RA and is therefore considered potentially related.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bell's palsy
Hospital-Tage: -
Labordaten: Test Date: 20210413; Test Name: CT SCAN; Result Unstructured Data: blood clots in neck, discovered by accident a meningioma (a tumor found in the front right side near pituitary glands); Test Date: 20210712; Test Name: MRI; Result Unstructured Data: to look at the meningioma; Test Date: 20211023; Test Name: CT SCAN; Result Unstructured Data: performed for swelling in neck and blood clots which confirmed blood clots in neck; Test Name: MRI; Result Unstructured Data: result not reported, performed to check whether patient had a stroke or Bell's Palsy
Aktuelle Erkrankungen: Abstains from alcohol; Blood pressure high (blood pressure medication Lucinapro, in conjunction with Zeratek over the counter - as reported); Drug allergy (prednisone and all type of blood pressure medications); Food allergy (oranges); Non-smoker
Vorgeschichte: Comments: The patient did not have any drug abuse or illicit drug usage.
Andere Medikamente: VITAMIN D [ERGOCALCIFEROL]; LISINOPRIL; ZYRTEC [CETIRIZINE HYDROCHLORIDE]
Allergien: -
Vorherige Impfungen: -

VAERS 2327642

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CA
Alter: 28,0
Geschlecht: F
Eingang: 22.06.2022
Impfdatum: 29.06.2021
Beginn: 14.08.2021
Tage bis Beginn: 46,0
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Anaphylactic reaction Drug hypersensitivity Food allergy

Symptomtext

After the date of application of the vaccine, I took an ibuprofen pill, which was the first reaction of knowing that she had anaphylaxis, later, I took an ADVIL pill, which gave me the same reaction, which before the vaccination was never present. The 2 times I took those medications and went to the Emergency Room in which I was administered epinephrine. I couldn't or had no help knowing what caused me to become allergic to these medications, yet on 6/20/22 I went to the Emergency Room again for shrimp. The truth is that this time it was something more serious to the point of paying attention and asking for help for my condition, which I really know was after I had been given the vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Anaphylactic reaction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Anaphylaxis
Andere Medikamente: -
Allergien: Ibuprofen; ADVIL; Shrimp
Vorherige Impfungen: -

VAERS 1540434

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: FL
Alter: -
Geschlecht: F
Eingang: 18.06.2022
Impfdatum: 09.08.2021
Beginn: 09.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Anti-ganglioside antibody Blood albumin Blood glucose Blood lactate dehydrogenase CSF test Arthralgia Bell's palsy Chills Fatigue Glossodynia Electromyogram Guillain-Barre syndrome Magnetic resonance imaging head Magnetic resonance imaging spinal Nerve conduction studies Gait disturbance Hypoaesthesia Immunoglobulin therapy

Symptomtext

GUILLAIN-BARRE SYNDROME; This spontaneous report received from a literature article and also from a consumer via a company representative via social media. The author's objective was to report the first case of guillain-barre following the COVID-19 vaccination with the Johnson & Johnson COVID-19 vaccine. This report concerned concerned a 53 year old female of an unspecified race and ethnicity. The patient's height, and weight were not reported. The patient's concurrent conditions included: hypothyroidism, and bell's palsy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number and expiry date were not reported) dose was not reported, 1 total administered on 09-AUG-2021 for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications reported. On 09-AUG-2021, minutes after receiving the vaccine the patient reported that patient started feeling the development of a rash in palms, followed by the appearance of numbness and tingling in the distal left upper extremity. Hours after, the numbness progressed slowly in an ascending fashion through the left lower extremity, and overnight it extended to the contralateral lower extremity and left side of the face. The numbness was later accompanied by lower thoracic and lumbar pain. Because of patient's symptomatology, patient went to see primary care provider, who prescribed a short course of steroids and valganciclovir after suspecting a new episode of peripheral facial palsy. Due to the lack of improvement in patient's symptoms and a near syncopal episode at patient's home, patient decided to came to Emergency Department with complaints of a two-week history of progressive lower extremity weakness, paresthesias, and difficulty walking that started after receiving the COVID-19 J and J vaccination 14 days before presentation. At the time, the neurological examination revealed mild left-sided weakness in the left side of her body when compared to the contralateral side and intact reflexes throughout. MRI of the brain without contrast done during this first encounter was negative for any acute intracranial pathology, and patient was advised to continue to follow up with neurology as an outpatient and to consider electromyography and nerve conduction studies. Five days later, the patient presented again to institution due to progressive proximal weakness, paresthesias, and difficulty standing up from a chair and walking. At the time, patient denied any dyspnea, dysphagia, or diurnal variation in the weakness. On neurological exam, patient's mental status was alert, attentive, and oriented to person, place, and time. The speech was clear and fluent, with a good repetition, comprehension, and naming. Patient recalled 3/3 objects after five minutes. Cranial Nerves were intact, with full visual fields for confrontation. Pupils were round and reactive to light and accommodation. Extraocular movements were normal, and no nystagmus or diplopia was apparent. Patient's facial sensation was intact in all three branches of the trigeminal nerve bilaterally; the face was symmetric with normal eye closure and smile, the palate elevated symmetrically, phonation was normal, head-turning and shoulder shrug were intact, tongue protruded towards the midline, with normal movements and no atrophy. On motor exam, patient was noted to have proximal weakness 4/5 in hip flexors and hip extensors bilaterally, 4/5 knee extensors and flexors, 4/5 plantar flexion, 4/5 dorsiflexion bilaterally, 4/5 shoulder abductors and adduction, 4/5 elbow extensor and flexors. Reflex examination was pertinent for 2 plus reflexes in the biceps and triceps 2plus, knees, and 1plus Achilles' tendon reflex bilaterally. Sensory examination revealed normal sensation to light touch, pinprick, position sense, and vibration in fingers and toes. Coordination was normal, with rapid alternating movements intact. Gait was steady with normal steps, base arm swing, and turning. Heel and toe walking and tandem gait was normal. An MRI of the lumbar spine with and without contrast revealed subtle enhancement of the cauda equina nerve roots without overt thickening, suggestive of acute inflammatory demyelinating polyradiculoneuropathy (AIDP). Patient was admitted to the hospital out of suspicion of probable Guillain-Barre Syndrome. Due to this concern, the patient was started with intravenous immunoglobulin. Subsequent Lumbar puncture and CSF analysis reported a clear appearance, a very mild elevated protein with a slightly elevated mononuclear pleocytosis, and normal glucose levels (Protein 47 mg/dL, Albumin 25 mg/dL, Glucose 63 mg/dL, red blood cells [RBCs] 0/mcL, WBC 1/mcL 100% mononuclear, venereal disease research laboratory test [VDRL] non-reactive, lactate dehydrogenase [LDH] 23 IU/L). GM1 and GQ1b antibodies were reported as negative. The patient started to feel improvement in weakness from day two of IVIg and continued to receive this treatment for a total of five days without any complications or adverse effects. Patient's physical exam on the day of discharge showed 5/5 proximal and distal strength in all patient's extremities and normal deep tendon reflexes. Patient was discharged home with home health care, with outpatient physical therapy, and was scheduled for follow-up as an outpatient in our neurology clinic. The Centers for Disease Control Vaccine Adverse Event Reporting System (VAERS) was notified about this abnormal reaction. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from guillain-barre syndrome. The authors concluded that to the best of their knowledge, they report the first real-life case of guillain-barre syndrome associated with the Johnson & Johnson Covid-19 vaccine. While there is insufficient evidence to establish a temporal correlation, they strongly believe that physicians should remain watchful, have a high degree of suspicion, and be able to recognize neurological complications associated with the Covid-19 vaccination. Early diagnosis and subsequent management can prevent disability. The risk of neurological complications after the Covid-19 vaccination is low, and the benefits of the vaccination outweigh the risks and side effects. This report was serious (Hospitalization Caused / Prolonged). This case is a duplicate of 20220618274. Additional information was received from a literature article on 09-JUN-2022. The following information was updated and incorporated into the case narrative: Literature article information and authors information, author's objective and conclusion, case level and event level updated to medically confirmed, onset date for the event, therapy start date, and upon follow up, case validity assessment was updated to valid from the previously assessment of non-valid. It was determined that deletion was required for Manufacturer Report Number 20220618274 as it was duplicate of Manufacturer Case Number 20220437168. All relevant information regarding Manufacturer Report Number 20220618274 will be submitted under Manufacturer Case Number 20220437168.; Sender's Comments: V1: This follow up version updates information: Literature article information and authors information, author's objective and conclusion, onset date for the event, therapy start date, and case validity assessment was updated to valid from the previously assessment of non-valid. All relevant information regarding Manufacturer Report Number 20220618274 will be submitted under Manufacturer Case Number 20220437168. The follow up information does not change the causality of the previous reported events. 20220437168-covid-19 vaccine ad26.cov2.s-guillain-barre syndrome. This event(s) is labeled per RSI and is therefore considered potentially related.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Guillain-Barre syndrome
Hospital-Tage: -
Labordaten: Test Name: MRI OF THE BRAIN; Result Unstructured Data: negative for any acute intracranial pathology; Test Name: PHYSICAL EXAMINATION; Result Unstructured Data: 5/5 proximal and distal strength in all her extremities and normal deep tendon reflexes.; Test Name: ELECTROMYOGRAPHY; Result Unstructured Data: not reported; Test Name: NEUROLOGICAL EXAMINATION; Result Unstructured Data: mental status was alert, attentive, and oriented to person, place, and time. The speech was clear and fluent, with a good repetition, comprehension, and naming. She recalled 3/3 objects after five minutes. Cranial Nerves were intact, with full visual fields for confrontation. Pupils were round and reactive to light and accommodation. Extraocular movements were normal, and no nystagmus or diplopia was apparent. Her facial sensation was intact in all three branches of the trigeminal nerve bilaterally; the face was symmetric with normal eye closure and smile, the palate elevated symmetrically, phonation was normal, head-turning and shoulder shrug were intact, tongue protruded towards the midline, with normal movements and no atrophy.; Test Name: MRI OF THE LUMBAR SPINE; Result Unstructured Data: with and without contrast revealed subtle enhancement of the cauda equina nerve roots without over thickening, suggestive of acute inflammatory demyelinating polyradiculoneuropathy (AIDP); Test Name: MOTOR EXAMINATION; Result Unstructured Data: proximal weakness proximal weakness; Test Name: SENSORY EXAMINATION; Result Unstructured Data: normal sensation to light touch, pinprick, position sense, and vibration in fingers and toes. Coordination was normal, with rapid alternating movements intact. Gait was steady with normal steps, base arm swing, and turning. Heel and toe walking and tandem gait was normal.; Test Name: CSF ANALYSIS; Result Unstructured Data: a clear appearance, a very mild elevated protein with a slightly elevated mononuclear pleocytosis, and normal glucose levels.; Test Name: PROTEIN; Result Unstructured Data: 47 mg/dL; Test Name: ALBUMIN; Result Unstructured Data: 25 mg/dL; Test Name: GLUCOSE; Result Unstructured Data: 63 mg/dL; Test Name: RED BLOOD CELL COUNT; Result Unstructured Data: 0 cells/microL; Test Name: WHITE BLOOD CELL COUNT; Result Unstructured Data: 1 cells/microL; Test Name: LDH; Result Unstructured Data: 23 IU/L; Test Name: GM1 AND GQ1B ANTIBODIES; Test Result: Negative ; Test Name: NEUROLOGICAL EXAMINATION; Result Unstructured Data: mild left-sided weakness in the left side of her body when compared to the contralateral side and intact reflexes throughout.
Aktuelle Erkrankungen: Bell's palsy; Hypothyroidism
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1540434

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: FL
Alter: -
Geschlecht: F
Eingang: 18.06.2022
Impfdatum: 09.08.2021
Beginn: 09.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Anti-ganglioside antibody Blood albumin Blood glucose Blood lactate dehydrogenase CSF test Arthralgia Bell's palsy Chills Fatigue Glossodynia Electromyogram Guillain-Barre syndrome Magnetic resonance imaging head Magnetic resonance imaging spinal Nerve conduction studies Gait disturbance Hypoaesthesia Immunoglobulin therapy

Symptomtext

GUILLAIN-BARRE SYNDROME; This spontaneous report received from a literature article and also from a consumer via a company representative via social media. The author's objective was to report the first case of guillain-barre following the COVID-19 vaccination with the Johnson & Johnson COVID-19 vaccine. This report concerned concerned a 53 year old female of an unspecified race and ethnicity. The patient's height, and weight were not reported. The patient's concurrent conditions included: hypothyroidism, and bell's palsy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number and expiry date were not reported) dose was not reported, 1 total administered on 09-AUG-2021 for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications reported. On 09-AUG-2021, minutes after receiving the vaccine the patient reported that patient started feeling the development of a rash in palms, followed by the appearance of numbness and tingling in the distal left upper extremity. Hours after, the numbness progressed slowly in an ascending fashion through the left lower extremity, and overnight it extended to the contralateral lower extremity and left side of the face. The numbness was later accompanied by lower thoracic and lumbar pain. Because of patient's symptomatology, patient went to see primary care provider, who prescribed a short course of steroids and valganciclovir after suspecting a new episode of peripheral facial palsy. Due to the lack of improvement in patient's symptoms and a near syncopal episode at patient's home, patient decided to came to Emergency Department with complaints of a two-week history of progressive lower extremity weakness, paresthesias, and difficulty walking that started after receiving the COVID-19 J and J vaccination 14 days before presentation. At the time, the neurological examination revealed mild left-sided weakness in the left side of her body when compared to the contralateral side and intact reflexes throughout. MRI of the brain without contrast done during this first encounter was negative for any acute intracranial pathology, and patient was advised to continue to follow up with neurology as an outpatient and to consider electromyography and nerve conduction studies. Five days later, the patient presented again to institution due to progressive proximal weakness, paresthesias, and difficulty standing up from a chair and walking. At the time, patient denied any dyspnea, dysphagia, or diurnal variation in the weakness. On neurological exam, patient's mental status was alert, attentive, and oriented to person, place, and time. The speech was clear and fluent, with a good repetition, comprehension, and naming. Patient recalled 3/3 objects after five minutes. Cranial Nerves were intact, with full visual fields for confrontation. Pupils were round and reactive to light and accommodation. Extraocular movements were normal, and no nystagmus or diplopia was apparent. Patient's facial sensation was intact in all three branches of the trigeminal nerve bilaterally; the face was symmetric with normal eye closure and smile, the palate elevated symmetrically, phonation was normal, head-turning and shoulder shrug were intact, tongue protruded towards the midline, with normal movements and no atrophy. On motor exam, patient was noted to have proximal weakness 4/5 in hip flexors and hip extensors bilaterally, 4/5 knee extensors and flexors, 4/5 plantar flexion, 4/5 dorsiflexion bilaterally, 4/5 shoulder abductors and adduction, 4/5 elbow extensor and flexors. Reflex examination was pertinent for 2 plus reflexes in the biceps and triceps 2plus, knees, and 1plus Achilles' tendon reflex bilaterally. Sensory examination revealed normal sensation to light touch, pinprick, position sense, and vibration in fingers and toes. Coordination was normal, with rapid alternating movements intact. Gait was steady with normal steps, base arm swing, and turning. Heel and toe walking and tandem gait was normal. An MRI of the lumbar spine with and without contrast revealed subtle enhancement of the cauda equina nerve roots without overt thickening, suggestive of acute inflammatory demyelinating polyradiculoneuropathy (AIDP). Patient was admitted to the hospital out of suspicion of probable Guillain-Barre Syndrome. Due to this concern, the patient was started with intravenous immunoglobulin. Subsequent Lumbar puncture and CSF analysis reported a clear appearance, a very mild elevated protein with a slightly elevated mononuclear pleocytosis, and normal glucose levels (Protein 47 mg/dL, Albumin 25 mg/dL, Glucose 63 mg/dL, red blood cells [RBCs] 0/mcL, WBC 1/mcL 100% mononuclear, venereal disease research laboratory test [VDRL] non-reactive, lactate dehydrogenase [LDH] 23 IU/L). GM1 and GQ1b antibodies were reported as negative. The patient started to feel improvement in weakness from day two of IVIg and continued to receive this treatment for a total of five days without any complications or adverse effects. Patient's physical exam on the day of discharge showed 5/5 proximal and distal strength in all patient's extremities and normal deep tendon reflexes. Patient was discharged home with home health care, with outpatient physical therapy, and was scheduled for follow-up as an outpatient in our neurology clinic. The Centers for Disease Control Vaccine Adverse Event Reporting System (VAERS) was notified about this abnormal reaction. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from guillain-barre syndrome. The authors concluded that to the best of their knowledge, they report the first real-life case of guillain-barre syndrome associated with the Johnson & Johnson Covid-19 vaccine. While there is insufficient evidence to establish a temporal correlation, they strongly believe that physicians should remain watchful, have a high degree of suspicion, and be able to recognize neurological complications associated with the Covid-19 vaccination. Early diagnosis and subsequent management can prevent disability. The risk of neurological complications after the Covid-19 vaccination is low, and the benefits of the vaccination outweigh the risks and side effects. This report was serious (Hospitalization Caused / Prolonged). This case is a duplicate of 20220618274. Additional information was received from a literature article on 09-JUN-2022. The following information was updated and incorporated into the case narrative: Literature article information and authors information, author's objective and conclusion, case level and event level updated to medically confirmed, onset date for the event, therapy start date, and upon follow up, case validity assessment was updated to valid from the previously assessment of non-valid. It was determined that deletion was required for Manufacturer Report Number 20220618274 as it was duplicate of Manufacturer Case Number 20220437168. All relevant information regarding Manufacturer Report Number 20220618274 will be submitted under Manufacturer Case Number 20220437168.; Sender's Comments: V1: This follow up version updates information: Literature article information and authors information, author's objective and conclusion, onset date for the event, therapy start date, and case validity assessment was updated to valid from the previously assessment of non-valid. All relevant information regarding Manufacturer Report Number 20220618274 will be submitted under Manufacturer Case Number 20220437168. The follow up information does not change the causality of the previous reported events. 20220437168-covid-19 vaccine ad26.cov2.s-guillain-barre syndrome. This event(s) is labeled per RSI and is therefore considered potentially related.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Guillain-Barre syndrome
Hospital-Tage: -
Labordaten: Test Name: MRI OF THE BRAIN; Result Unstructured Data: negative for any acute intracranial pathology; Test Name: PHYSICAL EXAMINATION; Result Unstructured Data: 5/5 proximal and distal strength in all her extremities and normal deep tendon reflexes.; Test Name: ELECTROMYOGRAPHY; Result Unstructured Data: not reported; Test Name: NEUROLOGICAL EXAMINATION; Result Unstructured Data: mental status was alert, attentive, and oriented to person, place, and time. The speech was clear and fluent, with a good repetition, comprehension, and naming. She recalled 3/3 objects after five minutes. Cranial Nerves were intact, with full visual fields for confrontation. Pupils were round and reactive to light and accommodation. Extraocular movements were normal, and no nystagmus or diplopia was apparent. Her facial sensation was intact in all three branches of the trigeminal nerve bilaterally; the face was symmetric with normal eye closure and smile, the palate elevated symmetrically, phonation was normal, head-turning and shoulder shrug were intact, tongue protruded towards the midline, with normal movements and no atrophy.; Test Name: MRI OF THE LUMBAR SPINE; Result Unstructured Data: with and without contrast revealed subtle enhancement of the cauda equina nerve roots without over thickening, suggestive of acute inflammatory demyelinating polyradiculoneuropathy (AIDP); Test Name: MOTOR EXAMINATION; Result Unstructured Data: proximal weakness proximal weakness; Test Name: SENSORY EXAMINATION; Result Unstructured Data: normal sensation to light touch, pinprick, position sense, and vibration in fingers and toes. Coordination was normal, with rapid alternating movements intact. Gait was steady with normal steps, base arm swing, and turning. Heel and toe walking and tandem gait was normal.; Test Name: CSF ANALYSIS; Result Unstructured Data: a clear appearance, a very mild elevated protein with a slightly elevated mononuclear pleocytosis, and normal glucose levels.; Test Name: PROTEIN; Result Unstructured Data: 47 mg/dL; Test Name: ALBUMIN; Result Unstructured Data: 25 mg/dL; Test Name: GLUCOSE; Result Unstructured Data: 63 mg/dL; Test Name: RED BLOOD CELL COUNT; Result Unstructured Data: 0 cells/microL; Test Name: WHITE BLOOD CELL COUNT; Result Unstructured Data: 1 cells/microL; Test Name: LDH; Result Unstructured Data: 23 IU/L; Test Name: GM1 AND GQ1B ANTIBODIES; Test Result: Negative ; Test Name: NEUROLOGICAL EXAMINATION; Result Unstructured Data: mild left-sided weakness in the left side of her body when compared to the contralateral side and intact reflexes throughout.
Aktuelle Erkrankungen: Bell's palsy; Hypothyroidism
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1540434

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: FL
Alter: -
Geschlecht: F
Eingang: 18.06.2022
Impfdatum: 09.08.2021
Beginn: 09.08.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Anti-ganglioside antibody Blood albumin Blood glucose Blood lactate dehydrogenase CSF test Arthralgia Bell's palsy Chills Fatigue Glossodynia Electromyogram Guillain-Barre syndrome Magnetic resonance imaging head Magnetic resonance imaging spinal Nerve conduction studies Gait disturbance Hypoaesthesia Immunoglobulin therapy

Symptomtext

GUILLAIN-BARRE SYNDROME; This spontaneous report received from a literature article and also from a consumer via a company representative via social media. The author's objective was to report the first case of guillain-barre following the COVID-19 vaccination with the Johnson & Johnson COVID-19 vaccine. This report concerned concerned a 53 year old female of an unspecified race and ethnicity. The patient's height, and weight were not reported. The patient's concurrent conditions included: hypothyroidism, and bell's palsy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number and expiry date were not reported) dose was not reported, 1 total administered on 09-AUG-2021 for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications reported. On 09-AUG-2021, minutes after receiving the vaccine the patient reported that patient started feeling the development of a rash in palms, followed by the appearance of numbness and tingling in the distal left upper extremity. Hours after, the numbness progressed slowly in an ascending fashion through the left lower extremity, and overnight it extended to the contralateral lower extremity and left side of the face. The numbness was later accompanied by lower thoracic and lumbar pain. Because of patient's symptomatology, patient went to see primary care provider, who prescribed a short course of steroids and valganciclovir after suspecting a new episode of peripheral facial palsy. Due to the lack of improvement in patient's symptoms and a near syncopal episode at patient's home, patient decided to came to Emergency Department with complaints of a two-week history of progressive lower extremity weakness, paresthesias, and difficulty walking that started after receiving the COVID-19 J and J vaccination 14 days before presentation. At the time, the neurological examination revealed mild left-sided weakness in the left side of her body when compared to the contralateral side and intact reflexes throughout. MRI of the brain without contrast done during this first encounter was negative for any acute intracranial pathology, and patient was advised to continue to follow up with neurology as an outpatient and to consider electromyography and nerve conduction studies. Five days later, the patient presented again to institution due to progressive proximal weakness, paresthesias, and difficulty standing up from a chair and walking. At the time, patient denied any dyspnea, dysphagia, or diurnal variation in the weakness. On neurological exam, patient's mental status was alert, attentive, and oriented to person, place, and time. The speech was clear and fluent, with a good repetition, comprehension, and naming. Patient recalled 3/3 objects after five minutes. Cranial Nerves were intact, with full visual fields for confrontation. Pupils were round and reactive to light and accommodation. Extraocular movements were normal, and no nystagmus or diplopia was apparent. Patient's facial sensation was intact in all three branches of the trigeminal nerve bilaterally; the face was symmetric with normal eye closure and smile, the palate elevated symmetrically, phonation was normal, head-turning and shoulder shrug were intact, tongue protruded towards the midline, with normal movements and no atrophy. On motor exam, patient was noted to have proximal weakness 4/5 in hip flexors and hip extensors bilaterally, 4/5 knee extensors and flexors, 4/5 plantar flexion, 4/5 dorsiflexion bilaterally, 4/5 shoulder abductors and adduction, 4/5 elbow extensor and flexors. Reflex examination was pertinent for 2 plus reflexes in the biceps and triceps 2plus, knees, and 1plus Achilles' tendon reflex bilaterally. Sensory examination revealed normal sensation to light touch, pinprick, position sense, and vibration in fingers and toes. Coordination was normal, with rapid alternating movements intact. Gait was steady with normal steps, base arm swing, and turning. Heel and toe walking and tandem gait was normal. An MRI of the lumbar spine with and without contrast revealed subtle enhancement of the cauda equina nerve roots without overt thickening, suggestive of acute inflammatory demyelinating polyradiculoneuropathy (AIDP). Patient was admitted to the hospital out of suspicion of probable Guillain-Barre Syndrome. Due to this concern, the patient was started with intravenous immunoglobulin. Subsequent Lumbar puncture and CSF analysis reported a clear appearance, a very mild elevated protein with a slightly elevated mononuclear pleocytosis, and normal glucose levels (Protein 47 mg/dL, Albumin 25 mg/dL, Glucose 63 mg/dL, red blood cells [RBCs] 0/mcL, WBC 1/mcL 100% mononuclear, venereal disease research laboratory test [VDRL] non-reactive, lactate dehydrogenase [LDH] 23 IU/L). GM1 and GQ1b antibodies were reported as negative. The patient started to feel improvement in weakness from day two of IVIg and continued to receive this treatment for a total of five days without any complications or adverse effects. Patient's physical exam on the day of discharge showed 5/5 proximal and distal strength in all patient's extremities and normal deep tendon reflexes. Patient was discharged home with home health care, with outpatient physical therapy, and was scheduled for follow-up as an outpatient in our neurology clinic. The Centers for Disease Control Vaccine Adverse Event Reporting System (VAERS) was notified about this abnormal reaction. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from guillain-barre syndrome. The authors concluded that to the best of their knowledge, they report the first real-life case of guillain-barre syndrome associated with the Johnson & Johnson Covid-19 vaccine. While there is insufficient evidence to establish a temporal correlation, they strongly believe that physicians should remain watchful, have a high degree of suspicion, and be able to recognize neurological complications associated with the Covid-19 vaccination. Early diagnosis and subsequent management can prevent disability. The risk of neurological complications after the Covid-19 vaccination is low, and the benefits of the vaccination outweigh the risks and side effects. This report was serious (Hospitalization Caused / Prolonged). This case is a duplicate of 20220618274. Additional information was received from a literature article on 09-JUN-2022. The following information was updated and incorporated into the case narrative: Literature article information and authors information, author's objective and conclusion, case level and event level updated to medically confirmed, onset date for the event, therapy start date, and upon follow up, case validity assessment was updated to valid from the previously assessment of non-valid. It was determined that deletion was required for Manufacturer Report Number 20220618274 as it was duplicate of Manufacturer Case Number 20220437168. All relevant information regarding Manufacturer Report Number 20220618274 will be submitted under Manufacturer Case Number 20220437168.; Sender's Comments: V1: This follow up version updates information: Literature article information and authors information, author's objective and conclusion, onset date for the event, therapy start date, and case validity assessment was updated to valid from the previously assessment of non-valid. All relevant information regarding Manufacturer Report Number 20220618274 will be submitted under Manufacturer Case Number 20220437168. The follow up information does not change the causality of the previous reported events. 20220437168-covid-19 vaccine ad26.cov2.s-guillain-barre syndrome. This event(s) is labeled per RSI and is therefore considered potentially related.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Guillain-Barre syndrome
Hospital-Tage: -
Labordaten: Test Name: MRI OF THE BRAIN; Result Unstructured Data: negative for any acute intracranial pathology; Test Name: PHYSICAL EXAMINATION; Result Unstructured Data: 5/5 proximal and distal strength in all her extremities and normal deep tendon reflexes.; Test Name: ELECTROMYOGRAPHY; Result Unstructured Data: not reported; Test Name: NEUROLOGICAL EXAMINATION; Result Unstructured Data: mental status was alert, attentive, and oriented to person, place, and time. The speech was clear and fluent, with a good repetition, comprehension, and naming. She recalled 3/3 objects after five minutes. Cranial Nerves were intact, with full visual fields for confrontation. Pupils were round and reactive to light and accommodation. Extraocular movements were normal, and no nystagmus or diplopia was apparent. Her facial sensation was intact in all three branches of the trigeminal nerve bilaterally; the face was symmetric with normal eye closure and smile, the palate elevated symmetrically, phonation was normal, head-turning and shoulder shrug were intact, tongue protruded towards the midline, with normal movements and no atrophy.; Test Name: MRI OF THE LUMBAR SPINE; Result Unstructured Data: with and without contrast revealed subtle enhancement of the cauda equina nerve roots without over thickening, suggestive of acute inflammatory demyelinating polyradiculoneuropathy (AIDP); Test Name: MOTOR EXAMINATION; Result Unstructured Data: proximal weakness proximal weakness; Test Name: SENSORY EXAMINATION; Result Unstructured Data: normal sensation to light touch, pinprick, position sense, and vibration in fingers and toes. Coordination was normal, with rapid alternating movements intact. Gait was steady with normal steps, base arm swing, and turning. Heel and toe walking and tandem gait was normal.; Test Name: CSF ANALYSIS; Result Unstructured Data: a clear appearance, a very mild elevated protein with a slightly elevated mononuclear pleocytosis, and normal glucose levels.; Test Name: PROTEIN; Result Unstructured Data: 47 mg/dL; Test Name: ALBUMIN; Result Unstructured Data: 25 mg/dL; Test Name: GLUCOSE; Result Unstructured Data: 63 mg/dL; Test Name: RED BLOOD CELL COUNT; Result Unstructured Data: 0 cells/microL; Test Name: WHITE BLOOD CELL COUNT; Result Unstructured Data: 1 cells/microL; Test Name: LDH; Result Unstructured Data: 23 IU/L; Test Name: GM1 AND GQ1B ANTIBODIES; Test Result: Negative ; Test Name: NEUROLOGICAL EXAMINATION; Result Unstructured Data: mild left-sided weakness in the left side of her body when compared to the contralateral side and intact reflexes throughout.
Aktuelle Erkrankungen: Bell's palsy; Hypothyroidism
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2320208

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: -
Alter: 66,0
Geschlecht: M
Eingang: 15.06.2022
Impfdatum: 09.04.2021
Beginn: 04.06.2021
Tage bis Beginn: 56,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Angiogram cerebral abnormal Angiogram normal Arteriosclerosis Basal ganglia infarction Carotid artery stenosis Cerebral artery stenosis Cerebral infarction Computerised tomogram head normal Dysarthria Echocardiogram normal Hemiparesis Hypoaesthesia Immunisation reaction Intensive care Magnetic resonance imaging head abnormal Scan with contrast abnormal Transient ischaemic attack

Symptomtext

Narrative: Patient is a 65 year old MALE with PMH significant for CVD s/p TIA on 6/4/21, GERD, COPD, adjusted disorder with mixed disturbance of emotions and conduct. Pt received Janssen COVID-19 vaccine on 4/9/21. No ADEs immediately after administration per chart review. Per 6/14/21 fax of records, pt presented to ED on 6/4/21 with sudden onset of slurred speech and R sided weakness and numbness. CT head was negative and CT showed no large vessel occlusion. Tele neurology was consulted and TPA administered and admitted to ICU for post TPA monitoring. MRI was done which showed a left periventricular and left basal ganglia small infarct. Repeat CT head after 24 hours was negative. Echocardiogram with bubble was done which was negative for a shunt. Patient was seen by Neurology who recommended PT OT and ST. They also recommended aspirin and statin. Later admitted to rehab at facility x 2 weeks and since then pt has been followed by PT for rehabilitation. No hx of HTN/CAD/DM prior to TIA. Risk factors include history of tobacco usage per screening reminders but pt had quit some time prior to 8/25/20 per nursing outpatient progress note. History of substance usage in 2015 with (+) UDS with methamphetamine at clinic but reports one time usage per 5/25/16 PCP f/u. No (+) UDS per clinic draws since. Pt currently on olanzapine up to 10 mg QHS (since 8/21/20) - previously on quetiapine up to 50 mg QHS (9/13/19-8/21/20). Antipsychotics could increase risk of ASCVD. On 9/21/21, at f/u with PCP, pt requested COVID vaccine booster from Pfizer or Moderna as pt felt that J&J vaccination was related to TIA on 6/14/21. None administered at the time d/t no updated guidance from the CDC on administering boosters for people who received the J&J vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Intensive care
Hospital-Tage: -
Labordaten: 6/4/2021 EXAM: CT Angiography Head With Intravenous Contrast CLINICAL HISTORY: Reason for Exam: Cerebrovascular Accident CVA Notes: Cerebrovascular Accident CVA. TECHNIQUE: Axial computed tomographic angiography images of the head with intravenous contrast. CTDI is 20.09, 62.84 mGy and DLP is 2499.67 mGy-cm. One or more of the following dose reduction techniques were used: automated exposure control, adjustment of the mA and or kV according to patient size, use of iterative reconstruction technique. MIP reconstructed images were created and reviewed. COMPARISON: No relevant prior studies available. FINDINGS: HEAD: Right anterior cerebral artery: A1 segment is not seen and may be congenitally absent. No occlusion or significant stenosis. No aneurysm. Right middle cerebral artery: Unremarkable. No occlusion or significant stenosis. No aneurysm. Right posterior cerebral artery: Unremarkable. No occlusion or significant stenosis. No aneurysm. Left anterior cerebral artery: Mild to moderate stenosis of the clinoid and supraclinoid ICA secondary to calcific atheromatous disease. Left middle cerebral artery: Unremarkable. No occlusion or significant stenosis. No aneurysm. Left posterior cerebral artery: Unremarkable. No occlusion or significant stenosis. No aneurysm. Basilar artery: Unremarkable. No occlusion or significant stenosis. No aneurysm. Right internal carotid artery: Unremarkable. No significant stenosis. No dissection or occlusion. Right vertebral artery: Unremarkable. No significant stenosis. No dissection or occlusion. Left internal carotid artery: Mild to moderate stenosis of the clinoid or supraclinoid ICA secondary to calcific atheromatous disease. Left vertebral artery: Unremarkable. No significant stenosis. No dissection or occlusion. HEAD and NECK: Bones joints: No acute fracture. No dislocation. Soft tissues: Unremarkable as visualized. No mass. CAROTID STENOSIS REFERENCE USING CRITERIA: % ICA stenosis = (1 - narrowest ICA diameter diameter of distal cervical ICA) x 100. Mild - <50% stenosis. Moderate - 50-69% stenosis. Severe - 70-94% stenosis. Near occlusion - 95-99% stenosis. Occluded - 100% stenosis. EXAM: CT Angiography Neck With Intravenous Contrast CLINICAL HISTORY: Reason for Exam: Cerebrovascular Accident CVA Notes: Cerebrovascular Accident CVA. TECHNIQUE: Axial computed tomographic angiography images of the neck with intravenous contrast. CTDI is 82.93 mGy and DLP is 2499.67 mGy-cm. One or more of the following dose reduction techniques were used: automated exposure control, adjustment of the mA and or kV according to patient size, use of iterative reconstruction technique. MIP reconstructed images were created and reviewed. COMPARISON: No relevant prior studies available. FINDINGS: VASCULATURE: Right common carotid artery: Unremarkable. No significant stenosis. No dissection or occlusion. Right internal carotid artery: Unremarkable. Extracranial segment is patent with no significant stenosis. No dissection or occlusion. Right vertebral artery: Unremarkable. No significant stenosis. No dissection or occlusion. Left common carotid artery: Unremarkable. No significant stenosis. No dissection or occlusion. Left internal carotid artery: Unremarkable. Extracranial segment is patent with no significant stenosis. No dissection or occlusion. Left vertebral artery: Unremarkable. No significant stenosis. No dissection or occlusion. NECK: Bones joints: No acute fracture. No dislocation. Soft tissues: Unremarkable as visualized. No mass. CAROTID STENOSIS REFERENCE USING CRITERIA: % ICA stenosis = (1 - narrowest ICA diameter diameter of distal cervical ICA) x 100. Mild - <50% stenosis. Moderate - 50-69% stenosis. Severe - 70-94% stenosis. Near occlusion - 95-99% stenosis. Occluded - 100% stenosis. Communications: Call Doctor Stroke IMPRESSION: Mild to moderate stenosis within the clinoid and supraclinoid ICAs.
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2266148

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: TX
Alter: 57,0
Geschlecht: F
Eingang: 06.05.2022
Impfdatum: 09.04.2021
Beginn: 10.04.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Diarrhoea Dizziness Headache Pyrexia Seizure Vomiting

Symptomtext

Approximately 12 hours after the vaccine I had severe vomiting and diarrhea along with fever and convulsions. Those symptoms lasted about 6 hours. For several months afterward I experienced headaches and dizziness.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 2174173

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: -
Alter: 43,0
Geschlecht: F
Eingang: 11.03.2022
Impfdatum: 07.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 2,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Abdominal pain Abdominal pain upper Abdominal tenderness Areflexia Asthenia Babinski reflex test Back pain Bacterial test negative Blood culture negative Blood iron normal Blood lactic acid normal Blood thyroid stimulating hormone normal C-reactive protein normal CSF cell count CSF cell count normal CSF glucose normal CSF immunoglobulin increased CSF oligoclonal band absent

Symptomtext

Guillain Barre Syndrome- Several ED Visits between 4/14 and 5/22/21 for GBS symptoms and abdominal pain/gastritis. 5/22 ED Visit -- > Hospital Admission (5/22 to 6/3) back pain with progressive lower extremity weakness and paresthesias x 10 days, consistent with Guillain Barre Syndrome. 43 y.o. female with history of left vestibular schwannoma in 2015 - who presents with back pain as her chief complaint. She has actually been struggling with which has been diagnosis abdominal pain for the past 1 month. She has been seen for headache bilateral lower extremity pain is her first visit mid April. She then was seen for epigastric pain 2 weeks later radiating to her back and she was diagnosed gastritis given H2 blockers. She was seen third time for epigastric pain radiating to her back given medication for muscle spasm and Protonix and checked for H. pylori which ultimately came back and she received a 14-day course of antibiotics which she finished little over 24 hours ago. About 2 and half weeks ago she started to have severe back pain which was worse when she sleeps at night, again was noted to be reported as epigastric pain radiating to her back but it that she says that she primarily has back pain. She has been taking ibuprofen. For the past week she has noted some tingling in her toes and some numbness and she feels very tired in her legs when she tries to walk. Her mid back pain continues. She does have a history of lumbar pain but she says this is entirely different. She has not had any problems eating she does not have any nausea or vomiting no diarrhea. She does not think she has any fevers. CT scan of the abdomen and abdominal ultrasound abdomen have been unrevealing for an etiology of her pain. Hospital Problems: # New diagnosis of GBS # Tingling/numbness of BLE, bilateral hands # Acute midline thoracic back pain Acute on chronic low back pain with bilateral weakness, diminished sensation, diminished-absent reflexes. Concerning for GBS or AIDP. Blood cultures x2 negative. Neurology consulted and work diagnosis is some type of GBS/demyelinating disease. Patient improved with IVIG and physical therapy and was ultimately discharged home with PT/OT follow-up as outpatient. Also will have neurology follow-up in 3 months. Imaging as noted below. Return precautions extensively discussed with patient. CT T spine without fracture; MRI T spine with no cord compression, MRI L spine with bilateral L5 pars defects, minimal anterolisthesis of L5 on S1, bilateral neuroforaminal stenosis without spinal canal stenosis. LP with clear albuminocytological dissociation - no PMNs seen; need to still f/u with Oligoclonal bands; no concerning cytology or cell count; LP also negative for HSV, VZV, EBV, CMV, enterovirus, west nile, syphilis, bacterial growth in CSF fluid. PMR performed EMG/NCS suggesting motor demyelinating polyneuropathy LLE > LUE S/p IVIG x3 doses Continue gabapentin 300mg PO TID; can likely uptitrate as outpatient Continue PT/OT for one more day F/u with neuro in ~3 months; ordered # Elevated liver enzymes: GGT mildly elevated at 71. No worsening abdominal symptoms. US abdomen shows diffusely echogenic liver consistent with hepatic steatosis, and repeat lipase is within normal limits. Iron normal, CRP normal, TSH normal, d-dimer negative, lactate normal, lipase normal on admission. Smooth muscle antibodies negative, liver-kidney WNL, HCV and HBV negative, ESR within normal limits. LFTs appear to be trending down. Hep B core IgG and IgM negative. # H pylori gastritis: Reports recently history of H. pylori gastritis, completed 2 weeks of antibiotics/treatment, still having some epigastric tenderness/discomfort occasionally but better prior to discharge. - stopped pantoprazole on 6/1; will need to be off Protonix for at least 2 weeks before rechecking H pylori for clearance - counseled patient to make appt with GI once she leaves # Microscopic hematuria - repeat UA with resolution of hematuria # HTN - continue amlodipine 5 mg PO daily and propranolol # H/o Vestibular Schwannoma For now will not get MRI as due to have FU as outpatient Advised symptomatic tx and expect symptom resolution over days F/u Neurology Visit 8/24/21 Past and Interval history: Paresthesias: Present on toes and fingers/palms, has improved slightly since onset but is still noticeable by patient. Pain: no neuropathic pain, some aching and TTP on lower calf (soleus region), some from mid back that wraps around abdomen (~T8), not as severe as in 5/2021 that prevented her from sleeping. Weakness: reports dramatic improvement, is able to walk on her own and go up stairs, with moderate exertion has some pain and feels the weakness, just finished PT but is continuing to practice what she was taught at home. \ Review of Systems: Constitutional--Negative for fevers, chills, fatigue Cardiovascular--Negative for orthopnea, PND, and lower extremity edema Pulmonary--Negative for intermittent dyspnea on exertion, negative for cough or hemoptysis Objective: Last in person exam 5/30/2021: Neck flexion/extension 5/5 Able to count to 20 in a single breath Muscle Right, Left: Shoulder abduction 5, 5; Elbow flexion 5, 5; Elbow extension 5, 5; Wrist extension 4+, 4+; Finger flexion 4+, 4+; Finger extension 4, 4; Hip flexion 4-, 4-; Knee extension- 4+, 4+; Knee flexion 4+, 4+; Ankle dorsiflexion 4+, 4+; Ankle plantarflexion 5, 5 Sensory: Decreased vibratory sensation to all distal extremities. Reflexes: R brachioradialis absent, L brachioradialis 1+. Biceps, Triceps and Knee jerks absent bilaterally with Ankle jerks absent bilaterally. Babinski sign absent. BP 112/68 (Site: Left Arm, Position: Sitting, Cuff Size: Normal) | Pulse 67 | Temp 36.5 ?C (97.7 ?F) (Temporal) | Ht 1.46 m | Wt 61.1 kg | BMI 28.64 kg/m? General appearance: Normal body habitus. Neurologic exam today: Mental status: Oriented to person, place and time. No aphasia. Cranial nerves: II: Pupils equal and round III,IV,VI: extraocular muscles intact VII: facial muscle function normal bilaterally VIII: hearing intact to conversation IX: soft palate elevation normal bilaterally XI: trapezius strength normal bilaterally XII: tongue strength normal Coordination: accurate finger to nose maneuver. Musculoskeletal: Bulk: normal bulk throughout, Tone: normal tone throughout Muscle, Right, Left: Deltoid 5, 5; Biceps 5, 5; Triceps 5, 5; Wrist extensors 5, 5; Finger flexors 5, 5; Finger extensors 5, 5; Iliopsoas 5-, 5-; Quadriceps 5-, 5; Hamstrings5, 5-; Anterior tibialis 5, 5; Gastrocnemius 5, 5 Gait: Normal gait. Sensation: intact to light touch over 4 limbs Reflexes: R Biceps 1+, Brachioradialis absent, Knee jerks absent, ankle jerks absent bilaterally. Mute to down going toes Assessment and Plan: Patient is a 43 y.o. female w/ L vestibular schwannoma (2015) presented to ED on 5/22 for back pain with progressive lower extremity weakness and paresthesias x 10 days. Exam with symmetrical bilateral upper and lower extremity weakness, distal>proximal in the uppers and proximal>distal in the lowers with absent reflexes and diminished vibratory sensation concerning for polyradiculopathy. MRI T- and L-spine were normal. LP with elevated protein and albuminocytological dissociation. EMG/NCS with evidence of demyelination. History, exam, and workup all consistent with AIDP (Guillain Barre Syndrome) and was treated with IVIG (5/27-5/29). AIDP is a monophasic illness, and patient indeed has had improvement in her symptoms (most prominently strength and neuropathic pain), with residual paresthesias in hands and toes that is not too bothersome. She has not had any new or worsening symptoms to suggest CIDP or an alternative diagnosis. As of 1/19/22 patient reports that she is improving and able to ambulate well. Followed by Neuro.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Guillain-Barre syndrome
Hospital-Tage: 12,0
Labordaten: Lab Results Component Value Date WBC 4.54 05/28/2021 ESR 13 05/23/2021 CRP 0.5 05/23/2021 5/27/2021 09:33 5/26/2021 20:35 Appearance, Fluid Clear RBC Count 2 WBC Count <3 Total Nucleated Cell Count <3 Fluid Type Fluid CSF Fluid Color Clear and Colorless Fluid Container Number 3 Glucose, CSF 68 Total Protein, CSF 527 (H) OCG negative, elevated IgG index 05/26/2021 HIV negative, ZVZ, EBV, CMZ Imaging and Other Diagnostics: new neuroimaging since last evaluation: MRI L-spine wwo contrast 05/24/2021 1. No focal disc protrusion or canal stenosis. 2. No abnormal enhancement. 3. Bilateral L5 pars defects with minimal anterolisthesis of L5 on S1. There is resulting bilateral neuroforaminal stenosis as described above without spinal canal stenosis. MRI T-spine wwo contrast 05/24/2021 The thoracic cord is normal in signal without abnormal enhancement. No cord compression. MRI IAC 6/25/21 IAC regions: Small regions of susceptibility induced signal loss are seen superior to the left petrous apex and medial to it along the left cerebellar tentorium consistent with postsurgical changes. On the left a small punctate 3 mm focus of enhancement is seen at the inferior intracanalicular portion of the seventh 8th nerve complex (series 10, image 11) and this may represent postsurgical change versus small residual vestibular schwannoma. Attention at time of follow-up cyst. Normal appearance of the seventh and eighth cranial nerve complexes on the right, without abnormal enhancement to indicate a vestibular schwannoma. (series 10, image 11) EMG 05/27/2021 Impression: Abnormal Electrodiagnostic Study 1. There is electrodiagnostic evidence for a predominantly motor demyelinating polyneuropathy affecting the LLE > LUE (only L side tested today). Motor amplitudes were normal for L median and ulnar nerves, and slightly reduced for L peroneal nerve -- indicating minimal axonal loss and overall is positive prognostically.
Aktuelle Erkrankungen: -
Vorgeschichte: PMH: Vestibular schwannoma (left, resected 2015)
Andere Medikamente: NK Medications
Allergien: NKA
Vorherige Impfungen: -

VAERS 2134363

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: MI
Alter: 73,0
Geschlecht: M
Eingang: 23.02.2022
Impfdatum: 10.04.2021
Beginn: 22.11.2021
Tage bis Beginn: 226,0
Dosis: 1
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Angioplasty Anticoagulant therapy COVID-19 Carbohydrate antigen 19-9 increased Condition aggravated Deep vein thrombosis Failure to thrive Melaena SARS-CoV-2 test positive Thrombectomy Weight decreased

Symptomtext

Provider hospital summary "Patient is a 74-year-old male with a past medical history of hypertension, asthma who presented with a extensive left lower extremity DVT. Interventional radiology performed thrombectomy and angioplasty on 11/24. Unable to place a stent at this time as they did not have the correct size of 16 mm. Patient will need to remain on anticoagulation and follow-up with Interventional Radiology as an outpatient have stent placed. this was emphasized with patient and contact information for Dr. was placed on AVS. Patient is to remain on Eliquis strictly until stent can be placed and this was also emphasized to patient. Some concern for May Thurner syndrome. Transition from heparin drip to Eliquis on 11/24. Pharmacy was contacted and did not have supply of Eliquis until 11/26 around noon. Patient was discharged with 2 doses of Eliquis to get him through until that time. Patient had some melena/weight loss/failure to thrive and GI was consulted. He will need follow-up colonoscopy for screening purposes as an outpatient, deferred as patient was COVID positive. His blood clot could have been caused by COVID certainly, but worried there may be possible malignancy. His CA 19-9 was elevated and will need further evaluation and workup. He will also need age-appropriate cancer screening. Patient was incidentally found to have COVID and receive regenerate and therapy in the hospital."

Weitere VAERSDATA-Felder

Praegender Schweregrund: Deep vein thrombosis
Hospital-Tage: 3,0
Labordaten: Positive COVID PCR Test 11/22/21
Aktuelle Erkrankungen: -
Vorgeschichte: Chronic low back pain Microcytic anemia Anorexia Essential hypertension DVT, lower extremity, proximal, acute, left (*) Iron deficiency Melena FTT (failure to thrive) in adult Hematuria
Andere Medikamente: acetaminophen 650 mg Oral EVERY 6 HOURS PRN amlodipine besylate 5 mg Oral Daily apixaban 5 mg Take 2 tablets by mouth 2 (two) times daily for 7 days, THEN 1 tablet 2 (two) times daily for 23 days. cholecalciferol (vitamin D3) 1,000 Units
Allergien: No Known Allergies
Vorherige Impfungen: -

VAERS 2131221

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: WI
Alter: 35,0
Geschlecht: M
Eingang: 22.02.2022
Impfdatum: 07.07.2021
Beginn: 08.07.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Muscle strain Pain in extremity Thrombosis

Symptomtext

I had moderate pain in my right leg, just above my knee, for several days. It felt like a muscle strain. It was likely due to a blood clot following my Covid 19 vaccination.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Multi-vitamin
Allergien: None
Vorherige Impfungen: -

VAERS 2128327

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: ME
Alter: 22,0
Geschlecht: M
Eingang: 19.02.2022
Impfdatum: 08.02.2022
Beginn: 17.02.2022
Tage bis Beginn: 9,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Blood culture negative CSF culture negative CSF glucose normal CSF lymphocyte count increased CSF protein normal Condition aggravated Echocardiogram normal Electroencephalogram abnormal Endotracheal intubation Headache Laboratory test Lumbar puncture abnormal Magnetic resonance imaging head abnormal Seizure Toxicologic test abnormal Urine analysis normal

Symptomtext

Presented 2/17 with ongoing seizures for >60 minutes. Received ativan and midazolam in the ER. Loaded with Keppra. Continued to seize. Intubated. Started on propofol but still having seizures. Loaded with fosphenytoin and started on midazolam infusion. Remains intubated and sedated. Sedation is being weaned and seizures are now controlled on Keppra 1500mg BID, fosphenytoin 100mg TID, and lamotrigine. Patient had been compliant with lamotrigine and not missed any doses. He had been complaining of severe headache after his COVID booster prior to presentation. His last seizure was 2 years prior to presentation.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: 3,0
Labordaten: MRI brain 2/17 showed known mesial temporal sclerosis, no new lesions, no inflammation, no stroke, no enhancement. Lumbar puncture 2/18 with normal protein and glucose, mild lymphocytic pleocytosis, negative culture. Other studies pending. Continuous EEG with seizures controlled on referenced medications. Urinalysis negative. Urine toxicology THC positive. Echo normal. Blood cultures negative.
Aktuelle Erkrankungen: -
Vorgeschichte: mesial temporal sclerosis with epilepsy
Andere Medikamente: lamotrigine
Allergien: no known allergies
Vorherige Impfungen: -

VAERS 2086165

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CA
Alter: 95,0
Geschlecht: F
Eingang: 10.02.2022
Impfdatum: -
Beginn: 13.06.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Abdominal pain Acute kidney injury Blood urine present Contusion Deep vein thrombosis Diarrhoea haemorrhagic Gait disturbance Hypophagia Skin haemorrhage Skin weeping Sticky skin Thrombosis

Symptomtext

ACUTE CHRONIC RENAL FAILURE; ACUTE DEEP VEIN THROMBOSIS; BLOOD CLOT; BLOOD SPOTS UNDER SKIN; BRUISES UNDER SKIN; URINATING BLOOD; DIFFICULTY WALKING; OOZING OF SKIN; SKIN STICKY; STOPPED EATING AT THIS POINT / DID NOT EAT OR DRINK; ABDOMINAL PAIN; BLOODY DIARRHEA; This spontaneous report received from a consumer concerned a 95 year old female. The patient's height, and weight were not reported. The patient's past medical history included: hypertension (HTN), and hyperlipidemia (the patient was not on any medications for these diseases for the last 10 years) and other pre-existing medical conditions included: Patient was not pregnant in last year. The patient received covid-19 vaccine ad26.cov2.s (dose number in series 1) (suspension for injection, route of administration not reported, batch number: 201A21A and expiry: 21-SEP-2021) dose was not reported, 01 total was administered at right arm on 19-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On 13-JUN-2021, the patient experienced bloody diarrhea, and abdominal pain (dose number in series 1). She was rushed to the hospital and admitted. She was checked and released. She stopped eating at this point. She was admitted to a hospital on 24-JUL-2021. The legs were swelling and then photographed at a later time which was on 24-JUL-2021. Was started on Heparin on the same day and was administered for two days. Attending physicians explained that the treatment of heparin could cause death and if they did not do treatment then she may still die as the clot may travel. She was discharged on 27-JUL-2021. She was hospitalized for 4 day and did not eat or drink for these 4 days (dose number in series 1). Vaccine destroyed her kidneys per the doctor. On an unspecified date, she experienced acute deep vein thrombosis, acute chronic renal failure, blood spots under skin, bruises under her skin, urinating blood, difficulty walking, oozing of skin, skin sticky and blood clot (dose number in series 1). The date of the photo was 02-AUG-2021. On 04-AUG-2021, she died from acute deep vein thrombosis and acute chronic renal failure (dose number in series 1). No operation was performed for the conditions/events experienced by the patient. An autopsy was not performed. No biopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from oozing of skin, and skin sticky, and the outcome of bloody diarrhea, stopped eating at this point / did not eat or drink, blood spots under skin, bruises under skin, urinating blood, difficulty walking, abdominal pain and blood clot was not reported, the outcome of acute deep vein thrombosis and acute chronic renal failure was fatal. This report was serious (Death, and Hospitalization Caused / Prolonged).; Sender's Comments: V0: 20220200861- covid-19 vaccine ad26.cov2.s-acute chronic renal failure , acute deep vein thrombosis , bloody diarrhea, blood clot, blood spots under skin, abdominal pain , stopped eating at this point / did not eat or drink, bruises under skin, urinating blood, difficulty walking, oozing of skin, skin sticky. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: ACUTE DEEP VEIN THROMBOSIS; ACUTE CHRONIC RENAL FAILURE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Deep vein thrombosis
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Hyperlipidemia; Hypertension; Comments: Patient was not pregnant in last year.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2086165

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CA
Alter: 95,0
Geschlecht: F
Eingang: 10.02.2022
Impfdatum: -
Beginn: 13.06.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Abdominal pain Acute kidney injury Blood urine present Contusion Deep vein thrombosis Diarrhoea haemorrhagic Gait disturbance Hypophagia Skin haemorrhage Skin weeping Sticky skin Thrombosis

Symptomtext

ACUTE CHRONIC RENAL FAILURE; ACUTE DEEP VEIN THROMBOSIS; BLOOD CLOT; BLOOD SPOTS UNDER SKIN; BRUISES UNDER SKIN; URINATING BLOOD; DIFFICULTY WALKING; OOZING OF SKIN; SKIN STICKY; STOPPED EATING AT THIS POINT / DID NOT EAT OR DRINK; ABDOMINAL PAIN; BLOODY DIARRHEA; This spontaneous report received from a consumer concerned a 95 year old female. The patient's height, and weight were not reported. The patient's past medical history included: hypertension (HTN), and hyperlipidemia (the patient was not on any medications for these diseases for the last 10 years) and other pre-existing medical conditions included: Patient was not pregnant in last year. The patient received covid-19 vaccine ad26.cov2.s (dose number in series 1) (suspension for injection, route of administration not reported, batch number: 201A21A and expiry: 21-SEP-2021) dose was not reported, 01 total was administered at right arm on 19-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On 13-JUN-2021, the patient experienced bloody diarrhea, and abdominal pain (dose number in series 1). She was rushed to the hospital and admitted. She was checked and released. She stopped eating at this point. She was admitted to a hospital on 24-JUL-2021. The legs were swelling and then photographed at a later time which was on 24-JUL-2021. Was started on Heparin on the same day and was administered for two days. Attending physicians explained that the treatment of heparin could cause death and if they did not do treatment then she may still die as the clot may travel. She was discharged on 27-JUL-2021. She was hospitalized for 4 day and did not eat or drink for these 4 days (dose number in series 1). Vaccine destroyed her kidneys per the doctor. On an unspecified date, she experienced acute deep vein thrombosis, acute chronic renal failure, blood spots under skin, bruises under her skin, urinating blood, difficulty walking, oozing of skin, skin sticky and blood clot (dose number in series 1). The date of the photo was 02-AUG-2021. On 04-AUG-2021, she died from acute deep vein thrombosis and acute chronic renal failure (dose number in series 1). No operation was performed for the conditions/events experienced by the patient. An autopsy was not performed. No biopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from oozing of skin, and skin sticky, and the outcome of bloody diarrhea, stopped eating at this point / did not eat or drink, blood spots under skin, bruises under skin, urinating blood, difficulty walking, abdominal pain and blood clot was not reported, the outcome of acute deep vein thrombosis and acute chronic renal failure was fatal. This report was serious (Death, and Hospitalization Caused / Prolonged).; Sender's Comments: V0: 20220200861- covid-19 vaccine ad26.cov2.s-acute chronic renal failure , acute deep vein thrombosis , bloody diarrhea, blood clot, blood spots under skin, abdominal pain , stopped eating at this point / did not eat or drink, bruises under skin, urinating blood, difficulty walking, oozing of skin, skin sticky. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: ACUTE DEEP VEIN THROMBOSIS; ACUTE CHRONIC RENAL FAILURE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Deep vein thrombosis
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Hyperlipidemia; Hypertension; Comments: Patient was not pregnant in last year.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2088177

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: NY
Alter: 46,0
Geschlecht: M
Eingang: 09.02.2022
Impfdatum: -
Beginn: 29.04.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood glucose normal Blood test normal Computerised tomogram normal Generalised tonic-clonic seizure Magnetic resonance imaging normal

Symptomtext

GRAND MAL SEIZURE; This spontaneous report received from a consumer concerned a 46 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included: type 1 diabetic, and other pre-existing medical conditions included: no known allergies. The patient did not have history or family history of ever having a seizure before. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A expiry: UNKNOWN) 1 total, dose was not reported, administered on left arm on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 29-APR-2021, approximately three weeks after vaccination, the patient experienced his first grand mal seizure. Patient was rushed to the emergency room. Patient since had three more seizures for a total of 4. Patient had to go to the emergency an additional time on 10-JAN- 2022. Patient was being seen by a neurologist and a cardiologist in addition to his family doctor. They had ruled out blood clots, aneurysm and stroke, but still did not know origin of the grand mal seizures. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from grand mal seizure. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20220213197-COVID-19 VACCINE AD26.COV2.S-Grand mal seizure. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Generalised tonic-clonic seizure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Type 1 diabetes mellitus
Vorgeschichte: Comments: No known allergies. The patient did not have history or family history of ever having a seizure before.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2088177

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: NY
Alter: 46,0
Geschlecht: M
Eingang: 09.02.2022
Impfdatum: -
Beginn: 29.04.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood glucose normal Blood test normal Computerised tomogram normal Generalised tonic-clonic seizure Magnetic resonance imaging normal

Symptomtext

GRAND MAL SEIZURE; This spontaneous report received from a consumer concerned a 46 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included: type 1 diabetic, and other pre-existing medical conditions included: no known allergies. The patient did not have history or family history of ever having a seizure before. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A expiry: UNKNOWN) 1 total, dose was not reported, administered on left arm on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 29-APR-2021, approximately three weeks after vaccination, the patient experienced his first grand mal seizure. Patient was rushed to the emergency room. Patient since had three more seizures for a total of 4. Patient had to go to the emergency an additional time on 10-JAN- 2022. Patient was being seen by a neurologist and a cardiologist in addition to his family doctor. They had ruled out blood clots, aneurysm and stroke, but still did not know origin of the grand mal seizures. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from grand mal seizure. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20220213197-COVID-19 VACCINE AD26.COV2.S-Grand mal seizure. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Generalised tonic-clonic seizure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Type 1 diabetes mellitus
Vorgeschichte: Comments: No known allergies. The patient did not have history or family history of ever having a seizure before.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1976816

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: FL
Alter: 46,0
Geschlecht: M
Eingang: 24.01.2022
Impfdatum: -
Beginn: 17.09.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Asthma Chest discomfort Chest pain Chronic obstructive pulmonary disease Dysgeusia Blood test Chest X-ray Electrocardiogram Pericarditis Immediate post-injection reaction Pain

Symptomtext

PERICARDITIS; TASTED METAL AND SALTY IN MOUTH; This spontaneous report received from a patient concerned a 46-year-old male of unknown race and ethnicity. The patient's height, and weight were not reported. The patient's concurrent conditions included: asthma, alcohol user (very rarely), and non-smoker, and other pre-existing medical conditions included the patient had no known allergies and the patient did not abuse drug or illicit drug usage. The patient experienced flu like symptoms when treated with influenza vaccine, so he stopped getting the flu shot. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, expiry: 21-SEP-2021) dose was not reported, 1 total administered to left arm on 17-SEP-2021 for prophylactic vaccination. No concomitant medications were reported. On 17-SEP-2021, immediately after the vaccination the patient had metal taste (a salty taste) in his mouth. He experienced chest burning and chest pressure within a day (on 18-Sep-2021). The patient stated that it was hard to breathe, was fatigued and short of breath. On an unspecified date in SEP-2021, after 1 week, he went to hospital, laboratory test included blood work, chest X-ray and EKG (electrocardiography) and everything was normal. He said the hospital was useless. Then he saw his PCP (primary care provider). His PCP assumed pericarditis and he treated him with prednisone (a course of 5 days) and he felt better but once the medication was out he felt miserable again. He also saw a cardiologist and the cardiologist said that his heart was okay. He mentioned that his PCP wants him to take Pulmicort but he could not afford it. On an unspecified date the patient visited emergency room. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from pericarditis, and the outcome of tasted metal and salty in mouth was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0 : 20220133399-COVID-19 VACCINE AD26.COV2.S-Pericarditis. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pericarditis
Hospital-Tage: -
Labordaten: Test Date: 202109; Test Name: Blood test; Result Unstructured Data: Normal; Test Date: 202109; Test Name: EKG; Result Unstructured Data: Normal; Test Date: 202109; Test Name: Chest X-ray; Result Unstructured Data: Normal
Aktuelle Erkrankungen: Alcohol use (Very rarely.); Asthma (It was well controlled.); Non-smoker
Vorgeschichte: Comments: Patient had no known allergies. Patient did not have drug abuse or illicit drug usage.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1976816

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: FL
Alter: 46,0
Geschlecht: M
Eingang: 24.01.2022
Impfdatum: -
Beginn: 17.09.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Asthma Chest discomfort Chest pain Chronic obstructive pulmonary disease Dysgeusia Blood test Chest X-ray Electrocardiogram Pericarditis Immediate post-injection reaction Pain

Symptomtext

PERICARDITIS; TASTED METAL AND SALTY IN MOUTH; This spontaneous report received from a patient concerned a 46-year-old male of unknown race and ethnicity. The patient's height, and weight were not reported. The patient's concurrent conditions included: asthma, alcohol user (very rarely), and non-smoker, and other pre-existing medical conditions included the patient had no known allergies and the patient did not abuse drug or illicit drug usage. The patient experienced flu like symptoms when treated with influenza vaccine, so he stopped getting the flu shot. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, expiry: 21-SEP-2021) dose was not reported, 1 total administered to left arm on 17-SEP-2021 for prophylactic vaccination. No concomitant medications were reported. On 17-SEP-2021, immediately after the vaccination the patient had metal taste (a salty taste) in his mouth. He experienced chest burning and chest pressure within a day (on 18-Sep-2021). The patient stated that it was hard to breathe, was fatigued and short of breath. On an unspecified date in SEP-2021, after 1 week, he went to hospital, laboratory test included blood work, chest X-ray and EKG (electrocardiography) and everything was normal. He said the hospital was useless. Then he saw his PCP (primary care provider). His PCP assumed pericarditis and he treated him with prednisone (a course of 5 days) and he felt better but once the medication was out he felt miserable again. He also saw a cardiologist and the cardiologist said that his heart was okay. He mentioned that his PCP wants him to take Pulmicort but he could not afford it. On an unspecified date the patient visited emergency room. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from pericarditis, and the outcome of tasted metal and salty in mouth was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0 : 20220133399-COVID-19 VACCINE AD26.COV2.S-Pericarditis. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pericarditis
Hospital-Tage: -
Labordaten: Test Date: 202109; Test Name: Blood test; Result Unstructured Data: Normal; Test Date: 202109; Test Name: EKG; Result Unstructured Data: Normal; Test Date: 202109; Test Name: Chest X-ray; Result Unstructured Data: Normal
Aktuelle Erkrankungen: Alcohol use (Very rarely.); Asthma (It was well controlled.); Non-smoker
Vorgeschichte: Comments: Patient had no known allergies. Patient did not have drug abuse or illicit drug usage.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2515132

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: -
Alter: 37,0
Geschlecht: M
Eingang: 01.01.2022
Impfdatum: 15.06.2021
Beginn: 15.06.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Anaphylactic reaction Dysphagia Lethargy Oropharyngeal pain Pain Pruritus Respiratory distress Respiratory symptom

Symptomtext

Narrative: Per RN: "Patient came in on 6/15/21 to the clinic reporting 60+ medication and food allergies and asking for the Janssen vaccine. Patient has had anaphylactic reactions to yellow jacket stings and a typhoid vaccine in the past, but received the flu and pneumonia vaccine without incident. After checking ingredients in the typhoid vaccine and discussing the case with a RN, decision was made to allow patient to receive vaccine. Pt stated he understood the risk, and he and his wife were prepared with their own Benadryl and epipen. Janssen vaccine given at 0915, at 0925, patient said he was itchy and took some of his own benadryl, 25 mg. Pt was offered clinic benadryl, but declined. At 0932, patient reported difficulty swallowing and promptly administered his own epipen in left thigh. Emergency medical response was called at this ime and arrived within 1 minute. Vitals were taken and ambulance was called. Pt had no issues breathing, O2 sats stable, and lung sounds clear. Continued to report difficulty swallowing that was not worsening. Ambulance arrived at 0955 and transported patient to hospital. Per follow up with patient's wife on 6/16, patient was given antihistamines at the ER and stayed for a couple of hours. He is now home with body soreness and lethargy, taking Benadryl q6." Per Primary care f/u on 6/18/21: "Pt arrived w/o severe resp. distress. Pt. had sig upper airway sx. c/w anaphylaxis. Pt treated aggressively with epi and additional meds. Pt had no evid to suggest pharyngeal abscess, no evid. of pneumonia or indication of ptx. no evid arrhythmia on monitor/EKG, no evid by hx or eval to suggest aspirated f.b. Given resp. sx, pt required epi to break sx. quickly. pt. was placed in a room and on a monitor upon arrival. IV started We monitored the patient. During the hour the symptoms began to resolve. The patient had no further respiratory symptoms I discussed possible causes of anaphylaxis. They also understood they should F/U with PCP within 1-2 days, Rx written. Today, spoke to patient over the phone. He is doing well, he continues to take Zyrtec and Zantac. He is no longer taking Benadryl. He denies any swelling. He does continue to have a sore throat but no swelling reported. He was talking in full sentences over the phone with no evidence of respiratory distress. He is doing well otherwise and happy that he at least was able to get the vaccination to limit his risk for developing Covid."

Weitere VAERSDATA-Felder

Praegender Schweregrund: Anaphylactic reaction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1992524

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CO
Alter: 49,0
Geschlecht: M
Eingang: 30.12.2021
Impfdatum: 16.05.2021
Beginn: 22.06.2021
Tage bis Beginn: 37,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Deep vein thrombosis Pain in extremity Ultrasound Doppler abnormal

Symptomtext

Sudden extreme leg pain

Weitere VAERSDATA-Felder

Praegender Schweregrund: Deep vein thrombosis
Hospital-Tage: -
Labordaten: 06/29/21 Urgent Care visit, ultrasound performed, DVT diagnosed
Aktuelle Erkrankungen: None
Vorgeschichte: GERD, leg pain, kidney stones
Andere Medikamente: Tamsulosin, Prilosec, Ibuprofen, Requip, Finasteride, Multi-vitamin, calcium/magnesium/zinc
Allergien: Adhesive tape, Rose bush
Vorherige Impfungen: -

VAERS 2525113

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: -
Alter: 30,0
Geschlecht: M
Eingang: 28.12.2021
Impfdatum: 15.07.2021
Beginn: 15.07.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Electrocardiogram normal Loss of consciousness Peripheral swelling Syncope Visual impairment

Symptomtext

Narrative: Patient received COVID-19 vaccine in clinic. Reports he looked down at his arm, vision went dim and passed out. Rapid response was called. RN initially noted arm swelling; not mentioned in ED evaluation. First sternal rub resulted in no response. Pulse hard to palpate. Responded to second sternal rub and transferred to ED per rapid response team. ED provider noted patient back to normal self in ED. Patient reports no symptoms prior to this episode. No shortness of breath. No chest pain. No history of passing out. No recent illness. Normal EKG. Unremarkable orthostatic vital signs. Final diagnosis of vasovagal syncope. Discharged to home with no specific follow-up required.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1968221

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: NJ
Alter: 20,0
Geschlecht: M
Eingang: 21.12.2021
Impfdatum: 18.06.2021
Beginn: 01.07.2021
Tage bis Beginn: 13,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Bronchial hyperreactivity Cardiac function test Computerised tomogram Dizziness Gastrointestinal scan Hypotension Magnetic resonance imaging Myalgia Pancreatitis chronic Postural orthostatic tachycardia syndrome Syncope

Symptomtext

Since the last check in, new diagnoses: chronic pancreatitis, postural orthostatic tachycardia syndrome (POTS), dizziness, fainting, muscle aches, low blood pressure.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: 4,0
Labordaten: CT, MRI, Autonomic Testing, Neurology, Cardiac testing, GI procedures
Aktuelle Erkrankungen: Recently diagnosed with Reactive Airway Disease (08/2021)
Vorgeschichte: Exocrine Pancreatic Insufficiency; Hemorrhoids
Andere Medikamente: Creon; Omeprazole; Vitamin D; Iron; Vitamin B12
Allergien: None
Vorherige Impfungen: -

VAERS 1952118

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: IL
Alter: 67,0
Geschlecht: F
Eingang: 15.12.2021
Impfdatum: 15.12.2021
Beginn: 15.12.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Hyperhidrosis Immediate post-injection reaction Incontinence Loss of consciousness Seizure

Symptomtext

Patient c/o pain immediately after injection, became diaphoretic, loss of consciousness, seizure, incontinent. Managed by EMT on site. B/P 142/74, pulse 74, R 16, temp 97.2. recovered quickly. Picked up by her husband, a physician,

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Unknown
Andere Medikamente: Unknown
Allergien: Unknown
Vorherige Impfungen: fainting

VAERS 1886177

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: HI
Alter: 31,0
Geschlecht: M
Eingang: 19.11.2021
Impfdatum: 04.08.2021
Beginn: 11.11.2021
Tage bis Beginn: 99,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

C-reactive protein Chest pain Differential white blood cell count Dizziness Dyspnoea Full blood count Nausea Pericarditis Red blood cell sedimentation rate

Symptomtext

11/11/21 @ 0900 PT found on floor of bathroom. PT experienced nausea, dizziness; BP 77/50 HR 98; PT complained of SOB and chest pain. Emergency number was called, PT transported to ED, PT admitted to hospital; diagnosis of idiopathic pericarditis. PT discharged with medication Colchicine 0.6mg PO BID X14 days. PT readmitted to our facility 11/12 @1950. PT will need follow-up with medical consultant following post hospitalization.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pericarditis
Hospital-Tage: 1,0
Labordaten: CBC with Differential 11/16/21 ESR Auto 11/18/21 CRP 11/18/21
Aktuelle Erkrankungen: NONE
Vorgeschichte: SCHIZOPHRENIA, OCD, STIMULANT USE DISORDER, HYPERTENSION, DEPRESSION, MUSCLE SPASMS, BACK PAIN
Andere Medikamente: Amlodipine 10mg PO QDaily; Clozapine 200mg QHS; Cyclobenzaprine 5mg PO TID; Escitalopram 20mg PO QAM; Quetiapine 500mg QHS
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2573988

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: -
Alter: 29,0
Geschlecht: F
Eingang: 07.11.2021
Impfdatum: 18.05.2021
Beginn: 18.05.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Presyncope

Symptomtext

Narrative: Unclear what reaction patient had. It sounds as if patient may have had a vasovagal response to their Janssen covid vaccine. Reports having passed out with other vaccinations. It was not reported that patient needed any intervention.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2582119

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: -
Alter: 74,0
Geschlecht: M
Eingang: 06.11.2021
Impfdatum: 21.05.2021
Beginn: 14.08.2021
Tage bis Beginn: 85,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

COVID-19 SARS-CoV-2 test positive Syncope

Symptomtext

Narrative: COVID infection following COVID vaccine series 05/21 Janssen, dose #1 08/11 COVID swab, result: detected 08/11 pt admit to OBS DX: Syncope w collapse ro TIA ** pt AMA an COVID19 illness without hypoxia 08/14 pt cc: exposure: unknown clinically resolved

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1832536

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CA
Alter: -
Geschlecht: F
Eingang: 01.11.2021
Impfdatum: -
Beginn: 01.09.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Blood pressure measurement Body temperature Cardiac monitoring Chills Computerised tomogram thorax Dyspnoea exertional Ear swelling Echocardiogram Erythema Feeling cold Generalised oedema Heart rate Heart rate increased Hypertension Injection site erythema Injection site induration Injection site pain Injection site swelling

Symptomtext

ELEVATED BLOOD PRESSURE; ELEVATED HEART RATE; SWOLLEN HANDS; DIDN'T FEEL WELL; TEMPERATURE 103; ITCHINESS EVERYWHERE/HANDS BECOME VERY ITCHY; SWELLING ALL OVER LEGS, ARMS, CHEST, TORSO; VERY ITCHY, RED RASH ON HER WHOLE BODY; SHIVERING UNCONTROLLABLY; COULDN'T STOP SHAKING; ALMOST PASSED OUT/FELT LIKE PASSING OUT; COULDN'T GET WARM; PSORIASIS ON THE LOWER LEFT CALF; SMALL BLOOD CLOT IN THE LEFT ARM; SWOLLEN FACE; SWOLLEN EARS AND COULD NOT HEAR WELL DUE TO SWELLING; LOW PLATELETS; INJECTION SITE SWELLING; INJECTION SITE REDNESS; INJECTION SITE HARDNESS; INJECTION SITE HOTNESS; LYMPH NODES UNDER THE ARMPITS; SUPER, VERY PAINFUL INJECTION SITE/SUPER SORE INJECTION SITE; VERY PAINFUL LEFT ARM; REDNESS ON THE NECK DOWN TO HER CHEST AND ARMS/LOOKED SUNBURNT ALL OVER; SHORTNESS OF BREATH WHEN WALKING/BREATHING HEAVILY AFTER WALKING; SKIN PEELED OFF THE SOLES OF FEET; BROWN SPOT ON THUMB; SUPRAVENTRICULAR TACHYCARDIA; This spontaneous report received from a patient concerned a 39 year old female of unspecified race and ethnic origin. The patient's height, and weight were not reported. The patient's had skin cancer (mole) which was removed in JUN-2021 and was suffering from psoriasis. The patient was severely allergic to dust and dust mites and had a reaction to MMR vaccine 19 years ago. The patient was also allergic to penicillin and had seasonal allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, and expiry: UNKNOWN) 1 total dose was not reported, administered on 09-SEP-2021 for prophylactic vaccination on left arm. No concomitant medications were reported. On 10-SEP-2021, the patient experienced itchiness everywhere on torso, chest, arms and redness on neck, down to chest and arms. On 11-SEP-2021, the patient felt injection site was super, very painful and could feel in her sleep for overnight. The patient woke up and after shower, her left arm was very painful and injection site was super sore and hard and felt hot, red and swollen. The patient did not feel well so she laid down and was shivering uncontrollably. The patient's hands became very itchy and swollen and called her primary care provider who advised to take additional dose of Allegra and Benadryl, along with her doses which she took. The patient noted that she couldn't get warm and stop shaking and when she stood her eyes went black and couldn't hear. She almost passed out so she laid down for bit and when she could stand up again she left to hospital. The patient was driven by her partner and notes she was out of it on way to urgent care. On the same day she attended emergency room which was connected to hospital. The patient felt like throwing up or passing out during triage so she laid down in bed and IV has started. The temperature was 103 F and was still shivering, her heart rate and blood pressure were elevated and she had swelling all over(legs, arms, torso, chest) and had very itchy, red rash on her body. The heart rate went up to 130 when lying and 160 when on bed and settled to over 100. The patient had CT of chest and fund that there were no blood clot in lungs but prominent lymph nodes under armpit. Laboratory data included: Blood pressure (NR: not provided) Elevated, Body temperature (NR: not provided) 103 F, Chest CT (NR: not provided) no blood clots in lungs, and Heart rate (NR: not provided) 130 {beats}/min, Over 100, Elevated, 160 {beats}/min. She was admitted in the hospital and received Tylenol and Benadryl until 12-SEP-2021 and was given with Prednisone which made her feel better. On 12-SEP-2021, Prednisone was stopped and Benadryl was given along with allergy medication. On 13-SEP-2021, the patient had swollen ears due to which couldn't hear, face body, elevated heart rate, low platelets and was given with Prednisone. Laboratory data included: Heart rate (NR: not provided) Still elevated, and Platelet count (NR: not provided) Too low. On 14-SEP-2021, the patient experienced small blood clot in the left arm. Laboratory data included: Diagnostic ultrasound (NR: not provided) small blood clot in left arm. Laboratory data included: Heart rate (NR: not provided) Still elevated, and Platelet count (NR: not provided) Too low. On 14-SEP-2021, the patient experienced small blood clot in the left arm. Laboratory data included: Diagnostic ultrasound (NR: not provided) small blood clot in left arm. On 14-SEP-2021, ultrasound of arms showed small blood clot in left arm and got 2 blood thinner injections and got discharged on 14-SEP-2021. The patient had follow up and ultrasound, mammogram which were normal, echo was fine, VIO patch, electrocardiogram monitor for 2 weeks with no results and 3 day cardiac monitor showed 1 episode of SVT. Laboratory data included: Diagnostic ultrasound (NR: not provided) small blood clot in left arm. On an unspecified date, the patient experienced elevated blood pressure, elevated heart rate, and psoriasis on the lower left calf Laboratory data (dates unspecified) included: Cardiac monitoring (NR: not provided) 1 episode of SVT, unknown, Echocardiogram (NR: not provided) normal, Heart rate (NR: not provided) 85-95, 60-90, 100-140, Mammogram (NR: not provided) Normal, and Ultrasound breast (NR: not provided) Normal. On 22-OCT-2021, the patient consulted PCP who stated her heart would take a month to go back to normal. The redness, itchiness, rash went away 2 weeks ago, injection site pain, arm pain remained for 2 weeks and injection site remained hard for weeks. The patient stated that hot, swollen, itchiness around injection site subsided in SEP-2021. The patient felt like heart rate was 100-140 and when sitting it was 60-90 which was high for her. The patient also felt shortness of breathe while walking and was being noticed with breathing heavily after 90 seconds of walking. When the heart rate would go down to 85-95, shortness of breathe would go away. The patient experienced a thick layer of skin peeling in sole of both feet and developed a new brown spot on her thumb, between thumb knuckles that was itchy and had a size of small dime. The patient was told to keep a look on the spot by her PCP. The patient also stated that she did not experience outbreak of psoriasis in 8 years until she got vaccinated and developed a patch on her left inner calf. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from shivering uncontrollably, couldn't stop shaking, couldn't get warm, almost passed out/felt like passing out, itchiness everywhere/hands become very itchy, swollen hands, swelling all over legs, arms, chest, torso, very itchy, red rash on her whole body, redness on the neck down to her chest and arms/looked sunburnt all over, injection site hardness, swollen face, swollen ears and could not hear well due to swelling, and very painful left arm, temperature 103 on 12-SEP-2021, and super, very painful injection site/super sore injection site, injection site hotness, injection site swelling, and injection site redness on SEP-2021, had not recovered from elevated blood pressure, elevated heart rate, and shortness of breath when walking/breathing heavily after walking, and the outcome of lymph nodes under the armpits, low platelets, small blood clot in the left arm, supraventricular tachycardia, skin peeled off the soles of feet, brown spot on thumb, psoriasis on the lower left calf and didn't feel well was not reported. This report was serious (Hospitalization Caused / Prolonged, and Other Medically Important Condition).; Sender's Comments: V0: 20211056242-Covid-19 vaccine ad26.cov2.s-couldn't stop shaking, almost passed out/felt like passing out, itchiness everywhere/hands become very itchy, swollen hands, swelling all over legs, arms, chest, torso, elevated blood pressure, elevated heart rate . These events are considered unassessable. The events have a compatible/suggestive temporal relationship, are unlabeled, and have unknown scientific plausibility. There is no information on any other factors potentially associated with the events 20211056242- Covid-19 vaccine ad26.cov2.s- small blood clot in left arm, couldn't get warm, didn't feel well, very itchy, red rash on her whole body, temperature 103, shivering uncontrollably. These events are labeled and are therefore considered potentially related.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: Test Date: 20210911; Test Name: Chest CT; Result Unstructured Data: no blood clots in lungs; Test Date: 20210911; Test Name: Heart rate; Result Unstructured Data: Over 100; Test Date: 20210911; Test Name: Heart rate; Result Unstructured Data: 160 {beats}/min; Test Date: 20210911; Test Name: Heart rate; Result Unstructured Data: 130 {beats}/min; Test Date: 20210911; Test Name: Blood pressure; Result Unstructured Data: Elevated; Test Date: 20210911; Test Name: Heart rate; Result Unstructured Data: Elevated; Test Date: 20210911; Test Name: Body temperature; Result Unstructured Data: 103 F; Test Date: 20210913; Test Name: Platelet count; Result Unstructured Data: Too low; Test Date: 20210913; Test Name: Heart rate; Result Unstructured Data: Still elevated; Test Date: 20210914; Test Name: Diagnostic ultrasound; Result Unstructured Data: small blood clot in left arm; Test Name: Ultrasound breast; Result Unstructured Data: Normal; Test Name: Cardiac monitoring; Result Unstructured Data: unknown; Test Name: Cardiac monitoring; Result Unstructured Data: 1 episode of SVT; Test Name: Heart rate; Result Unstructured Data: 100-140; Test Name: Heart rate; Result Unstructured Data: 60-90; Test Name: Echocardiogram; Result Unstructured Data: normal; Test Name: Mammogram; Result Unstructured Data: Normal; Test Name: Heart rate; Result Unstructured Data: 85-95
Aktuelle Erkrankungen: Allergy (takes allergy medication); House dust mite allergy; Penicillin allergy; Psoriasis; Seasonal allergy
Vorgeschichte: Medical History/Concurrent Conditions: Mole excision (removed in June 2021); Vaccination adverse reaction (19 years ago)
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1821576

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: TX
Alter: 62,0
Geschlecht: M
Eingang: 27.10.2021
Impfdatum: 31.08.2021
Beginn: 07.09.2021
Tage bis Beginn: 7,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: ja Erholt: nein

Deep vein thrombosis Erythema Peripheral swelling Skin warm Ultrasound Doppler abnormal

Symptomtext

Right leg DVT, below knee had severe swelling, redness of skin and very warm to touch

Weitere VAERSDATA-Felder

Praegender Schweregrund: Deep vein thrombosis
Hospital-Tage: 4,0
Labordaten: Ultra Sound 09/22/2021, 09/26/2021 , intravenous flushing above knee 09/23/2021
Aktuelle Erkrankungen: None
Vorgeschichte: Diabetes, Heart Disease, Obesity
Andere Medikamente: Plavix, Atorvastatin, Lyrica, Lantus Solostar, Novolog NPH, Copiderol, Multivitamin, Gemfibozil, Ranolizine, Carvedilol,Jardiance, Allopurinol, Lisinopril,
Allergien: Darvocet, Percocet
Vorherige Impfungen: -

VAERS 1777974

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CA
Alter: 45,0
Geschlecht: M
Eingang: 12.10.2021
Impfdatum: 07.09.2021
Beginn: 09.09.2021
Tage bis Beginn: 2,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: ja Erholt: nein

Blood test Erythema Induration Pain in extremity Peripheral swelling Superficial vein thrombosis Ultrasound scan abnormal Vascular pain

Symptomtext

On September 7, 2021, I received my J &J Covid-19 shot in my left arm. Around September 9th, 2021, the inside of my left arm began to swell, was rosy red in color and was painful to the touch. The vein along the inside of my left arm was hard extending from the middle bicep to the break in my arm. Around September 13th or 14th, the vein in my left arm continued to be hard and the hardness began to extend to my left forearm. On September 16th, 2021, the physical symptoms and pain in the vein were still present and I went to the Hospital ER. During that visit, an ultrasound was conducted, reviewed by the ER doctor and PA. I was diagnosed with Superficial Thrombophlebitis.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Superficial vein thrombosis
Hospital-Tage: -
Labordaten: ultrasound & bloodwork on 9/16
Aktuelle Erkrankungen: None
Vorgeschichte: Fatigue
Andere Medikamente: 5 mg of Tadalafil
Allergien: None
Vorherige Impfungen: -

VAERS 1772053

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: NC
Alter: 37,0
Geschlecht: M
Eingang: 08.10.2021
Impfdatum: 16.06.2021
Beginn: 16.06.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Chest pain Dyspnoea Electrocardiogram Fluid retention Hypertension Laboratory test Myocarditis Pericarditis X-ray

Symptomtext

37yo M with 6 days of diffuse, constant chest pain after receiving J&J vaccine on 16JUN. Patient reporting SOB and increased symptoms when laying flat. Patient hypertensive on exam, otherwise vitals wnl. CV/PULM exam unremarkable. EKG nsr. Concern for possible post vaccination pericarditis vs myocarditis vs much lower concern for PE. Patient counseled on findings and escorted to the ED for further evaluation and treatment. Patient will f/u after clearance from ED. Pt was sent to Medical Center. Pt was given a cardio referral. Had a full lab work up, and x-rays. Pt has been seen in clinic multiple times for follow up and continued chest pain. Pt also reports extreme fluid retention.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocarditis
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: No known allergies
Vorherige Impfungen: -

VAERS 1768605

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CA
Alter: 23,0
Geschlecht: M
Eingang: 07.10.2021
Impfdatum: 16.09.2021
Beginn: 16.09.2021
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Dizziness Fall Head injury Syncope

Symptomtext

Fainted and Dizziness BP 108/68, Pulse 50/min. Patient felt dizzy and fainted, fell from chair and hit back of head to floor. Patient had no head bleeding or change of consciousness. Noted head to toe assessment done, no bleeding noted. No complaint of any pain. Pulse is 50/min. Patient states this is his normal pulse rate. Patient is advised to go to ER for CT scan of head and for further evaluation. Patient had only fruits for breakfast. Patient refused to go to ER for further evaluation. Vitals rechecked after 15 minutes, BP 127/73, Pulse 54, Patient feels fine and left for home with father.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1768448

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: TX
Alter: 33,0
Geschlecht: F
Eingang: 07.10.2021
Impfdatum: 17.08.2021
Beginn: 15.09.2021
Tage bis Beginn: 29,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Angiogram Arthralgia Cardiac stress test Chest pain Dyspnoea Echocardiogram normal Electrocardiogram normal Fibrin D dimer normal Full blood count normal Metabolic function test normal Neck pain Pain Pericarditis Troponin normal

Symptomtext

9/15/21 began experiencing sharp left side chest pain that would radiate up left shoulder and neck, accompanied with shortness of breath upon mild exertion. Was evaluated at the ER that night for pulmonary embolism and MI. All test at hospital were normal. was referred to cardiologist and diagnosed with pericarditis on 9/29/21. symptoms began to improve on 9/28/21 and have resolved on 10/1/21.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pericarditis
Hospital-Tage: -
Labordaten: 9/15/21- CBC, CMP, Troponin, EKGx3, CTA, D-dimer- all normal 9/23/21- stress test- abnormal due to peak HR reached at 5 minutes. Echo- normal
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: Orthotricyclen lo
Allergien: Amoxicillin
Vorherige Impfungen: -

VAERS 1758957

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CA
Alter: 54,0
Geschlecht: M
Eingang: 04.10.2021
Impfdatum: 22.06.2021
Beginn: 05.09.2021
Tage bis Beginn: 75,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Activated partial thromboplastin time Alanine aminotransferase normal Aspartate aminotransferase normal Atrial fibrillation Bilirubin conjugated increased Blood alkaline phosphatase normal Blood bilirubin increased Bradycardia COVID-19 COVID-19 pneumonia Cardiac monitoring abnormal Chest X-ray Colonoscopy abnormal Cough Delirium Echocardiogram Echocardiogram abnormal Ejection fraction normal

Symptomtext

55 year old male, vaccinated with J&J on 6/22/2021 who tested positive for COVID-19 on 9/1 ultimately requiring intubation on 9/17 and VV ECMO cannulation on 9/24, CVICU course complicated by: 1. Hemorrhagic shock 2/2 GIB (rectal ulcers) s/p colonoscopy and clipping -- > hemodynamically stable, low dose pressors, stable 2. Delirium 3. Bradycardia 4. Klebsiella pneumonia PLAN: NEURO: Sedation - paralytics off 9/27 - limited dex (caution with bradycardia), continue propofol, continue versed, dilaudid gtts -> weaning as tolerated - Gabapentin q8 -> increased to 600mg TID on 10/2, seroquel 100mg qhs. Added seroquel 50mg PO BID to try to wean other drips on 10/2. - monitor prolonged Qtc when adding oral agents -> QTc on EKG from 10/3 was 451 - Of note, does overbreathe the vent, gags and coughs, but not following commands and not moving extremities so if he does not wake up with aggressive weaning of sedation today, may need to consider head CT in the next 24-48H. CARDIAC: Normal biventricular function Afib - resolved on 9/22 Baseline bradycardia - DC amio given bradycardia noted 9/27-9/29 - Minimize dex gtt - repeat TTE 9/27 relatively stable, normal EF, mildly dilated RV with normal RV function - on and off neo/vaso as needed for MAP goal > 65mmHg PULM: COVID PNA s/p VV ECMO cannulation. S/p toci on 9/8, remdesivir (9/6-9/10) - CXR daily - Continue low tidal volume ventilation for plateau < 25 and minimize FiO2 - s/p solumedrol taper to 9/23-9/27. - consult ENT for trach once off isolation ECMO: - Keep flows > 4L/min to maintain oxygen saturations >80% (assuming SVO2 > 55%, based on desired goal: DO2/VO2 > 3). - Started bival 9/28, goal PTT 40 to 60, at goal FEN/GI: GIB 2/2 rectal ulcerations. S/p emergent EGD/colonoscopy (9/26): no evidence of upper GI source; 2 rectal ulcers found w/ pulsating arterial lesions; hemostasis obtained w/ 5x clips, cautery, and epi injection. - TF on 9/28, no active bleeding since GI clipping 9/26 - No rectal tube given rectal clips - Per GI conversation 9/30, ok to give rectal enema if absolutely needed, but would try suppository first - Goal is BM daily - GI ppx with PPI - Continue bowel regimen, last BM: 10/2 with stool. Given high OGT output on 10/3 and no BM yet on 10/3, restarted reglan 5mg IV Q6H x 8 doses and also gave 1 dose of lactulose as well.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Intensive care
Hospital-Tage: -
Labordaten: Results as of 10/4/2021 11:15 9/26/2021 04:30 ALT: 36 AST: 35 ALKP: 49 TBILI: 5.6 (H) BILID: 2.4 (H) 9/27/2021 03:20 ALT: 27 ALKP: 69 TBILI: 3.7 (H) BILID: 1.0 (H) 9/28/2021 03:20 ALT: 26 ALKP: 87 TBILI: 2.6 (H) BILID: 0.8 (H) 9/29/2021 03:53 ALT: 26 ALKP: 89 TBILI: 2.2 (H) BILID: 0.7 (H) 9/30/2021 03:30 ALT: 31 ALKP: 78 TBILI: 2.2 (H) BILID: 0.5 (H) 10/1/2021 03:30 ALT: 23 ALKP: 80 TBILI: 2.2 (H) BILID: 0.7 (H) 10/2/2021 04:15 ALT: 23 AST: 21 ALKP: 81 TBILI: 2.1 (H) BILID: 0.7 (H) 10/3/2021 03:15 ALT: 23 AST: 20 ALKP: 85 TBILI: 1.8 (H) BILID: 0.6 (H) 10/4/2021 03:45 ALT: 16 AST: 18 ALKP: 61 TBILI: 1.5 (H) BILID: 0.6 (H)
Aktuelle Erkrankungen: None
Vorgeschichte: Elevated LFTs and inguinal hernia
Andere Medikamente: None
Allergien: nkda
Vorherige Impfungen: -

VAERS 1753744

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201a21a

schwer

Staat: KY
Alter: 46,0
Geschlecht: M
Eingang: 01.10.2021
Impfdatum: 24.08.2021
Beginn: 24.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Dizziness Headache Heart rate increased Hyperhidrosis Syncope Tinnitus

Symptomtext

Excessive sweating, severe headache, ringing in ears, dizziness, syncope, and rapid heart beat.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: Unsure. Called 911 and he was transported to the ER.
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Unknown
Andere Medikamente: Unknown
Allergien: Unknown
Vorherige Impfungen: -

VAERS 1750193

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CA
Alter: 48,0
Geschlecht: M
Eingang: 30.09.2021
Impfdatum: 01.06.2021
Beginn: 10.06.2021
Tage bis Beginn: 9,0
Dosis: 1
Route/Site: SYR / UN

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Cerebral artery embolism

Symptomtext

patetin had an embolic cerebral vascular event 6/10/21- currently under investigation- remains cryptogenic

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebral artery embolism
Hospital-Tage: 21,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: HTN with bilateral retinopathy, DM2 with peripheral neuropathy, CKD, OSA
Andere Medikamente: -
Allergien: rosuvastatin
Vorherige Impfungen: -

VAERS 1741458

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201a21a

schwer

Staat: LA
Alter: 31,0
Geschlecht: F
Eingang: 28.09.2021
Impfdatum: 17.09.2021
Beginn: 20.09.2021
Tage bis Beginn: 3,0
Dosis: UNK
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Chest X-ray Chest pain Laboratory test Pericarditis Red blood cell sedimentation rate increased

Symptomtext

pt presented for chest pain for 7 days. labs and chest xray ordered. elevated ESR. presumptively dx with acute pericarditis treated colchicine and motrin

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pericarditis
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1736472

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: FL
Alter: 28,0
Geschlecht: F
Eingang: 27.09.2021
Impfdatum: 30.08.2021
Beginn: 31.08.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Asthenia Back pain Chills Crying Gait disturbance Headache Hypoaesthesia Insomnia Migraine Myalgia Paralysis Pyrexia

Symptomtext

Approximately 6 hours after receiving the vaccine I experienced the typical chills, followed by fever (around 9pm). Then, I experienced pulsating muscle pain that radiated out of my lower back; it was excruciatingly painful. Then, I experienced migraines that were on & off the entire night. In the morning around 4am, since I was unable to sleep more than 4 hours, I had difficulty walking. Not only did I feel weak, but my legs began feeling numb. Within 24 hours, those symptoms went away (praise God), but I almost became paralyzed. I could not stop crying with how much pain I was in. In addition, for 3 weeks after the vaccine, I would get a headache each morning upon waking. I do not have a history of any of these symptoms.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paralysis
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: Augmentin, all grains, dairy, legumes, soy, high-oxalate plant foods
Vorherige Impfungen: -

VAERS 1735805

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CA
Alter: 44,0
Geschlecht: M
Eingang: 26.09.2021
Impfdatum: 10.04.2021
Beginn: 18.04.2021
Tage bis Beginn: 8,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blindness Blood pressure increased Blood test normal Dizziness Heart rate increased Loss of consciousness

Symptomtext

Ongoing dizziness and elevated heart rate when standing up. Multiple episodes of losing vision during light headlines. Near miss with multiple episodes of loss of consciousness.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: Blood tests show no abnormalities. Blood pressure is normal in all situations except when standing at which time spikes in blood pressure and heart rate are recorded. Dr. recommendations were to hydrate additionally which has not changed any of the side effects which are still ongoing 6 months later.
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 1729022

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CA
Alter: 18,0
Geschlecht: M
Eingang: 23.09.2021
Impfdatum: 23.09.2021
Beginn: 23.09.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Confusional state Head injury Hyperhidrosis Loss of consciousness

Symptomtext

AFTER ADMINISTERING THE VACCINE THE PATIENT WALKED OUT AND WITHIN MINUTES HE PASSED OUT FELL DOWN HIT HIS HEAD AND DIDN'T KNOW WHERE HE WAS HE WAS CONFUSED SWEATING WE CALLED EMS THEY WERE HERE WITHIN FEW MINUTES AND WORKED ON HIM THE PATIENT REFUSED TO GO TO ER AFTER A WHILE 1/2 HOURS OR SO HE CLAIMED HE WAS GETTING BETTER AND HE WENT TO HIS CAR WAITING FOR HIS FATHER TO GIVE HIM A RIDE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 1705274

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201a21a

schwer

Staat: CA
Alter: 36,0
Geschlecht: F
Eingang: 19.09.2021
Impfdatum: 16.09.2021
Beginn: 16.09.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Anxiety Aphasia Condition aggravated Feeling hot Partial seizures Seizure Posture abnormal Tremor

Symptomtext

Seizure less 15 min

Weitere VAERSDATA-Felder

Praegender Schweregrund: Partial seizures
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: N/a
Vorgeschichte: Neuropathy, seizure
Andere Medikamente: Gabapentin, Lamoitrigne, Pregabalin
Allergien: Mangos, papaya, fresh pineapple, seafood, airborne tilapia allergy, morphine, stadholder, topamax, max alt, diclofenac
Vorherige Impfungen: -

VAERS 1705274

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CA
Alter: 36,0
Geschlecht: F
Eingang: 19.09.2021
Impfdatum: 16.09.2021
Beginn: 16.09.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Anxiety Aphasia Condition aggravated Feeling hot Partial seizures Seizure Posture abnormal Tremor

Symptomtext

Seizure less 15 min

Weitere VAERSDATA-Felder

Praegender Schweregrund: Partial seizures
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: N/a
Vorgeschichte: Neuropathy, seizure
Andere Medikamente: Gabapentin, Lamoitrigne, Pregabalin
Allergien: Mangos, papaya, fresh pineapple, seafood, airborne tilapia allergy, morphine, stadholder, topamax, max alt, diclofenac
Vorherige Impfungen: -

VAERS 1710787

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CO
Alter: 64,0
Geschlecht: M
Eingang: 18.09.2021
Impfdatum: -
Beginn: 14.09.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Fear Paralysis

Symptomtext

FULL BODY PARALYSIS; IT WAS FRIGHTENING; This spontaneous report received from a patient concerned a 64 year old male of unspecified ethnicity. The patient's height, and weight were not reported. The patient's concurrent conditions included: nonsmoker, and non-alcohol user, and other pre-existing medical conditions included: The patient had no known allergies, no history of drug abuse or illicit drug usage. The patient was pretty healthy and was not on medicine. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A expiry: unknown) dose was not reported, 1 total administered on 31-AUG-2021 to right arm for prophylactic vaccination. No concomitant medications were reported. On 14-SEP-2021 in night, patient reported that he believed he had stroke, he was sitting down listening to music when his body stopped responding, mostly right arm was totally not responsive but did not affect heart, lungs or brain. He had this episode which did not last that long, only lasted a minute but it was frightening. According to patient after 30-40 second he began to have some animation on his right hand, he was able to take off his shirt to help cool off and eventually everything turned back to normal. He took acetylsalicylic acid (Aspirin) as it would eliminate or minimized "long term side" (sic) and did not seek medical attention as it was only lasted a few seconds and they were most likely going to give him aspirin anyways. The patient said he thought it was probably something autonomic in the cerebellum, might a bit like sleep paralysis and later stated he thought it was probably the vaccine as he had not done anything different. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from full body paralysis, and it was frightening on 14-SEP-2021. This report was serious (Other Medically Important Condition).; Sender's Comments: V0-20210929008-COVID-19 VACCINE Ad26.COV2.S-Full Body Paralysis. This event is considered un-assessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paralysis
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Abstains from alcohol; Non-smoker
Vorgeschichte: Comments: The patient had no known allergies. The patient had no history of drug abuse or illicit drug usage. The patient was pretty healthy and was not on medicine.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1708804

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CA
Alter: 34,0
Geschlecht: M
Eingang: 17.09.2021
Impfdatum: 17.09.2021
Beginn: 17.09.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Lip injury Syncope Tooth fracture

Symptomtext

Patient fainted, chipped tooth, and cut his lip.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1705505

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CA
Alter: 64,0
Geschlecht: F
Eingang: 16.09.2021
Impfdatum: 14.09.2021
Beginn: 14.09.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Loss of consciousness Syncope

Symptomtext

64 yo female with vasovagal syncope ~5 minutes after receiving Janssen Covid-19 vaccine. Patient was sitting on a bench with a friend after receiving the vaccine when noted to slump over suddenly and briefly lose consciousness. The patient?s friend helped ease her to the ground and called for help. Patient immediately regained consciousness and was helped to a supine position onto the bench by another PA and a medical assistant. I assessed the patient and noted that she was alert and oriented with SBP 120 (supine), regular pulse, respirations were non labored and O2 sat was 98%. She had a small superficial abrasion to her left forehead that was treated with antibiotic ointment by the medical assistant. Patient admitted to a prior h/o syncope immediately after receiving a cortisone injection and a h/o anxiety with needles. She reported that she was not diabetic and had eaten a regular meal earlier that day. She was monitored for an additional 30 minutes and then reassessed with BP of 135/84 (sitting), pulse 70, and O2 sat 99%. Patient was allowed to leave in the care of her friend after reporting that she felt fine and was ambulating without c/o lightheadedness, headache, or N/V.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1704434

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201a21a

schwer

Staat: CT
Alter: 19,0
Geschlecht: M
Eingang: 16.09.2021
Impfdatum: 16.09.2021
Beginn: 16.09.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Feeling hot Hyperhidrosis Loss of consciousness Posture abnormal Staring Tension Unresponsive to stimuli

Symptomtext

Patient was administer a Janssen vaccine on 09/16/21 at 10:30 a.m.. patient was walked over to the waiting area and started feeling hot with in 3 minutes. He was accompanied by his sister and father who also received the same vaccine.. his sister gave him some water...then in a few minutes pt had a blank stare look on his face, he had no response, head went backwards, hand clamped tight into a fist, pt was out and no response for a few seconds. I was assisted by the store manager who called 911.. patient came back and was responsive, he knew his name and where he was he was sweating profusely and very damp... I had patient lay down on the floor and gave him some orange juice. Patient had nothing to eat or drink that morning.. EMT arrived and assessed patient and pt went to the hospital.. I called pt to follow up but no answer, at arounf 12:00 pt and sister came back to pharmacy to let me know everything was ok and to thank me for helping..

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 1704376

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: -
Alter: 26,0
Geschlecht: M
Eingang: 16.09.2021
Impfdatum: 16.09.2021
Beginn: 16.09.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Syncope

Symptomtext

Pt experienced a syncopal episode during observation period after receiving Janssen vaccine. Pt did not sustain any falls while sitting in chair. Pt was given water, sugary snack, and had leg raised. Pt reported "feels fine" and was able to walk out of the vaccination site after approximately 20 minutes.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Hx: anemia, syncope after blood draw
Andere Medikamente: -
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1704126

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: FL
Alter: 21,0
Geschlecht: M
Eingang: 16.09.2021
Impfdatum: 14.09.2021
Beginn: 14.09.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Dizziness Loss of consciousness

Symptomtext

Passed out for 15 seconds. Says he was dehydrated from PT from the (place of work), had not eaten and felt dizzy prior to passing out.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1703899

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: KY
Alter: 21,0
Geschlecht: F
Eingang: 16.09.2021
Impfdatum: 16.09.2021
Beginn: 16.09.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Heart rate decreased Malaise Nausea Pallor Syncope Vision blurred

Symptomtext

Patient was administered vaccine at 7:40AM. At 7:45 AM patient reported she wasn't feeling well with loss of color, dizziness, syncope episode, nauseous, blurred vision and slow to recover. Patient never passed out, but heart rate dropped to 32. Oxygen remained normal the entire time. 911 was called and arrived around 7:50 and performed a full evaluation on the patient. The patient refused to be transported and was released after recovering, but had someone drive her home.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: EMS was called and arrived at around 9:50 AM. EMS performed all necessary evaluations, patient recovered and felt better, but weak when released by EMS. Someone drove the patient home and she was advised to follow up with her family physician, but patient did state she had not eaten anything since 9:00 PM last night.
Aktuelle Erkrankungen: None.
Vorgeschichte: None.
Andere Medikamente: None.
Allergien: None.
Vorherige Impfungen: -

VAERS 1696941

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: IL
Alter: 95,0
Geschlecht: F
Eingang: 14.09.2021
Impfdatum: 08.04.2021
Beginn: 07.08.2021
Tage bis Beginn: 121,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Asthenia Chest X-ray abnormal Infection Interstitial lung disease Pulmonary oedema Pyrexia Somnolence

Symptomtext

Came to ER with fever, generalized weakness starting on 8/7/2021. Temp of 101.9, Saturating 90s on 2L NC. Patient was drowsy and alert and oriented x 1. Received azithromycin and ceftriaxone. Admitted to the hospital. Through stay was treated with supplemental oxygen, Decadron, azithromycin, ceftriaxone.Over the course of hospitalization patient was successfully weaned off the oxygen. Had no noted fever spikes. Was breathing on room air. Finished antibiotics and steroids. Patient was taken of isolation precautions before discharge based on institutional protocols. discharged to SNF on 8/18/21

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary oedema
Hospital-Tage: 11,0
Labordaten: 8/7/21 Chest xray: Bilateral increased interstitial markings of uncertain etiology. Atypical infection and pulmonary edema are considerations. 8/13/21 Chest xray: same as 8/7/21
Aktuelle Erkrankungen: -
Vorgeschichte: Barrett's esophagus, hypertension , IBS, shingles, hypothyroid
Andere Medikamente: Furosemide, levothyroxine, lovastatin, metoprolol succinate, nitro PRN, omeprazole, miralax, raloxifene
Allergien: Dexfenfluramine
Vorherige Impfungen: -

VAERS 1689665

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: KY
Alter: 75,0
Geschlecht: F
Eingang: 10.09.2021
Impfdatum: 08.04.2021
Beginn: 18.08.2021
Tage bis Beginn: 132,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute kidney injury Anisocytosis Anticoagulant therapy Bladder catheterisation Blood creatinine increased Condition aggravated Confusional state Culture urine positive Deep vein thrombosis Dysphagia COVID-19 COVID-19 pneumonia Cardiac failure Chronic kidney disease Computerised tomogram abdomen Dysuria Echocardiogram Feeding disorder

Symptomtext

Vaccinated for COVID, admitted with COVID Admit 8/18 Discharge 9/3 to home with home health covid + 8/19/2021 Hospitalization Admit Date/Time: 8/18/2021 5:20 PM Discharge Date: 9/3/2021 Referring provider name and address: No referring provider defined for this encounter. 75 yo F who is a poor historian but has been having dysuria, n/v and was hypoxic to 85% in triage. States that she was recently discharged from hospital w/ concern for urinary retention/UTI; has a hx of previous stroke and was sent to rehab. At rehab, states that she has had poor oral intake and has been feeling nauseous with intermittent emesis. Family in the room has been concerned that she was more confused recently. Does state that she has been having dysuria, of note was supposed to note be cathed 2/2 hx of frequent UTIs and was supposed to follow up with urology. Pt was having retention and was cathed multiple times/day. Chief Concern, Brief History of Present Illness, and Hospital Course 75 y.o. female with a PMH of GERD, anxiety, depression, obesity, HTN, DMII, CVA with residual right sided weakness, breast cancer s/p mastectomy, and thyroid nodules s/p thyroidectomy who was admitted to hospital 7/24 to 8/6 for presented to ED from rehab on 8/19 with concerns for encephalopathy, hypoxia, dysuria and urinary retention. Found to be COVID positive on admission. Finished steroid and remdesivir course and now doing well in room air. PT/OT recommeneded acute rehab but denied by insurance. Hence, being discharged to SNF today. Assessment and Plan on Discharge Day Acute Hypoxic Respiratory Failure likely 2/2 COVID-19 PNA Chronic B/L Pleural Effusions (R>L) 2/2 HFmREF and mild/moderate MR -Hypoxic on presentation and requiring NC, now weaned off and satting well in room air since last few days -TTE 08/23 with EF of 40-50% with mild to moderate MR and signs of increased LVEDP, mild TR with ePASP of 35-50 mm Hg -COVID+ on 8/19. -S/p Dexamethasone (08/19 - 08/28) and Remdesivir (8/19-8/23) -Pro-BNP on 8/23-03764>>3609 on 8/18 but no signs of volume overload clinically -XR chest 8/18 with B/L effusions (R>L) and B/L airspace opacities on L base and mid/lower right lung, rpt XR chest 9/1 AM with improved aeration of R effusion and decreased R sided effusion -No need for isolation on discharge given clinical symptomatic improvement and no fever for a while and >10 days since tested positive AKI on CKD Stage IIIb/IV 2/2 COVID-19 ATN vs Obstructive AKI in the setting of preexisting diabetic nephropathy (resolved) Urinary Retention POA s/p Foley's insertion UTI -Cr on presentation-1.53 (close to baseline of 1.5-1.7), peaked to 2.14 on 8/24 and now improved almost back to baseline to 1.60 on 9/3 -UA with pyuria/hematuria/proteinuria. Urine protein to creatinine ratio 5.0 suggestive of nephrotic range proteinuria (3.9 1 month ago) -CT abdomen (08/23) without evidence of hydronephrosis or obstruction. -Presented with urinary retention, failed voiding trial x3 this admission (Last on 9/2) -Urine Cx growing Klebsiella pneumoniae, given urinary retention requiring Foley's, will continue Cefdinir for 7 days course until 9/6 on discharge -Continue bowel regimen, encourage ambulation -Flomax stopped on 8/31 as there is no evidence of clinical benefit with flomax in urinary retention in females -Sees urology as OP and reportedly had prior issues with urination as per sister, will try voiding trial again today, otherwise will plan to discharge with Foley's with OP urology follow up (has appointment scheduled on 9/8) -Monitor Cr as outpatient, repeat protein-creatinine ratio in 1 month -Follow up with nephrology as outpatient, referral provided Acute metabolic encephalopathy (resolved) Oropharyngeal Dysphagia Hx of CVA with residual right sided weakness -Mental status back to baseline -On mech soft diet as per SLP -Continue ASA, statin and thiamine -Delirium precautions Leukopenia and thrombocytopenia (resolved) Lymphopenia 2/2 due to COVID Normocytic Anemia 2/2 Anemia of CKD -WBCs-3.29 on 8/18, decreased to 1.81 on 8/21, improved to 5.61 on 9/1 -Lymphocyte 0.68 on 8/18, decreased to 0.25 on 8/23 and improved to 1.34 on 9/1 -Plt 155 on 8/18, decreased to 128 on 8/25 and improved to 159 on 9/1 -Hb 9.3 on admission, stable at 8.9 on 9/1 (prior iron studies on 7/26 suggestive of AOCD) -B12/folate normal -Blood smear with Leukopenia including neutropenia with normal white blood cells morphology and moderate normocytic anemia with anisocytosis and rare schistocytes, Normal platelets Hypomagnesemia (resolved) -Mg: 2.0 on 8/26<<1.4 on 8/20 Physical Debility with Chronic T12 Compression Fracture and CVA with Right Sided Weakness -Tylenol and lidocaine patch PRN -PT/OT-recs acute rehab, however denied by insurance despite peer to peer review, hence, being discharged to home with home health today Right Lower Extremity Edema -Pt reports this is chronic but a poor historian -Venous duplex -ve for DVT Type 2 DM -Last A1c 8.5% on 7/25 -Maneged with basal/bolus insulin regimen while inpatient -Resume home Tradjenta and start lantus 5 U daily on discharge Hypertension -Continue same doses of home Nifedipine and Isosorbide and increased dose of coreg 25 BID on discharge Depression Anxiety -Continue home Effexor

Weitere VAERSDATA-Felder

Praegender Schweregrund: Deep vein thrombosis
Hospital-Tage: 17,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Anxiety disorder, unspecified Anxiety and depression ? Breast cancer ? Cancer ? Chronic kidney disease ? Disease of thyroid gland ? Essential (primary) hypertension Hypertension ? GERD (gastroesophageal reflux disease) ? Hearing loss 8/19/2021 ? Hyperlipidemia ? Major depressive disorder, single episode, moderate 8/19/2021 ? Obesity ? Polyneuropathy, unspecified Peripheral neuropathy ? Stroke ? Thyroid nodule ? Type 2 diabetes mellitus without complications Diabetes mellitus ? Unspecified osteoarthritis, unspecified site Arthritis
Andere Medikamente: aspirin, atorvastatin, calcium carbonate-cholecalciferol, cyanobalamin, isorbide dinitrate ER, linagliptin, nifedipine XL, ondansetron, Miralax, venlafaxine XR, carvedilol
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1688987

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: GA
Alter: 34,0
Geschlecht: F
Eingang: 10.09.2021
Impfdatum: 10.09.2021
Beginn: 10.09.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Cold sweat Disorientation Dizziness Syncope

Symptomtext

PATIENT FELT LIGHTHEADED AND THEN FAINTED. WOKE UP, SEEMED DISORIENTED, CLAMMY. CALLED EMS WHO CHECKED HER BLOOD PRESSURE, BLOOD SUGAR, TEMPERATURE, AND PULSE. PATIENT REFUSED ANY OTHER SERVICE FROM EMS. LEFT AFTER ABOUT 30 MINUTES

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: UNKNOWN
Vorgeschichte: NONE
Andere Medikamente: UNKNOWN
Allergien: NONE
Vorherige Impfungen: -

VAERS 1685780

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CA
Alter: 27,0
Geschlecht: F
Eingang: 09.09.2021
Impfdatum: 09.09.2021
Beginn: 09.09.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Anaphylactic reaction Chills Dysphagia Dyspnoea Nausea Productive cough Vomiting

Symptomtext

Moderna COVID-19 Vaccine EUA Patient came to vaccine clinic with her family member and received J&J vaccine at 1245. I took her to the back room to observe her for 30 minutes. She reported history of anaphylaxis to Pfizer in January of 2021. I took her vitals at 1253. BP 119/64; HR 96, SpO2 97 % on RA. At 1301 she reported difficulty breathing. I administered 3 mg of Epi via left lateral thigh. Vitals after first dose of Epi was: BP 120/63; HR 91, SpO2 99% on 6 liters via nasal cannula. Patient reported that her breathing was getting better. At 1310 patient stated that she was having difficulty swallowing her saliva. I administered 50 mg IM Benadryl. I called Dr.and reported patient had Anaphylaxis and was not improving. Dr. and his team came right away. Nurse called urgent care. Nurse called emergency services. At 1315 second dose of Epi was given. Vital signs at 1318 were BP 92/73; HR 111, SpO2 100% on 6 liters via nasal cannula. She was shivering and coughing out phlegm. Silver blanket was applied to keep patient warm. At 1320 the third dose of Epi was given and patient reported some relief. Paramedics came around 1325. Patient BP was 160/100. Patient had two episodes of nausea and vomiting. She was taken to Medical Center via ambulance. Nurse manager was notified.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Anaphylactic reaction
Hospital-Tage: -
Labordaten: n/a
Aktuelle Erkrankungen: Asthma, Bronchitis
Vorgeschichte: Asthma, bronchitis
Andere Medikamente: During the code the patient's family member stated that she used an inhaler. She has a history of Asthma and bronchitis.
Allergien: Penicillin, Amoxicillin, Toradol, Morphine, Ibuprophen, Pfizer
Vorherige Impfungen: Anaphylaxis to Pfizer in January 2021

VAERS 1684873

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: OH
Alter: 43,0
Geschlecht: M
Eingang: 09.09.2021
Impfdatum: 09.09.2021
Beginn: 09.09.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Cold sweat Dizziness Loss of consciousness

Symptomtext

Patient felt light headed, clammy, thought he was going to pass out, loss of color and blacked out for a few seconds. Called 911 to ensure patient was ok. EMS arrived and cleared patient because he refused to be transported to the hospital.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: No
Vorgeschichte: Allergies
Andere Medikamente: No
Allergien: No
Vorherige Impfungen: -

VAERS 1683037

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: TX
Alter: 46,0
Geschlecht: M
Eingang: 08.09.2021
Impfdatum: 20.08.2021
Beginn: 26.08.2021
Tage bis Beginn: 6,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Asthenia Blood test Computerised tomogram Head discomfort Headache Hyperacusis Metamorphopsia Migraine Musculoskeletal discomfort Nausea Photophobia Swelling Syncope Visual impairment

Symptomtext

Headache developed followed by fainting spell, narrowed vision, head and neck pressure, kaleidoscope eye and later progressed into migraine like symptoms. Debilitating head pain, sensitivity to light and sound and slight nausea. this persisted for four days before slowly fading in intensity. Slight headache and occasional swelling of head and neck pressure persist to this day.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: At the emergency room on the first day of event I was given an IV of saline, they took blood for analysis and a CT scan.
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 1679286

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CO
Alter: 28,0
Geschlecht: M
Eingang: 07.09.2021
Impfdatum: 07.09.2021
Beginn: 07.09.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Cold sweat Dizziness Feeling hot Hyperhidrosis Loss of consciousness Pallor

Symptomtext

Given vaccine @ 14:15 and taken to observation area, no acute issues reported. ~14:25 pt asked for water, c/o temporary LOC. Pt laid down and feet elevated, LOC less than 7secs. Pt very diaphoretic, cool and pale. Pt reports feeling very hot and clammy. EMS called and arrived within 10mins. HR 100, SBP 115s. Pt continued to improve over time, reporting feeling hot but less lightheaded. Upon arrival of EMS pt HR still in the low 100s and SBP 112, no abnormal rhythm found. EMS advised to take pt to ED for observation d/t reports of feeling dizzy and lightheaded. Pt reports he has passed out from blood draws before and did not eat lunch prior to arriving for vaccination.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Unknown
Andere Medikamente: Unknown
Allergien: Unknown
Vorherige Impfungen: -

VAERS 1663596

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CA
Alter: 31,0
Geschlecht: F
Eingang: 01.09.2021
Impfdatum: 01.09.2021
Beginn: 01.09.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Anxiety Ear discomfort Syncope

Symptomtext

At approximately 1630 hrs, a syncopal episode occurred at the location site on 09/01/2021. A 21 yo female vaccination patient had a syncopal episode post-vaccination with JJ. The patient did not experience any trauma and was provided care by 2 RNs and 2 LVNs with a pharmacist as well. Patient woke up after approximately 5 seconds. Patient had ear pressure upon waking but mentioned it was just her anxiety. Vitals were taken and were all within normal range. Heart rate was 56 with the patient mentioning they ?are an acrobat and athletic?. Patient left after 45 minutes of monitoring stating that she ?was feeling much better and will eat a snack soon?. The patient was medically screened appropriately by an RN with no contraindications to vaccination. When the incident occurred, the patient was seated in the observation area. All staff responded appropriately, as discussed in the morning briefing.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1659097

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: MD
Alter: 27,0
Geschlecht: M
Eingang: 31.08.2021
Impfdatum: 31.08.2021
Beginn: 31.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Dizziness Fall Head injury Syncope

Symptomtext

Patient had a fainting episode after receiving a dose of Janssen Covid-19 Vaccine. Patient walk out of the consultation room, and immediately reported feeling lightheaded and fell backwards landing on his buttocks first and then hitting is head. The pharmacy staff called 911 and they came within about 5 minutes. The patient quickly recovered and was sitting up by the time the medics arrived. The patient refused service, citing feeling much better.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: NA
Vorgeschichte: NA
Andere Medikamente: NA
Allergien: NA
Vorherige Impfungen: -

VAERS 1656204

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: OH
Alter: 30,0
Geschlecht: F
Eingang: 30.08.2021
Impfdatum: 30.08.2021
Beginn: 30.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Blood pressure increased Disorientation Seizure like phenomena Unresponsive to stimuli Vomiting

Symptomtext

A few minutes after receiving vaccine, patient became unresponsive and was frozen in a seizure-like trance. She then vomited and became responsive but remained disoriented. Blood pressure was elevated but she was stable. EMS arrived and she was taken to local ED

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure like phenomena
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Possible neurologic issues per friend
Andere Medikamente: Prozac, medical marijuana
Allergien: NA
Vorherige Impfungen: -

VAERS 1653885

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: NC
Alter: 54,0
Geschlecht: F
Eingang: 29.08.2021
Impfdatum: 29.07.2021
Beginn: 29.07.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Anxiety Blood pressure fluctuation Blood thyroid stimulating hormone decreased Condition aggravated Diarrhoea Electric shock sensation Feeling jittery Feeling of body temperature change Flushing Heart rate abnormal Impaired work ability Nausea Palpitations Paraesthesia Weight decreased

Symptomtext

About an hour after I got it I felt an odd shock all over my body, then a cold and hot flushing sensation all over. I was jittery the rest of the day. Five days later I had more of the cold shot flushes and realized they were adrenaline surges, accompanied by severe anxiety. It has progressively worsened and I am having loose stools, a 10 lb weight loss, and have been increasingly unable to work (I am a Public Health RN). I am having symptoms of POTS syndrome. I wish I had never taken the vaccine. This is absolutely horrible. My heart pounds when I get up and move about. My BP and heart rate are fluctuating wildly. I am nauseated. Having flushing. Went to the ER because my arms and legs were tingling so badly and the adrenaline surges.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Electric shock sensation
Hospital-Tage: -
Labordaten: TSH July 9 was 2.6 TSH Aug 10 was 1.5 TSH Aug 14 was 2.3
Aktuelle Erkrankungen: none.
Vorgeschichte: asthma Hypothyroidism (total thyroidectomy in 2010 multiple environmental allergies
Andere Medikamente: Levothyroxine, singular, allegra, buspar, atenolol, magnesium, Vitamin D, vitamin B12,
Allergien: levaquin Tequin Epinephrine
Vorherige Impfungen: -

VAERS 1637376

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CO
Alter: 39,0
Geschlecht: F
Eingang: 26.08.2021
Impfdatum: 26.08.2021
Beginn: 26.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Syncope

Symptomtext

PATIENT FAINTED AFTER VACCINATIN

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1628508

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CO
Alter: 28,0
Geschlecht: F
Eingang: 24.08.2021
Impfdatum: 18.08.2021
Beginn: 18.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Loss of consciousness

Symptomtext

Patient after receiving the vaccine was waiting in the observation area when she told us that she was dizzy. Soon after that she briefly passed out on the chair she was sitting on. Patient was passed out for about 5-10 seconds and came out soon after.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1617482

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: TX
Alter: 21,0
Geschlecht: M
Eingang: 22.08.2021
Impfdatum: 20.08.2021
Beginn: 21.08.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Back pain Fatigue Migraine Nausea Psychogenic seizure

Symptomtext

Woke up due to pseudo seizure, migraine like headache, unbearable lower back pain, fatigue, and nausea

Weitere VAERSDATA-Felder

Praegender Schweregrund: Psychogenic seizure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1603044

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CA
Alter: 56,0
Geschlecht: M
Eingang: 21.08.2021
Impfdatum: 09.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Headache Pain Paralysis

Symptomtext

Approxamatly 12 hours after injection and after going to bed I awoke to a severe headache. I attempted to get out of bed but realized I could not lift my head off the pillow. I attempted to reach the phone by my bed side but found that I was almost totally paralyzed neck, both arms and shoulders to the point that I could not get out of bed to call 911 for help. I believe I was Simi conscious on and off for approximately 8 hours. at some point during the night I fell back asleep. When I awoke at approximately 11:00 am I was able to get out of bed with extreme difficulty and pain in my entire body. The symptoms took almost two weeks to go away however the headache continued for almost a month.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paralysis
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: high blood pressure /hypertension
Andere Medikamente: Fish oil, Vitamin C, CoQ10.
Allergien: None
Vorherige Impfungen: -

VAERS 1582293

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: KY
Alter: 21,0
Geschlecht: F
Eingang: 18.08.2021
Impfdatum: 11.04.2021
Beginn: 06.08.2021
Tage bis Beginn: 117,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Pain in extremity Thrombosis Ultrasound Doppler abnormal

Symptomtext

Pain noticed in right calf (8/6/21). Pain got worse and prompted ER visit. Blood clot diagnosed in right leg/calf area via Doppler ultrasound (8/11/21). Eliquis prescribed for three months minimum and compression sleeve to be worn daily.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: -
Labordaten: Doppler ultrasound (08/11/2021)
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Lo Loestrin Fe
Allergien: None
Vorherige Impfungen: -

VAERS 1578450

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: HI
Alter: 42,0
Geschlecht: M
Eingang: 17.08.2021
Impfdatum: 16.08.2021
Beginn: 16.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Dizziness Syncope

Symptomtext

5 minutes after giving JJ vaccine. Patient came to counter and said he needed to lie down bc he was feeling faint. I instructed him to lie down and by the time I got to him he had fainted. He was out for a few seconds. He remained lying down and felt dizzy. But was uninjured.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1569250

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201a21a

schwer

Staat: MA
Alter: 22,0
Geschlecht: M
Eingang: 15.08.2021
Impfdatum: 15.08.2021
Beginn: 15.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Hyperhidrosis Loss of consciousness Pallor Syncope

Symptomtext

Patient received Janssen Covid-19 vaccine 8/15/2021; after 7 minutes in the waiting room, he fainted and was unconscious. 911 was called immediately. He was very pale and sweaty. After several minutes, he gained consciousness and was able to sit in his chair. Ambulance arrived and they assessed patient. Patient stated he was fine, and was able to answer several questions from ambulance team. Patient walked out of the store and went home. He was advised to seek medical attention if the adverse event occurs again in the future.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: n/a
Aktuelle Erkrankungen: n/a
Vorgeschichte: n/a
Andere Medikamente: n/a
Allergien: n/a
Vorherige Impfungen: -

VAERS 1549002

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: OH
Alter: 19,0
Geschlecht: F
Eingang: 12.08.2021
Impfdatum: 10.08.2021
Beginn: 10.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Syncope

Symptomtext

PATIENT FAINTED 1O MINUTES AFTER VACCINE. SHE FELT LIKE SHE WAS ABOUT TO PASS OUT BEFORE WALKING TO THE COUNTER, AT WHICH POINT SHE FAINTED. PATIENT WAS OUT FOR ABOUT 5-15 SECONDS. WE MOVED THE PATIENT TO A CHAIR UPON WAKENING, GAVE HER WATER AND COKE. NO OTHER TREATMENT WAS NECESSARY. SHE REMAINED IN THE STORE FOR 45 MINUTES, BEFORE RELEASING THE PATIENT

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: NONE
Aktuelle Erkrankungen: NONE
Vorgeschichte: NONE
Andere Medikamente: NONE
Allergien: N/A
Vorherige Impfungen: -

VAERS 1541396

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: HI
Alter: 31,0
Geschlecht: M
Eingang: 10.08.2021
Impfdatum: 10.08.2021
Beginn: 10.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Syncope

Symptomtext

Patient felt dizzy then fainted about 5 minutes after getting the vaccine

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: NKA
Vorherige Impfungen: -

VAERS 1540887

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: GA
Alter: 56,0
Geschlecht: M
Eingang: 10.08.2021
Impfdatum: 09.08.2021
Beginn: 10.08.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia Circumoral swelling Facial paralysis Hemiplegia

Symptomtext

PATIENT REPORTS SWELLING ROUND THE RIGHT SIDE OF HER MOUTH, PARTIAL FACIAL PARALYSIS, AND RIGHT-SIDE PARTIAL PARALYSIS AND/OR WEAKNESS.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Facial paralysis
Hospital-Tage: -
Labordaten: UNKNOWN
Aktuelle Erkrankungen: UNKNOWN
Vorgeschichte: UNKNOWN
Andere Medikamente: UNKNOWN
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1535509

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CO
Alter: 28,0
Geschlecht: M
Eingang: 08.08.2021
Impfdatum: 08.08.2021
Beginn: 08.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Loss of consciousness

Symptomtext

SHORTLY AFTER RECEIVING JANSSEN VACCINE, PATIENT LEANED BACK IN SEAT IN PARKED VEHICLE AND LOST CONSCIOUSNESS FOR APPROXIMATELY 15 SECONDS. MEDIC APPROACHED PATIENT JUST AS HE WAS GAINING UNCONSCIOUSNESS. AFTER CONDUCTING A FULL COGNITIVE ASSESSMENT THE PT RESPONDED WITH FULL CLARITY. PT WAS PROVIDED WATER AND SNACKS AS WELL A FULL SET OF VITALS IN ADDITION TO AN EXTENDED OBSERVATION PERIOD. PT WAS RECOMMENDED TO CONSULT A HIGHER LEVEL OF CARE(PCP). RR 18 BP 124/78 PR 91 SPO2 97 SKIN: WARM GCS: 15

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: BP 124/78 PR 91 SPO2 97 SKIN: WARM GCS: 15
Aktuelle Erkrankungen: NA
Vorgeschichte: ADHD
Andere Medikamente: NA
Allergien: NA
Vorherige Impfungen: -

VAERS 1526172

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CA
Alter: 70,0
Geschlecht: F
Eingang: 04.08.2021
Impfdatum: 01.08.2021
Beginn: 01.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Continuous positive airway pressure Dyspnoea Endotracheal intubation Feeding disorder Flushing Intensive care Mobility decreased Tachycardia

Symptomtext

Per report pt started to have SOB night of 8/1/21. During the day, 8/2/21 was not able to even eat. Started on 5L via NC, face was flushed, hadexternal cath because pt was unable to get out of bed. MD notified. CXR ordered, antibiotic given, BVG sent, breathing tx given twice, RT came and put pt on high flow at 45L 40%. Pt was getting Tachy, Md notified. This RN went to lunch and break RN called Rapid Response because pt c/o not able to stand the high flow. They tried to put pt on a face CPAP while waiting to transfer pt to ICU. Pt intubated in ICU

Weitere VAERSDATA-Felder

Praegender Schweregrund: Intensive care
Hospital-Tage: -
Labordaten: CXR ordered, antibiotic given, BVG sent, breathing tx given twice, RT came and put pt on high flow at 45L 40%. Pt was getting Tachy, Md notified. This RN went to lunch and break RN called Rapid Response because pt c/o not able to stand the high flow. They tried to put pt on a face CPAP while waiting to transfer pt to ICU 8/2/21. Pt intubated in ICU 8/2/21.
Aktuelle Erkrankungen: type 2 diabetes, COPD, paroxsymal Afib, precapillary pHTN, nonischemic HFrEF 15-20% with past history of methamphetamine use who was BIBA due to SOB and wheezing - medication noncompliance
Vorgeschichte: history of type 2 diabetes, COPD, paroxsymal Afib, precapillary pHTN, nonischemic HFrEF 15-20% with past history of methamphetamine use
Andere Medikamente: empagliflozin 10mg, nicotine 7mg/24hr patch, spironolactone 12.5mg, potassium chloride 40mEq, amiodarone 200mg, aspirin 81mg, apixaban 5mg, atorvastatin 80mg, budesonide/formoterol 160-4.5mcg/at 2 puffs, digoxin 0.125mg, docusate 100mg, fur
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1525776

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CO
Alter: 20,0
Geschlecht: M
Eingang: 04.08.2021
Impfdatum: 04.08.2021
Beginn: 04.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Dizziness Posture abnormal Seizure Somnolence

Symptomtext

Patient received Janssen vaccine and within 3 minutes felt faint, slouched and was assisted to a position laying on the floor, 911 was called.. Patient had a seizure lasting approximately one - two minutes and slowly revived to nearly full attentiveness. EMT arrived within 5 minutes and assumed patient care. Within the next 10 minutes patient had another seizure. Patient was taken to the Emergency Room by EMT staff.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: At 5 pm the parent was called and he was present with pt and expected to have a C.T Scan.
Aktuelle Erkrankungen: NONE
Vorgeschichte: NONE
Andere Medikamente: UnKnown
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1518509

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: NY
Alter: 27,0
Geschlecht: M
Eingang: 31.07.2021
Impfdatum: 30.07.2021
Beginn: 30.07.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Syncope

Symptomtext

syncope

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 1518495

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: MD
Alter: 71,0
Geschlecht: M
Eingang: 31.07.2021
Impfdatum: 08.04.2021
Beginn: 06.05.2021
Tage bis Beginn: 28,0
Dosis: 1
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Blood test Computerised tomogram Fall Gait disturbance Guillain-Barre syndrome Infusion Lumbar puncture Magnetic resonance imaging Muscle atrophy Muscular weakness Pain Pain in extremity Scan brain

Symptomtext

Burning pain started in right leg and thighs on 5/6. On 5/8 he fell from his legs giving out. Pain continued to worsen and both legs began the burning. From 5/8-5/26 he fell 8 times from his legs giving out. On 5/26 he was admitted to hospital and was released on 5/28. He had bloodwork, CT scan, MRI?s and a brain scan and no cause was discovered. The pain and his legs usage continued to worsen. He had in-house physical therapy from hospital discharge. By 7/4 the pain was horrendous and he went to the emergency room at a different hospital. He was admitted and they did bloodwork, MRI?s, and a spinal tap. On 7/6 he was diagnosed with Guillain Barre Syndrome. He immediately started treatment which consisted of infusions for 5 days. After the infusion treatment it has been the task of pain control. By this time his muscles have deteriorated and walking has become a challenge and struggle. On 7/24 he was discharged from the hospital to a rehab for physical therapy and occupational therapy.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Guillain-Barre syndrome
Hospital-Tage: 80,0
Labordaten: -
Aktuelle Erkrankungen: Prostate Cancer
Vorgeschichte: Hypertension (high blood pressure) Cortisone shots foe herniated disc
Andere Medikamente: Lisinopril-HCTZ 20-25 mg tab Lisinopril 20 mg tab Carvedilol 20 mg tab Carvedilol 6.25 mg tab Gabapentin
Allergien: N/a
Vorherige Impfungen: -

VAERS 1515580

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: KY
Alter: 44,0
Geschlecht: M
Eingang: 30.07.2021
Impfdatum: 01.07.2021
Beginn: 15.07.2021
Tage bis Beginn: 14,0
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Bell's palsy Dysphagia Hypoaesthesia Hypoaesthesia oral Magnetic resonance imaging Ocular discomfort Oesophageal rupture

Symptomtext

2 weeks after vaccine patient experience eye discomfort followed by face and tongue numbness, dx with Bells Palsay 7/24 experience difficulty swallowing food resulting in a torn esophagus.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bell's palsy
Hospital-Tage: 1,0
Labordaten: MRI
Aktuelle Erkrankungen: none
Vorgeschichte: hearing impaired, back surgery
Andere Medikamente: none
Allergien: clindamycin amoxicillin
Vorherige Impfungen: -

VAERS 1515111

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: WI
Alter: 54,0
Geschlecht: M
Eingang: 30.07.2021
Impfdatum: 13.07.2021
Beginn: 13.07.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Condition aggravated Loss of consciousness

Symptomtext

Pt was given J&J vaccine while lying down. patient passed out in waiting area 15 min after COVID vaccine was administered. wife was with patient in waiting area. Patient was sitting in chair when passed out. wife lowered him to floor. no injury sustained. pt was attended to by clinic staff. patient transferred to cot and recovered in separate room. vitals were taken, pt monitored in clinic for approx. 1 hour. pt discharged in wife's company after he was awake, alert, had eaten some crackers and drank some juice. pt did report he has a history of passing out when giving blood in past.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1513407

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201a21a

schwer

Staat: CA
Alter: 19,0
Geschlecht: M
Eingang: 29.07.2021
Impfdatum: 29.07.2021
Beginn: 29.07.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Syncope

Symptomtext

slightly fainted, recovered within 5 min

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: none, took blood pressure twice first slightly low around 110 and 15 min later blood pressure normalized to 120
Aktuelle Erkrankungen: none known
Vorgeschichte: none known
Andere Medikamente: none
Allergien: none known
Vorherige Impfungen: -

VAERS 1512413

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: FL
Alter: 58,0
Geschlecht: F
Eingang: 29.07.2021
Impfdatum: 28.07.2021
Beginn: 28.07.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Immediate post-injection reaction Loss of consciousness Presyncope

Symptomtext

Pt had 2 episodes of vasovagal responses , pt passed out within 10 seconds of receiving vaccine, she recovered then passed out again 10 minutes later for a longer period, paramedics were called. BP was initially at 90/52 with a pulse of 58. A physician was on site and patient was not experiencing any symptoms of stroke or other issues

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: none, examined by EMT
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 1509724

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: TX
Alter: 22,0
Geschlecht: F
Eingang: 28.07.2021
Impfdatum: 27.07.2021
Beginn: 27.07.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dehydration Injection site pain Loss of consciousness

Symptomtext

Patient received her vaccination in her left arm. (Janssen Covid-19). About 1-2 minutes after vaccination, the patient began to black out for about 10-15 seconds. She woke up and water was provided. 911 was called and the patient began to black out again for about 10-15 seconds. She refused medical attention from 911, and began to drink more water and electrolytes. She remained on site for 30 minutes for observation. She stated she was dehydrated and has a history of fainting after vaccines and piercings. She did not disclose this information prior to vaccination. A follow up call was placed on 07/28/2021, and the patient stated she was feeling much better and only experiencing slight pain at the injection site.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: None
Vorgeschichte: Dizziness and Fainting after vaccines and piercings
Andere Medikamente: None to my knowledge
Allergien: None
Vorherige Impfungen: -

VAERS 1500965

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: IL
Alter: 19,0
Geschlecht: M
Eingang: 24.07.2021
Impfdatum: 24.07.2021
Beginn: 24.07.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Drooling Hyperhidrosis Loss of consciousness Unresponsive to stimuli Vomiting

Symptomtext

PATIENT CAME IN WITH HIS MOTHER, I ADDRESSED ALL CONCERNS AND QUESTIONS REGARDING JANSSEN VACCINE AND ALLERGIES PATIENT HAD. MOTHER STATED THAT THEY DISCUSSED WITH PCP ABOUT ALLERGIES AND VACCINE OPTIONS, MOTHER STATED SHE HAS HIS EPIPEN ON THEM INCASE OF EMERGENCY. VACCINE WAS GIVEN TO PATIENT, HE SAT DOWN AND WITHIN 10 MINUTES OR SO PATIENT LOSS CONSCIOUSNESS, BEGAN DROOLING, AND COULD NOT BE WOKEN UP AFTER REPEATED ATTEMPTS. EPIPEN 0.3MG (IM) WAS ADMINISTERED TO THIGH AND PATIENT REGAINED CONSCIOUSNESS. 911 WAS CALLED AND PARAMEDICS ARRIVED WITH 5-10 MINUTES. PATIENT VOMITED TWICE, AND WAS SWEATING PROFUSELY. ONCE AWOKEN, HE WAS AWARE OF HIS SURROUNDINGS, WHO I WAS AND HIS MOTHER, APOLOGIZED FOR THE INCIDENT. MOTHER AND SON THEN LEFT WITH PARAMEDICS TO HOSPITAL.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: UNKNOWN
Aktuelle Erkrankungen: UNKNOWN, NONE THAT MOTHER OR SON EXPRESSED DURING CONSULTATION PRIOR TO VACCINE
Vorgeschichte: NONE THAT MOTHER OR SON DISCLOSED VERBALLY OR ON CONSENT FORM
Andere Medikamente: UNKNOWN
Allergien: PEANUTS, GREENUTS, SESAME, SHELLFISH, BLUE CHEESE
Vorherige Impfungen: -

VAERS 1495688

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CA
Alter: 31,0
Geschlecht: M
Eingang: 22.07.2021
Impfdatum: 21.07.2021
Beginn: 21.07.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Syncope

Symptomtext

Patient experienced a syncopal event. Patient was lowered to the floor, legs were elevated, and vital signs were monitored. Provided ice packs and fluids. Patient returned to a sitting position, and then standing position. Patient was monitored for an additional 30 minutes after event.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1494377

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CA
Alter: 49,0
Geschlecht: M
Eingang: 22.07.2021
Impfdatum: 21.07.2021
Beginn: 21.07.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Syncope

Symptomtext

Patient experienced a syncopal event. Patient was lowered to the floor, legs were elevated, and vital signs were monitored. Provided ice packs and fluids. Patient returned to a sitting position, and then standing position. Patient was monitored for an additional 30 minutes after event, before stating he "felt better" and was ready to return to his room.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1490854

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CA
Alter: 23,0
Geschlecht: U
Eingang: 21.07.2021
Impfdatum: 21.07.2021
Beginn: 21.07.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Cold sweat Dizziness Hyperhidrosis Pallor Syncope

Symptomtext

The patient received the Janssen vaccine at 10:30, approximately 10 minutes later, around 10:40, the patient was feeling lightheaded with clammy, sweaty, and pale skin. The onset of syncope occurred at 10:41, heart rate was 102 BPM, O2 Sat 98%. The patient was put into a supine position with both legs elevated on a chair. The total syncope time was approximately 30 seconds. At 10:43, her HR was 79 BPM, O2 sat 98%, alert and oriented. The patine remained supine for another 5 minutes and stayed for another 5 minutes in a sitting position, had some fluid and snack before leaving, the last HR was 81 BPM, O2 Sat 97%.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Unknown
Andere Medikamente: Unknown
Allergien: None
Vorherige Impfungen: -

VAERS 1490638

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: GA
Alter: 40,0
Geschlecht: M
Eingang: 21.07.2021
Impfdatum: 21.07.2021
Beginn: 21.07.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Loss of consciousness Malaise

Symptomtext

Clerk in observation noted pt looked unwell during observation. Per report no fall at time of reaction, pt was seated and did experience LOC.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: BP measured X2 142/82.
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1478495

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: IL
Alter: 18,0
Geschlecht: M
Eingang: 20.07.2021
Impfdatum: 13.07.2021
Beginn: 13.07.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Anticoagulant therapy Chest pain Dyspnoea Electrocardiogram ST segment elevation Myocarditis Aspartate aminotransferase increased Blood calcium decreased Blood creatine phosphokinase increased Laboratory test Pyrexia Troponin increased SARS-CoV-2 test negative Sleep disorder Troponin

Symptomtext

18 y/o man who was seen on 16 JUL complaining of chest pain. Reports that his symptoms started on the afternoon of 13 JUL, after receiving the COVID-19 Janssen vaccine and other P4 vaccines in the AM. The pain was initially mild, located substernal, and constant. Pain worsened as days progressed. On 16 JUL, at 0200 the pain woke him up from his sleep and was subsequently brought to the ED. Associated symptoms include a fever of 101 F on 15JUL that resolved spontaneously, and mild shortness of breath. In the ED his EKG showed diffuse ST elevations and troponin was 17.5. He was transferred to outside hospital with diagnosis of acute myopericarditis. Admitted for 3 nights, echocardiogram was normal, troponin was trended and peaked at 36, discharge troponin 16. COVID testing negative. Was started on colchicine 0.6mg daily and aspirin 325mg TID.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocarditis
Hospital-Tage: 3,0
Labordaten: COVID testing negative on 16 JUL EKG showed diffuse ST elevations on 16 JUL Troponin was 17.5 on 16 JUL Troponin was trended and peaked at 36 Discharge troponin was 16 on 18JUL
Aktuelle Erkrankungen: No illness at time of vaccine; unknown one month prior
Vorgeschichte: Denies
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1478489

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CT
Alter: 25,0
Geschlecht: M
Eingang: 16.07.2021
Impfdatum: 16.07.2021
Beginn: 16.07.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Loss of consciousness Malaise Pallor

Symptomtext

Patient reported history of vasovagal syncope after fingersticks, vaccines & blood draws. The patient stated that he felt comfortable receiving the vaccine in this particular retail pharmacy setting. Shortly after vaccination, patient became very pale and stated he did not feel well. I had the patient sit on the floor with his back against the wall, and shortly after he passed out. I remained at the patient's side and made sure his head and upper body remained supported. Patient regained consciousness after about 45 seconds and was able to report where he was, what the date was and what had happened shortly upon awakening. Patient had a lollipop, 2 bottles of water and one granola bar and was able to get back into a chair where he sat for additional observation with me for approximately 30 minutes. Patient had someone in the car waiting for him that was able to drive him home.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: Vasovagal syncope experienced with all vaccines, fingersticks and blood draws

VAERS 1474795

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CA
Alter: 37,0
Geschlecht: M
Eingang: 15.07.2021
Impfdatum: 15.07.2021
Beginn: 15.07.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Blood glucose normal Deafness Dizziness Dyspnoea Electrocardiogram normal Hyperventilation Hypoaesthesia Immediate post-injection reaction Loss of consciousness Pallor Paraesthesia Vision blurred

Symptomtext

Right after the vaccine was administered, patient complained about dizziness, temporary blurred vision & loss of hearing. Patient became pale, hyperventilating and complaining of shortness of breath. Soon after, he passed out for 20 seconds. When he gained consciousness, he felt tingling and numbing on both hands.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: 911 was called and BP, glucose and EKG were checked which were normal. Patient was cleared to go home.
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1465372

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CA
Alter: 30,0
Geschlecht: M
Eingang: 12.07.2021
Impfdatum: 12.07.2021
Beginn: 12.07.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Seizure Urinary incontinence

Symptomtext

Patient had seizures for an unknown time and urinated in his seat. Pharmacy is next to an urgent care so the doctor from urgent care checked him in to make sure vitals were stable. Unknown outcome.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: history of seizures
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1461681

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CA
Alter: 30,0
Geschlecht: F
Eingang: 09.07.2021
Impfdatum: 09.07.2021
Beginn: 09.07.2021
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Bradycardia Hypotension Lethargy Presyncope Slow response to stimuli

Symptomtext

Patient had near syncope episode with slow responses. Upon eval pt was bradycardic, hypotensive and lethargic.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: None
Allergien: nkda
Vorherige Impfungen: -

VAERS 1450666

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: FL
Alter: 35,0
Geschlecht: M
Eingang: 06.07.2021
Impfdatum: 05.07.2021
Beginn: 05.07.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Confusional state Dizziness Fatigue Hyperhidrosis Malaise Nausea Syncope Unresponsive to stimuli

Symptomtext

Once vaccine was administered patient was still seated in vaccine room and we were reviewing the vaccine card, he reported that he was 'not feeling well'. He then had stated he was feeling dizzy and had an episode of syncope. He remained in the chair but was not able to respond to me. His mother was present and I called for assistance and she came into the room at which point the patient was able to respond to me verbally but he reported being confused, feeling nausea and fatigued. He was visibly sweating. His mother reported that he had previous episodes of syncope when having blood draws or other injections. He remained seated and I offered multiple times to contact emergency medically services but he and his mother wanted to just wait as he usually feels better after a short time. We did give him cold water bottles which his mother used at the nape of his neck. We also provided him with wet paper towels.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: Patient stated that he was visually impaired
Vorgeschichte: I was not able to get a list of other medical conditions, but patient did not check that he had asthma, serious heart condition, liver disease, chronic lung disease, chronic kidney disease, diabetes, severe obesity or immunocompromised
Andere Medikamente: I was not able to get a list of these items
Allergien: Bacitracin
Vorherige Impfungen: -

VAERS 1446928

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CA
Alter: 69,0
Geschlecht: F
Eingang: 05.07.2021
Impfdatum: 22.06.2021
Beginn: 29.06.2021
Tage bis Beginn: 7,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Abdominal pain Confusional state Laboratory test Thrombosis

Symptomtext

SEVERE ABDOMINAL PAIN, BLOOD CLOT IN RIGHT LEG, CONFUSION (CURRENTLY STILL IN THE HOSPTIAL FOR THESE ISSUES)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: 6,0
Labordaten: MULTIPLE TESTS - CONTACT HOSPITAL
Aktuelle Erkrankungen: NONE
Vorgeschichte: HIGH BLOOD PRESSURE, THYROID DISEASE
Andere Medikamente: LEVOTHYROXINE 100 MCG, GABAPENTIN 300 MG, ATENOLOL 25MG, AMIODIPINE 10MG
Allergien: TETRACYCLINE
Vorherige Impfungen: -

VAERS 1441049

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: UT
Alter: 18,0
Geschlecht: M
Eingang: 01.07.2021
Impfdatum: 28.06.2021
Beginn: 28.06.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Seizure

Symptomtext

Within 1 minute of receiving vaccine, patient experienced seizure. Called 911 and got patient safe and stable while waiting for EMS.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: n/a
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Unknown
Allergien: None
Vorherige Impfungen: -

VAERS 1437539

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: OH
Alter: 29,0
Geschlecht: M
Eingang: 30.06.2021
Impfdatum: 25.06.2021
Beginn: 25.06.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Fall Loss of consciousness

Symptomtext

The patient was administered the vaccine at 4 pm. About 20 minutes later, as he was sitting in the waiting area, he fell face first out of his chair and passed out (at minute 12 of his 15 minute wait period). The pharmacist went to tend to him and he came to within a few minutes. A frozen water bottle was place on the back of his neck as he continued to lay on the ground for about 5 minutes. He then moved into the chair a she was starting to feel a little better. At about 4:45 he left to go home on his own.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: n/a
Vorgeschichte: n/a
Andere Medikamente: n/a
Allergien: allergy - cephalosporins
Vorherige Impfungen: -

VAERS 1437405

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: FL
Alter: 52,0
Geschlecht: M
Eingang: 30.06.2021
Impfdatum: 09.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Breast cancer male Breast operation Facial paralysis Hypoaesthesia Injection site reaction Movement disorder Speech disorder Transient ischaemic attack

Symptomtext

Pt. states 04/09/2021 @ 8:30am started experiencing symptoms from injection site (paralysis), numbness in the face (Left) droop 30mins-45mins, 05/18/2021 numbness in the face/difficulty speaking 2-3hrs, 06/12/2021 again numbness in the face05/20/2021 diagnosed with male Breast Cancer. Breast tissue removed. 06/27/2021 severe facial droop, whole numbness left-side of body, Admitted for observation. 06/28/2021 discharged TIA. Currently experiencing numbness.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Facial paralysis
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: Metaphorim, HCDZ, Baby Aspirin, Multi-Vitamin
Allergien: N/A
Vorherige Impfungen: -

VAERS 1430961

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: -
Alter: 30,0
Geschlecht: M
Eingang: 28.06.2021
Impfdatum: 22.06.2021
Beginn: 22.06.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Loss of consciousness Malaise

Symptomtext

BP 115/64 (BP Location: RA-RIGHT ARM, BP Patient Position: LYING, Cuff Size: Standard Adult) | Pulse 52 | Resp 16 | SpO2 100% Location of event Vaccine Center Description of Event: Pt reported not feeling ok. Was sitting in chair and began to slump back into chair. Reports having blacked out for a moment. Interventions: Transferred to gurney, given water, juice, assessed, vitals taken. Medications administered: None Response to interventions and/or medications given: Improvement to baseline Disposition:Home Treatment

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: NKA
Vorherige Impfungen: -

VAERS 1429709

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: IL
Alter: 32,0
Geschlecht: M
Eingang: 26.06.2021
Impfdatum: 26.06.2021
Beginn: 26.06.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Condition aggravated Fall Hyperhidrosis Loss of consciousness Syncope

Symptomtext

During the post vaccine observation period, patient had a sync opal episode and fell off a charge face down on the floor. He was turned over he came to immediately and was oriented to place, person, time ,and ,situation . He was noted to be diaphoretic. He reported to staff that he usually passes out after a vaccination and had not had eaten. He was observed for an additional 45 mins before leaving the site of the vaccination.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: None His vitals were as follows 120/90 58 20
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1418098

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201a21a

schwer

Staat: KY
Alter: 18,0
Geschlecht: F
Eingang: 22.06.2021
Impfdatum: 22.06.2021
Beginn: 22.06.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Loss of consciousness Syncope

Symptomtext

PATIENT HAD SYNCOPE IMMEDIATELY UPON RECEIVING THE INJECTION IN HER LEFT ARM. PATIENT REPORTED HISTORY OF FEAR OF NEEDLES AND WAS NERVOUS PRIOR TO RECEIVING THE VACCINE. PATIENT DID NOT FALL OR HIT THEIR HEAD. PATIENT REGAINED CONSCIOUSNESS WITHIN SECONDS. BLOOD PRESSURE WAS CHECKED AND OK.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: NONE
Vorgeschichte: NONE
Andere Medikamente: ORAL CONTRACEPTIVE
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1415179

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CA
Alter: 26,0
Geschlecht: M
Eingang: 21.06.2021
Impfdatum: 21.06.2021
Beginn: 21.06.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Amnesia Blood glucose Dizziness Electrocardiogram Head injury Joint contracture Loss of consciousness Miosis Syncope Tachypnoea Vomiting

Symptomtext

Pt w/o medical hx/drug allergies presents with syncope in observation area s/p J&J injection. Patient stood up with dizziness and loss consciousness with head injury on counter. (Estimated 10 Seconds KO). Upon arousal pt presents tachypnea, pin-point pupils, hand contractions, one episode of vomiting, loss of memory. Orientated to name/dob although does not know location or recollection of receiving vaccine. EMS called responding to seen. Initial VS: BP: 86/55, O2: 96%, HR 81. Paramedics responding on scene EKG/BS checked patient taken to . Pt stabilized and transported with AMR paramedics to .

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: NA. No medical lab tests related to adverse event.
Aktuelle Erkrankungen: Patient denies any illness recently
Vorgeschichte: Patient denies any past medical history.
Andere Medikamente: Patient denies taking any medications, dietary supplements, or herbal remedies at time of vaccination.
Allergien: Denies any allergies to medications, food or other products.
Vorherige Impfungen: -

VAERS 1413032

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CA
Alter: 50,0
Geschlecht: M
Eingang: 19.06.2021
Impfdatum: 19.06.2021
Beginn: 19.06.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Blood glucose normal Fall Head injury Loss of consciousness

Symptomtext

1325 Pt lost consciousness and feel to the floor from a sitting position. Per reports, pt hit his head on the floor. EMS team activated. POD Director at pt side along with NP. 1326 911 called and emergency services activated 1327 Pt is not A/O x4 and answering all questions appropriately. 1340 Fire dept arrived. Pt sat up and being transferred to fire care 1341 Patient placed in a sitting position, A/Ox4 and swering all questions appropriately Vitals 1326 HR 50, RR 16, Sat 93% 1328 HR 85, RR 16, Sat 98%, BP 139/83 laying position 1331 Glucose 90 1338 HR 89, RR 16, Sat 99%, 1341 HR 69, RR 16, Sat 98%, BP 140/87 Sitting position 1343 BP 136/83

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: Glucose
Aktuelle Erkrankungen: denies
Vorgeschichte: denies
Andere Medikamente: denies
Allergien: denies
Vorherige Impfungen: -

VAERS 1405260

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CO
Alter: 46,0
Geschlecht: F
Eingang: 17.06.2021
Impfdatum: -
Beginn: 01.05.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Asthenia Blood test Computerised tomogram Fatigue Guillain-Barre syndrome Hypoaesthesia Limb injury Muscular weakness Paralysis Peripheral swelling

Symptomtext

FELT PARALYSED; DIAGNOSED WITH GUILLEN BARRE SYNDROME; INJURED RIGHT FOOT; NUMBNESS IN FACE; LEFT LEG WEAKNESS; SWELLING IN LEGS; TIREDNESS; FEELINGS OF WEAKNESS; NUMBNESS IN LEFT HAND; This spontaneous report received from a consumer concerned a 46 year old female. The patient's weight was 113 kilograms, and height was 66 inches. The patient's pre-existing medical conditions included the patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 201A21A, and expiry: 07-AUG-2021) dose was not reported, administered on 01-MAY-2021 to left arm for prophylactic vaccination. Concomitant medications included immunoglobulin human normal for guillen barre syndrome. On 01-MAY-2021, the subject experienced feelings of weakness, numbness in left hand. On 28-MAY-2021, the subject experienced tiredness. On 29-MAY-2021, the subject experienced left leg weakness and swelling in legs. On 02-JUN-2021, the subject experienced numbness in face. On 09-JUN-2021, the subject experienced diagnosed with guillen barre syndrome, and was hospitalized. On an unspecified date, the subject experienced injured right foot, and felt paralysed, and was hospitalized on 08-Jun-2021. On 01-MAY-2021, the patient developed numbness in her hand on the left side and felt weak. The patient travelled overseas and had a connection to a country and her husband stated that she started to have swelling in her legs. When she reached her destination, she was admitted to the hospital and was diagnosed with Guillen Barre Syndrome by the neurologist per her husband's recollection. In the hospital she was given Immunoglobulin G for 5-7 days and she did regain some feeling in her legs. Based on patient's husband recollection this may have occurred "maybe tired due to travelling," but when she arrived to the country that was when her left leg weak and requested a wheelchair. The patient then injured her "right foot" in another country, but "she didn't feel it and she requested help because she couldn't walk." per her husband. After she reached her final destination, she felt tired and then she completely fell. It was reported that she could not "control herself and felt paralyzed." On 08-JUN-2021, she entered the hospital and was still in hospital at the time of this report. Her husband states that he "does not know any side effect from any vaccine" that caused this in the past. Lastly, he mentioned "she may have numbness in her face when she reached original country". He also stated that the on 04-JUN-2021, doctors conducted a computerized tomography scan and did not find a blood clot. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the feelings of weakness, swelling in legs, diagnosed with guillen barre syndrome, numbness in left hand, tiredness, left leg weakness, numbness in face, injured right foot and felt paralysed was not reported. This report was serious (Hospitalization Caused / Prolonged, and Other Medically Important Condition).; Sender's Comments: V0: This is a spontaneous report received from consumer concerning a 46 year old female, unknown ethnicity, who experienced weakness and numbness of the left hand on the same day after receiving the Janssen Covid-19 vaccine and was diagnosed with Guillain-Barre Syndrome 39 days after. Patient's height was 66 inches and weight was 113 kilograms. Past medical, previous surgery, current illnesses and medications taken as well as history of allergy, smoking, drug abuse and alcohol abuse were not reported. On the same day as the vaccine was given, patient developed weakness and numbness on the left hand. Patient still travelled. Twenty-eight (28) days post vaccine, patient experienced left leg weakness and swelling on the legs. Patient was noted to feel tired the day before. Thirty-two (32) days post vaccine, patient developed numbness on the face. Computerized Tomography (CT) scan was done and there was no blood clot found. Thirty-eight (38) days post vaccine, patient felt 'paralyzed' and injured her right foot. Patient was brought to the hospital the following day and was subsequently admitted. Patient was diagnosed with Guillain-Barre Syndrome and was given IVIG. Information regarding other potential etiologies was insufficient. Considering the temporal relationship, the event is assessed to have an indeterminate relationship with vaccination.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Guillain-Barre syndrome
Hospital-Tage: -
Labordaten: Test Date: 202106; Test Name: Blood test; Result Unstructured Data: Positive; Comments: Blood work to determine gullain barre syndrome; Test Date: 20210604; Test Name: CAT scan; Result Unstructured Data: Negative for blood clots
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: The patient had no known allergies.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1402588

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CT
Alter: 56,0
Geschlecht: M
Eingang: 16.06.2021
Impfdatum: 15.06.2021
Beginn: 15.06.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Fatigue Feeling abnormal Generalised tonic-clonic seizure Headache

Symptomtext

Pt had tonic-clonic seizure after covid-19 vaccine Janssen

Weitere VAERSDATA-Felder

Praegender Schweregrund: Generalised tonic-clonic seizure
Hospital-Tage: -
Labordaten: 911 was called, when EMS services arrived, pt refused to go to the hospital. Pt was contacted by this RN on 6/16/21 and he reported he has a headache, feels foggy and tired, but other than that feeling ok.
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Unknown
Andere Medikamente: Unknown
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 1400634

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: -
Alter: 34,0
Geschlecht: M
Eingang: 15.06.2021
Impfdatum: 15.06.2021
Beginn: 15.06.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Eye movement disorder Loss of consciousness Musculoskeletal stiffness Wheezing

Symptomtext

Rec'd vaccine at 1500, reaction started at 1505- pt observed to be stiff posture, eyes rolled to back of head and unconscious. Pt transferred to a gurney and heard to be wheezing. Epi x1 given and 911 was called. Pt became arousable after a few minutes as ambulance arrived. Pt breathing improved and able to answer simple questions. Transferred to nearest hospital.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: NKA
Vorherige Impfungen: -

VAERS 1385296

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CA
Alter: 55,0
Geschlecht: F
Eingang: 09.06.2021
Impfdatum: 12.04.2021
Beginn: 13.04.2021
Tage bis Beginn: 1,0
Dosis: N/A
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood test Bone pain Computerised tomogram Condition aggravated Dizziness Electrocardiogram abnormal Feeling abnormal Headache Laboratory test abnormal Loss of consciousness Loss of personal independence in daily activities Memory impairment Migraine Pain Post-traumatic stress disorder Pulmonary mass Urinary tract infection Vomiting

Symptomtext

The next day after vaccine, about 4:00pm - pain hit me and it was so severe I started to throw up from the pain. Short term memory/brain fog has been an issue. I've had massive migraines. Complete body aches - even my bones hurt. The worse one was on both of my arms - above the wrist - and it was horrible (mostly on the right). One big blur of pain - I'm in a lot of pain all the time. I have a constant headache. I keep losing consciousness and that started after the vaccine. It use to hit every three hours. Now it's more than that. I have been two ERs in the couple of weeks. I've been to the doctor, too. I am referred to a neurologist - can't get me in until middle of July. I pass out and when I wake up from it I am in excruciating pain - my whole body hurts. I can only take Tylenol because I'm on Warfarin. I use Tylenol as needed and ice pack and heating pad for the pain. I started to almost lose consciousness when I have been completing this but I'm okay - it is like a blanking out of the moment.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: ER - I've been twice. May 23, 2021 and then the second visit was 6/2. First time - CAT scans; Bloodwork - complete. They found a lot of things going on in there. I had a small mass in my right lung that I didn't know I had. I had an abnormal EKG. They said I might have seizures but they didn't find anything in my brain. I had a UTI and an indication of possible heart disease. 2nd visit: they said I was just dizzy. No medicine given; no antibiotic for UTI.
Aktuelle Erkrankungen: no
Vorgeschichte: Was getting better where I could go out and do things and be strong enough to walk etc (I had Mersa in my leg for long term) - with my COMPLEX PTSD - but after the vaccine those have gotten really bad; Bi-Polar; Sleep Apnea; Asthma; High Blood Pressure
Andere Medikamente: Tylenol; Hydroxyzine Pamoate - every four hours - dosage 50 mg; Trazadone 50 mg -at bedtime one pill; Seroquel - 50 mg - 1 at bedtime; Gabapentin - 600 mg - 4 times daily; Warfarin - blood thinners - take as directed - 10 mg on Monday and a
Allergien: Brieo Ellipta - for asthma; Aver -for asthma; Vancomycin; Haldrol; Percocet; all the opiates - can't have
Vorherige Impfungen: flu shot - immediate bad headaches and pain; once it made me feel immediately like I had the flu - 2020

VAERS 1380661

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: OH
Alter: -
Geschlecht: M
Eingang: 08.06.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Deep vein thrombosis Rash Ultrasound scan

Symptomtext

DEEP VEIN THROMBOSIS; RED SPOTS ON RIGHT LEG; This spontaneous report received from a consumer concerned a 66-year-old white and Non-Hispanic or Latino male. The patient's height and weight were not reported. The patient's concurrent conditions included hard of hearing, and other pre-existing medical conditions included, patient had no comorbidities condition, was not overweight and was very healthy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A and expiry: UNKNOWN) dose was not reported, 1 total dose administered on 22-MAY-2021 in left arm for prophylactic vaccination. No concomitant medications were reported. On an unspecified date in 2021, about 5 days later after vaccination, patient started getting red spots on both legs, but the spots on the right leg went away later it became worse next day. On an unspecified date, patient experienced the pain which became bad and when reporter looked at it she thought it was cellulitis because it was hot, red and swollen. The Patient had swelling from the knee down and experienced lot of pain in his knee. The patient was sent to outpatient clinic where the ultrasound was done on 02-JUN-2021 and DVT (Deep vein thrombosis) was diagnosed. The blood clot was behind the knee of patient. The patient visited the emergency room but since he had no comorbidities condition he was not admitted and was sent home with medication. The patient was given Eliquis as a treatment drug for the event. The reporter mentioned that the medication was expensive, and the patient was on Medicare and there were programs to help with it. The reporter mentioned that medication can put the patient at risk of kidney failure. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from red spots on right leg on 2021 and had not recovered from Deep vein thrombosis. This report was serious (Other Medically Important Condition).; Sender's Comments: V0:20210607591- JANSSEN COVID-19 VACCINE Ad26.COV2.S- Deep Vein thrombosis- This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Deep vein thrombosis
Hospital-Tage: -
Labordaten: Test Date: 20210602; Test Name: Diagnostic ultrasound; Result Unstructured Data: DVT was diagnosed
Aktuelle Erkrankungen: Hard of hearing (Patient wears hearing aids.)
Vorgeschichte: Comments: Patient had no comorbidities condition. Patient was not overweight and was very healthy.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1372551

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CA
Alter: 25,0
Geschlecht: M
Eingang: 03.06.2021
Impfdatum: 03.06.2021
Beginn: 03.06.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Bradycardia Electrocardiogram abnormal Pallor Syncope

Symptomtext

Patient had a syncopal episode, pallor; VS taken- bradycardia; 4 lead and 12 leads EKG done- abnormal rhythm. ASA and oxygen given. Paramedics called.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: EKG 4 & 12 leads abnormal. Aspirin and oxygen given. EMS called.
Aktuelle Erkrankungen: Stated None
Vorgeschichte: Stated None
Andere Medikamente: Stated None
Allergien: Stated None
Vorherige Impfungen: -

VAERS 1371480

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: OH
Alter: 18,0
Geschlecht: M
Eingang: 03.06.2021
Impfdatum: 25.05.2021
Beginn: 25.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Loss of consciousness

Symptomtext

Reported that pt "passed out" in parking lot

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: n/a
Aktuelle Erkrankungen: unknown
Vorgeschichte: none per pt
Andere Medikamente: unknown
Allergien: Per pt, no
Vorherige Impfungen: -

VAERS 1371215

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: KY
Alter: 18,0
Geschlecht: F
Eingang: 03.06.2021
Impfdatum: 03.06.2021
Beginn: 03.06.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Immediate post-injection reaction Loss of consciousness

Symptomtext

Patient passed out immediately after receiving vaccination

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: NONE
Vorgeschichte: NOne
Andere Medikamente: unknown
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1371207

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: FL
Alter: 30,0
Geschlecht: M
Eingang: 03.06.2021
Impfdatum: 03.06.2021
Beginn: 03.06.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Blood glucose normal Electrocardiogram Fall Presyncope Sinus rhythm

Symptomtext

9:50- Patient was sitting in chair talking to girlfriend. Per girlfriend patient's head started to tilt back, and then he fell on his right side. Patient had a vasovagal response X 10 seconds. EMT and NP rushed to patient, immediately assessing patient, hooked him up to EKG, took vitals and blood sugar. When patient woke up he was A&OX3, patient stated he did not eat anything for the day. Vitals: 140/88, pulse 67, 100% O2, BG 101. 1000: 12 LEAD EKG was performed, patient is in SINUS RHYTHM. Another set of vitals were taken. 115/70, 91 pulse, 100% O2. Patient was given cereal bar and orange juice. 1010: Third set of vitals 123/71, pulse 74, 100% O2 1030: Patient stated he was well. Patient was able to walk to car with girlfriend. Did not request any further medical intervention.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: EKG: SINUS RHYTHM BG: 101
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: nka
Vorherige Impfungen: -

VAERS 1365735

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21a

schwer

Staat: IL
Alter: 18,0
Geschlecht: M
Eingang: 01.06.2021
Impfdatum: 01.06.2021
Beginn: 01.06.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Fall Head injury Skin abrasion Syncope

Symptomtext

Pt received vaccine at 5:55 pm At 6:00pm Pt had syncopal episode fell out of chair and hit head on concrete Pt had abrasion to right head right wrist and right knee Ot was able to answer questions A&Ox 4 No vomiting No blurred vision 911 called and ot was transported to hospital via Ambulance

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: Assessment completed Upon mrs arrival BP and pt was placed on heart monitor
Aktuelle Erkrankungen: None
Vorgeschichte: Asthma
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1362004

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: -
Alter: 20,0
Geschlecht: M
Eingang: 30.05.2021
Impfdatum: 27.05.2021
Beginn: 28.05.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chills Loss of consciousness Nausea

Symptomtext

patient reports that he passed out before coming to ED, states felt nauseas. states received J&J vaccine yesterday, started having chills, nausea last night. denies V/D/fever.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: ROS HEENT: no eye pain, no sore throat, no ear pain CV: no chest pain, no palpitations Pulm: no shortness of breath, no cough Abd: no abdominal pain, no N/V/D MSK: no joint pain, no
Aktuelle Erkrankungen: N/A
Vorgeschichte: -
Andere Medikamente: UNK
Allergien: NKA
Vorherige Impfungen: -

VAERS 1356522

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201a21a

schwer

Staat: CA
Alter: 54,0
Geschlecht: F
Eingang: 28.05.2021
Impfdatum: 27.05.2021
Beginn: 27.05.2021
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Asthenia Dyspnoea Presyncope

Symptomtext

Felt difficulty breathing, vasovagal event - weakness, Epi-pen 0.3mg x1, called 911, paramedics took her to Arcadia Methodist.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Hypertension
Andere Medikamente: -
Allergien: Vicodin
Vorherige Impfungen: -

VAERS 1356345

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: DE
Alter: 20,0
Geschlecht: M
Eingang: 27.05.2021
Impfdatum: 24.05.2021
Beginn: 26.05.2021
Tage bis Beginn: 2,0
Dosis: N/A
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Blood creatine phosphokinase MB Blood creatine phosphokinase increased C-reactive protein increased Chest pain Electrocardiogram ST segment elevation Electrocardiogram abnormal Pain in extremity Pericarditis Red blood cell sedimentation rate increased Sinus rhythm Troponin I increased Troponin increased

Symptomtext

DEVELOPED CHEST PAIN, LEFT ARM PAIN ON 26TH MAY 2021

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pericarditis
Hospital-Tage: 1,0
Labordaten: Ref Range & Units 11:31 Total CK 39.0 - 308.0 U/L 440.0High Specimen Collected: 05/27/21 11:31 Last Resulted: 05/27/21 12:11 Ref Range & Units 11:31 Troponin I 0.00 - 0.05 ng/mL 5.13High Panic Specimen Collected: 05/27/21 11:31 Last Resulted: 05/27/21 12:38 Ref Range & Units 11:31 CRP 0.0 - 3.0 mg/L 38.0High Specimen Collected: 05/27/21 11:31 Last Resulted: 05/27/21 12:11 Ref Range & Units 11:31 ESR <15 mm/Hr 19High Specimen Collected: 05/27/21 11:31 Last Resulted: 05/27/21 11:54 Ref Range & Units 11:31 CK-MB 0.0 - 5.0 ng/mL 24.1High CK-MB Index 0.0 - 3.0 % 5.5High Specimen Collected: 05/27/21 11:31 Last Resulted: 05/27/21 12:28 Ref Range & Units 16:54 Troponin I 0.00 - 0.05 ng/mL 9.18High Panic Specimen Collected: 05/27/21 16:54 Last Resulted: 05/27/21 18:05 12 LEAD EKG - SINUS RHYTHM, ST ELEVATION SUGGESTING ACUTE PERICARDITIS
Aktuelle Erkrankungen: NONE
Vorgeschichte: NONE
Andere Medikamente: NONE ADMITS TO SMOKING MARIJUANA
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1354678

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: TX
Alter: 44,0
Geschlecht: F
Eingang: 27.05.2021
Impfdatum: 25.05.2021
Beginn: 26.05.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Behaviour disorder Dizziness Fall Fatigue Head injury Joint injury Pyrexia Syncope

Symptomtext

Fever 101.1, Fatigued, Dizzy, Disoriented, Fainted and fell off couch, hit head and knee

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: 3 Stents, Triple Bypass, Severe Neck problems with loss of feeling
Andere Medikamente: Verapamil 240mg, Symbicort AERO 80/4.5, Solifenacin Succ 10mg, Pravastin 40gmg, Nitroglycerin SL 0.4mg, Metoprolol Tar 25mg, Hysingla ER 30mg, Tylenol #4, Gabapentin 800mg, Fenoprofen 600mg, Nexium 40mg, Duloxetine 30mg, Cyclobenzaprine 10m
Allergien: Augmentin, Belbucca
Vorherige Impfungen: -

VAERS 1350935

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201a21a

schwer

Staat: -
Alter: 20,0
Geschlecht: F
Eingang: 26.05.2021
Impfdatum: 26.05.2021
Beginn: 26.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Loss of consciousness Syncope

Symptomtext

She had a syncopal episode 10 minutes into vaccine administration. Reported history of syncopal episodes with injections. Vital signs checked and stable. She was passed out for approximately 2 minutes, woke up and was not post-ictal. 911 was called and medics came in to check on patient. She was stable. Refused and signed AMA form for hospital transport. We observed her for approximately 30 minutes and made full recovery. Left in stable condition, asymptomatic.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: none
Allergien: nka
Vorherige Impfungen: -

VAERS 1347920

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: OH
Alter: 21,0
Geschlecht: M
Eingang: 25.05.2021
Impfdatum: 25.05.2021
Beginn: 25.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood pressure normal Dizziness Headache Heart rate normal Malaise Migraine Nausea Paraesthesia Presyncope Syncope Visual impairment

Symptomtext

Patient received Janssen COVID19 vaccine (LOT#201A21A) in his left arm at approximately 14:43 on 5/25/21. During the 15 minute observation period, he expressed "I don't feel well" and endorsed dizziness/ lightheadedness, slight tingling feeling in fingers, and nausea. Shortly thereafter at approximately 14:50, he started to slouch and appeared faint while sitting in a chair with eyes closed. He did not fall or hit any part of his body. He was easily aroused with a touch on his arm and responded to verbal questions immediately. He denied trouble breathing, chest pain, palpitations, headache, muscle weakness, vision changes, skin reactions, swelling. He was oriented x3 and not exhibiting verbal or swallowing problems. His vitals were normal- HR 80 bpm and BP 105/80 mmHg. He was offered a receptacle to vomit in if needed; however, he did not vomit. This initial reaction was consistent with potential vasovagal reaction/ near-syncope after vaccination. Patient was encouraged and instructed to sit on the floor to prevent injury in case of fall but he refused. Staff offered him water, a fan, and opened windows while monitoring. Later while waiting for a ride at around 15:10, he endorsed headache (first above his eyes and then toward the back of his head) and clarified this did not feel like a typical migraine that he has had before. Then at around 15:20 he endorsed vision changes in his right eye- he could not see a portion of vision out of that eye except peripheral vision and described not being able to see writing on the right side of a whiteboard in front of him in the room. Later he described a resolution of that gap in vision but then had blurry vision out of that eye. He denied any vision changes in the left eye. Due to alarming symptoms of vision changes and onset of headache, patient was recommended to go to ER for further observation and evaluation. He was not in urgent distress and patient did not wish for EMS to be called but agreed to go to ER when his emergency contact picked him up. Patient's emergency contact came to pick up patient at approximately 15:40 and was recommended to take him to the ER. Patient and emergency contact were amenable to this plan. He was able to stand up and walk to the car without issues.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: 5/25/21 HR: 80 bpm 5/25/21 BP: 105/80 mmHg
Aktuelle Erkrankungen: none known
Vorgeschichte: Migraine with aura
Andere Medikamente: unknown
Allergien: none
Vorherige Impfungen: -

VAERS 1347361

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CA
Alter: 22,0
Geschlecht: M
Eingang: 25.05.2021
Impfdatum: 25.05.2021
Beginn: 25.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Dizziness Head injury Loss of consciousness Skin laceration

Symptomtext

22 year old received Janssen vaccine at 10:50 am, and while in recovery area, reported that he became light headed, dizzy, and passed out. He slumped out of the chair hitting the right side of his head on the floor. Sustained a cut near his right eye. At 10:56 am blood pressure @140/65, pulse @ 53, 97% O2 sats while sitting on the floor. EMS was called 10:57am. When interacting with staff and friend accompanying him, eye was cleaned and ice applied. EMS arrived 11:05am. EMS reported vitals to be 86/49, 59, 100% O2. EMS recommended transport to client. Client accepted. EMS transported to Medical Center at 11:12 am.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: unknown at this time
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: NKA
Vorherige Impfungen: -

VAERS 1346470

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: IL
Alter: 27,0
Geschlecht: F
Eingang: 25.05.2021
Impfdatum: 08.04.2021
Beginn: 29.04.2021
Tage bis Beginn: 21,0
Dosis: UNK
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Thrombosis Vaginal haemorrhage

Symptomtext

Three weeks after J& J vaccine abnormally heavy vaginal bleeding with large clots.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: hypothyroid, Anxiety
Andere Medikamente: Seasonique, Wellbutrin,
Allergien: treenuts
Vorherige Impfungen: -

VAERS 2623754

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CA
Alter: 37,0
Geschlecht: M
Eingang: 24.05.2021
Impfdatum: 22.05.2021
Beginn: 22.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Clonic convulsion Cold sweat Face injury Fall Muscle rigidity Pallor

Symptomtext

At 10:26 pt rolled off the chair and fell face first on to the carpet. pt had a clonic seizure. His body was rigid with hyperextending extremities. I placed the pt in a side recoery position. 4 liters of oxygen via nasal canula was given. Staff member called EMS. Duration of seizure 1 minute. pt sat up after seizure and had no memory of seizure. As I was asking pt questions at 10:35 he had a 2nd seizure that lasted 5 secounds. I caught him and laid him gently on his side. pt appeared pale and skin was cool and clamy. EMT arrived at 10:36. His o2 was 99%, HR 39-42, BP 113/71. pt refused to go to the hospital. EMT waited with pt till a family member arrived to drive pt home. pt denies any headache, nausea, dizziness.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Clonic convulsion
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: none
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 1387921

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: IL
Alter: 48,0
Geschlecht: M
Eingang: 22.05.2021
Impfdatum: 21.05.2021
Beginn: 21.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Syncope

Symptomtext

Patient was scared of Needles; Experienced Syncopy & Fainted about 5 min. after the dose given! Layed on floor with feet up for about 5 min. Sat upright for about 30 min & seemed fine. Walked to car wife was a nurse & with him.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: NONE
Vorgeschichte: NONE
Andere Medikamente: None
Allergien: NKA
Vorherige Impfungen: -

VAERS 1337285

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: -
Alter: 34,0
Geschlecht: M
Eingang: 21.05.2021
Impfdatum: 21.05.2021
Beginn: 21.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Blindness Loss of consciousness Vision blurred

Symptomtext

Patient received the Janssen COVID vaccine then shortly after administration patient stated that their vision started to go blurry and the next thing their sight went dark, patient was seen falling out of chair head first after passing out.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1333383

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CA
Alter: 24,0
Geschlecht: F
Eingang: 20.05.2021
Impfdatum: 20.05.2021
Beginn: 20.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Loss of consciousness Presyncope

Symptomtext

client stated feeling dizzy few seconds after injection and had vasovagal response and passed out for approx 3 seconds, v/s remained stable, client required no further treatment, observed for a total of 35 mins, client states feeling better after 5 mins. left facility in stable condition, ambulating w/o assist, accompanied by mother ( who also received injection w/o incident)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: n/a
Aktuelle Erkrankungen: n/a
Vorgeschichte: n/a
Andere Medikamente: n/a
Allergien: -
Vorherige Impfungen: -

VAERS 1330199

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: IL
Alter: 29,0
Geschlecht: M
Eingang: 19.05.2021
Impfdatum: 06.05.2021
Beginn: 06.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Angiogram Blood fibrinogen decreased Brain injury Computerised tomogram head abnormal Fibrin D dimer increased Headache Nausea Platelet factor 4 Seizure Status epilepticus Superior sagittal sinus thrombosis Thrombocytopenia Vomiting

Symptomtext

Patient with PMH of Aspergers, ADD and obesity brought to ED in status epilepticus. Headaches and nausea/vomiting started day of vaccine and progressively worsened. Was observed to have 2-3 seizures before arriving to ED (possibly over a 2 hour period) on 5/18. Found to have Superior sagittal sinus thrombosis and thrombocyctopneia with elevated D-Dimer and PF4 and low fibrinogen. Patient suffered irreverisible brain injury. Decision made with family to withdraw care

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: D-Dimer >32 (5/18/21), Fibrinogen 161 (5/18/21), PF4 w/o heparin 2.634 (5/18/21), PF4 w/ 100 units heparin 0.055 (5/18/21)
Aktuelle Erkrankungen: -
Vorgeschichte: Asperger's syndrome, ADD, obesity
Andere Medikamente: Vyvanse 70mg daily
Allergien: -
Vorherige Impfungen: -

VAERS 1196601

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: OH
Alter: 31,0
Geschlecht: F
Eingang: 19.05.2021
Impfdatum: 12.04.2021
Beginn: 12.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood glucose Blood test Hyperhidrosis Loss of consciousness Nausea Chills Dizziness Vomiting Tremor

Symptomtext

Within 15 mins I was sweating and nausea, shaking, I passed out for less than 30 secs. I was shaking.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: Blood Sugar, Blood Work, IV of fluids
Aktuelle Erkrankungen: no
Vorgeschichte: no
Andere Medikamente: Albuterol Inhaler, one a day women's vitamin
Allergien: synergic, Compazine
Vorherige Impfungen: -

VAERS 1196601

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: OH
Alter: 31,0
Geschlecht: F
Eingang: 19.05.2021
Impfdatum: 12.04.2021
Beginn: 12.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood glucose Blood test Hyperhidrosis Loss of consciousness Nausea Chills Dizziness Vomiting Tremor

Symptomtext

Within 15 mins I was sweating and nausea, shaking, I passed out for less than 30 secs. I was shaking.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: Blood Sugar, Blood Work, IV of fluids
Aktuelle Erkrankungen: no
Vorgeschichte: no
Andere Medikamente: Albuterol Inhaler, one a day women's vitamin
Allergien: synergic, Compazine
Vorherige Impfungen: -

VAERS 1327205

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201a21a

schwer

Staat: NY
Alter: 38,0
Geschlecht: M
Eingang: 18.05.2021
Impfdatum: 09.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: unbekannt Erholt: nein

Blood test Chills Computerised tomogram Coordination abnormal Facial paralysis Fatigue Feeling cold Headache Hypoaesthesia Immunology test abnormal Lumbar puncture Lyme disease Magnetic resonance imaging Metabolic function test Paraesthesia Red blood cell sedimentation rate SARS-CoV-2 test

Symptomtext

04/09/2021- I had fatigue, headache, chills. 04/19/2021- I started experiencing tingling and numbness in legs and feet, lasted couple days, two days later started fatigue and cold, took off work 4/21/2021, went Urgent Care. Loss of coordination. Ran blood test. I felt better on 04/22/2021, got fatigue, had severe headache, went back to same urgent care, they prescribed prednisone. 04/23/2021- Started doxycycline in response to mixed result Lyme disease test, symptoms remained steady, on 04/25/2021, I began experiencing facial paralysis, can move my job and my tongue, lips don't move, symptom persists, went to ER 04/26/2021, admitted to hospital Discharged 04/30/2021 around noon. My symptoms seemed to temporarily improve but then a few days after being discharged, they started getting worse again. I continue to experience partial paralysis.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Facial paralysis
Hospital-Tage: -
Labordaten: Blood work 04/21/2021 Covid Test- 04/21/2021 Metabolic panel- 04/21/2021 Lyme Disease 04/21/2021 Sedimentation rate test 04/21/2021 I had too many tests to list, MRI, CT SCAN, BLOOD PANELS INFETCIOUS DISEASE TESTS, and multiple other tests- Completed the entire week at hospital stay, also did a spinal tap. They increased blood pressure medication, stopped the doxycycline, started me on ceftriaxone started that 04/26/2021, still taking. May 1st, I started increase numbness, spreading on arms and slowly across, feet and abdomen, currently at ER waiting to be see.
Aktuelle Erkrankungen: None
Vorgeschichte: Blood pressure- Borderline Heart beats irregular- Left bundle branch blockage
Andere Medikamente: Lisinopril Mens Multivitamin B complex
Allergien: None
Vorherige Impfungen: -

VAERS 1323957

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: MD
Alter: 18,0
Geschlecht: F
Eingang: 17.05.2021
Impfdatum: 17.05.2021
Beginn: 17.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Syncope

Symptomtext

Patient received the Janssen COVID vaccine on 5/17/2021 around 1513. Prior to vaccine administration during prescreening questions, the client reported "I have a history of passing out after vaccines because I have to have monthly vaccines in my leg for headaches and I hate them" Client was taken to another room with a reclining seat to lay down during vaccine administration. She remained in the supine position for several minutes afterwards and after reporting she felt fine was changed to the sitting position for several minutes and again reported feeling fine. Patient was then changed to standing, reported she felt fine and ambulated to the waiting area, escorted by an RN assistant to be observed for 15 minutes by the EMS provider on site. Soon after, patient appeared to be having a syncopal episode. EMS provider on site called 911 to transport patient to the nearest hospital.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: no
Vorgeschichte: headaches
Andere Medikamente: unknown
Allergien: no
Vorherige Impfungen: -

VAERS 1321343

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CA
Alter: 40,0
Geschlecht: F
Eingang: 15.05.2021
Impfdatum: 15.05.2021
Beginn: 15.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Cold sweat Dizziness Electrocardiogram Loss of consciousness Pallor Vital signs measurement

Symptomtext

right when the injection was given, patient c/o dizziness. RN attention was called. patient look pale, clammy. briefly loss consciousness, called 911. Vital signs taken, BP 93/59, HR 59, Sat 100% in room air. repositioned patient, BP 94/64, hr is 57, 97% in room air. paramedics came. patient transferred to gurney. A/Ox4. patient awake. feeling better. BP stable. EKG done by paramedics. patient refused to go to ED for further eval. will monitor patient onsite

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: hypothyroidism, hashimoto thyroiditis
Vorgeschichte: hypothyroidism
Andere Medikamente: armor Thyroid 15 mg daily
Allergien: none
Vorherige Impfungen: -

VAERS 1310960

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CA
Alter: 55,0
Geschlecht: M
Eingang: 12.05.2021
Impfdatum: 07.05.2021
Beginn: 08.05.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Bell's palsy

Symptomtext

New onset Bell's palsy L face on 5/8/2021. Confirmed on examination 5/12/2021

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bell's palsy
Hospital-Tage: -
Labordaten: NONE
Aktuelle Erkrankungen: NONE
Vorgeschichte: DIABETES MELLITUS
Andere Medikamente: NONE
Allergien: NONE
Vorherige Impfungen: -

VAERS 1310737

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: OH
Alter: 18,0
Geschlecht: F
Eingang: 12.05.2021
Impfdatum: 07.04.2021
Beginn: 03.05.2021
Tage bis Beginn: 26,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: unbekannt Erholt: nein

Deep vein thrombosis Pain in extremity Peripheral swelling Thrombophlebitis superficial

Symptomtext

Deep venous thrombosis involving the common femoral vein and central portions of both superficial and deep femoral veins. Thrombus is also present within the saphenous vein. symptoms- leg swelling and pain since 5/2/21

Weitere VAERSDATA-Felder

Praegender Schweregrund: Deep vein thrombosis
Hospital-Tage: 5,0
Labordaten: US doppler on 5/3/21
Aktuelle Erkrankungen: G tube site cellulitis
Vorgeschichte: AV canal s/p repair, gastric fisula at G tube site s/p repair, obesity, asthma, nocturnal enuresis, IBS, premature baby- had multiple central lines placed as an infant
Andere Medikamente: ? polyethylene glycol 3350 17 gram/dose oral powder (Miralax) ? famotidine 40 mg tablet (Pepcid) ? lansoprazole 30 mg capsule,delayed release (Prevacid) ? linaCLOtide 145 mcg capsule (Linzess) ? azelastine 137 mcg (0.1 %) nasal spra
Allergien: environmental
Vorherige Impfungen: -

VAERS 1294558

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: -
Alter: 29,0
Geschlecht: F
Eingang: 07.05.2021
Impfdatum: 05.05.2021
Beginn: 06.05.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Dizziness postural Fatigue Headache Illness Loss of consciousness Malaise Myalgia Syncope Tunnel vision Visual impairment

Symptomtext

29-year-old female brought to the emergency room by EMS after syncopal episode at sick all this morning. Patient states that she receive the Johnson and Johnson coronavirus vaccine yesterday at approximately 1500. Throughout the evening and overnight she developed the expected side effects of myalgias, mild headache and fatigue. She states because she was not feeling well this morning she was instructed to give us a call. She is sick, she was sitting in a chair and when she was called to code forward she stood up, developed tunneling of her vision with spots in front of her eyes, felt dizzy and then passed out. When she woke up the dizziness had resolved. She states that she feels dizzy intermittently at basel

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: NKA
Allergien: N/A
Vorherige Impfungen: -

VAERS 1293543

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: TX
Alter: 58,0
Geschlecht: F
Eingang: 06.05.2021
Impfdatum: 12.04.2021
Beginn: 14.04.2021
Tage bis Beginn: 2,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: unbekannt Erholt: nein

Anticoagulant therapy Computerised tomogram thorax abnormal Intracardiac thrombus Magnetic resonance imaging abnormal Magnetic resonance imaging heart Pulmonary thrombosis Skin discolouration Thrombosis

Symptomtext

Feet turned black blood thinner 3 blood clots in lungs 1 clot in heart

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary thrombosis
Hospital-Tage: 2,0
Labordaten: Cat scan,mri, xrays
Aktuelle Erkrankungen: Other than a rash and sinus infection I was feeling pretty good for me
Vorgeschichte: Fibromyalgia
Andere Medikamente: Lorazepam,gabapentin,cyclobenzaprine, uprenorphine,aspirin,cetirizine,esomeprazole,ondansatron,nystatin
Allergien: Stadol, Tortola,imitrex, penicillin,
Vorherige Impfungen: -

VAERS 1416845

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: IL
Alter: 59,0
Geschlecht: M
Eingang: 04.05.2021
Impfdatum: 29.04.2021
Beginn: 29.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute pulmonary oedema Blood lactic acid Brain natriuretic peptide increased Chest X-ray abnormal Dyspnoea International normalised ratio normal Lactic acidosis Leukocytosis Malignant hypertension Positive airway pressure therapy Prothrombin time shortened Respiratory distress Troponin White blood cell count increased

Symptomtext

Patient became severely SOB 1 hour after receiving J&J vaccine. Called 911 & brought to ED in severe respiratory distress on CPAP changed to bipap in ED. Diagnosed with Flash Pulmonary Edema, malignant hypertension, lactic acidosis, leukocytosis

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute pulmonary oedema
Hospital-Tage: -
Labordaten: CXR-Pulmonary Edema, WBC 18.6, Lactate 4.9, Troponin 0.06 BNP 952, PT 10.3, INR 1.0
Aktuelle Erkrankungen: -
Vorgeschichte: MI, HTN, COPD, CHF ICD, Angio with stent placement
Andere Medikamente: KCL, Metoprolol Suc XL, Lisinopril, Lasix, Plavix, Lipitor, ASA
Allergien: Bee Stings
Vorherige Impfungen: -

VAERS 1282868

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: NY
Alter: 25,0
Geschlecht: M
Eingang: 03.05.2021
Impfdatum: 09.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Condition aggravated Immediate post-injection reaction Loss of consciousness

Symptomtext

Patient has a history of vasovagal syncope when getting vaccines. Patient received COVID vaccine and about 30 seconds later passed out. Patient did not fall. Nurse was able to stabilize him. Within 15 seconds patient regained consciousness and was fine. Patient with no injuries or issues after. Was able to ambulate with no issues.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: n/a
Aktuelle Erkrankungen: n/a
Vorgeschichte: n/a
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 1281891

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: TX
Alter: 41,0
Geschlecht: M
Eingang: 03.05.2021
Impfdatum: 11.04.2021
Beginn: 11.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Presyncope

Symptomtext

dizziness, near syncope

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1281604

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: TX
Alter: 31,0
Geschlecht: F
Eingang: 03.05.2021
Impfdatum: 11.04.2021
Beginn: 11.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Dizziness Presyncope

Symptomtext

dizziness, near syncope, resolved

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1281433

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: TX
Alter: 40,0
Geschlecht: F
Eingang: 03.05.2021
Impfdatum: 11.04.2021
Beginn: 11.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Feeling hot Hypoacusis Loss of consciousness Nausea Syncope

Symptomtext

pt experienced a syncopal episode secondary to receiving Johnson and Johnson vaccinated. pt stated feeling "hot, dizzy" and her ears became "muffled" and she then became nauseated. pt sat down and "passed out" en route to the bathroom. History of Anxiety and Bi-Polar, unknown medications and pt stated NKDA. pt refused further treatment or transportation.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1278241

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: HI
Alter: 43,0
Geschlecht: M
Eingang: 01.05.2021
Impfdatum: 29.04.2021
Beginn: 29.04.2021
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Hyperhidrosis Nausea Presyncope Vital signs measurement

Symptomtext

Vasovagal episode. After receiving dose patient complained of feeling lightheaded, nauseous and was visibly sweating. Vitals were taken 10:10 106/60 97% HR: 52. At 1015 vitals were 118/10, 98% and HR 65. Patient was given wet towels around his neck and on his forehead. brought cot to patient and patient placed in trendelenburg position. pt given water and stated he was no longer lightheaded or nauseous but continued to have HA. Pt at that time was being evaluated by both doctors. Patient then walked to monitor area where was continuously checked on until 1100 when his vitals were rechecked (118/80, 68HR). Pt stated he felt better and was released and recommended not to drive. Pt says his brother would drive him home. - RN

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: no
Vorgeschichte: no
Andere Medikamente: no
Allergien: no
Vorherige Impfungen: -

VAERS 1276503

UNKNOWN MANUFACTURER · COVID19 (COVID19 (UNKNOWN)) · Charge 201A21A

schwer

Staat: CA
Alter: -
Geschlecht: U
Eingang: 01.05.2021
Impfdatum: -
Beginn: 01.04.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Body temperature Headache Pyrexia Thrombosis Ultrasound scan

Symptomtext

LEG PAIN DIAGNOSED AS BLOOD CLOT; HEADACHE; MILD FEVER; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 201A21A expiry: unknown) dose was not reported, 1 in total administered on 09-APR-2021 to left arm for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, in APR-2021, the patient experienced mild fever (99 degrees fahrenheit), headache and leg pain diagnosed as blood clot (leg pain) on 21-APR-2021. On an unspecified date in APR-2021, laboratory data included: Body temperature (NR: not provided) 99 F, and Diagnostic ultrasound (NR: not provided) unknown. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the leg pain diagnosed as blood clot, headache and mild fever was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0:2021045225-covid-19 vaccine ad26.cov2.s-Leg pain diagnosed as blood clot. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: -
Labordaten: Test Date: 202104; Test Name: Diagnostic ultrasound; Result Unstructured Data: unknown; Test Date: 202104; Test Name: Body temperature; Result Unstructured Data: 99 F
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Unknown
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1272105

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CA
Alter: 62,0
Geschlecht: F
Eingang: 29.04.2021
Impfdatum: 09.04.2021
Beginn: 16.04.2021
Tage bis Beginn: 7,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

CSF protein normal Guillain-Barre syndrome Immunoglobulin therapy Muscular weakness

Symptomtext

Guillain Barre Syndrome. Leg weakness one week following vaccine. Hospitalized. Treated with IVIG. Improved with leg weakness only sequela.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Guillain-Barre syndrome
Hospital-Tage: 6,0
Labordaten: CSF negative for protein elevation.
Aktuelle Erkrankungen: -
Vorgeschichte: CHF, Restrictive lung disease, depression, chronic pain, gastroparesis, interstitial cystitis, chronic headaches.
Andere Medikamente: Trazodone, Alprazolam, Percocet
Allergien: Zyprexa, Elavil, DHE, Imitrex, Talwin, Nubain, Xyrem, Lexapro, mirtazapine, stadol, sulfa, prochloperazine, sumatriptan, metoclopramide, sodium oxybate, meperidine, morphine
Vorherige Impfungen: -

VAERS 1267864

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: TX
Alter: 52,0
Geschlecht: M
Eingang: 28.04.2021
Impfdatum: 12.04.2021
Beginn: 25.04.2021
Tage bis Beginn: 13,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Confusional state Headache Impaired driving ability Loss of consciousness Rash

Symptomtext

Rash on arm, then bad headaches, real bad headaches, When driving this last Monday. I would pass out at the wheel. At least 4 times I jumped the median. Got lost in a nearby neighborhood. Once I figured out what was going on I went straight home.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: None. Stayed home and rest.
Aktuelle Erkrankungen: None
Vorgeschichte: Bad back
Andere Medikamente: Tylenol, cyclobenzaprin (not that morning) if at all that day. I usually take Gabapentin but have been out for a while.
Allergien: Mostly antibiotics. Augmentin, Levaquin, Amoxacilin. Levaquin being the worst. Been years since I took it but you don't forget.
Vorherige Impfungen: -

VAERS 1248552

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: MA
Alter: 95,0
Geschlecht: F
Eingang: 23.04.2021
Impfdatum: 12.04.2021
Beginn: 23.04.2021
Tage bis Beginn: 11,0
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Deep vein thrombosis Pain in extremity Ultrasound Doppler abnormal

Symptomtext

Developed severe right leg pain within two days after the vaccine. She had confirmed deep venous thrombosis on ultrasound confirmed on 4/23/21 without other known provocation.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Deep vein thrombosis
Hospital-Tage: -
Labordaten: 4/23/21 right lower extremity ultrasound
Aktuelle Erkrankungen: asthma, polymyalgia rheumatica, osteoarthritis, hypertension, diabetes, hyperlipidemia
Vorgeschichte: History of breast cancer 2009
Andere Medikamente: prednisone, glipizide, ondansetron, vitamin D3, pantoprazole, furosemide, simvastatin, acetaminophen, albuterol sulfate hand held nebulizer
Allergien: amlodipine, anastrozole, ciprofloxacin, lisinopril
Vorherige Impfungen: -

VAERS 1248235

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CA
Alter: 51,0
Geschlecht: M
Eingang: 23.04.2021
Impfdatum: 09.04.2021
Beginn: 21.04.2021
Tage bis Beginn: 12,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Muscle swelling Myalgia Pain in extremity Peripheral swelling Platelet count normal Thrombosis Ultrasound scan abnormal Venous occlusion

Symptomtext

Pain and swelling in Left Calf muscle. Treating the blood clot with Xeralto

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: -
Labordaten: Ultrasound shows (blood clots) Occlusive thrombus within left peroneal and gastrocnemius veins. Platelets came back normal.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1247598

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: IL
Alter: 27,0
Geschlecht: F
Eingang: 23.04.2021
Impfdatum: 11.04.2021
Beginn: -
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Loss of consciousness Malaise

Symptomtext

while walking to the waiting area she was feeling sick and she lay down on the floor before passed out. Never pass out. BP and pulse were stable. Able to sit on a chair and observed for 10 minutes client voices feeling fine and sign the observation release form and went home in accompany of her mother.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: NONE
Vorgeschichte: NONE
Andere Medikamente: NONE
Allergien: NONE
Vorherige Impfungen: -

VAERS 1246578

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: TX
Alter: 30,0
Geschlecht: M
Eingang: 23.04.2021
Impfdatum: 08.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blood test normal Computerised tomogram normal Dizziness Fatigue Injection site pain Loss of consciousness Seizure

Symptomtext

Seizure - I have never had a seizure before and there is no history of epilepsy in my family. I had the Janssen vaccine shot at around 5PM on Thursday and felt mostly fine on Friday. I had typical shot symptoms (tired and soreness near injection sight). On Friday night around 10:00, I was standing talking to one of my friends in the living room when I had a blackout seizure without any warning. The seizure only lasted about 30-45 seconds, and then I became conscious again. It took me about 5-10 minutes to become completely aware and able to stand up. I have never had a seizure before and have not had one since then. Later the following week, I did have a couple of hours where I felt extremely dizzy and lightheaded, but it went away without another seizure. This is also not typical for me.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: I have had bloodwork and a CT scan of my skull to ensure there aren't any other issues that could have caused the seizure. All of these tests came back normal.
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: Minocyline - For Acne
Allergien: Allergic to Erythromycin and Shellfish.
Vorherige Impfungen: -

VAERS 1244067

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: IL
Alter: 45,0
Geschlecht: F
Eingang: 22.04.2021
Impfdatum: 09.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Hypotension Syncope

Symptomtext

Patient experienced syncope and hypotension, transported to hospital via ambulance

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: Unknown
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Unknown
Andere Medikamente: Unknown
Allergien: Unknown
Vorherige Impfungen: -

VAERS 1244001

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: IL
Alter: 32,0
Geschlecht: M
Eingang: 22.04.2021
Impfdatum: 09.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Hypotension Syncope

Symptomtext

Patient experienced syncope, hypotension, recovered and released

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Unknown
Andere Medikamente: Unknown
Allergien: Unknown
Vorherige Impfungen: -

VAERS 1241970

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: IL
Alter: 45,0
Geschlecht: M
Eingang: 22.04.2021
Impfdatum: 10.04.2021
Beginn: 10.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Hypotension Syncope

Symptomtext

Patient experienced syncope and hypotension post vaccination, recovered and released

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Unknown
Andere Medikamente: Unknown
Allergien: Unknown
Vorherige Impfungen: -

VAERS 1241730

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: IL
Alter: 27,0
Geschlecht: F
Eingang: 22.04.2021
Impfdatum: 09.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Hypotension Syncope

Symptomtext

Patient experienced syncope and hypotension, recovered and released

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Unknown
Andere Medikamente: Unknown
Allergien: Unknown
Vorherige Impfungen: -

VAERS 1241691

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: IL
Alter: 45,0
Geschlecht: M
Eingang: 22.04.2021
Impfdatum: 09.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Hypotension Syncope

Symptomtext

Patient experienced syncope, hypotension, recovered and released

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Unknown
Andere Medikamente: Unknown
Allergien: Unknown
Vorherige Impfungen: -

VAERS 1240882

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CA
Alter: 51,0
Geschlecht: F
Eingang: 22.04.2021
Impfdatum: -
Beginn: 07.04.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chills Dizziness Headache Hyperhidrosis Injection site pain Nausea Neck pain Paraesthesia Presyncope Pyrexia

Symptomtext

DIZZY; INJECTION SITE PAIN RADIATING TO NECK; ALMOST FAINTED; EXCESSIVE SWEATING AROUND ABDOMEN; FINGERS TINGLING AND JUMPING; CHILLS; SORE ARM AT INJECTION SITE; NAUSEA; FEVER; HEADACHE; This spontaneous report received from a patient concerned a 51 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, and expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 07-APR-2021, the subject experienced injection site pain radiating to neck. On 07-APR-2021, the subject experienced dizzy. On 07-APR-2021, the subject experienced almost fainted. On 07-APR-2021, the subject experienced excessive sweating around abdomen. On 07-APR-2021, the subject experienced fingers tingling and jumping. On 07-APR-2021, the subject experienced chills. On 07-APR-2021, the subject experienced sore arm at injection site. On 07-APR-2021, the subject experienced nausea. On 07-APR-2021, the subject experienced fever. On 07-APR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from dizzy, almost fainted, fingers tingling and jumping, chills, nausea, and fever on 08-APR-2021, and had not recovered from headache, sore arm at injection site, excessive sweating around abdomen, and injection site pain radiating to neck. This report was non-serious.; Sender's Comments: V0:MAC comment is not required for nonserious case as per standard protocol.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Unknown
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1240648

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: TX
Alter: -
Geschlecht: U
Eingang: 22.04.2021
Impfdatum: -
Beginn: 10.04.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Dizziness Nausea Syncope

Symptomtext

FAINTING SPELLS/ SYNCOPE; DIZZINESS/ LIGHTHEADEDNESS; NAUSEA; This spontaneous report received from a health care professional concerned multiple patients of unspecified age and sex. The patients' heights and weights were not reported. The patients had no known drug allergies. The patients received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 201A21A, expiry: Unknown) frequency one total, dose was not reported, administered on 10-APR-2021 in left arm for prophylactic vaccination. No concomitant medications were reported. The reporter stated that, on 10-APR-2021, the patients experienced side effects which included fainting spells/syncope, dizziness/lightheadedness and nausea within 15 minutes or so after vaccination at a mass vaccination clinic. The events were reported as serious by the reporter. The patients visited a healthcare professional office for fainting spells/syncope, dizziness/lightheadedness and nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fainting spells/syncope, dizziness/lightheadedness and nausea were not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: v0 This spontaneous report from a health care professional concerns multiple adult patients of unspecified age and gender from a mass vaccination site who experienced fainting spells/syncope, dizziness/lightheadedness and nausea within 15 minutes or so after the Janssen COVID-19 Vaccine Ad26.COV2 had been administered. Given the close temporal relationship and the nature of the events, the events are considered possibly related to the vaccination.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: The patient had no known drug allergies.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1240499

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: GA
Alter: -
Geschlecht: U
Eingang: 22.04.2021
Impfdatum: -
Beginn: 07.04.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Pain in extremity Seizure

Symptomtext

SEIZURE-LIKE ACTIVITY; PAIN IN ARM; This spontaneous report received from a health care professional concerned multiple patients of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, expiry: unknown) dose was not reported, 1 total administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 07-APR-2021, the patients experienced seizure-like activity and pain in arm. It was reported that, while the patients sat in the observation area, seizure-like activity was noted for 5 seconds. The patients complained of dizziness (subsumed under seizure-like activity), and pain in arm. The patients were observed for 2 hours and discharged. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the seizure-like activity and pain in arm was not reported. This report was serious (Other Medically Important Condition). This case, from the same reporter is linked to 20210417256, 20210417209 and 20210417456.; Reporter's Comments: The case is a multiple patient case.; Sender's Comments: V0: 20210418457-covid-19 vaccine ad26.cov2.s-seizure-like activity. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Unknown
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1191533

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201a21a

schwer

Staat: TX
Alter: 52,0
Geschlecht: F
Eingang: 22.04.2021
Impfdatum: -
Beginn: 08.04.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood pressure measurement Blood test Dizziness Electrocardiogram Feeling hot Blood test normal Electrocardiogram abnormal Full blood count normal Metabolic function test Heart rate Heart rate decreased Hyperhidrosis Hypotension Loss of consciousness Malaise Muscle rigidity Mydriasis Nausea

Symptomtext

FELT DIZZY; EXTREMELY HOT; VERY SWEATY; RIGID; EYES WERE OPEN /PUPILS DILATED; NAUSEOUS; DID NOT SLEEP WELL; FELT UNWELL; ACHEY; NON RESPONSIVE, THAT WENT ON FOR ABOUT A MINUTE; LOW BLOOD PRESSURE; SLOW HEART RATE; This spontaneous report received from a consumer concerned a 52 year old female. The patient's weight, height, and medical history were not reported. The patient had no underlying medical condition at the time of vaccination. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, expiry: unknown) dose was not reported, 1 total administered on 08-APR-2021 09:00 to right arm for prophylactic vaccination. No concomitant medications were reported. On 08-APR-2021 21:00, 12 hours after vaccination the patient felt achey, she did not felt well, ran down and went to bed at 22:30. She could not sleep at all well, her husband used a fit bit to track sleep and it was up and down all night long. On 09-apr-2021, in the morning the patient came downstairs and she felt dizzy, then she was rigid, her eyes were wide open and pupils dilated. She was non-responsive, that went on for about a minute and then she came out of that. The patient's husband had called the emergency and the emergency technician came and did an EKG (electrocardiogram); also the patient had very low blood pressure and very low pulse. She was taken to the hospital and was treated with an unspecified IV. The patient stayed in the emergency room for few hours, her blood tests were normal and then the patient wanted to see a cardiologist. The patient was feeling better but was also feeling nauseous; she was extremely hot and very sweaty. The patient's husband was not clear if it was a seizure or not, that her muscles were locked up and rigid. The reporter said that the patient never had anything happened like this before and they were concerned and naturally linked the reactions to vaccine at the time of this report. The reporter also wanted to know if there was any correlation between vaccine and cardiovascular system. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from rigid, and eyes were open /pupils dilated, and was recovering from achey, non responsive, that went on for about a minute, felt unwell, low blood pressure, slow heart rate, nauseous, felt dizzy, did not sleep well, extremely hot, and very sweaty. This report was serious (Hospitalization Caused/Prolonged, and Other Medically Important Condition).; Sender's Comments: V0: 20210419979-covid-19 vaccine ad26.cov2.s-non responsive that went on for about a minute, low blood pressure, slow heart rate. These events are considered unassessable. The events have a compatible/suggestive temporal relationship, are unlabeled, and have unknown scientific plausibility. There is no information on any other factors potentially associated with the events.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: Test Date: 202104; Test Name: EKG; Result Unstructured Data: unknown; Test Date: 202104; Test Name: Blood test; Result Unstructured Data: normal; Test Date: 202104; Test Name: Pulse rate; Result Unstructured Data: very low; Test Date: 202104; Test Name: Blood pressure; Result Unstructured Data: very low
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: The patient had no underlying medical condition.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1238729

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: IL
Alter: 45,0
Geschlecht: F
Eingang: 21.04.2021
Impfdatum: 09.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Syncope

Symptomtext

Patient experienced a syncopal episode post vaccination, recovered and released

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Unknown
Andere Medikamente: Unknown
Allergien: Unknown
Vorherige Impfungen: -

VAERS 1238585

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: IL
Alter: 51,0
Geschlecht: F
Eingang: 21.04.2021
Impfdatum: 09.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Nausea Syncope Vomiting

Symptomtext

Patient experienced a syncopal episode, assisted to ground, nauseated, vomited, IV started, transported to hospital via ambulance

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: Unknown
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Unknown
Andere Medikamente: Unknown
Allergien: Unknown
Vorherige Impfungen: -

VAERS 1238460

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: IL
Alter: 32,0
Geschlecht: F
Eingang: 21.04.2021
Impfdatum: 09.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Hypotension Syncope

Symptomtext

Patient experienced a syncopal episode, hypotension post vaccination, recovered and released

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Unknown
Andere Medikamente: Unknown
Allergien: Unknown
Vorherige Impfungen: -

VAERS 1238366

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: IL
Alter: 41,0
Geschlecht: M
Eingang: 21.04.2021
Impfdatum: 09.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Hyperhidrosis Incontinence Pallor Seizure Syncope

Symptomtext

Patient became pale, diaphoretic, and experienced a syncopal episode, laid flat and then had simple partial seizure lasting 10 seconds, became incontinent, IV started, A and O x4 , transported to hospital via ambulance

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: Unknown
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Unknown
Andere Medikamente: Unknown
Allergien: Unknown
Vorherige Impfungen: -

VAERS 1236104

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: OH
Alter: 18,0
Geschlecht: F
Eingang: 21.04.2021
Impfdatum: -
Beginn: 01.04.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Fatigue Headache Hyperhidrosis Muscle spasms Nausea Pain Pyrexia Seizure

Symptomtext

SPASMS ON LEGS, ARMS AND HEAD; SLIGHT HEADACHE; EXTREME TIREDNESS; SLIGHT FEVER; NAUSEA; BODY ACHES; PROFUSE SWEATING; POSSIBLE SEIZURE; This spontaneous report received from a consumer concerned an 18 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included food allergy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, and expiry: unknown) dose was not reported, 1 total administered on 11-APR-2021 around 11:30 to left arm for prophylactic vaccination. No concomitant medications were reported. On 11-APR-2021, after vaccination patient had done lower body workout. On 11-APR-2021, the patient experienced nausea, extreme tiredness, slight fever, slight headache, body aches, and profuse sweating by evening. She took some children's liquid paracetamol (Tylenol). On 12-APR-2021 about 02:00, she also had spasms of her arms, legs, and head that lasted about 20 minutes. She took paracetamol (Tylenol) at about 03:00 and was pretty out of it. The patient's mother was concerned that it could had been a seizure (possible seizure). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from spasms on legs, arms and head on 12-APR-2021, and the outcome of nausea, extreme tiredness, slight fever, slight headache, body aches, profuse sweating and possible seizure was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0:20210423951-Covid-19 vaccine ad26.cov2.s-seizure. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Food allergy
Vorgeschichte: Comments: Unknown
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1233922

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: IL
Alter: 48,0
Geschlecht: M
Eingang: 20.04.2021
Impfdatum: 11.04.2021
Beginn: 11.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Feeling hot Hyperhidrosis Syncope

Symptomtext

Patient experienced sweating, feeling hot and syncope post vaccination, recovered and released

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Unknown
Andere Medikamente: Unknown
Allergien: Unknown
Vorherige Impfungen: -

VAERS 1223427

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: IL
Alter: 44,0
Geschlecht: F
Eingang: 17.04.2021
Impfdatum: 10.04.2021
Beginn: 10.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Blood pressure measurement Dizziness Feeling hot Heart rate Loss of consciousness

Symptomtext

Feels hot, dizzy, passed out . transported by medics to observation area. BP low, Pulse stable. In observation for 30 minutes recuperate and went home on her own.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: NONE
Vorgeschichte: none
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 1221578

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CA
Alter: 62,0
Geschlecht: F
Eingang: 17.04.2021
Impfdatum: 09.04.2021
Beginn: 12.04.2021
Tage bis Beginn: 3,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Blood test normal Chest X-ray normal Computerised tomogram abdomen normal Computerised tomogram head normal Computerised tomogram neck Dizziness Echocardiogram normal Hypoaesthesia oral Presyncope Transient ischaemic attack

Symptomtext

Received the vaccine friday then monday has numbness to the tongue , near syncope, dizziness, ems called taken to ER and admitted to hospital for TIA. CT of neck, head, abd done, chest xray, full blood work, echo, results sent to primary care said all test ok

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: 3,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: diabetes, hypertension, hyperlipidemia
Andere Medikamente: Lisinopril, Jardiance
Allergien: none
Vorherige Impfungen: -

VAERS 1219890

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CA
Alter: 34,0
Geschlecht: M
Eingang: 16.04.2021
Impfdatum: 11.04.2021
Beginn: 12.04.2021
Tage bis Beginn: 1,0
Dosis: UNK
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Chest X-ray normal Computerised tomogram head Computerised tomogram neck Facial paralysis Hypoaesthesia Laboratory test normal Speech disorder Transient ischaemic attack

Symptomtext

Diagnosed at ER with a transient ischemic attack. Right side went numb, struggled to speak and right side of face drooped

Weitere VAERSDATA-Felder

Praegender Schweregrund: Facial paralysis
Hospital-Tage: -
Labordaten: Ct head normal Ct neck there was evasive of ascending aorta 3.8 cm Chest X-ray normal Blood test normal
Aktuelle Erkrankungen: None
Vorgeschichte: Back injury
Andere Medikamente: None
Allergien: Ceclor
Vorherige Impfungen: -

VAERS 1219115

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201a21a

schwer

Staat: TX
Alter: 47,0
Geschlecht: F
Eingang: 16.04.2021
Impfdatum: 12.04.2021
Beginn: 12.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Presyncope

Symptomtext

near syncope

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: htn, hypothyroid, abdominal aneurysm, dysautonomia, LBBB
Andere Medikamente: coreg
Allergien: azithromycin
Vorherige Impfungen: -

VAERS 1219086

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201a21a

schwer

Staat: TX
Alter: 29,0
Geschlecht: M
Eingang: 16.04.2021
Impfdatum: 12.04.2021
Beginn: 12.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Presyncope

Symptomtext

near syncope

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: none
Andere Medikamente: -
Allergien: none
Vorherige Impfungen: -

VAERS 1219076

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: IL
Alter: 35,0
Geschlecht: F
Eingang: 16.04.2021
Impfdatum: 08.04.2021
Beginn: 08.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Anxiety Blood glucose Cold sweat Dizziness Feeling hot Hyperventilation Malaise Neck pain Pallor Presyncope Vital signs measurement

Symptomtext

Within 15 minute observation period, patient reported not feeling well, feeling dizzy and hot. Patient stated she had been anxious prior to injection, after injection felt a pain in her neck and then did not feel well. Patient was brought by another staff member as patient appeared pale ,hands were clammy, and patient seem to have near syncope where she fell and patient was held by two staff members. This RN went to get vitals machine. Patient seemed to be hyperventilating, vital signs were checked while a provider was called for help. Oxygen was 100%, BP 94/63, HR 45. The doctor came in auscultated heart, patient was drinking water while speaking to provider, HR seemed to be improving to 70s and BP went to 101/67. Patient reported feeling better. The Doctor requested that fingerstick glucose and hemoglobin be checked which were also normal. Patient reported feeling much better after about 5-7 minutes. Patient was stable and sent home with call back parameters. Patient had follow up appointment with provider next day with improvement.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: 4/8/2021 Finger stick Glucose 136, Fingerstick Hgb 11
Aktuelle Erkrankungen: -
Vorgeschichte: Attention deficit disorder
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 2044466

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: HI
Alter: 34,0
Geschlecht: M
Eingang: 15.04.2021
Impfdatum: 12.04.2021
Beginn: 12.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Cold sweat Fall Hyperhidrosis Loss of consciousness Tongue biting Tongue haemorrhage

Symptomtext

Post vaccination, recipient "blacked out" and fell onto floor. Regained consciousness after about 2-3 seconds. Recipient awake, alert, and conversant. Skin diaphoretic, and cool/clammy. Reported he had bitten his tongue. Tongue slightly bleeding. Denied hitting his head. Observation TL (physician) on site and attended to recipient. Assisted him to a supine position with legs elevated. Allowed to lay for a wheelchair and escorted to observation area. VS monitored and stable. Tongue had stopped bleeding. Ambulating with steady gait. Released at 0930 in no acute distress and without incident.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: NONE
Aktuelle Erkrankungen: UNKNOWN
Vorgeschichte: UNKNOWN
Andere Medikamente: UNKNOWN
Allergien: NONE
Vorherige Impfungen: -

VAERS 1214429

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CA
Alter: 64,0
Geschlecht: M
Eingang: 15.04.2021
Impfdatum: 09.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Fall Head injury Syncope

Symptomtext

Patient was found on the floor next to his chair facing forward in observation area. When we attended patient alert, awake and oriented x3. Denied any resp distress. No HA. No n/v. Patient has h/o dvt on coumadin. No h/o DM. recommended further evaluation in ER due to patient had syncope, on coumadin, hit his head to ground. But pt declined and signed AMA. patient reported that he will seek emergency if he feels any worsening symptoms.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1207898

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: IL
Alter: 56,0
Geschlecht: F
Eingang: 14.04.2021
Impfdatum: 07.04.2021
Beginn: 07.04.2021
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Activated partial thromboplastin time shortened Alanine aminotransferase normal Albumin globulin ratio decreased Angiogram cerebral abnormal Anion gap decreased Arteriogram carotid abnormal Aspartate aminotransferase normal Back pain Basophil count normal Basophil percentage Blood albumin decreased Blood alkaline phosphatase normal Blood bilirubin normal Blood calcium decreased Blood chloride increased Blood creatinine normal Blood glucose normal Blood osmolarity decreased

Symptomtext

Left arm and left neck/face tingling, decreased sensation with subsequent Bell's palsy like facial asymmetry on the left side, brain fog, dizziness with position changes, pressure in head when bending over behind the left eye, aching pain in left arm, fullness in the anterior lower right neck, episode of visual stars, food and drink dripping/falling out of left side of mouth, Pain in left rib cage/chest into the left back causing her to breath shallower. ER evaluation confirmed CT finding of right superficial vein thrombosis just above the sternoclavicular joint - see imaging report info.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Facial paralysis
Hospital-Tage: -
Labordaten: CT ANGIOGRAM HEAD AND NECK IMPRESSION: 1.Negative for dural venous sinus thrombosis. Bilateral filling defects seen in the transverse sinuses are most likely arachnoid granulations. 2.Negative for DVT in the internal jugular or subclavian veins in the neck. 3.Filling defect seen within a tortuous superficial vein adjacent to the right sternoclavicular joint, consistent with a superficial venous thrombosis. The exact origin of the vein is uncertain but it appears to drain into the right subclavian vein via some engorged collaterals. Surrounding mild soft tissue inflammation and venous varices are noted. This corresponds to the site of patient's symptoms and palpable abnormality. The right subclavian vein itself is free of clot at this time. 4.Approximately 2.2 cm diameter likely extra-axial hyperdense lesion in the anterior cranial fossa extending to the right of midline, without any adjacent vessels in the area to suspect aneurysm. This most likely reflects a planum sphenoidale meningioma. Recommend follow-up evaluation with nonemergent contrast enhanced MRI. I discussed these results with Dr. Dunaway via telephone at 4/13/2021 17:46, immediately at the time of interpretation. Report signed on 4/13/2021 5:47 PM Report created with Powerscribe360 Component WBC Value: 7.31 Flag: Ref Range: 3.87 - 9.10 Units: 10*3/uL Status: Final RBC Value: 4.69 Flag: Ref Range: 3.92 - 4.97 Units: 10*6/uL Status: Final HGB Value: 13.9 Flag: Ref Range: 12.1 - 14.8 Units: g/dL Status: Final HCT Value: 42.5 Flag: Ref Range: 37.1 - 45.1 Units: % Status: Final MCV Value: 90.6 Flag: Ref Range: 82.0 - 99.0 Units: fL Status: Final MCH Value: 29.6 Flag: Ref Range: 28.5 - 32.1 Units: pg Status: Final MCHC Value: 32.7 Flag: Ref Range: 31.4 - 34.5 Units: g/dL Status: Final Platelets Value: 288 Flag: Ref Range: 150 - 400 Units: 10*3/uL Status: Final RDW-CV Value: 13.1 Flag: Ref Range: 11.4 - 14.0 Units: % Status: Final NRBC Absolute Value: 0.00 Flag: Ref Range: 0 Units: 10*3/uL Status: Final MPV Value: 10.5 Flag: Ref Range: 8.8 - 12.2 Units: fL Status: Final Differential Type Flag: Status: Final AUTOMATED DIFFERENTIAL Neutrophil % Value: 60.2 Flag: Units: % Status: Final Neutrophils Absolute Value: 4.40 Flag: Ref Range: 1.57 - 6.01 Units: 10*3/uL Status: Final Lymphocytes % Value: 32.7 Flag: Units: % Status: Final Lymphocytes Absolute Value: 2.39 Flag: Ref Range: 0.92 - 2.93 Units: 10*3/uL Status: Final Monocyte % Value: 5.2 Flag: Units: % Status: Final Monos Absolute Value: 0.38 Flag: Ref Range: 0.26 - 0.87 Units: 10*3/uL Status: Final Eosinophils Relative % Value: 1.1 Flag: Units: % Status: Final Eosinophils Absolute Count Value: 0.08 Flag: Ref Range: 0.0 - 0.35 Units: 10*3/uL Status: Final Basophils % Value: 0.5 Flag: Units: % Status: Final Basophils Absolute Value: 0.04 Flag: Ref Range: 0.01 - 0.09 Units: 10*3/uL Status: Final Immature Granulocytes% Value: 0.3 Flag: Units: % Status: Final Immature Granulocytes Absolute Value: 0.02 Flag: Ref Range: 0.00 - 0.05 Units: 10*3/uL Status: Final Component Value Flag Ref Range Units Status Sodium 138 135 - 145 mmol/L Final Potassium 3.9 3.5 - 5.1 mmol/L Final Chloride 107 98 - 107 mmol/L Final CO2 29 21 - 32 mmol/L Final Glucose 97 65 - 100 mg/dL Final BUN 9 5 - 20 mg/dL Final Creatinine 0.69 0.55 - 1.02 mg/dL Final Calcium 8.5 8.3 - 10.3 mg/dL Final Total Protein 7.1 6.4 - 8.3 g/dL Final Albumin 3.2 Low 3.4 - 5.0 g/dL Final Bilirubin Total 0.4 0.2 - 1.0 mg/dL Final Alkaline Phosphatase 85 45 - 117 U/L Final AST 14 Low 15 - 37 U/L Final ALT 18 13 - 56 U/L Final Anion Gap 2 Low 6 - 14 mmol/L Final BUN/Creatinine Ratio 13.0 Final Osmolality Calculated 274 mosm/kg Final Globulin 3.9 g/dL Final A/G Ratio 0.8 Low 1.2 - 2.4 Final Creatinine Based eGFR >90 >60 mL/min/[1.73_m2] Final Status: Final result (Collected: 4/13/2021 13:55) Provider Status: Ordered Component Value Flag Ref Range Units Status PTT 25.4 22.6 - 34.1 s Final Comment: Therapeutic range for Heparin Monitoring based on serum concentrations of 0.3-0.7 units/mL. Therapeutic APTT range: 67-101 seconds Status: Final result (Collected: 4/13/2021 13:55) Provider Status: Ordered Component Value Flag Ref Range Units Status Protime 12.6 11.5 - 14.4 s Final INR 1.0 Final Comment: ---- THERAPEUTIC RANGE: Patients on standard dose for treatment of prophlaxis of thrombosis or embolism: Target INR Range: 2.0-3.0 High risk patients with mechanical heart valves: Target INR Range: 2.5-3.5
Aktuelle Erkrankungen: None known.
Vorgeschichte: Essential hypertension, chronic neck and back pain, chronic venous insufficiency, BMI 30.50, vitamin D deficiency, pure hypercholesterolemia,
Andere Medikamente: vitamin D 4000 IU daily over the counter, Zyrtec 10 mg daily as needed over the counter, Cryselle 28 norgestrel-ethinyl estradiol 0.3-30 mg-mcg per tablet once daily, lisinopril 40 mg daily.
Allergien: Lidocaine oral spray - anaphylaxis. Orange fruit/orange flavoring - hives swelling, rash. Prednisone - anaphylaxis. Hydrocodone-acetaminophen - rash. Metoprolol - rash. Sulfa antibiotics - rash. Mucinex Swelling lower extremities and throat.
Vorherige Impfungen: -

VAERS 1206041

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: MD
Alter: 31,0
Geschlecht: M
Eingang: 13.04.2021
Impfdatum: 09.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Atrial fibrillation Head injury Syncope

Symptomtext

Patient was in attendance at the JANSSEN vaccination clinic on 4/9/21. After vaccination while he was in the observation area, PT experienced a syncopal episode and hit his head on the window sill next to where he was sitting. Staff responded and assessed PT and decided to initiate a MET call. There was concern that the patient may have experienced a seizure. Patient was taken to the Emergency Department. Patient was ultimately admitted on 4/9/21 with new onset of a. fib. He was discharged on 4/11/21. While hospitalized, the patient received IV cardizem

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: 2,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1205784

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: OH
Alter: 20,0
Geschlecht: F
Eingang: 13.04.2021
Impfdatum: 11.04.2021
Beginn: 11.04.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chills Dizziness Fall Headache Loss of consciousness

Symptomtext

At 10PM (8 hours after getting the JnJ vaccine) pt developed chills and pulsate headache. Pt was able to sleep. Next day in the morning by 7:40AM she went downstairs and got dizzy and fall gradually on the floor. Pt got help, but when she was trying to get up she got lightheaded/passed out again bumping her head on the wall. Pt reacted, fluids were given. Pt slept all morning. At 2PM she got up from bed. No pulsate headache, just "mild headache." Today, 48 hours later, pt reported light headache. Denies abdominal pain or pain in extremities. Pt and parents of pt were encouraged to report to patient's PCP.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: Denies
Andere Medikamente: Prozac
Allergien: None
Vorherige Impfungen: -

VAERS 1205651

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CA
Alter: 20,0
Geschlecht: M
Eingang: 13.04.2021
Impfdatum: 05.04.2021
Beginn: 05.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Deafness unilateral Fall Feeling cold Head injury Hypotension Pallor Syncope

Symptomtext

Experienced syncopal episode; ground level fall; PHN witnessed from vaccination station and provided assistance along with NP on-site. Recipient was lying on side and assisted to supine position; assessed skin pallor, bilateral hands cool to the touch; denied SOB, denied chest pain; no swelling noted; alert & conversing; stated "I can't hear from my right ear"; d/t fall skull examined and small raised area noted with no skin break. Spanish interpreter utilized.911 called. Denied any h/o of allergies or medical condition; remained alert until arrival of emergency responders. BP taken supine WNL; informed by responders hypotensive standing. Reported hearing returned back to normal. Recipient was taken to local ER for further evaluation. Patient returned to mobile vaccine site after discharge from ED to discuss vaccine and stated ER physician indicated episode was possibly d/t vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: Unknown at this time
Aktuelle Erkrankungen: Denies other illnesses.
Vorgeschichte: Denies chronic health conditions
Andere Medikamente: No Rx regimen reported.
Allergien: NKA reported
Vorherige Impfungen: -

VAERS 1205083

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CA
Alter: 24,0
Geschlecht: M
Eingang: 13.04.2021
Impfdatum: 12.04.2021
Beginn: 12.04.2021
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Flushing Loss of consciousness Muscle contractions involuntary Paraesthesia Syncope Vision blurred Vital signs measurement

Symptomtext

Patient had a brief syncopal episode w/flushing followed by muscle contractions. 911 was called. Blood Pressure 94/43. O2 sat was 98% on room air. Per patient, vision got blurry and then went black. Tingling in bilateral hands. Paramedics arrived and assessed patient. Per paramedics request patient was to wait another 20 minutes before leaving. 10:34am patient is alert & oriented x4. Walking and feeling back to baseline. patient was then walked to his vehicle and was informed that if he began to feel that way again, to call 911 immediately. from time of vaccination to time patient left was a total of 42 minutes.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: Patient stated no
Vorgeschichte: Patient stated no
Andere Medikamente: Patient did not state
Allergien: Patient stated no
Vorherige Impfungen: -

VAERS 1204625

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: TX
Alter: 46,0
Geschlecht: F
Eingang: 13.04.2021
Impfdatum: 10.04.2021
Beginn: 10.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood glucose Electrocardiogram Fatigue Feeling abnormal Loss of consciousness Muscle discomfort Seizure Urine analysis

Symptomtext

About five minutes after receiving the vaccine I began to feel something was terribly wrong. I then blackout for several minutes. From my son's description I believe I might of had a seizure. He said my eyes were wide open, I was slumped over, and gurgling. I was completely unresponsive to him. He summoned the paramedics who loaded me in an ambulance soon after I came to. They checked my vitals. My heart rate was 47 bpm and blood pressure was 80/40. They also checked my blood sugar. It was 116. They decided I needed to go to the hospital and began giving me iv fluids in route. At the hospital an EKG was taken, which came out normal, they continued iv fluids, and did a urinalysis on me. All test indicated I was healthy. It about three hours before my blood pressure and heart rate stabilized. Just as long for me to feel like I would be ok. They discharged me at this point. Since they I have just been extra tired and have had muscle discomfort.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: EKG, Blood Glucose test, and urinalysis 4/10/2021
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Cbd and Kratom
Allergien: No known allergies
Vorherige Impfungen: -

VAERS 1204196

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: IL
Alter: 23,0
Geschlecht: F
Eingang: 13.04.2021
Impfdatum: 09.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood pressure decreased Dizziness Hyperhidrosis Syncope

Symptomtext

Feels dizzy, syncopal episode, blood pressure drop, sweaty. BP monitor by paramedics and stay low, was transported to an area hospital emergency room or follow-up

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: unknown
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: Unknown
Allergien: none
Vorherige Impfungen: -

VAERS 1204034

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: TX
Alter: 25,0
Geschlecht: M
Eingang: 13.04.2021
Impfdatum: 11.04.2021
Beginn: 11.04.2021
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Syncope

Symptomtext

Dizziness and syncope

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1203940

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: TX
Alter: 43,0
Geschlecht: M
Eingang: 13.04.2021
Impfdatum: 11.04.2021
Beginn: 11.04.2021
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Syncope

Symptomtext

Syncope

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1203915

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CO
Alter: 27,0
Geschlecht: F
Eingang: 13.04.2021
Impfdatum: 07.04.2021
Beginn: 07.04.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Blood glucose Blood pressure measurement Dizziness Head injury Heart rate Oxygen therapy Respiratory rate Syncope Vital signs measurement

Symptomtext

symptoms: light headed & syncope episode in which patient hit head on pavement Vitals: BP 93/51 RR 16, Pulse 115 O2 67% Intervention/treatment: Oxygen at 6L/minute by non-rebreather , re-assessed vitals, called for EMS transport O2 Sats after oxygen was 100%. Paramedics assessed patient and took a blood glucose which was 118. Patient denied drug and alcohol usage and denied pregnancy NKDA NDMedical Condition other than anxiety and fear of needles. Patient refused medical transport and signed waiver with Paramedics

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1203752

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: TX
Alter: 23,0
Geschlecht: F
Eingang: 13.04.2021
Impfdatum: 11.04.2021
Beginn: 11.04.2021
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Syncope

Symptomtext

Syncopal Episode

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1203710

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: TX
Alter: 61,0
Geschlecht: F
Eingang: 13.04.2021
Impfdatum: 08.03.2021
Beginn: 08.03.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Syncope

Symptomtext

syncope

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: asthma, htn, cardiac
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1203519

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: TX
Alter: 50,0
Geschlecht: F
Eingang: 13.04.2021
Impfdatum: 12.04.2021
Beginn: 12.04.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Presyncope

Symptomtext

near syncope, dizziness

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: Zyrtec
Allergien: none
Vorherige Impfungen: -

VAERS 1203512

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: TX
Alter: 29,0
Geschlecht: M
Eingang: 13.04.2021
Impfdatum: 12.04.2021
Beginn: 12.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Presyncope

Symptomtext

Near Syncope

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1201895

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: IN
Alter: 70,0
Geschlecht: F
Eingang: 13.04.2021
Impfdatum: 08.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 1,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Movement disorder Paralysis

Symptomtext

Patient states that on the night of 4/9/2021 around 10PM she was laying down and felt paralyzed and could not move for 6 hours. Patient states that she was unable to call 911 because she could not move.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paralysis
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Hypertension, Atrial Fibrillation, fatigue chronic, hypothyroidism, Mild cognitive impairment, Mitral valve disorder, Insomnia, Urinary incontinence
Andere Medikamente: Acetaminophen, Aspirin, Multivitamin, Fluoxetine, Flonase, Levothyroxine, Metoprolol, Pantoprazole, Rosuvastatin, and Trazodone.
Allergien: Epinephrine and mint
Vorherige Impfungen: -

VAERS 1201649

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: FL
Alter: 61,0
Geschlecht: F
Eingang: 13.04.2021
Impfdatum: 06.04.2021
Beginn: 07.04.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Chills Dehydration Differential white blood cell count Dizziness Electrocardiogram Fall Fatigue Full blood count Hyperhidrosis Loss of consciousness Metabolic function test Nausea Peripheral coldness Syncope Troponin

Symptomtext

Beginning approximately 10 PM (about 8 hours post-injection), I started to have chills (feet were freezing) and was exhausted. Went to bed, and slept most of the night, only waking once to urinate and to drink a small amount (approx 2 oz) of Coca Cola -- I was very nauseous and thought it would help settle my stomach. During the night I sweated profusely. At 8 AM, I woke again and went to urinate. At that time I felt very nauseous, dizzy, and light headed. When I walked about 2 -3 feet to my bedroom, I collapsed on the floor - unconscious. My partner called EMS, they arrived minutes later. By then I was conscious. They transported me to Medical Center Emergency Room, where I remained for several hours. They indicated that my SYNCOPE was a result of dehydration. TODAY, 4/13, news of BLOOD CLOTS has compelled me to report my adverse reaction.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: On April 7, 2021 at Medical Center: ECG; CBC with differential; CMP - Complete Metabolic Panel Troponin 1 Quantitative
Aktuelle Erkrankungen: NONE
Vorgeschichte: NONE
Andere Medikamente: Daily Vitamin D pill
Allergien: NONE
Vorherige Impfungen: -

VAERS 1176226

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: -
Alter: 35,0
Geschlecht: F
Eingang: 13.04.2021
Impfdatum: 07.04.2021
Beginn: 07.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Anxiety Dizziness Hyperhidrosis Loss of consciousness Nausea Pallor Syncope Presyncope Seizure

Symptomtext

History of anxiety around injectables Symptoms: diaphoretic, pale, light headed, husband stated she had first syncope episode after receiving the vaccine. As EMT arrived to assess the patient she had a second syncope episode that presented as seizure activity that lasted for 40-50 seconds. After the second episode patient came alert stated she felt much better, which she state she didn?t feel well after the first syncope episode. We witnessed patient ambulate to the stretcher and loaded into ambulance for further assessment and transport then patient refused transport. VS: BP 140/95, RR, 18, pulse 70, Oxygen 98%

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: history of anxiety
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1086197

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: TX
Alter: 23,0
Geschlecht: F
Eingang: 13.04.2021
Impfdatum: 08.03.2021
Beginn: 08.03.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Blood pressure decreased Chills Hypoaesthesia Syncope Vision blurred Vomiting

Symptomtext

syncope

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: unknown
Vorgeschichte: none
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 1198403

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CA
Alter: 22,0
Geschlecht: M
Eingang: 12.04.2021
Impfdatum: 09.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Loss of consciousness Panic attack

Symptomtext

Patient passed out. Mother stated he gets panic attacks every time he has a needle stick. Patient was fine shortly after.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: Patient has passed out before. Likely a panic attack.

VAERS 1197965

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: AL
Alter: 44,0
Geschlecht: F
Eingang: 12.04.2021
Impfdatum: 09.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Loss of consciousness Muscle rigidity

Symptomtext

PASSED OUT, WENT RIGID TEMPORARILY

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: HUSBAND CALLED 911. SHE WAS TAKEN TO MEDICAL CENTER TO BE CHECKED OUT. SHE SAID SHE FELT FINE AFTER BEING RELEASED. SHE SAID MEDICAL PERSONNEL THOUGHT IT WAS RELATED TO THE VACCINATION. SHE CALLED AND REPORTED TO ME 4/10/21. SHE STATED THAT SHE STILL FELT OK.
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1197040

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: IL
Alter: 24,0
Geschlecht: F
Eingang: 12.04.2021
Impfdatum: 10.04.2021
Beginn: 10.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Depressed level of consciousness Dizziness Lethargy Loss of consciousness Vomiting

Symptomtext

Patient began to feel dizzy around 10 minutes of waiting after the vaccine administration. Patient then began to vomit but could not get all of the vomit out of her throat. She then passed out. Patient was lethargic and difficult to arouse. Patient's blood pressure was 122/80. Medics were called and arrived on scene and took patient to the ER.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: None
Allergien: Seasonal allergies
Vorherige Impfungen: -

VAERS 1196929

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: OH
Alter: 58,0
Geschlecht: F
Eingang: 12.04.2021
Impfdatum: 10.04.2021
Beginn: 10.04.2021
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Hyperhidrosis Syncope

Symptomtext

Syncopal episode: +lighthead, +dizziness, +diaphoretic. Patient placed on cot in supine position within medically monitored clinic area. Vitals obtained: BP- initial 88/54, 112/68, 117/72, 118/70; HR 66; SpO2 97% on room air. Patient given orange juice and fruit snacks. Patient felt better.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: unknown
Vorgeschichte: unknown
Andere Medikamente: unknown
Allergien: none noted
Vorherige Impfungen: -

VAERS 1196920

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: IA
Alter: 33,0
Geschlecht: M
Eingang: 12.04.2021
Impfdatum: 10.04.2021
Beginn: 10.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Confusional state Dizziness Hyperhidrosis Lethargy Loss of consciousness Pallor

Symptomtext

Around 5-10 minutes after the injection, patient began to feel faint. Patient turned pale and diaphoretic and passed out. Patient was lethargic and confused when coming back. Patient then began to remember where he was and started to feel better for about 2 minutes. Patient then fainted again and was able to regain consciousness with tactile and verbal stimulation. Medics were called for the patient. Patient's blood pressure was 80/55. When medics arrived, the patient had started to feel better and refused ER treatment. Medics left patient without doing vitals or assessments. Patient stayed at the vaccine clinic for another hour and then left after feeling better.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: None
Vorherige Impfungen: Unknown, patient states he does get dizzy and occasionally passes out from blood draws/injections.

VAERS 1196788

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: OH
Alter: 19,0
Geschlecht: F
Eingang: 12.04.2021
Impfdatum: 10.04.2021
Beginn: 10.04.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Hyperhidrosis Pallor Syncope

Symptomtext

Syncope 1 minute witnessed by clinic staff in monitoring area approximately 10 minutes after vaccine administered. Patient denied chest pain, shortness of breath, abdominal pain and dizziness. Patient's skin assessment: pale, cool, diaphoretic. Vital signs obtained: BP 110/60, HR 84, Pulse Ox: 99%, RR 18. Patient remained in medical monitoring area for 30 minutes with no further reaction. Patient given fruit snacks and juice. Patient's skin color returned to normal, stated she felt better after lying down and eating.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: unknown
Vorgeschichte: none
Andere Medikamente: unknown
Allergien: nothing noted
Vorherige Impfungen: -

VAERS 1196717

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: OH
Alter: 19,0
Geschlecht: F
Eingang: 12.04.2021
Impfdatum: 12.04.2021
Beginn: 12.04.2021
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Syncope

Symptomtext

Vasovagal syncope within 10 minutes following administration of vaccine

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1196672

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: OH
Alter: 28,0
Geschlecht: F
Eingang: 12.04.2021
Impfdatum: 11.04.2021
Beginn: 11.04.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Seizure

Symptomtext

After sitting in chair to be monitored pt felt dizzy and had seizure for 15 min. VS right after seizure@1113: BP 138/94, HR 42, OxSat97%. Rechecked vitals after sitting back up for 20 min: Blood sugar 108, OxSat: 99%, HR 56, BP 117/75. This was the first seizure for the patient. He does not want to go to ER. Pt was monitored longer. EMS reported he could be released to go home. Parents were instructed to notify MD and to monitor pt status if any seizure like activity call 911. This patient frequently passes out with shots.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1196646

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: OH
Alter: 39,0
Geschlecht: F
Eingang: 12.04.2021
Impfdatum: 11.04.2021
Beginn: 11.04.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Fall Loss of consciousness

Symptomtext

Pt. passed out, hit floor 5 minutes after vaccine. Vs 130/78, HR 68, OxSat. 98%. Pt on floor, legs elevated, water offered. Pt is now able to sit down in chair un assisted.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1196604

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: OH
Alter: 23,0
Geschlecht: F
Eingang: 12.04.2021
Impfdatum: 11.04.2021
Beginn: 11.04.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Fall Loss of consciousness

Symptomtext

Pt. passed out, hit floor 5 minutes after vaccine. Vs 130/78, HR 68, OxSat. 98%. Pt on floor, legs elevated, water offered. Pt is now able to sit down in chair un-assisted.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: -
Andere Medikamente: None
Allergien: NKA
Vorherige Impfungen: -

VAERS 1196445

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: OK
Alter: 21,0
Geschlecht: F
Eingang: 12.04.2021
Impfdatum: 08.04.2021
Beginn: 08.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Chills Dizziness Fatigue Headache Hot flush Hyperhidrosis Immediate post-injection reaction Injection site pain Muscular weakness Nausea Pain Presyncope Sensitive skin Vision blurred

Symptomtext

Immediately (a minute or two) after receiving the vaccine: lightheadedness, nausea, nearly fainted, vision started going blurry/black, sweating for about 5-10 minutes. Stayed seated until it mostly passed, then went outside for fresh air and to cool down. Put a cold rag on forehead/back of neck for half hour following symptoms. Drank water at soon as possible. For the next 36 hours after receiving the vaccine: sensitive skin, muscle weakness, tiredness, headache, body aches (including the sight of injection), chills, hot flashes. Took Advil every few hours to reduce pain, kept lights off, laid in bed to rest.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: Tri-Linyah, Vitamin D
Allergien: Latex
Vorherige Impfungen: -

VAERS 1196251

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201a21a

schwer

Staat: CA
Alter: 18,0
Geschlecht: F
Eingang: 12.04.2021
Impfdatum: 10.04.2021
Beginn: 10.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Loss of consciousness

Symptomtext

passed out after vaccine was given moved to EMS room BP: 108/61 HR:77 O2 98%

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: none
Allergien: -
Vorherige Impfungen: -

VAERS 1194422

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: OK
Alter: 19,0
Geschlecht: F
Eingang: 11.04.2021
Impfdatum: 08.04.2021
Beginn: 08.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Dizziness Fall Haematoma Loss of consciousness Syncope Vital signs measurement

Symptomtext

Female pt felt lightheaded and dizzy after receiving vaccine. Did not alert staff and had a syncopal episode, falling out of her chair. EMRs at pts side, pt regained consciousness. She did have a small hematoma on her head measuring approx. 1 inch. Pts vitals were HR 68, BP 116/70, RR12 , sats 100%. Pt sts all symptoms have resolved. She denies all further treatment and/or transport.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: n/a
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: prior similar symptoms with injections

VAERS 1194306

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CA
Alter: 51,0
Geschlecht: F
Eingang: 11.04.2021
Impfdatum: 08.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Chills Dizziness Heart rate increased Pyrexia Syncope

Symptomtext

- Rapid Heart Beat along with Chills and Fever starting around 4/8/21 6:00 pm. -At 9:45 pm, Fever was 102.1. Took Tylenol ( 500 mg x2). - At 10:30 pm, Pulse rate was 145 bpm and fever was 101.9. - On 4/9/21 4:30 am, after urinating felt dizzy and fainted. Called 911 and went to the Emergency Room. Was treated there for syncope.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: High Blood Pressure
Andere Medikamente: Lisinopril 10 mg-hydrochlorothiazide 12.5 mg ( 2 tablets a day)
Allergien: None
Vorherige Impfungen: -

VAERS 1194221

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: NY
Alter: 20,0
Geschlecht: M
Eingang: 11.04.2021
Impfdatum: 11.04.2021
Beginn: 11.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Syncope

Symptomtext

Syncope 5 min after injection

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: N/a
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Unknown
Andere Medikamente: Unkniwn
Allergien: None known
Vorherige Impfungen: -

VAERS 1194190

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201a21a

schwer

Staat: OH
Alter: 21,0
Geschlecht: F
Eingang: 11.04.2021
Impfdatum: 11.04.2021
Beginn: 11.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Syncope

Symptomtext

Syncope following vaccine

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: N/a
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Unknown
Andere Medikamente: Birth control
Allergien: None jnown
Vorherige Impfungen: -

VAERS 1192676

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: HI
Alter: 43,0
Geschlecht: M
Eingang: 11.04.2021
Impfdatum: 08.04.2021
Beginn: 10.04.2021
Tage bis Beginn: 2,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Blood test normal Depressed level of consciousness Electrocardiogram normal Hypotension Presyncope Syncope Unresponsive to stimuli

Symptomtext

Approximately five minutes after the shot, I experienced vasovagal syncope. I was, reportedly, non-responsive for about three minutes. When aroused, my heart was reportedly beating about 40 beats per minute, my blood pressure was low, and it took me quite a while to regain my senses.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: The medical professionals at the vaccination site told me that I needed to go to the ER immediately and arranged for me to go get tested to make sure this wasn't a cardiac event or something else. The emergency room did a cardiac trace and blood tests, all of which showed I was fine, and concluded that I had a vasovagal reaction to the covid shot. I was released after an hour or two later, the same day, April 8 2021.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1192346

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: -
Alter: 64,0
Geschlecht: M
Eingang: 10.04.2021
Impfdatum: 09.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Syncope

Symptomtext

Patient had syncope from a sitting position, history of vasovagal syncope, occurred 10 minutes after receiving vaccine. Patient recovered in the recovery area, advised to follow up with MD

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1192040

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: -
Alter: 26,0
Geschlecht: F
Eingang: 10.04.2021
Impfdatum: 08.04.2021
Beginn: 08.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Blood pressure decreased Presyncope Vital signs measurement

Symptomtext

Patient has history of vasovagal reaction to blood draw and vaccines, BP dropped to 90/60 HR80, then 10 minutes later 94/64. Discharged in stable condition

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1191715

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: -
Alter: 19,0
Geschlecht: M
Eingang: 10.04.2021
Impfdatum: 07.04.2021
Beginn: 07.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Dizziness Flushing Hyperhidrosis Syncope

Symptomtext

Patient experienced syncope, flushing/sweating, and dizziness, likely vasovagal response. Patient fell, fall braced by healthcare provider, did not hit head. BP 96/46, HR 49, R16. Given water and crackers, stabilized within 30 minutes, BP 124/49 P52, stable and released from vaccination site

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1191359

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: -
Alter: 19,0
Geschlecht: F
Eingang: 10.04.2021
Impfdatum: 10.04.2021
Beginn: 10.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Syncope Vital signs measurement

Symptomtext

After vaccine, patient fainted and registered nurse and CNA assisted to floor with no incidents. EMT and Doctor at side. Vitals 123/75, HR 86, 97%. Food and water was given. Dr. cleared patient to sit at the thirty minutes tent for closer observation.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1191191

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: UT
Alter: 24,0
Geschlecht: F
Eingang: 10.04.2021
Impfdatum: 09.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Presyncope

Symptomtext

Patient become dizzy and very close to passing out after vaccine. As patient became closer to passing out she was laid down on floor and immediately improved. After a couple minutes patient was monitored in waiting room and began to again experience dizziness and come close to passing out. We again moved her to the floor in our vaccinate room where to immediately improved. After monitoring for another 5 or store minutes patient said she was good and stayed in the store for another 15 minutes with no issues. Patient did report prior issues with dizziness following vaccines.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: none known
Vorgeschichte: none known
Andere Medikamente: Unknown
Allergien: None
Vorherige Impfungen: Unknown, said flu shots

VAERS 1191042

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: UT
Alter: 23,0
Geschlecht: M
Eingang: 10.04.2021
Impfdatum: 09.04.2021
Beginn: 10.04.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Nausea Pyrexia Syncope Tremor

Symptomtext

Approximately 12 hours after vaccination, awoke with severe trembling and nausea. Fainted twice. Fever of 100F. Nausea lasted approximately 30 minutes, trembling lasted about 45 minutes. Important to note that I previously had COVID-19 60-70 days prior to vaccination. The symptoms from the vaccine were significantly worse; however, they appear to have lasted for a much shorter period.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Sertraline
Allergien: None
Vorherige Impfungen: -

VAERS 1190392

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: -
Alter: 24,0
Geschlecht: M
Eingang: 10.04.2021
Impfdatum: 10.04.2021
Beginn: 10.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Dizziness Loss of consciousness

Symptomtext

Client recieved J&J vaccination and arrived at obseravtion area. Client stated he was feeling faint and dizzy, Prior to passing out. Nurses and EMT beside client. Client was assisted gradually to the floor with legs elevated. Client Vital signs 101/62 99% O2 HR 69. Dr educated patient to hydrate and to stay in observation area longer to be monitored. Client states he has a fear of needels and has experinced fainting after recieving a vaccine in the past. Client states he feels much better and no longer feeling faint.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1190384

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: -
Alter: 24,0
Geschlecht: M
Eingang: 10.04.2021
Impfdatum: 10.04.2021
Beginn: 10.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Dizziness Loss of consciousness

Symptomtext

Client recieved J&J vaccination and arrived at obseravtion area. Client stated he was feeling faint and dizzy, Prior to passing out. Nurses and EMT beside client. Client was assisted gradually to the floor with legs elevated. Client Vital signs 101/62 99% O2 HR 69. Dr educated patient to hydrate and to stay in observation area longer to be monitored. Client states he has a fear of needels and has experinced fainting after recieving a vaccine in the past. Client states he feels much better and no longer feeling faint.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1189961

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: NM
Alter: 63,0
Geschlecht: F
Eingang: 10.04.2021
Impfdatum: 07.04.2021
Beginn: 07.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Catatonia Chills Dizziness Eye movement disorder Headache Hypotension Loss of consciousness Muscle rigidity Nausea Vomiting

Symptomtext

Dizzy ,nausea ,complete loss of consciousness, catatonic, eyes rolled back , rigid total body ,extreme low blood pressure for over 1/2 hour Immediately at vaccine time ... 24 hours later chills , bad headache, nausea vomiting

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1189901

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: TX
Alter: 23,0
Geschlecht: M
Eingang: 10.04.2021
Impfdatum: 08.04.2021
Beginn: 08.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Syncope Vital signs measurement

Symptomtext

About 5 minutes after receiving the vaccine, patient felt dizzy and fainted but quickly regained consciousness. We had him lay flat on the floor and continued to monitor and have conversations with him. His vitals were confirmed to be normal by the EMS and patient declined to be transported to the hospital. He remained in the premises for about an hour for observation after which he had a friend drive him home.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1187061

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CA
Alter: 35,0
Geschlecht: M
Eingang: 10.04.2021
Impfdatum: 09.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blood glucose normal Cold sweat Dizziness Electrocardiogram normal Feeling abnormal Feeling cold Loss of consciousness Mydriasis Nausea Pallor Immediate post-injection reaction Presyncope Pupillary light reflex tests abnormal Syncope Unresponsive to stimuli

Symptomtext

I passed out in my vehicle right after the vaccine was administered. A nurse found me unconscious at the vehicle and called 911

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1187061

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CA
Alter: 35,0
Geschlecht: M
Eingang: 10.04.2021
Impfdatum: 09.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blood glucose normal Cold sweat Dizziness Electrocardiogram normal Feeling abnormal Feeling cold Loss of consciousness Mydriasis Nausea Pallor Immediate post-injection reaction Presyncope Pupillary light reflex tests abnormal Syncope Unresponsive to stimuli

Symptomtext

I passed out in my vehicle right after the vaccine was administered. A nurse found me unconscious at the vehicle and called 911

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1187755

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CO
Alter: 29,0
Geschlecht: M
Eingang: 09.04.2021
Impfdatum: 09.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Cardiac monitoring Dizziness Electrocardiogram Full blood count Metabolic function test Nausea Syncope

Symptomtext

Nausea, Lightheadedness and Syncope 5 minutes after receiving Janssen Covid Vaccine. Given epinephrine at the facility, transported to ER by ambulance. Pt discharged in stable condition after 3 hours of monitoring.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: EKG, CBC, CMP, cardiac monitoring
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: none
Allergien: no known allergies
Vorherige Impfungen: -

VAERS 1187359

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CA
Alter: 35,0
Geschlecht: M
Eingang: 09.04.2021
Impfdatum: 09.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Syncope

Symptomtext

Syncope (Vasovagal Response)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: Syncope

VAERS 1187087

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201a21a

schwer

Staat: OH
Alter: 19,0
Geschlecht: F
Eingang: 09.04.2021
Impfdatum: 09.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Blood glucose normal Immediate post-injection reaction Syncope

Symptomtext

Syncope immediately following vaccine Rapid recovwry

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: BS. 99
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Unknown
Andere Medikamente: Unknown
Allergien: Unknown
Vorherige Impfungen: -

VAERS 1186839

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: NV
Alter: 23,0
Geschlecht: M
Eingang: 09.04.2021
Impfdatum: 09.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Syncope

Symptomtext

Syncope

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: None
Vorherige Impfungen: -

VAERS 1186686

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: OH
Alter: 56,0
Geschlecht: M
Eingang: 09.04.2021
Impfdatum: 08.04.2021
Beginn: 08.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Asthenia Dizziness Drooling Hyperhidrosis Loss of consciousness Tachycardia Vital signs measurement

Symptomtext

Pt became dizzy and called for help. Upon arrival ambulance was called and pt was ALOC w/bilateral weakness slowly progressing and sweating profusely. Pt was A&O x 3 to self and location. Then patient seemed to have lost consciousness completely for about a minute. Pt was still breathing normally, and was tachycardic. Left sided drooling was present. By the time the ambulance arrived patient regained consciousness and strength. Pt stated this happened before when he had a root canal fixed. Stated he seems to have anxiety induced seizures. Pt VS were taken by EMTs and where stable, Pt refused to go to the hospital. He called his wife to pick him up and pt was monitored until she arrived.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: Vital signs were taken by EMT Pt refused to go to the hospital
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: Zinc, Vitmain D, Unisom
Allergien: none
Vorherige Impfungen: -

VAERS 1185450

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: IL
Alter: 28,0
Geschlecht: F
Eingang: 09.04.2021
Impfdatum: 09.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Fall Seizure

Symptomtext

Patient with previous hx of seizure disorder started convulsing within 10 minutes of vaccination, fell to the ground and convulsed for approximately 7 minutes. Convulsions reduced significantly and patient was coherent without post-ictal state. EMS was called and she was taken to nearby hospital for further evaluation. Patient had reportedly taken ativan and depakote this morning prior to arrival.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: "anxiety seizures"
Vorgeschichte: N/A
Andere Medikamente: Depakote, ativan, valtrex
Allergien: neosporin, sunscreen
Vorherige Impfungen: -

VAERS 1184402

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: GA
Alter: 33,0
Geschlecht: F
Eingang: 09.04.2021
Impfdatum: 07.04.2021
Beginn: 07.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Injection site pain Seizure like phenomena

Symptomtext

After vaccination, patient had seizure-like activity lasting approximately 5 seconds. After seizing activity ended, patient complained of dizziness and pain in the vaccinated arm. Patient remained at the fairgrounds with her husband (who was also vaccinated) for approximately 2 hours after episode. Patient was driven home by her husband.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure like phenomena
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: unknown
Vorgeschichte: unknown
Andere Medikamente: unknown
Allergien: no known allergies
Vorherige Impfungen: -

VAERS 1181457

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: GA
Alter: 34,0
Geschlecht: M
Eingang: 09.04.2021
Impfdatum: 07.04.2021
Beginn: 07.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Back pain Blood glucose normal Dizziness Electrocardiogram normal Loss of consciousness Balance disorder Dyskinesia Fatigue Hyperhidrosis Pallor

Symptomtext

After vaccination, patient appeared to be slouched over in chair in observation area. Two bystanders approached him and held him to prevent him from falling from his chair. Patient was diaphoretic and eyes half-closed. Attempt was made to arouse patient by talking to him and rubbing chest. His head and body moved erratically for approx. 3 seconds. Patient was lowered to the floor. Nurse continued speaking to patient and rubbing his chest. He then opened his eyes and was startled. Patient abruptly sat up and said, ?what happened and where is my phone?? The nurse reassured him he was being taken care of and she asked if he knew where he was? Patient replied, ?I have no idea.? A paramedic approached and asked the patient if he knew his name. The patient correctly replied. The patient had no recollection of what had taken place, but did know where he was. Patient was then evaluated by the paramedics. All tests performed were normal and patient refused to be transported to hospital. Patient was driven home by his wife. Follow up phone call to patient yesterday evening with no answer. Follow up phone call to wife (listed as emergency contact), 4/7 at approx. 6 pm. Per wife, patient experiencing fatigue and still very pale. She said he just wasn?t himself. Patient was concerned that they did not know what to expect a week or two from now. I advised patient that if she had concerns, she needed to have patient evaluated in ER.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: evaluated by paramedic and all tests normal
Aktuelle Erkrankungen: unknown
Vorgeschichte: unknown
Andere Medikamente: unknown
Allergien: no
Vorherige Impfungen: -

VAERS 1181457

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge 201A21A

schwer

Staat: GA
Alter: 34,0
Geschlecht: M
Eingang: 09.04.2021
Impfdatum: 07.04.2021
Beginn: 07.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Back pain Blood glucose normal Dizziness Electrocardiogram normal Loss of consciousness Balance disorder Dyskinesia Fatigue Hyperhidrosis Pallor

Symptomtext

After vaccination, patient appeared to be slouched over in chair in observation area. Two bystanders approached him and held him to prevent him from falling from his chair. Patient was diaphoretic and eyes half-closed. Attempt was made to arouse patient by talking to him and rubbing chest. His head and body moved erratically for approx. 3 seconds. Patient was lowered to the floor. Nurse continued speaking to patient and rubbing his chest. He then opened his eyes and was startled. Patient abruptly sat up and said, ?what happened and where is my phone?? The nurse reassured him he was being taken care of and she asked if he knew where he was? Patient replied, ?I have no idea.? A paramedic approached and asked the patient if he knew his name. The patient correctly replied. The patient had no recollection of what had taken place, but did know where he was. Patient was then evaluated by the paramedics. All tests performed were normal and patient refused to be transported to hospital. Patient was driven home by his wife. Follow up phone call to patient yesterday evening with no answer. Follow up phone call to wife (listed as emergency contact), 4/7 at approx. 6 pm. Per wife, patient experiencing fatigue and still very pale. She said he just wasn?t himself. Patient was concerned that they did not know what to expect a week or two from now. I advised patient that if she had concerns, she needed to have patient evaluated in ER.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: evaluated by paramedic and all tests normal
Aktuelle Erkrankungen: unknown
Vorgeschichte: unknown
Andere Medikamente: unknown
Allergien: no
Vorherige Impfungen: -

VAERS 1182049

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: TX
Alter: 24,0
Geschlecht: F
Eingang: 08.04.2021
Impfdatum: 08.04.2021
Beginn: 08.04.2021
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Fall Head injury Seizure

Symptomtext

PATIENT HAD A SEIZURE AND FELL. SHE DID HIT HER HEAD. FALL WAS NOT WITNESSED BY THE RESPONDERS. VITAL SIGNS WERE TAKEN: BP 142/88, PULSE 98, O2 SATS 100%, RESPIRATIONS 20, BLOOD SUGAR LEVEL 84. HELPED PATIENT TO WHEELCHAIR AND SECURED HER TO THE FIRST AID AREA. AMBULANCE WAS CALLED AND SHE WAS TRANSPORTED TO THE ER.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: NONE
Vorgeschichte: SEIZURES
Andere Medikamente: NONE
Allergien: NONE
Vorherige Impfungen: -

VAERS 1182034

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: UT
Alter: 36,0
Geschlecht: F
Eingang: 08.04.2021
Impfdatum: 08.04.2021
Beginn: 08.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Emotional distress Loss of consciousness Muscle spasms Nausea

Symptomtext

Pt was give vaccine and was not nervous or anxious. About 1 to 2 minutes after receiving the shot pt passed out for about 20 seconds. The technician held the pt up and supported her head and neck while asking pt if she was OK. When pt came to she was happy and said "hi" to the technician. Soon after she laid on the floor and started crying and saying her hands were cramping and in pain. She also stated she was very nauseous and felt like she was going to throw up. Pts husband agreed that we should call an ambulance which we did. When paramedics arrived pt was feeling better and refused a ride to the ER. Pt's husband took her to the car and drove her to the ER.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: unknown
Aktuelle Erkrankungen: No illnesses
Vorgeschichte: None
Andere Medikamente: Not known
Allergien: None reported by pt.
Vorherige Impfungen: -

VAERS 1181626

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge 201A21A

schwer

Staat: OH
Alter: 35,0
Geschlecht: F
Eingang: 08.04.2021
Impfdatum: 08.04.2021
Beginn: 08.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Abdominal pain upper Loss of consciousness Tremor

Symptomtext

Stomach cramps, blacking out, shaking, seizure like activity

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1180221

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201a21a

schwer

Staat: GA
Alter: 33,0
Geschlecht: F
Eingang: 08.04.2021
Impfdatum: 07.04.2021
Beginn: 07.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Dizziness Seizure Vaccination site pain

Symptomtext

Pt had seizure lasting approx 5 seconds. After seizure pt complained of continued dizziness and pain in the arm that vaccine was given. she remained at vaccine site for an hour or more with her husband , then they left together.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: UNKNOWN
Vorgeschichte: UNKNOWN
Andere Medikamente: UNKNOWN
Allergien: UNKNOWN
Vorherige Impfungen: -

VAERS 1179042

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CO
Alter: 37,0
Geschlecht: M
Eingang: 08.04.2021
Impfdatum: 07.04.2021
Beginn: 07.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Loss of consciousness Syncope Tinnitus

Symptomtext

within in minutes of the vaccine and while driving to the rest area almost fainted, started to black out, dizziness an hollow hearing/tinitus. Lasted for 10 mins and gradually subsided over 20 minutes

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1177738

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: CA
Alter: 38,0
Geschlecht: M
Eingang: 07.04.2021
Impfdatum: 06.04.2021
Beginn: 07.04.2021
Tage bis Beginn: 1,0
Dosis: UNK
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Chills Fall Haemorrhage Headache Hypotension Loss of consciousness Myalgia Nausea Oropharyngeal pain Vomiting

Symptomtext

Mild side effects in the hours after the injection (headache, sore throat, muscle aches, chills). Mild enough to not need any medications. At 1:30am, I woke up needing to urinate. I went into the bathroom and lost consciousness, finding myself with one hand in the toilet and one on the side. I felt nauseous and thought I would vomit, but didn't and believe I lost consciousness again. I was able to make it to the sink to try to wash my hands, and I fell down on my knees. I knew I was bleeding somewhere but didn't know from where (my right pinky was cut on an item in the bathroom when I fell). My wife made it to me, and I lost consciousness a couple more times while talking with her. I laid on the bathroom floor for a

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: Blood pressure was low (at times 100-110/60-65). The EMTs said it dropped more when I stood up. O2 was 98%. All conducted around 3am on 4/7/21.
Aktuelle Erkrankungen: N/A
Vorgeschichte: Depression/anxiety
Andere Medikamente: Zoloft (75mg), OTC multivitamin, probiotic, melatonin, cetiriz
Allergien: Penicillin, gluten
Vorherige Impfungen: -

VAERS 1172326

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: UT
Alter: 23,0
Geschlecht: M
Eingang: 06.04.2021
Impfdatum: 06.04.2021
Beginn: 06.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Loss of consciousness Muscle twitching

Symptomtext

Patient passed out shortly after receiving the vaccine. He lost consciousness for a minute and seemed to be twitching in his eyes and his mouth. He regained consciousness after a few minutes and we monitored him for 30+ minutes. We referred him to urgent care to be monitored further.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: No medications
Allergien: No drug allergies
Vorherige Impfungen: -

VAERS 1172270

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

schwer

Staat: TX
Alter: 59,0
Geschlecht: F
Eingang: 06.04.2021
Impfdatum: 06.04.2021
Beginn: 06.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Arthralgia Blood glucose normal Dry skin Pain Pain in jaw Skin warm Syncope

Symptomtext

Patient syncopal episode that occurred 15 minutes post vaccination. Staff arrived, put patient recumbent position, vital signs taken. BP 80/40, pulse 68, 12 Respirations per min, O2 sat 96%. Patient arousable after 2 minutes. Complained of R jaw pain w/ radiation to R shoulder. Skin warm and dry, PERRLA. Neuro checks assessed, within normal limits. EMS called immediately., arrived to the scene at 11:55. BP 135/83, O2 sat 98%, NSR @ 78, respirations 14 per min. ALert, oriented X3. Transported to ER.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: Blood Sugar 74 per EMS.
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Unknown
Andere Medikamente: none
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2727682

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: CA
Alter: 25,0
Geschlecht: M
Eingang: 27.12.2023
Impfdatum: 24.08.2021
Beginn: 20.09.2021
Tage bis Beginn: 27,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Angina pectoris Chest pain

Symptomtext

Sharp pains around the heart and upper left chest area. I started to feel them every other week to weekly.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Essential Tremor
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 2689715

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: TX
Alter: 72,0
Geschlecht: F
Eingang: 03.10.2023
Impfdatum: 17.05.2021
Beginn: 12.12.2021
Tage bis Beginn: 209,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Asthenia Chest X-ray abnormal Dyspnoea Pulmonary congestion Total lung capacity decreased

Symptomtext

Presented with weakness/SOB x3 days; CXR: "low lung volumes with central congestion"; no inflammation lab values drawn; placed on supplemental oxygen, zinc and steroids. He was initiated on remdesivir by Dr. He tolerated this very well and was able to wean quickly to room air

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: 3,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2689705

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: TX
Alter: 65,0
Geschlecht: M
Eingang: 03.10.2023
Impfdatum: 03.05.2021
Beginn: 28.12.2021
Tage bis Beginn: 239,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Anticoagulant therapy Atrial fibrillation COVID-19 pneumonia Cardiomegaly Chest X-ray abnormal Computerised tomogram thorax normal Cough Dizziness Fatigue Incentive spirometry Legionella test Lung infiltration Nausea Oxygen saturation decreased Prone position Streptococcus test negative Walking distance test abnormal

Symptomtext

Presented with afib with RVR, cough, dizziness, nausea, fatigue; CXR: bilat infiltrates: Dx Covid PNA, afib; TX- Remdesivir, Vit C, Rocephin, Vit D3, Decadron, Lovenox, Singulair, Zinc, Baricitinib; significant improvement and down to 4 L of NC O2 satting in the low 90s -CXR on admission showed bilateral infiltrates with cardiomegaly. CTPE negative for PE -strep pneumo and Legionella negative -continue self proning and incentive spirometer use -completed remdesivir course. S/p 7 doses of baricitinib, -Patient was also treated with Solu-Medrol, vitamin-C, vitamin-D, zinc, Singulair and Flonase -s/p treatment with doxycycline and Rocephin for initial suspicion for superimposed bacterial PNA Walk test was done and patient required 1-2L of O2 with rest and 3L of NC O2 with exertion.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19 pneumonia
Hospital-Tage: 10,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2661542

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: TX
Alter: 64,0
Geschlecht: M
Eingang: 27.07.2023
Impfdatum: 20.05.2021
Beginn: 14.01.2022
Tage bis Beginn: 239,0
Dosis: 1
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Dyspnoea Respiratory failure

Symptomtext

Came in with chief complaint of shortness of breath cough was diagnosed with respiratory failure secondary to COVID-19. Tx w/remdesivir, abx, steroids, zinc, O2;

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: 11,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2644281

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: AZ
Alter: 59,0
Geschlecht: M
Eingang: 12.06.2023
Impfdatum: 21.07.2021
Beginn: 24.07.2021
Tage bis Beginn: 3,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Hypertension

Symptomtext

high blood pressure

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hypertension
Hospital-Tage: 3,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Cancer
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2595088

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: CA
Alter: 51,0
Geschlecht: M
Eingang: 11.03.2023
Impfdatum: 08.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cardiac flutter Dizziness Dyspnoea

Symptomtext

Heart fluttering and shortness of breath with slight dizziness. Started the day after the shot. Every few hours for the 1st month, then once a day for about 3 months, then about 3 times a week since then.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: No testing.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: Sulpha based antbiotic.
Vorherige Impfungen: -

VAERS 2533133

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: IL
Alter: 32,0
Geschlecht: F
Eingang: 15.12.2022
Impfdatum: 12.04.2021
Beginn: 16.04.2021
Tage bis Beginn: 4,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Asthenia Balance disorder Blood test Computerised tomogram head Dizziness Dyspnoea Echocardiogram Electromyogram Head discomfort Hypoaesthesia Magnetic resonance imaging head Magnetic resonance imaging neck Palpitations

Symptomtext

4 days after the vaccine, intense non-stop lightheaded and dizziness began. A couple days later, left side head pressure began, left side numbness/weakness began. Began feeling off-balance. Months later it became difficult to get a good deep breath, and lately have begun feeling heart palpitations.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: Head CT scan (April 2021), brain MRI (July 2021), blood work, nerve testing (emg/ncv November 2021), echocardiogram (December 2021), MRI cervical spine (August 2022).
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 2497231

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: MD
Alter: 40,0
Geschlecht: M
Eingang: 02.11.2022
Impfdatum: 10.04.2021
Beginn: 10.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: unbekannt Erholt: nein

Angiogram Antibody test Asphyxia Blood test Borrelia test Botulinum toxin injection COVID-19 Cardiac monitoring Computerised tomogram head Computerised tomogram neck Confusional state Diplopia Dysphagia Ear pain Echocardiogram Facial pain Fatigue Lumbar puncture

Symptomtext

This field does not give me the space to add all of this info. Migraines, facial pain, strangulation feeling, swallowing trouble, tinittus, inner ear pain, confusion, double vision, fatigued. 2/2/21 POSITIVE for Covid (1st) Amoxi/Clav 5 day treatment began for possible sinus infection, Amoxi/Clav, Sudafed, motrin, Benadryl to sleep, sertraline 3/5/21 Meds- Began ivermentin treatment, Zinc, D3, Sertraline 3/8/21 3/12/21 Meds- Began methylprednisone 4mg dosepack, felt SO much worse once completed 3/22/21 Azithomycin 250 5 days 3/23/21 Meds- Began z-pack 250 mg 5 days, Imitrex 50 mg for migraine attack Sumaptriptan 25mg 3/23/21 Bloodwork 3/26/21 Radiology CT of Head w/o contrast 4/2/21 Neurologist Prednisone 20mg (didn?t take) 4/5/21 4/5/21 Thyroid Test 4/8/21 MD Cardiologist 4/8/21 MD Cardiologist CRNP B2 and Magnesium 4/10/21 Covid Vaccine 4/14/21 MRI of Brain with and w/o contrast 4/21/21 Cardiologist Zio Monitor 4/23/21 Cardiologist 4/29/21 MD Cardiologist Car Echo 2d 4/29/21 Prescribed Meds- Topomax, Naproxen, Imitrex 4/29/21 Cardiologist 5/7/21 5/10/21 Cardiologist 5/11/21 Cardiologist Myocardial Perfusion 5/15/21 MD ER 5/15/21 Meds- Started Pepcid & Prilosec 5/18/21 Intake questionnaire 6/2/21 Neurologist 6/3/21 Cardiologist CT Angiography 6/4/21 Neurologist 6/11/21 Post covid Clinic Post Covid Clinic 6/11/21 Neurologist 6/19/21 Ivermectin 6/23/21 6/24/21 CT with contrast of neck 6/24/21 Internal Medicine 7/8/21 7/12/21 Internal Medicine 7/14/21 Post covid Clinic Neuro Radiology 7/16/21 Post covid Clinic Physical Medicine Post Covid Clinic 7/20/21 Bloodwork Hormone labs & lyme 7/23/21 Neurologist Lumbar Puncture 7/28/21 Headache Clinic Neurologist acetaZOLAMIDE ? dihydroergotamine ? prochlorperazine 7/28/21 Headache Clinic Physc eval before intake 7/29/21 Nuro ophthalmologist 7/29/21 8/12/2021 - 8/14/21 Headache Clinic Inpatient 8/23/21 8/27/21 Post covid Clinic Rehabilitation Medicine 8/28/21 MRI of orbits 9/1/21 Nuro ophthalmologist 9/4/21 ER 9/9/21 Vascular Surgeon 9/10/21 Neurologist 9/13/21 Nuro ophthalmologist Miri MRI Venogram 9/23/21 10/11/21 Nuro ophthalmologist 10/12/21 Post covid Clinic Vascular Neurologist 11/5/21 Post covid Clinic Rehabilitation Medicine 1/10/22 Fioricet refill request 1/10/22 Bloodwork Antibody test 1/14/22 Post covid Clinic Rehabilitation Medicine 1/12/22 Internal Medicine 1/14/22 POSITIVE for Covid (2nd) 3/8/22 Rheumatologist Bloodwork 3/21/22 Bloodwork 3/25/22 Mamo 3/30/22 NP Hormone Pelleted (1st) 125 testosterone, DIM SGS, ADK, Methly factors 4/8/22 Mamo 4/12/22 Neurologist Neurology Engality (haven?t tried) 4/14/22 GYN 4/20/22 Nuro ophthalmologist 4/22/22 NP Hormone NP Thyroid (began) 5/12/22 Rheumatologist Followup 5/31/22 Bloodwork 6/14/22 NP Hormone Pelleted (2nd) 125 testosterone 7/1/22 Bloodwork 7/20/22 Nuro ophthalmologist Botox for migraines Botox 8/25/22 NP Hormone Pelleted (3rd) 150 testosterone 9/5/22 9/10/22 9/13/22 9/14/22 Bloodwork 9/16/22 9/20/22 GYN Annual Testosterone cream & Estrogen cream 10/25/2022

Weitere VAERSDATA-Felder

Praegender Schweregrund: Migraine
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: I was diagnosed with Covid 2/2/21. I had extreme headaches that would not subside. I was told that getting vaccinated would help with these symptoms.
Vorgeschichte: I had become increasing sicker after the vaccine and have neurological damage. I have had 94 documented doctor appointments since then and have been prescribed over 40 different medications to try and combat my symptoms. To this day I am still suffering with no relief.
Andere Medikamente: Sertraline 50mg
Allergien: n/a
Vorherige Impfungen: -

VAERS 2493767

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: -
Alter: 59,0
Geschlecht: M
Eingang: 26.10.2022
Impfdatum: 11.06.2021
Beginn: 03.05.2022
Tage bis Beginn: 326,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Hyperhidrosis Hypotension

Symptomtext

Narrative: The patient developed diaphoresis and hypotension within 5 min of administration of J&J COVID vaccine. He was given 12.5 mg diphenhydramine. No difficulty breathing, itching/hives or pain. He improved after monitoring.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hypotension
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2438751

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: TX
Alter: 38,0
Geschlecht: F
Eingang: 10.09.2022
Impfdatum: 18.05.2021
Beginn: 03.06.2021
Tage bis Beginn: 16,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: unbekannt Erholt: nein

Computerised tomogram head Computerised tomogram spine Constipation Gait disturbance Lumbar puncture Magnetic resonance imaging Mobility decreased Myelitis transverse Paraesthesia Urinary incontinence Walking aid user X-ray

Symptomtext

On June 3, 2021 tingling began in right buttocks. Within two hours tingling increased and began spreading up to right hip area and down right leg to right foot. Began having issues walking with a normal gait and right foot started to drag. Symptoms increasingly progressed within 6 hours and had to use a wall to brace walking in building. Outside walking gait was abnormal and struggled to move right leg and right foot. Went to clinic and was sent to get x-rays. Within 12 hours of onset of symptoms, began using crutches to get around. Called clinic on June 4, June 5, June 7, and June 8, 2021 and clinic received x-rays but had not viewed x-rays yet. Went to the emergency room with assistance from co-worker as symptoms were still present and not improving. Over that weekend loss of bladder control started, and had not had a bowel movement since June 5, 2021. Was admitted to the hospital, received CT Scan of Head, T-Spine, and L-Spine on June 8, 2021. MRI done on June 8, 2021. Lumbar puncture attempted bedside on June 9, 2021 with no success. Sent to get Lumbar puncture done on June 10, 2021. Was given medication on June 10, to assist with bowel movement; no bowel movement since June 5, 2021. Loss of bladder control continued. Was given Steroids to assist with improving ability to walk starting on June 10, 2021. Was discharged on June 13, 2021 with plan to have in-home physical therapy. Began outpatient physical therapy at the hospital by the end of June 2021. Continued monitoring with MRI scans and Neurology.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mobility decreased
Hospital-Tage: 6,0
Labordaten: CT Scan - Head, T-Spine, L-Spine June 8, 2021 MRI - June 8, 2021 Lumbar Puncture - June 9 (failed attempt at bedside) Lumbar Puncture - June 10 Diagnosis - Transverse Myelitis
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Sumatritptan for migraines (prescription) Tension headache (over-the-counter
Allergien: None
Vorherige Impfungen: -

VAERS 2431074

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: GA
Alter: 46,0
Geschlecht: M
Eingang: 07.09.2022
Impfdatum: 10.09.2021
Beginn: 01.09.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: unbekannt Erholt: nein

Cerebral atrophy Cognitive disorder Communication disorder Concussion Dysarthria Fall Hypoacusis Magnetic resonance imaging head abnormal Memory impairment Mobility decreased Neurological symptom Scan with contrast abnormal Visual impairment

Symptomtext

Within days of this shot I experienced stroked like symptoms and had to have an MRI. Itook a hard fall inside our home and suffered a bad concussion. My speech was slurred, he could not put a sentence together. Before getting this shot we had both had COVID-19 and it did hit us both pretty hard. Since I have had this shot my cognitive abilities have slowly declined and they have n explanations. My short term memory, my speech, my vision, and my hearing have all declined. They have declined to a point to where some days I do not leave our bedroom. I have trouble recalling conversations or events that may have happened just a few hours earlier. I have seen two Neurologist and a Neurosurgeon- One MRI stated brain Atrophy in a July 2022 MRI

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mobility decreased
Hospital-Tage: -
Labordaten: MRI with and without contrast - July 2022 MRI with and without contrast - September 2021
Aktuelle Erkrankungen: None
Vorgeschichte: PTSD Depression
Andere Medikamente: Lexapro Buspiron Pantropzilon
Allergien: None
Vorherige Impfungen: -

VAERS 2428614

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: IL
Alter: 54,0
Geschlecht: F
Eingang: 03.09.2022
Impfdatum: 06.05.2021
Beginn: 07.05.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: unbekannt Erholt: nein

Abdominal distension Condition aggravated Dyspnoea Exercise tolerance decreased Fatigue Hypophagia Immunisation reaction Insomnia Joint swelling Obesity Oedema Oedema peripheral Pain Pyrexia Quality of life decreased Restlessness Swelling Weight increased

Symptomtext

Immediately within 24 hours of the vaccine on 05-06-2021, significant increase in Chronic Pain everywhere, all Edema/Swelling increased, I felt like I had a fever, but temperature was normal. Sudden increase in weight, while eating less, drinking more water, gained 15# in 6 weeks, by 6/30/2021, Additional weight gain another 15# by 08/31/2021. Increase in weight from 175# to 205#, considered severely obese at present. Increased, chronic pain, increased swelling in the joints. Difficulty sleeping, increased SOB, walking reduced from one mile to 3 blocks. Difficulty resting due to increase of Chronic pain conditions.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: Saw Rheumatologist before end of June, 2021 for sudden increase in Chronic Pain. I saw my allergist in June 2021 for increased SOB, and I saw PCP for increase in chronic pain and swelling, unusual weight gain on multiple occasions starting in June 2021. I was then told this was an adverse reaction to the Vaccine by the Allergist, unknown how long this would effect me and my health. Fatigue has increased, sleeplessness has increased, quality of life has diminished. Weight has been steady at 205# never went down the 30# gained and increased abdominal swelling, leg edema increased.
Aktuelle Erkrankungen: Chronic Fatigue, Depression, Anxiety, Arthritis, Asthma, many food Allergies, multiple chemical sensitivities. Active Procedures for Multiple Skin removals Suspicious Growth monthly 03-2020 until 4-30-2021. Then discontinue for at least 3 months after Adverse Reaction.
Vorgeschichte: Fibromyalgia, CFS, Reflex Sympathetic Dystropy, IBS, Sibo, GERD, Anxiety, PTSD, Multiple Allergies and Chemical Sensitivities, Asthma, Arthritis, Lymphedema of Groin, upper thighs, Unknown Leg Edema, Melanoma and pre-cancerous Melanoma.
Andere Medikamente: Azelastine 137mcg (0.1%) spray, Biotin 5000mcg, Vitamin D3 5000IU, Cytomel 5mcg, Epinephrine 0.3mg/0.3mL pen injector, as needed, Guaifenesin 600mg SR CPD Dye Free, Lasix 40mg, Potassium Chloride 20mEQ, Levocetirizine 5mg, Lutein10mg-Zeaxa
Allergien: Latex, Peanut, Aloe Vera, all nuts, basil, carrot, cephalexin, Coconut derivates, coconut oil, Cinnamon, Cumin, Dicyclomine, Divalproex, Duloxetine, Erythromycin, Fish Derived, Flutcasone, Gabapentin, Ginger, Garlic, Green Pepper, Goat's Milk, Lemon, Citrus, Lexapro, Medroxyprogesterone, Mold, Oats, Orange, Other Omega 3's, Paprika, Paraxetine HCI, Parsley, peas, prednisolone, Prickly Lettuce, Prozac, Risperidone, Salmon Lb-1668, Scythian Lamb, Sesame Oil, Shellfish Derived, Silcone, Soybean, Spinach, Tomato, Tramadol Hcl, Tuna Oil, Turkey, Chicken, Egg yolks, Vanilla Extract, Wheat, Barley, Rye, Yeast Cell-Shark, Apple, Cherry, Famotidine, Levaquin, Lyrica, Ultram, Zantac, Celebrex, Coconut-Asthma, Lithium, Lamotrigine, Sol-Medrol, Amoxicillin-Pot Clavulanate, azithromycin, Spandex, Blue Dye in all meds, Blueberry, Buckwheat, Wellbutrin. Some are due to Blue Dye in Medications.
Vorherige Impfungen: Flu Vaccines last was fall of 2020, Egg Free and Non egg free Flu Vaccines given for years. I am always sick for one month or mo

VAERS 2417725

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: CA
Alter: 50,0
Geschlecht: F
Eingang: 22.08.2022
Impfdatum: 20.08.2021
Beginn: 01.10.2021
Tage bis Beginn: 42,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Arthralgia Blood albumin decreased Blood immunoglobulin G Blood iron decreased Blood test Blood uric acid Burning sensation C-reactive protein increased Carbon dioxide increased Complement factor C4 Computerised tomogram neck Computerised tomogram pelvis abnormal Computerised tomogram thorax abnormal Dizziness Eosinophil count increased Epstein-Barr virus antibody negative Epstein-Barr virus antibody positive Erythema nodosum

Symptomtext

About 1 1/2 months after my vaccine, I started having a severe headache just over my left eye. The area of pain never moved. About three weeks after that, I still had the headache but also started having a racing heart and palpitations. I went in to an urgent care clinic on November 24, 2021 and it showed my labs were off. My primary care doctor received a copy of my labs and then messaged me and told me to go to the ER if I experienced any problems with dizziness, lethargy. The doctor gave me a referral to a hematologist and rheumatologist. I saw the hematologist on 12-28 and at that time I had burning and very swollen hands and feet with my hands being white and stiff, especially at night. I also had small tender nodules with rash on my lower legs. He ordered CT scan of my chest, neck, abdomen and pelvis as well as ordering labs. He diagnosed me as having erythema nodosum on lower legs. On 1-7-2022 I went to the rheumatologist and she said said it was possible that I was having some kind of post viral hyperactive immune response. She said I needed further workup for Sarcoidosis or other auto immune disease. She ordered bloodwork. I had a telehealth visit with the hematologist on 1-28-2022. He had me take oral iron but I could not tolerate it well so i was given the iron by IV. On April 18, 2022 I went to the local ER with continued burning and pain at joints in ankles, feet and hands and a headache. They prescribed gabapentin but I did not ever start taking that. I did have blood drawn. They suggested neurology on an outpatient basis. I still suffer from headaches, insomnia, burning pain at my joints in my hands, ankles, feet and wrist. I am still having labs drawn periodically due to continued high levels of inflammation markers.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Palpitations
Hospital-Tage: -
Labordaten: November 24, 2021 - labwork - Platelets 126; Lymphocytes 0.8; December 16, 2021 - labwork - WBC 12.3, RBC 3.6; hemoglobin10.2; hematocrit 31.7; neutrophils 10.4; lymphocytes 0.8; monocytes 1.0; Platelets 258, Iron 20; Iron binding 233; Iron Saturation 9; December 20, 2021 Epstein Barr antibody panel EBVABIGM negative; VCAIGG positive; EAIGG positive; EBVNAIGG positive; 12-28-2021 Hemoglobin 11.0; Platelets 483; Neutrophils 8.4; MCHC 30.2; Albumin 2.8; CO2 35%; 1-5-2022 CReactive protein 42.9. 1-6-2022 Hemoglobin 10.8 Red Blood Cells 3.89; MCHC 30.8; Absolute Monocytes 1.2; Absolute Eosinophils 1.0; 1-10-2022 CT neck chest abdomen pelvis indeterminate lesions in the liver, small pericardial effusion, mild to moderate retroperitoneal adenopathy, indeterminate pulmonary nodules.1-11-2022 SARS Covid 2 Antibody reactive 10.26; IGG4 257.6; Lupus panel showed C4 Compliment 40;C-reactive protein 59.8; RBC 3.6; Hemoglobin 9.9; Hematocrit 32.5; MCHC30.5; Absolute Monocytes 1.1; Eosinophils 0.7; 2-16-2022 IGG4 256.2; Vitamin D125 at 93; MCHC 30.1; 4-18-2022 bloodwork at ER - SED Rate 46; CReactive protein 95; IGG4 207; Lymphocytes 0.8; Monocytes 1.3; Albumin 3.1; Uric Acid 2.4
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: Amoxycillin
Vorherige Impfungen: -

VAERS 2394876

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: MI
Alter: 62,0
Geschlecht: M
Eingang: 28.07.2022
Impfdatum: 08.04.2021
Beginn: 23.01.2022
Tage bis Beginn: 290,0
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Arthritis COVID-19 Cardiac failure Condition aggravated Conjunctivitis Diverticulitis General physical health deterioration Hallucination Nightmare Pharyngitis streptococcal Upper respiratory tract infection

Symptomtext

recipient of vaccine reports decline in health starting end of January 2022 lasting for eight weeks. Recipient was diagnosed with COVID 19 in January after receiving vaccine in April 2021. recipient reports onset of upper respiratory infections, heart failure, exacerbation of arthritis, diverticulitis, strep related infections, conjunctivitis, hallucinations and nightmares

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: hypertension over weight
Andere Medikamente: hydrocodone Blood pressure medications diclofenac sodium
Allergien: bees codeine penicillin
Vorherige Impfungen: exacerbation of arthritis following Hep A vaccine on 8/6/2018

VAERS 2268928

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201a21a

moderat

Staat: IL
Alter: 69,0
Geschlecht: F
Eingang: 10.05.2022
Impfdatum: 08.04.2021
Beginn: 09.05.2022
Tage bis Beginn: 396,0
Dosis: 1
Route/Site: SYR / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Chest pain Cough Dyspnoea

Symptomtext

Patient presents to ER with SOB, chest pain and cough. Patient has a hx of MI and stent.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: 2,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2265938

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: TX
Alter: 38,0
Geschlecht: F
Eingang: 06.05.2022
Impfdatum: 05.04.2021
Beginn: 08.08.2021
Tage bis Beginn: 125,0
Dosis: 1
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Electrocardiogram abnormal Heart rate increased Postural orthostatic tachycardia syndrome Raynaud's phenomenon Tachycardia

Symptomtext

I began experiencing fast heart rate when standing. The symptoms were exacerbated by heat, so I had to stop going to the sauna. I also started experiencing Raynaud's phenomenon in three fingers on my right hand, when exposed to colder temperatures. In the fall of 2021, my tachycardia symptoms worsened and I was sent to the emergency room and given saline (which improved my symptoms). I was referred to a cardiologist and finally diagnosed with Postural Orthostatic Tachycardia Syndrome in February of 2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Postural orthostatic tachycardia syndrome
Hospital-Tage: -
Labordaten: My heart rate was monitored on an EKG and data related to heart rate while laying, sitting, and standing led to diagnosis of POTS.
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2220982

UNKNOWN MANUFACTURER · COVID19 (COVID19 (UNKNOWN)) · Charge 201A21A

moderat

Staat: CO
Alter: 31,0
Geschlecht: M
Eingang: 07.04.2022
Impfdatum: 14.05.2021
Beginn: 14.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Ear discomfort Fibrin D dimer normal Head discomfort Hypoaesthesia Injection site hypoaesthesia Paraesthesia

Symptomtext

Patient has numbness at injection site and scapular area. Symptoms are intermittent and are specifically in the sub scapular area. Patient reports feeling pins and needles primarily on the left side in the left arm and left leg. Patient has numbness in arm that radiates down into fingers and leg. Patient reports numbness from shoulder to the elbow. 5 days after the vaccine, a Telehealth doctor sent him to the ER. Patient reported that the ER drew a D-dimer test, which came back normal. reported to ER where blood was drawn, D-dimer was drawn which was normal. Patient also reports feeling a pressure in the left lobe of the brain and intermittent fullness in the left ear. The patient's symptoms have never fully gone away. The symptoms remain at 50% and are intermittent. The patient never had these symptoms prior to the shot.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2217933

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: -
Alter: 68,0
Geschlecht: M
Eingang: 05.04.2022
Impfdatum: 23.07.2021
Beginn: 10.01.2022
Tage bis Beginn: 171,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

COVID-19 Cough Dizziness Dyspnoea Nausea SARS-CoV-2 test positive Vomiting

Symptomtext

Narrative: 67 Y/O MALE PRESENTED TO ER ON 1/10/22 FOR WORSENING COUGH AND SOB AFTER ONE WEEK OF SYMPTOMS. TESTED POSITIVE FOR COVID 3 DAYS PRIOR. ALSO EXPERIENCING NAUSEA, VOMITING AND LIGHTHEADEDNESS. TREATED WITH IV REMDESIVIR (1/10-01-15), AND DEXAMETHASONE 01/10-01/17/2022. DISCHARGED ON 1/18/22 ON PREDNISONE DAILY X 5 DAYS. PMH INCLUDES HCV, OPIOD DEPENDENCE, COPD AND VITAMIN D DEFICIENCY.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: COVID TEST POSITVE 1/10/22
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2216668

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: CA
Alter: 31,0
Geschlecht: F
Eingang: 05.04.2022
Impfdatum: 16.08.2021
Beginn: 16.08.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Abdominal distension Bedridden Chest pain Chills Condition aggravated Constipation Exercise tolerance decreased Gastrointestinal disorder Immediate post-injection reaction Impaired work ability Inflammation Injection site erythema Injection site swelling Insomnia Irritable bowel syndrome Laboratory test Malaise Menstrual disorder

Symptomtext

immediately after injection I experienced redness and swelling at injection site, fever, chills and body aches. Was advised by medical staff at testing site to wait for 30 minutes to be observed. Was cleared by staff to go home, I was too sick to return back to work. I went home and took medication for inflammation, fever & chills and was bedridden for 3 days with a temperature of 100 degrees F and chronic fever/chills. Day 3 I finally felt better and was able to get back to work. Within the following months I have experienced a change in my menstral cycles, late periods. Sharp Chest pain upon exertion, lower exercise capacity and insomnia. I also, have a history of GI issues (IBS, abdominal bloating, constipation) which have gotten worse since.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: Lab work up only ordered by my PCP. 2/24/22
Aktuelle Erkrankungen: see below
Vorgeschichte: GI issues, IBS, constipation, bloating
Andere Medikamente: multivitamin
Allergien: milk
Vorherige Impfungen: -

VAERS 2201404

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: KY
Alter: 62,0
Geschlecht: M
Eingang: 28.03.2022
Impfdatum: 08.04.2021
Beginn: 22.01.2022
Tage bis Beginn: 289,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

COVID-19 Chills Diarrhoea Dyspnoea Frequent bowel movements Headache Productive cough Pyrexia SARS-CoV-2 test positive

Symptomtext

Pt presented to the ED with shortness of breath of one day. Pt reports cough with sputum, developed fevers, chills SOB last night. + Loose stools and headaches with 4-5 BMs daily for week. General/Constitutional: No changes in appetite, weight. + fever, chills. No night sweats. Skin: No new sores, ulcers, rashes, or pruritus. Hematologic: No new bruising or increased bleeding. Endocrine: No intolerance to hot or cold, polydipsia, or polyuria. HENT: + headaches, No dysphagia, changes in hearing/smelling, or pharyngitis. Eyes: No changes in vision, diplopia, or ophthalmalgia. Cardiovascular: No chest pain, palpitations, or edema. Respiratory: + cough, dyspnea. No hemoptysis. Gastrointestinal: No nausea/vomiting, +diarrhea. No abd pain, or hematochezia/melena. For COVID-19: patient has completed 10 days of dexamethasone 6 mg daily, remdesivir 5 days, currently on room air, out of COVID isolation. Discharge Disposition/Condition Disposition: Home with Home Health Condition: Stable (s/sx potential problems absent or manageable)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: 45,0
Labordaten: COVID PCR positive on 01/22/22
Aktuelle Erkrankungen: N/A
Vorgeschichte: Abnormal levels of other serum enzymes Elevated alkaline phosphatase level ? Anemia, unspecified Normocytic normochromic anemia ? Benign prostatic hyperplasia without lower urinary tract symptoms BPH (benign prostatic hyperplasia) ? Charcot's joint, unspecified ankle and foot Charcot ankle ? Diarrhea, unspecified Diarrhea ? Dysuria Dysuria ? Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm Hospital discharge follow-up ? Essential (primary) hypertension Essential (primary) hypertension ? Hyperlipidemia, unspecified Hyperlipidemia ? Major depressive disorder, recurrent, unspecified (CMS/HCC) Major depressive disorder, recurrent ? Other specified abnormal findings of blood chemistry Elevated TSH ? Otitis media, unspecified, right ear Right acute otitis media ? Pain in left arm Pain and numbness of left upper extremity ? Pain in right knee Right knee pain ? Personal history of other diseases of the circulatory system History of hypertension ? Personal history of other endocrine, nutritional and metabolic disease History of diabetes mellitus ? Personal history of other specified conditions History of diarrhea ? Retention of urine, unspecified Bladder retention of urine ? Retention of urine, unspecified Urine retention ? Sprain of unspecified ligament of left ankle, initial encounter Left ankle sprain ? Umbilical hernia without obstruction or gangrene Umbilical hernia
Andere Medikamente: acetaminophen atorvastatin glyburide lisinopril metformin tamsulosin
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2200714

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201a21a

moderat

Staat: NY
Alter: 50,0
Geschlecht: M
Eingang: 26.03.2022
Impfdatum: 26.08.2021
Beginn: 26.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cardiac stress test Chest pain Injection site pain

Symptomtext

Soreness at sire 1 month, jchest pain irractic. Severe chest pain when over exerting

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: Stress test.
Aktuelle Erkrankungen: None
Vorgeschichte: Chronic ankle sprain. Metel plate in neck, pinched nerve in lower back
Andere Medikamente: None
Allergien: Penicillian
Vorherige Impfungen: -

VAERS 2188299

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: MD
Alter: 35,0
Geschlecht: F
Eingang: 18.03.2022
Impfdatum: 12.04.2021
Beginn: 15.02.2022
Tage bis Beginn: 309,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Injection site hypoaesthesia Injection site pain Pain Paraesthesia

Symptomtext

Arm is numb from top left shoulder, also having mild pulling pain in surrounding around the injection site on left arm. I have tingling sensation in all 5 fingertips of my left hand. The pains and sensations come & go periodically throughout a 24 hour period

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: N/a
Vorgeschichte: Asthma
Andere Medikamente: Advil PM, Albuterol inhaler and Ibuprofen
Allergien: Dust, mold, pollen and cats
Vorherige Impfungen: -

VAERS 2182341

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: TX
Alter: 63,0
Geschlecht: M
Eingang: 16.03.2022
Impfdatum: 07.06.2021
Beginn: 07.06.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Asthenia Dysstasia Gait disturbance Limb discomfort Magnetic resonance imaging spinal Muscle tightness Muscular weakness Musculoskeletal stiffness Pain Pain in extremity Paraesthesia Sitting disability Spinal X-ray X-ray of pelvis and hip

Symptomtext

That afternoon felt pulling on left side down to left hip; next morning symptoms were painful from shoulder down to lower thigh felt pain and stiffness; from then moved to calf for 3 weeks then back up to thigh and shoulder. scale of 1-10, pain would be 8. Around September tingling in fingers up to both shoulders and started feeling weakness in both arms; January getting worse-upper and lower body-heaviness in legs and arms. Can't sit for more than 15 minutes, when stand and try to walk lower body is very stiff in hip area, feel like lower body is locking up. No strength in arms or legs too weak to pull self up if on floor doing stretches. Had physical therapy for six weeks in December 2021 for L4-L5, no relief

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: X-Rays on hip and lumbar - October 7, 2021; MRI on lumbar- October 19, 2021; X-ray on neck February 15, 2022; waiting on approval for MRI on neck, initially denied due to lack of information from Dr.
Aktuelle Erkrankungen: N/A
Vorgeschichte: Diabetes, High Blood Pressure, High Cholesterol, Back Pain, Implant - Bengal-Cage 4 Cimplicity in neck.
Andere Medikamente: Quinapril, Amlodipine, Januvia, Ezetimibe, Aspirin, LiverAid, Fish Oil Pills, Garlic Pills
Allergien: Sulphur
Vorherige Impfungen: -

VAERS 2190291

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: -
Alter: 37,0
Geschlecht: M
Eingang: 11.03.2022
Impfdatum: 14.06.2021
Beginn: 15.06.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Chest pain Dyspnoea Laboratory test normal

Symptomtext

Narrative: 36 YOF who received J&J vaccine & remained in facility for 15 minutes following vaccination. Patient subsequently taken to ED by ambulance the day following vaccination due to complaints of chest pain & SOB. Patient reports that all results were normal at hospital. No additional details known.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2150862

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: MI
Alter: 62,0
Geschlecht: M
Eingang: 01.03.2022
Impfdatum: 14.12.2021
Beginn: 16.02.2022
Tage bis Beginn: 64,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Computerised tomogram abdomen Computerised tomogram thorax abnormal Coronavirus test positive Cough Immunisation Leukocytosis Lumbar spinal stenosis Lung consolidation Magnetic resonance imaging spinal abnormal Neutropenia Pneumonia SARS-CoV-2 test positive Scoliosis Spinal X-ray abnormal

Symptomtext

Hospitalized 02/15/2022; COVID-19 positive 02/16/2022; fully vaccinated plus booster BRIEF OVERVIEW: Primary Care Physician at Discharge: MD Hematologist/Oncologist: Dr. Admission Date: 2/15/2022 Discharge Date: 02/20/2022 Patient's Discharge Disposition: Home in stable condition. Discharge summary: This is a 62 y.o. year old patient who was admitted on 2/15/2022 with PMH of small cell lung cancer, CHF, cardiomyopathy, chronic obstructive pulmonary disease, and hypertension who presented for a direct admission for left flank pain. Patient was seen in the same-day clinic for this problem and was admitted for further evaluation treatment of this pain. X-ray of the lumbar spine as well as ribs were done which showed scoliosis with mild endplate compression at L2 as well as old rib fractures respectively. MRI of the lumbar spine was done on 02/15/2022 which showed severe left neural foraminal stenosis at L5 through S1. Ortho Spine was consulted to make recommendations and did not recommend any surgical intervention from their standpoint but recommended interventional radiology team evaluate for nerve block. Patient did undergo a left L5 SNRB under general anesthesia on 02/18/2022. Patient's pain was otherwise well controlled on Tylenol as well as Oxy IR. Patient felt nerve block was taking effect prior to discharge was very hopeful that he would gain great relief from this then would be able to stop the Oxy; patient very concerned about addiction properties. Incidentally upon routine admission testing, patient tested positive for COVID-19 as well as coronavirus 229E. CT of the chest abdomen pelvis was done on 02/16/2022 and showed bilateral lower lobe consolidation suspicious for pneumonia. Remdesivir was started as well as dexamethasone. Patient did complete remdesivir 5th dose on 2/20/2022. Patient did not have symptoms of COVID during this admission aside from chronic cough. Patient remained stable on room air. Patient did have leukocytosis during this admission though this is secondary to inappropriate that started upon admission given neutropenia. Patient also was on dexamethasone during this admission was also contribute to leukocytosis. We expect the leukocytosis will improve upon discharge. In any case, given exam findings, cough as well as leukocytosis, patient was discharged home on 7 days of Levaquin which he will complete. It was not felt that further dexamethasone upon discharge would be helpful. Unfortunately given patient has incidental finding of COVID, we cannot be sure exactly when patient did become 1st positive with this. Our office will not see him back in the office and tell he has been in isolation for 10 days. Patient is aware that our office will call him tomorrow morning to reschedule his appointment due this week for sometime after 2-26-22; this was confirmed to be appropriate per discussion with Dr. Prior to discharge today, patient denies new, worsening or changes in ROS at this time, including no fevers/chills/sweats, no CP/SOB/DOE, no abd pain/N/V/D, and no neuro changes. Patient eating/drinking/voiding well and ambulating as tolerated. Patient will plan to follow up in our office as per below. Patient's discharge medications were discussed and new prescriptions were sent to patient's requested pharmacy prior to discharge as per generated list below. Patient is aware to call our office should further questions or concerns arise following this discharge.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pneumonia
Hospital-Tage: 5,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Chronic obstructive pulmonary disease with acute exacerbation Small cell lung cancer, left Left vocal cord paralysis Aspiration pneumonia Recent pneumonia, with current left basilar mucous plugging Dyspnea on exertion Unspecified essential hypertension Pancreatitis, unspecified pancreatitis type Alcohol use disorder, moderate, dependence Left flank pain Flank pain Hyponatremia Tobacco use disorder
Andere Medikamente: acetaminophen (TYLENOL) 500 MG tablet albuterol (PROVENTIL) (2.5 MG/3ML) 0.083% nebulization albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler aspirin 81 MG enteric coated tablet cholecalciferol (VITAMIN
Allergien: NKA
Vorherige Impfungen: -

VAERS 2119321

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: KY
Alter: 58,0
Geschlecht: F
Eingang: 17.02.2022
Impfdatum: 03.06.2021
Beginn: 03.06.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Blood glucose abnormal COVID-19 Chest discomfort Cough Diarrhoea Dyspnoea Fatigue Pneumonia SARS-CoV-2 test positive

Symptomtext

Patient is a 59 y.o. female with past medical history significant for diabetes, smoking, asthma who presents to the emergency department with shortness of breath and diarrhea. Constitutional: Positive for fatigue. Respiratory: Positive for cough, chest tightness and shortness of breath. Cardiovascular: Negative for chest pain and leg swelling. Gastrointestinal: Positive for diarrhea. Negative for nausea and vomiting. She was on 6L NC on admission, moved to HFNC on 1/17 night. Started on dex and Remdesivir on 1/16. She completed a course of remdesivir and received 8 doses of Dex 6mg PO QD. Baricitinib was started on 1/18. She was on this from 1/18-1/23. She also completed a course of azithromycin/ceftriaxone for suspected CAP. After starting the dexamethasone her glucose became uncontrolled. She spent some time on an insulin gtt but was weaned down and stable with Glargine 48u at bedtime and lispro 12 u QAC. After starting the baricitinib, she had marked improvement in her oxygenation. She was weaned down daily until she plateaued at 2L NC. She is able to perform her ADLs and ambulating in the room w/ O2. She is requesting to go home to care for her son who has COVID as well. We will discharge her w/ home O2 and set her up with hospital at home. I will also refer her to pulmonary rehab. Discharge Disposition/Condition Disposition: Home w/ hospital at home Condition: Stable (s/sx potential problems absent or manageable)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: 10,0
Labordaten: COVID PCR confirmed positive on 1/17/22 and 1/14/22
Aktuelle Erkrankungen: N/A
Vorgeschichte: Past Medical History: Diagnosis Date ? Allergic rhinitis ? Anxiety ? Asthma ? Depression ? Essential hypertension ? GERD (gastroesophageal reflux disease) ? Hyperlipidemia ? Neuropathy due to type 2 diabetes mellitus (CMS/HCC) ? Obstructive sleep apnea ? Tobacco abuse
Andere Medikamente: albuterol atorvastatin cetirizine fluoxetine gabapentin insulin aspart insulin glargine lisinopril fluticasone
Allergien: premarin
Vorherige Impfungen: -

VAERS 2119126

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: KY
Alter: 67,0
Geschlecht: F
Eingang: 17.02.2022
Impfdatum: 13.09.2021
Beginn: 12.01.2022
Tage bis Beginn: 121,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Adult failure to thrive Bronchiectasis COVID-19 Cognitive disorder Computerised tomogram thorax abnormal Condition aggravated Decreased appetite Dyspnoea Hilar lymphadenopathy Hypophagia Hypoxia Major depression Mycobacterium tuberculosis complex test negative Productive cough Pyrexia SARS-CoV-2 test positive

Symptomtext

Please note, no further outside facility information is available in current Medical Record other than what is listed below. No provider information is available from Hospital Patient is a 67 y.o. female presenting from the Hospital with hypoxia. She has been at Hospital x 4 months for severe MDD with melancholic and psychotic features, neurocognitive disorder and failure to thrive. She tested positive for COVID-19 on 12/31/21. The patient reports she has had some dyspnea but believes this overall has improved. She still has a cough which is productive. Reports sputum is loose. She has not visualized color. She denies sinus congestion, sore throat, lost of taste or smell. Appetite has been poor and she has not been eating much, but states she has been drinking well. Per Hospital records, she has had low grade fevers, but otherwise no vital signs changes until this morning, when she was found to have O2 saturations of 81% on room air. She was brought to hospital via EMS and sats was 86% on 2L NC, and since have been in the mid 90s on 3L NC. She denies feeling dyspneic at this time. She did not receive any treatment for COVID while at Hospital. Original COVID-19 diagnosis was 12/31/21; had mild dyspnea (improved) and cough, and has done relatively well at facility until hypoxic PTA. On admission. CT chest "appears to have diffuse bronchiectasis w/ possible component of post-inflammatory fibrosis, and enlarged hilar lymph nodes, likely reactive; no PE" She was given from 1/12 Dexamethasone x 10 days, not a candidate for Remdesivir. QTB test negative. She was given supplemental O2 NC or HF and titrate as needed to keep O2 sat >93% and will discharged with home O2. Discharge Disposition/Condition Disposition: Other (specify) Condition: Stable (s/sx potential problems absent or manageable)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: 3,0
Labordaten: COVID-19 PCR positive on 1/10/22 and 1/12/22
Aktuelle Erkrankungen: N/A
Vorgeschichte: Past Medical History: Diagnosis Date ? Afib ? Anemia ? COVID 12/31/2021 ? Depression ? Diabetes mellitus ? Failure to thrive in adult ? Neurocognitive disorder ? Subdural hematoma ? UTI (urinary tract infection)
Andere Medikamente: acetaminophen Maalox atenolol diltiazem diphenhydramine fish oil magnesium hydroxide megestrol mirtazapine multivitamin olanzapine rivaroxaban sertraline thiamine
Allergien: penicillin
Vorherige Impfungen: -

VAERS 2099729

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: ME
Alter: 49,0
Geschlecht: F
Eingang: 09.02.2022
Impfdatum: 13.08.2021
Beginn: 19.08.2021
Tage bis Beginn: 6,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Facial pain Fatigue Headache Hyperacusis Magnetic resonance imaging Malaise Migraine Parosmia Photophobia

Symptomtext

Mild headache 3-4 hours after administration, headache (continued moderate) fatigue and general malaise started day after injection. Day 3 after injection, all symptoms besides the headache resolved. Experienced severe symptoms; pounding headache pain with additional new symptoms of pain on right side of face "could draw a line down the center of face", sensitivity to light, sounds, smells with rapid onset, on 8/20/21, never had experienced these symptoms previously. The severe "intense" headaches were diagnosed by PCP as migraine headaches, 8/27/21 and started on preventative and abortive migraine medications. Referred for MRI and consulted to neurologist after 3 months with symptoms worsening and serious adverse reaction with preventative treatment medication. Difficulties working and keeping up with caseload due to frequency and intensity of migraines without effective management. Seen by Neurologist 11/30/2021 for initial consult, with recommendation to continue abortive medication with Imitrex and trial preventative treatment with botox injections. The extent of how my life has dramatically changed since the Covid-19 Vaccine and the 4 months I suffered with these debilitating migraines cannot be regained. With neurology management the migraines are better controlled however the frequency and intensity increases as the time for next round of Botox injections come due.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Migraine
Hospital-Tage: -
Labordaten: MRI 10/22/2021
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2087641

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: -
Alter: 73,0
Geschlecht: M
Eingang: 04.02.2022
Impfdatum: -
Beginn: 30.12.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

COVID-19 COVID-19 pneumonia Chest pain Chills Cough Dyspnoea Fatigue Pneumonia Procalcitonin increased SARS-CoV-2 test positive White blood cell count increased

Symptomtext

A 73-year-old male, who has a past medical history of asthma, hypertension, TB (tuberculosis), and Type 2 diabetes mellitus, presented to ED due to worsening shortness of air. The patient reported he began to feel short of breath around 09:00 on 12/30/2021. This progressively got worse, prompting the patient's family to call EMS. Constitutional: Positive for chills and fatigue. Negative for activity change, appetite change, diaphoresis, fever and unexpected weight change. HENT: Negative for congestion, ear pain, hearing loss, rhinorrhea, sore throat, trouble swallowing and voice change. Eyes: Negative for discharge and visual disturbance. Respiratory: Positive for cough and shortness of breath. Negative for apnea, chest tightness and wheezing. Cardiovascular: Positive for chest pain. Negative for palpitations. He completed Remdesivir while inpatient. Regarding Dexamethasone, it was felt the benefits outweigh the cost as given high risk of a poor outcome from COVID-19 pneumonia. Given elevated procalcitonin and elevated WBC, he was treated for CAP with ceftriaxone and azithro during hospitalization. Discharge Disposition/Condition/Disposition: Home. Condition: Stable (s/sx potential problems absent or manageable).

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19 pneumonia
Hospital-Tage: 6,0
Labordaten: COVID-19 PCR positive on 12/30/2021 and 12/31/2021.
Aktuelle Erkrankungen: -
Vorgeschichte: Type 2 diabetes mellitus, asthma, hypertension and TB (tuberculosis)
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2087108

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: ME
Alter: 37,0
Geschlecht: M
Eingang: 04.02.2022
Impfdatum: -
Beginn: 01.06.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Electrocardiogram Gait disturbance Gait inability Paraesthesia

Symptomtext

BARELY WALKED AND WALKED IN AN ODD AND STRANGE WAY; TINGLING WENT UP TO ARMS AND LEGS; LOST THE ABILITY TO WALK; FINGERS TINGLING; This spontaneous report received from a patient concerned a 37 year old male. The patient's height, and weight were not reported. The patient's past medical history included: cancer of the kidney, and 2 strokes, and concurrent conditions included: non-alcohol user, and smoker, and other pre-existing medical conditions included: The patient had no known allergies and no drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, expiry: 21-SEP-2021) dose was not reported, administered on 05-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On JUN-2021, the patient experienced fingers tingling. On NOV-2021, the patient experienced lost the ability to walk. On an unspecified date, the patient experienced barely walked and walked in an odd and strange way, and tingling went up to arms and legs. Laboratory data (dates unspecified) included: EKG (NR: not provided) ECG was okay. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fingers tingling, tingling went up to arms and legs, lost the ability to walk, and barely walked and walked in an odd and strange way. This report was non-serious.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: Test Name: EKG; Result Unstructured Data: ECG was okay
Aktuelle Erkrankungen: Abstains from alcohol; Smoker (A pack to 1 and a 1/2 pack of cigarettes per day.)
Vorgeschichte: Medical History/Concurrent Conditions: Renal cancer (Before patient was born); Stroke (Before patient was born); Comments: The patient had no known allergies and no drug abuse or illicit drug usage. The patient was half Spanish.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2076662

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: IL
Alter: 74,0
Geschlecht: F
Eingang: 31.01.2022
Impfdatum: 08.04.2021
Beginn: 17.01.2022
Tage bis Beginn: 284,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Bacteraemia Blood creatinine increased Blood culture positive Blood gases abnormal Bronchial secretion retention COVID-19 Chest X-ray abnormal Culture urine Hypokalaemia Hypomagnesaemia Hypoxia Laboratory test abnormal Lethargy Leukopenia Lung opacity Mental status changes Metabolic encephalopathy Panic attack

Symptomtext

75 yo F, history of asthma, depression, anxiety, atrial fibrillation, and hyperventilation syndrome secondary to psychiatric disease. Presented to the ed from assisted living for altered mental status found to have toxic and metabolic encephalopathy and covid 19. Labs remarkable for hypokalemia, hypomagnesemia, leukopenia, UA concerning for infection, urine culture contaminated. ABG with hypoxia. CXR with left left lower lobe pneumonia. Started on ceftriaxone and doxycyline for CAP. Saturating well on room air, dexamethasone and remdesivir held. Patient developed lethargy after ativan administration for a panic attack AM of 1/18. Blood cultures positive for GPCs resembling staph in 2/2 bottles and vanc started, speciated to staph hominis and staph epi, oxacillin susceptible. ID consulted and placed patient on unasyn. Repeat cultures negative. Repeat cxr with subsegmental mucous plugging and urine ag positive for strep. SCR increased to 1.4 that resolved with MIVF. Patient to complete course of clindamycin and levofloxacin for strep pneumonia and bacteremia per ID recs.Discharged on 1/28/22

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pneumonia
Hospital-Tage: 11,0
Labordaten: 1/17/22 COVID 19: positive 1/17/22 chest xray: Interstitial prominence with patch like opacification left mid and lower lung suggesting infectious/inflammatory process such as pneumonia. This is new from prior examination.
Aktuelle Erkrankungen: -
Vorgeschichte: ? Anxiety ? Arthritis ? Asthma ? Atrial fibrillation
Andere Medikamente: montelukast 10 MG Tabs Commonly known as: SINGULAIR TAKE 1 TABLET BY MOUTH EVERY DAY AT NIGHT What changed: See the new instructions. risperiDONE 1 MG Tabs Commonly known as: RISPERDAL TAKE 1 TABLET BY MOUTH TWICE A DAY What changed: See
Allergien: none
Vorherige Impfungen: -

VAERS 2072271

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: CO
Alter: 49,0
Geschlecht: F
Eingang: 28.01.2022
Impfdatum: 18.08.2021
Beginn: 19.08.2021
Tage bis Beginn: 1,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Blood pressure abnormal Diplopia Fall Fear Head discomfort Hyperacusis Hyperhidrosis Hypophagia Mobility decreased Photophobia Polyuria Sensory disturbance Vomiting projectile

Symptomtext

Projectile vomited up to 20 times a day. I laid in bed two months almost immobilized unable to handle light or noise. My body would go into sweating fits and had extreme BP readings on and off a month. I stupidly waited 2 or 3 weeks and was told not allowed to go to Doctor, was told and ignored a few more days the scariest health issues in my life. I still to this day have the feeling my brain has pressure. I have almost never been sick for 20 years. Went to hospital twice locally, I was literally told on the 2 nd date at the hospital that I should not mention the Johnson and Johnson vaccination. I was told people think they can sue and make money. I never lost more faith in our health care system. Here I took one for the team got vaccinated then treated criminal like I was a con artist trying to sue J and J. In case CDC lacks nuisance let me clarify this is an unethical way to approach that involves a positive feedback loop of Bias! I am very stubborn, so stubborn my head popped a few days after the vaccination. I was running on a treadmill went straight down. I thought I was having a stroke at first. I wasn?t sure but didn?t want insane hospital bills. So I tried many interventions. Potassium, diuretics, didn?t eat for a couple of weeks which seemed to help. I had several BP readings like 190/100 BP, double vision, only intervention besides what I mentioned is I constantly had ice on my hea?. I am filling this out and VAERs complains I am timing out?

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mobility decreased
Hospital-Tage: 2,0
Labordaten: -
Aktuelle Erkrankungen: Autoimmune disease psoriatic arthritis 20 years or more.
Vorgeschichte: Anxiety occasionally, who doesn?t have anxiety the way our cdc runs things.
Andere Medikamente: Daily vitamin
Allergien: None
Vorherige Impfungen: -

VAERS 2062874

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: CA
Alter: 59,0
Geschlecht: F
Eingang: 25.01.2022
Impfdatum: 22.07.2021
Beginn: 22.07.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Discomfort Hypoaesthesia Neuropathy peripheral Pain in extremity Paraesthesia

Symptomtext

I had the first side effect approximately 5 hours after the injection. I was walking and I felt some sensation of neuropathy in my left foot. A sensation of not fully feeling my foot. I have continued to have tingling on and off in my left foot sporadically since the day of the injection. Approximately 4 months after the vaccine, I began to have joint pain in my left side which included shoulder, hip, knee and foot. This pain was almost constant if I was sitting but did not bother me during the day while moving. I went to the chiropractor to try and alleviate the discomfort and the treatments have helped. I have also used Advil and Tramadol for the pain. I have had no pain on the right side, only the left, where I had the injection in my left arm.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: I did not undergo any tests
Aktuelle Erkrankungen: none
Vorgeschichte: N/A
Andere Medikamente: Nothing
Allergien: Keflex
Vorherige Impfungen: -

VAERS 2054623

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201a21a

moderat

Staat: CA
Alter: 32,0
Geschlecht: M
Eingang: 21.01.2022
Impfdatum: 01.08.2021
Beginn: 21.01.2022
Tage bis Beginn: 173,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: ja Erholt: nein

Arthritis Autoimmune disorder Condition aggravated Dry eye Eye injury Iritis Musculoskeletal stiffness Myalgia

Symptomtext

Severe muscle pain, arthritis, stiffness, and autoimmune reactions related to my underlying medical condition. This persisted for approximately one month. I also developed dry eye symptoms that eventually resulted in a case of Iritis and damage to my left eye.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: Diagnosed with Iritis on 10/15/21.
Aktuelle Erkrankungen: Ankylosing Spondylitis, an autoimmune condition
Vorgeschichte: Ankylosing Spondylitis, an autoimmune condition
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 2040887

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: CA
Alter: 52,0
Geschlecht: F
Eingang: 17.01.2022
Impfdatum: 16.05.2021
Beginn: 16.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: unbekannt Erholt: nein

Allergy to chemicals Dizziness Dysstasia Feeling hot Gait disturbance Neuralgia Pain Pain in extremity Paraesthesia oral

Symptomtext

5/16/21 - experienced tingling in lips and dizziness within 5 minutes; drank some water and waited. Shooting pains down left side arm and leg for 2 weeks began about 2 hours after the injection. Then the shooting pains spread to the other foot and arm. I began to experience hot feet sensations, which continue to be present as of January 17,2022. Difficult to stand, walk, and even sit (as the pain persists). There are also shooting pains down both right and left legs - intermittently. Occasionally there are shooting pains down arms. However, the most persistent pain is in the right foot which aches most of the time (but not aways). I also have additional food allergies (wheat allergy is more intense, and allergic to red wine).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia oral
Hospital-Tage: -
Labordaten: None I am strong person, and have managed it. In increased my vitamins and added melatonin. I have kept thinking it would go away. My concern is that it isn't going away, and now we are supposed to get boosters. This is very concerning to me. I do not want to be fully disabled. I have a tremendous amount of responsibilities and cannot afford any further adverse reactions.
Aktuelle Erkrankungen: None
Vorgeschichte: None- until after the vaccine (J&J); Shooting nerve pain began on the date of 5/16 on the left side of body. After 2 weeks, shooting nerve pain both arms and feet; pervasive sensation of hot feet that continues even today. Makes walking, standing and even sitting painful. Currently, right foot is the most painful - sometimes causing me to limp. I can only wear two pairs of shoes (tennis shoes and one other pair). It is sometimes unbearable, and other times manageable.
Andere Medikamente: Took an allergy medicine when lips began to tingle and I began to feel dizzy.
Allergien: Wheat; Erythromycin
Vorherige Impfungen: -

VAERS 2040887

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: CA
Alter: 52,0
Geschlecht: F
Eingang: 17.01.2022
Impfdatum: 16.05.2021
Beginn: 16.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: unbekannt Erholt: nein

Allergy to chemicals Dizziness Dysstasia Feeling hot Gait disturbance Neuralgia Pain Pain in extremity Paraesthesia oral

Symptomtext

5/16/21 - experienced tingling in lips and dizziness within 5 minutes; drank some water and waited. Shooting pains down left side arm and leg for 2 weeks began about 2 hours after the injection. Then the shooting pains spread to the other foot and arm. I began to experience hot feet sensations, which continue to be present as of January 17,2022. Difficult to stand, walk, and even sit (as the pain persists). There are also shooting pains down both right and left legs - intermittently. Occasionally there are shooting pains down arms. However, the most persistent pain is in the right foot which aches most of the time (but not aways). I also have additional food allergies (wheat allergy is more intense, and allergic to red wine).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia oral
Hospital-Tage: -
Labordaten: None I am strong person, and have managed it. In increased my vitamins and added melatonin. I have kept thinking it would go away. My concern is that it isn't going away, and now we are supposed to get boosters. This is very concerning to me. I do not want to be fully disabled. I have a tremendous amount of responsibilities and cannot afford any further adverse reactions.
Aktuelle Erkrankungen: None
Vorgeschichte: None- until after the vaccine (J&J); Shooting nerve pain began on the date of 5/16 on the left side of body. After 2 weeks, shooting nerve pain both arms and feet; pervasive sensation of hot feet that continues even today. Makes walking, standing and even sitting painful. Currently, right foot is the most painful - sometimes causing me to limp. I can only wear two pairs of shoes (tennis shoes and one other pair). It is sometimes unbearable, and other times manageable.
Andere Medikamente: Took an allergy medicine when lips began to tingle and I began to feel dizzy.
Allergien: Wheat; Erythromycin
Vorherige Impfungen: -

VAERS 2037941

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: FL
Alter: 78,0
Geschlecht: M
Eingang: 15.01.2022
Impfdatum: 14.05.2021
Beginn: 29.12.2021
Tage bis Beginn: 229,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute kidney injury Ammonia normal Blood creatinine Blood culture negative COVID-19 Chronic kidney disease Condition aggravated Diabetic foot Echocardiogram Mental status changes Metabolic encephalopathy SARS-CoV-2 test positive SARS-CoV-2 viraemia Vaccine breakthrough infection X-ray limb normal

Symptomtext

Patient was hospitalized due to breakthrough COVID infection. Patient received J&J vaccine on 05/14/2021. Patient was hospitalized from 12/29/21 - 01/01/22. Below is copied from discharge summary: Hospital Course: Patient is a 79 y.o. male with a history of CKD, Hypertension, hyperlipidemia, insulin-dependent diabetes mellitus, coronary artery disease status post CABG, and CVA with residual left-sided weakness presented to the emergency department for altered mental status x1 day prior to admission. Acute Metabolic Encephalopathy Resolve Likely 2/2 COVID-19 Ammonia level WNL Diabetic foot ulcers, right foot Chronic XR neg for osteomyelitis Blood cultures NGTD Podiatry consulted, no intervention need will follow as OP COVID-19 viremia Not requiring oxygen COVID-19 order set initiated Supportive care AKI on CKD Resolve Cr at baseline Renally dose medications Avoid nephrotoxic agents CHF HFpEF 60%, TTE 8/22/21 No acute decompensation Continue statin and carvedilol IDDM with hyperglycemia Resume OP tx Coronary artery disease CVA with residual left-sided weakness Continue Plavix BPH Continue Flomax Gastroesophageal reflux disease Continue Protonix Patient is discharged in stable condition with stable vital signs. All questions rearding hospital course and plan of care after discharge have been answered to satisfaction. Prescriptions for medications needed to be taken after discharge have been given to patient. Patient has been instructed to follow up with PCP, MD within the next 7 days after discharge. Patient verbalizes understanding all given instructions and has no further doubts regarding discharge.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: 3,0
Labordaten: SARS-COV-2, NAA, Detected: 12/29/21
Aktuelle Erkrankungen: -
Vorgeschichte: 10/20/2018: Acute exacerbation of CHF (congestive heart failure) 6/1/2021: Acute hematogenous osteomyelitis of left foot 2007: Cerebral artery occlusion with cerebral infarction 1/28/2019: Cerebrovascular accident (CVA) No date: Diabetes mellitus 1/28/2019: Hx of CABG No date: Hypertension 6/1/2021: MRSA (methicillin resistant Staphylococcus aureus) infection 1/8/2010: Type 2 diabetes mellitus with stage 3 chronic kidney disease, with long-term current use of insulin
Andere Medikamente: ? acetaminophen-codeine (TYLENOL #3) 300-30 MG Oral Tablet 1-2 tablets, Oral, EVERY 6 HOURS PRN ? carvedilol (COREG) 12.5 mg, Oral, 2 TIMES DAILY ? cholecalciferol (VITAMIN D-3) 25 mcg, Oral, DAILY ? clopidogrel (PLAVIX) 75 MG PO Tablet 1 t
Allergien: Heparin, shellfish
Vorherige Impfungen: -

VAERS 2034931

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: MO
Alter: 46,0
Geschlecht: F
Eingang: 14.01.2022
Impfdatum: 22.07.2021
Beginn: 22.07.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: unbekannt Erholt: nein

Chest X-ray Chills Dyspnoea Impaired work ability Malaise Pain Pulmonary function test Respiratory disorder SARS-CoV-2 test Streptococcus test

Symptomtext

I became Ill that night with the standard temp, chills, body aches, and shortness of breath that I expected would come along. Over the next few days the symptoms eased and went away except the shortness of breath. By early August, I had developed a respiratory Illness and had to go get a chest xray and Covid tested. I also ended up having a PFT done once my resp illness was over because the SOB never subsided. I now have inhalers to add to my medications. This was not life before. I also misses several days of work from infusion date to mid August because of being so Ill.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: Pft, Covid Test, Strep test, chest xray
Aktuelle Erkrankungen: Htn and Depression
Vorgeschichte: -
Andere Medikamente: Prozac, Amlodipine, Metoprolol I only really took the Metoprolol religiously
Allergien: Wellbutrin and Sulfa
Vorherige Impfungen: -

VAERS 2373524

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201a21a

moderat

Staat: -
Alter: 51,0
Geschlecht: M
Eingang: 11.01.2022
Impfdatum: 07.09.2021
Beginn: 07.09.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Paraesthesia

Symptomtext

left hand fingers tingling after vaccine in left arm Narrative:

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2021183

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: LA
Alter: 37,0
Geschlecht: F
Eingang: 10.01.2022
Impfdatum: 19.07.2021
Beginn: 29.07.2021
Tage bis Beginn: 10,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Anxiety Computerised tomogram Dizziness Dyspnoea Echocardiogram Electrocardiogram Feeling abnormal Headache Hypertension Impaired work ability Laboratory test Loss of personal independence in daily activities Magnetic resonance imaging Malaise Nausea Pain Pulmonary function test Tremor

Symptomtext

nausea, dizziness, fogginess, uncontrolled trembling, high blood pressure, anxiety, headaches, body aches, generalized unwell feeling, weight loss, shortness of breath on and off for the passed 7 months and counting. multiple doctor visits, er visits, and specialists visits. almost $2000 in medical debt. Multiple labs, x-rays, CT scans, mri, pft, ekg, Ultrasound, Echo, and medications. Missed numerous days of work and important events from being sick. My life has been turned upside down since receiving this vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: hypothyroid, insulin resistance, PCOS
Andere Medikamente: synthroid, metformin, birth control
Allergien: none
Vorherige Impfungen: -

VAERS 2551110

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: -
Alter: 64,0
Geschlecht: M
Eingang: 06.01.2022
Impfdatum: 12.04.2021
Beginn: 12.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Dyspnoea

Symptomtext

Narrative: Pt presented to emergency department 04/15/2021. He reports having SOB since 04/12/2021. Patient had been watching news reports and is concerned that he may have a PE. No evidence of PE found.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2000565

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: CA
Alter: 52,0
Geschlecht: F
Eingang: 04.01.2022
Impfdatum: 01.04.2021
Beginn: 01.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: ja Erholt: nein

Anti-thyroid antibody Arteriogram carotid Blood calcium Blood corticotrophin Blood cortisol Blood creatine phosphokinase Blood follicle stimulating hormone Blood luteinising hormone Blood magnesium Blood parathyroid hormone Blood phosphorus Blood pressure increased Blood thyroid stimulating hormone Brain natriuretic peptide C-reactive protein Computerised tomogram head Dizziness Echocardiogram

Symptomtext

Sensation of ?fried nerves? over entire body intermittent. Sometimes have sharper prickling pain on bottom of feet and face. Pulsing tinnitus; ringing in ears constant and loud; dizziness: sensation of spinning at times; brain fog; increased blood pressure ( normally on lower end); pressure in mask of face as if I am about to get a nose bleed; sharp pain intermittently around temples like a clamp on head. The symptoms have increased significantly over the last 5-6 months.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: Imaging CT ANGIOGRAM NECK OUTSIDE IMAGING Nov 10, 2021 Imaging CT HEAD EXTERNAL IMAGE IMPORT Nov 10, 2021 The result is abnormalLab PTH,INTACT AND CALCIUM Nov 10, 2021 Lab MAGNESIUM Nov 10, 2021 Lab PHOSPHORUS Nov 10, 2021 Lab T3, TOTAL Nov 10, 2021 Lab T4, TOTAL Nov 10, 2021 Lab TSH WITH REFLEX FT4, FT3 Nov 10, 2021 Lab COMPREHENSIVE METABOLIC PANEL Nov 10, 2021 The result is abnormalLab PTH, INTACT Nov 10, 2021 Lab CALCIUM FOR PTH Nov 10, 2021 Imaging Echo Transthoracic Complete Aug 28, 2021 Lab CK, TOTAL Aug 25, 2021 Lab SEDIMENTATION RATE, ERYTHROCYTE Lab Aug 25, 2021 C-REACTIVE PROTEIN Aug 25, 2021 Lab HEMOGLOBIN A1C Aug 25, 2021 Lab HSCRP (CARDIO CRP) AND CV RISK Aug 25, 2021 Lab LIPID PANEL Aug 25, 2021 Lab BRAIN NATRIURETIC PEPTIDE Aug 25, 2021 Lab LIPOPROTEIN A (LPA) Aug 25, 2021 Lab TSH Aug 25, 2021 Lab FREE T4, AUTOMATED Aug 25, 2021 Lab THYROID PEROXIDASE AB Aug 25, 2021 Lab THYROGLOBULIN ANTIBODY Aug 25, 2021 Lab ACTH Aug 25, 2021 Lab CORTISOL Aug 25, 2021 Lab FOLLICLE STIMULATING HORMONE Aug 25, 2021 Lab LUTEINIZING HORMONE Aug 25, 2021 Lab ESTRADIOL Aug 25, 2021 Cardiology, endocrinology, audiology, pulmonary, ENT. Diagnosis of .
Aktuelle Erkrankungen: None really. I had a mild ringing in ears that was intermittent and TMJ. I also have a gene mutation in STK11 of an undetermined significance.
Vorgeschichte: Some mild hearing loss, hay fever in the fall usually, TMJ, history of lower blood pressure and irregular heart beats intermittent over the years but none for some of time prior to vaccine.
Andere Medikamente: No prescriptions. Vitamins -multiple (D,C,B,K, potassium, magnesium,?)
Allergien: Amoxicillin Cefaclor Prochlorperazine Lavender Pines Eucalyptus Misc other plants, grasses and molds
Vorherige Impfungen: -

VAERS 1981658

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: MI
Alter: 77,0
Geschlecht: F
Eingang: 27.12.2021
Impfdatum: 12.05.2021
Beginn: 20.12.2021
Tage bis Beginn: 222,0
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Abdominal pain upper Acute kidney injury Agitation Alanine aminotransferase normal Anion gap Anticoagulant therapy Antinuclear antibody positive Appetite disorder Aspartate aminotransferase normal Asthenia Blood albumin decreased Blood alkaline phosphatase normal Blood bilirubin normal Blood calcium normal Blood chloride decreased Blood creatinine increased Blood glucose increased Blood potassium normal

Symptomtext

Hospitalized (12.20.21 - 12.22.21); COVID-19 positive (12.20.21); Fully vaccinated - J&J x1 Pt left Hospital on 12/22/21 - calling PCP's office with complaints of weakness, pneumonia on 12/27/21 D/c summary: Discharge Summary Case was reviewed and discussed. Patient wanted to leave- refused steroids. Glucose levels are quite elevated. Still requiring oxygen so will try to help set up home oxygen for her. At high risk for deterioration and needing readmission. Reminded that she can and should return to the ER if she gets worse after leaving. Discharge Summary BRIEF OVERVIEW: Admission Date: 12/20/2021 Discharge Date: 12/22/2021 Active Hospital Problems Diagnosis Date Noted POA ? Pneumonia due to COVID-19 virus 12/20/2021 Yes ? Hypoxia 12/20/2021 Yes ? CKD (chronic kidney disease), stage III 03/03/2020 Yes ? Acute kidney injury 12/21/2021 No ? Lupus (HCC) 12/20/2021 Yes ? Type 2 diabetes mellitus, without long-term current use of insulin Yes ? Class 3 severe obesity in adult Yes ? Essential hypertension 03/26/2021 Yes ? Coronary artery disease involving native coronary artery of native heart without angina pectoris 04/23/2020 Yes ? Hyponatremia 12/20/2021 Yes ? Dyslipidemia Yes ? Depression Yes Resolved Hospital Problems Diagnosis Date Noted Date Resolved POA ? Sepsis (HCC) 12/20/2021 12/22/2021 Yes ? Hyperkalemia 12/21/2021 12/22/2021 Yes Pre-Existing Active Problems Diagnosis Date Noted POA ? ANA positive 07/29/2021 Unknown ? Ds DNA antibody positive 07/29/2021 Unknown ? Nephrotic syndrome 07/29/2021 Unknown ? Tremor 03/03/2021 Unknown ? Personal history of colonic polyps 09/08/2020 Unknown ? Chest pain 03/09/2020 Unknown ? Epigastric pain 12/10/2015 Unknown ? DJD (degenerative joint disease) of hip Unknown ? DJD (degenerative joint disease) of knee Unknown Active Issues Requiring Follow-up Issue: covid 19, PNA Recommended follow-up provider/specialty: PCP What is needed: hospital follow up; oxygen management Issue: DM Recommended follow-up provider/specialty: PCP What is needed: DM management DISCHARGE DISPOSITION: discharged No future appointments. Appointments Needing to be Scheduled Contact information for follow-up Next Steps: Follow up Instructions: f/u asap Specialty: Endocrinology, Diabetes and Metabolism, Internal Medicine Relationship: PCP - Diabetic Care Next Steps: Follow up Instructions for after discharge Call the Doctor for Persistent Nausea or Vomiting Complete by: As directed Call the Doctor for Redness, Tenderness, or Signs of Infection at IV or Procedure Site(s) Complete by: As directed Call the Doctor for Severe Uncontrolled Pain Complete by: As directed Call the Doctor for Temperature Greater Than 100.3 F Complete by: As directed Call the Doctor if Red Blood Found in Stool or Vomit Complete by: As directed Diabetic Diet Complete by: As directed Do Not Smoke or Use Tobacco Products Complete by: As directed Read New Medication Instructions Complete by: As directed Resume Normal Activity as Tolerated Complete by: As directed DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: COVID-19 [U07.1] HOSPITAL COURSE: Patient is a 77 year old female patient with knonw history of lupus and diabetes. She had presented to the Ed with 6 days of complaints of symptoms. She was found to be hypoxic and results showed positive for COVID 19 pneumonia. There was concern for a superimposed bacterial infection. She was vaccinated for COVID 19 with the J&J vaccine in 5/2021, and overdue for her booster since 7/2021. She was admitted and started on IV steroids, remdesivir and IV antibiotics. She continued to require oxygen supplementation. Today, she complained of feeling like her arm was hurting due to the IV, which nursing has had a difficult time with IV sticks requiring ultrasound guided. Her current IV flushing well without any sign of redness. She refused steroids on day of discharge and voiced that she just wants to go home. She insisted on going home against medical advice. Risks of leaving were explained up to the possibility of death and she verbalized understanding of the risks and still insists on leaving. We will have her evaluated for home oxygen prior to discharge as she was requiring 2L n/c. We will also discharge her on antibiotics to complete a 5 day course. She was instructed to follow up with her PCP ASAP and if she worsens or not improved to return to ER. Patient verbalized understanding. Paper was reviewed with 2 RNS witnessing her agreement. PHYSICAL EXAM: BP 159/81 | Pulse 100 | Temp 36.4 ?C (Oral) | Resp 20 | Ht 1.638 m | Wt 113.2 kg | SpO2 95% | BMI 42.18 kg/m? General: No apparent distress. Head: Normocephalic, atraumatic EENT: MMM & pink. Lungs: Respirations even & unlabored. CTA CV: RRR. No murmurs, rubs, gallops. Abd: Soft, nontender, nondistended. Bowel sounds normal. MS: No deformities. Neuro: A&O. No gross motor or focal deficits. Psych: Agitated H&P: Case was reviewed and discussed. COVID-19 viral pneumonia, likely with secondary bacterial pneumonia. AKI on CKD III and severe sepsis present. Avoid nephrotoxins and dose adjust medications. Repeat labs in am and give very gentle fluids if not improved. Agree with holding ACE-I. Expand All Collapse All Hide copied text Hover for details History & Physical CHIEF COMPLAINT: Pneumonia due to COVID-19 virus Assessment/Plan ASSESSMENT/PLAN: * Pneumonia due to COVID-19 virus Assessment & Plan - With superimposed bacterial CAP - Personally reviewed CXR consistent with multifocal pneumonia worse on R - Continue ceftriaxone and azithromycin for 5 day course - Onset of symptoms: 12/14/2021 - Start remdesivir monitor renal function and LFTs closely - Trend D-dimer and CRP - Start solumedrol 40mg Q8H as she is diminished throughout and on steroids at baseline for lupus - Encourage prone positioning and IS use Hypoxia Assessment & Plan -Placed on 2l NC - Does not require oxygen at baseline - Wean oxygen to maintain sats >90% Sepsis (HCC) Assessment & Plan - Due to COVID-19 pneumonia with superimposed bacterial pneumonia - Avoid additional IV fluid resuscitation given HD stability and COVID-19 status Hyponatremia Assessment & Plan - Mild due to dehydration - Received IV fluids - Trend with AM labs Lupus (HCC) Assessment & Plan - With nephrotic syndrome - Takes prednisone at home - Will hold for now while on IV steroids Essential hypertension Assessment & Plan - Pressure soft upon initial presentation - Hold home lisinopril, propranolol and norvasc Coronary artery disease involving native coronary artery of native heart without angina pectoris Assessment & Plan - Continue aspirin and statin CKD (chronic kidney disease), stage III (HCC) Assessment & Plan - Renally function slightly worse than baseline - In the setting of adequate PO intake and COVID-19 will hold off additional IVF - Trend renal function in AM, renally dose medications Class 3 severe obesity in adult (HCC) Assessment & Plan - Increases risk of complication with underlying COVID-19 - Recommend weight loss and outpatient follow-up Depression Assessment & Plan - No longer taking meds for this - Continue without patient follow-up Dyslipidemia Assessment & Plan - Continue statin Type 2 diabetes mellitus, without long-term current use of insulin (HCC) Assessment & Plan - Uncontrolled BG >300 upon admit - MDSS and lantus 15 units - POC BG AC/HS - Monitor closely for steroid induced hyperglycemia VTE prox: SQ lovenox GI prox: Pepcid Subjective HISTORY OF PRESENT ILLNESS: Patient is a 77 y.o. female type 2 diabetes, CKD stage 3,CAD (s/p LAD on Plavix), and hypertension who presented today with cough, fever, headache, shortness of breath, and chest pain for the past 6 days. The patient reports having associated productive cough, N/V and diarrhea. She also reports falling at home, she does not use an assitive device at baseline. She lives at home alone. Denies using home oxygen or CPAP machine. The patient is vaccinated against COVID-19 (1 shot J&J). She sought care due to increased weakness and notes that she probably should have come in sooner as she has been struggling to care for herself at home over the past week. The patient will be admitted with an expected length of stay greater than 2 midnights but less than 96 hours. Patient Active Problem List Diagnosis ? Type 2 diabetes mellitus, without long-term current use of insulin (HCC) ? Dyslipidemia ? Depression ? Class 3 severe obesity in adult (HCC) ? DJD (degenerative joint disease) of hip ? DJD (degenerative joint disease) of knee ? Epigastric pain ? CKD (chronic kidney disease), stage III (HCC) ? Chest pain ? Coronary artery disease involving native coronary artery of native heart without angina pectoris ? Personal history of colonic polyps ? Tremor ? Essential hypertension ? ANA positive ? Ds DNA antibody positive ? Nephrotic syndrome ? Pneumonia due to COVID-19 virus ? Sepsis (HCC) ? Lupus (HCC) ? Hypoxia ? Hyponatremia Medical History Past Medical History: Diagnosis Date ? Anemia ? Choledocholithiasis 12/23/15 ERCP ; post proc pancreatitis ? CKD (chronic kidney disease), stage III ? Coronary artery disease ? Depression ? Diabetes mellitus ? Diabetes mellitus type 2, noninsulin dependent (HCC) denies complications ? DJD (degenerative joint disease) of hip left replaced ? DJD (degenerative joint disease) of knee bilateral TKA's ? Dyspnea on exertion ? Former smoker ? GERD (gastroesophageal reflux disease) 8/17/11 ? Hard of hearing ? High cholesterol ? History of colon polyps ? History of sexual abuse ? Hypertension ? Hypothyroidism ? Lupus ? Morbid obesity ? Personal history of colonic polyps 9/8/2020 ? Stented coronary artery 03/18/2020 DES x1 to LAD Past Surgical History Past Surgical History: Procedure Laterality Date ? HX CARDIAC CATHETERIZATION 03/18/2020 DES to LAD ? HX COLONOSCOPY 6/16/10 Coates, polyps, repeat 5 yrs ? HX COLONOSCOPY 7/25/14 DAJ, neg ? HX COLONOSCOPY 09/08/2020 ? HX COLONOSCOPY 9/8/2020 ? HX CORONARY STENT PLACEMENT 03/18/2020 LAD ? HX ERCP 12/23/15 ? HX GASTROPLASTY 1978 stomach stapling 1982- gastric bypass ? HX HEART CATHETERIZATION 02/08/2010 2/10 ok ? HX HIP REPLACEMENT Left 2/9/10 ? HX KNEE ARTHROSCOPY 1990; 2002 Right; Left ? HX KNEE REPLACEMENT Bilateral 12/1/04 ? HX LUMBAR LAMINECTOMY 1/12/06 L4-L5; herniated disc ? HX OF BACK SURGERY ? HX OPEN CHOLECYSTECTOMY 1969 ? HX TAH AND BSO 1967 ? US BIOPSY THYROID FINE NEEDLE ASPIRATE 5/4/2021 Prescriptions Prior to Admission (Not in a hospital admission) Allergies Allergen Reactions ? Amaryl [Glimepiride] GI Upset Weight gain Social History Socioeconomic History ? Marital status: Divorced Spouse name: Not on file ? Number of children: 3 ? Years of education: Not on file ? Highest education level: Not on file Occupational History ? Occupation: retired truck driving Tobacco Use ? Smoking status: Former Smoker ? Smokeless tobacco: Never Used ? Tobacco comment: quit 12-13 years ago Vaping Use ? Vaping Use: Never used Substance and Sexual Activity ? Alcohol use: Yes Alcohol/week: 0.0 standard drinks Comment: wine occasionally, 3x per year ? Drug use: Never ? Sexual activity: Not on file Other Topics Concern ? Military Service No ? Blood Transfusions Yes Comment: uncertain ? Caffeine Concern Yes Comment: 2 glasses of Iced Tea daily, coffee occasionally, no pop ? Occupational Exposure No ? Hobby Hazards No ? Sleep Concern Yes Comment: snores ? Stress Concern No ? Weight Concern Yes ? Special Diet No ? Back Care Not Asked ? Exercise No Comment: nothing regular due to the heat ? Bike Helmet Not Asked ? Seat Belt Yes ? Self-Exams Not Asked Social History Narrative Lives alone with two dogs Social Determinants of Health Financial Resource Strain: Low Risk ? Difficulty of Paying Living Expenses: Not hard at all Food Insecurity: No Food Insecurity ? Worried About Running Out of Food in the Last Year: Never true ? Ran Out of Food in the Last Year: Never true Transportation Needs: No Transportation Needs ? Lack of Transportation (Medical): No ? Lack of Transportation (Non-Medical): No Physical Activity: Inactive ? Days of Exercise per Week: 0 days ? Minutes of Exercise per Session: 0 min Stress: Not on file Social Connections: Unknown ? Frequency of Communication with Friends and Family: More than three times a week ? Frequency of Social Gatherings with Friends and Family: More than three times a week ? Attends Religious Services: Not on file ? Active Member of Clubs or Organizations: Not on file ? Attends Club or Organization Meetings: Not on file ? Marital Status: Divorced Housing Stability: Not on file Family History Family History Problem Relation Age of Onset ? Coronary Artery Disease Father ? Diabetes Father ? Heart Failure Father CHF ? Heart Attack Father ? Hypertension Mother ? Diabetes Mother ? Alzheimers Mother ? Pacemaker Mother ? Colon Cancer Maternal Uncle ? Dementia Cousin ? Dementia Cousin ? Dementia Cousin ? Dementia Paternal Grandfather with all brothers and sisters; son (pt's father) did not have it Review of Systems Constitutional: Positive for appetite change, chills, diaphoresis, fatigue and fever. Negative for unexpected weight change. HENT: Negative for congestion and sore throat. Eyes: Negative for visual disturbance. Respiratory: Positive for cough, wheezing, shortness of breath, chest tightness and sputum production. Cardiovascular: Positive for chest pain. Negative for palpitations, orthopnea and leg swelling. Gastrointestinal: Positive for nausea, vomiting and diarrhea. Negative for abdominal pain and constipation. Genitourinary: Negative for difficulty urinating, dysuria, frequency, hematuria and urgency. Musculoskeletal: Positive for gait problem and falls. Neurological: Positive for weakness. Negative for headaches and dizziness. Endo/Heme/Allergy: Negative for easy bleeding or bruising. Psychiatric/Behavioral: Negative for depression. Skin: Negative for rash and wound. Objective OBJECTIVE: BP 137/61 | Pulse 68 | Temp 98.2 ?F (36.8 ?C) (Oral) | Resp 20 | Wt 116.9 kg (257 lb 11.5 oz) | SpO2 97% | BMI 42.89 kg/m? Physical Exam Constitutional: General: She is not in acute distress. Appearance: She is obese. She is ill-appearing. She is not toxic-appearing or diaphoretic. HENT: Head: Normocephalic. Ears: Comments: Hard of hearing Eyes: Pupils: Pupils are equal, round, and reactive to light. Cardiovascular: Rate and Rhythm: Normal rate and regular rhythm. Heart sounds: Normal heart sounds. No murmur heard. No gallop. Pulmonary: Effort: Pulmonary effort is normal. No respiratory distress. Breath sounds: Wheezing present. Comments: Diminished throughout, on 2L NC Chest: Chest wall: No tenderness. Abdominal: General: There is no distension. Palpations: Abdomen is soft. Tenderness: There is no abdominal tenderness. Comments: Hypoactive bowel sounds Musculoskeletal: General: No tenderness. Cervical back: Neck supple. Skin: General: Skin is warm and dry. Neurological: Mental Status: She is alert and oriented to person, place, and time. Psychiatric: Behavior: Behavior normal

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19 pneumonia
Hospital-Tage: 2,0
Labordaten: Lab Results Component Value Date WBC 14.95 (H) 12/20/2021 RBC 3.92 (L) 12/20/2021 HGB 11.9 (L) 12/20/2021 HCT 36.8 (L) 12/20/2021 MCV 93.9 12/20/2021 PLATELET 262 12/20/2021 NEUTABSOLU 12.64 (H) 12/20/2021 Lab Results Component Value Date GLUCOSE 321 (H) 12/20/2021 SODIUM 133 (L) 12/20/2021 POTASSIUM 4.8 12/20/2021 CHLORIDE 96 (L) 12/20/2021 ANIONGAP 12 12/20/2021 BUN 31 (H) 12/20/2021 CREATININE 1.72 (H) 12/20/2021 CALCIUM 10.0 12/20/2021 TOTALPROTE 6.9 12/20/2021 ALBUMIN 2.6 (L) 12/20/2021 ALKALINEPH 76 12/20/2021 AST 16 12/20/2021 ALT 10 12/20/2021 BILIRUBINT 0.4 12/20/2021 EGFR 29 (L) 12/20/2021 PERTINENT LABS AND STUDIES: Lab Results Component Value Date WBC 14.36 (H) 12/22/2021 RBC 3.39 (L) 12/22/2021 HGB 10.4 (L) 12/22/2021 HCT 31.5 (L) 12/22/2021 MCV 92.9 12/22/2021 PLATELET 287 12/22/2021 NEUTABSOLU 12.24 (H) 12/22/2021 Lab Results Component Value Date GLUCOSE 215 (H) 12/22/2021 SODIUM 137 12/22/2021 POTASSIUM 4.2 12/22/2021 CHLORIDE 102 12/22/2021 ANIONGAP 13 12/22/2021 BUN 57 (H) 12/22/2021 CREATININE 1.91 (H) 12/22/2021 CALCIUM 9.5 12/22/2021 TOTALPROTE 6.3 12/22/2021 ALBUMIN 2.2 (L) 12/22/2021 ALKALINEPH 61 12/22/2021 AST 15 12/22/2021 ALT 11 12/22/2021 BILIRUBINT <0.2 (L) 12/22/2021 EGFR 25 (L) 12/22/2021 DR CHEST SINGLE VIEW EXAMINATION: Chest 1 view EXAM DATE: 12/20/2021 9:46 AM CLINICAL HISTORY PROVIDED: sob. ICD 10 REQUIRED INFORMATION FROM ANOTHER SOURCE: No other pertinent information available. TECHNIQUE: Portable AP upright chest 0929 hours. COMPARISON: 9/16/2021. ENCOUNTER: Initial EXAM QUALITY: Suboptimal. FINDINGS INSPIRATION AND POSITION: * Inspiration: Suboptimal * Rotation: No significant rotation. CARDIAC SILHOUETTE AND MEDIASTINUM: * Cardiac silhouette has normal size and appearance.. LUNGS: * There is faint suggestion of multiple focal opacities in the lungs, right side greater than left side that could represent an infectious process. * No sign of effusion edema or pneumothorax. SKELETAL: * Ribs: Those that are visible appear intact * Clavicles and scapula: intact where visible.. * Arthritic changes of both humeral heads. LINES/CATHETERS: * None. OTHER FINDINGS * None. IMPRESSION * Pneumonia suspected.
Aktuelle Erkrankungen: -
Vorgeschichte: Past Medical History: Diagnosis Date ? Anemia ? Choledocholithiasis 12/23/15 ERCP; post proc pancreatitis ? CKD (chronic kidney disease), stage III ? Coronary artery disease ? Depression ? Diabetes mellitus ? Diabetes mellitus type 2, noninsulin dependent denies complications ? DJD (degenerative joint disease) of hip left replaced ? DJD (degenerative joint disease) of knee bilateral TKA's ? Dyspnea on exertion ? Former smoker ? GERD (gastroesophageal reflux disease) 8/17/11 ? Hard of hearing ? High cholesterol ? History of colon polyps ? History of sexual abuse ? Hypertension ? Hypothyroidism ? Lupus ? Morbid obesity ? Personal history of colonic polyps 9/8/2020 ? Stented coronary artery 03/18/2020 DES x1 to LAD
Andere Medikamente: amLODIPine Besylate 5 mg Oral Daily Ascorbic Acid,Vitamin Mixture,Bioflavonoid... 1 tablet Oral Daily Aspirin 81 mg Oral Daily Atorvastatin Calcium 40 mg Oral Daily Cetirizine HCl 5 mg Oral Daily Clopidogrel Bisulfate 75 mg Oral Daily
Allergien: amaryl - GI Upset/wt gain
Vorherige Impfungen: -

VAERS 1974490

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: KY
Alter: 82,0
Geschlecht: M
Eingang: 23.12.2021
Impfdatum: 09.04.2021
Beginn: 20.12.2021
Tage bis Beginn: 255,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 COVID-19 pneumonia Cough Exposure to SARS-CoV-2 Hypoxia SARS-CoV-2 test positive

Symptomtext

Per History and physical on 12/20/21: Patient is a 83 y.o. male with a PMH significant for NPH status post shunt in 2013, diabetes mellitus type 2, CKD stage III, CAD, HTN, HLD who presents to the ED due to cough with positive at home Covid testing today. Patient lives with his daughter. Today daughter who works in healthcare was routinely tested for Covid. She tested positive, asymptomatic. She returned home and tested both of her parents who live with her, patient and spouse both tested positive. Patient reports a cough for the past couple of days. He denies fever, fatigue, malaise, decreased appetite, nausea, vomiting, diarrhea, headache, loss of taste or smell, shortness of breath, chest pain, dysuria. Hypoxia due to Covid 19 Pneumonia. --Satting 92% on room air, not on home oxygen.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19 pneumonia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2537443

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: -
Alter: 49,0
Geschlecht: F
Eingang: 21.12.2021
Impfdatum: 09.07.2021
Beginn: 11.09.2021
Tage bis Beginn: 64,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Chest X-ray Chest discomfort Dyspnoea Fatigue Nasal congestion Pyrexia SARS-CoV-2 test positive

Symptomtext

COVID (+) WITH SYMPTOMS CHEST TIGHTNESS, SHORTNESS OF BREATH, NASAL CONGESTION, FATIGUE FEVER Narrative: Employee had chest x-ray ordered by her outside physician.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1955558

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: CO
Alter: 56,0
Geschlecht: M
Eingang: 16.12.2021
Impfdatum: 13.08.2021
Beginn: 21.08.2021
Tage bis Beginn: 8,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia Hypoaesthesia Paraesthesia

Symptomtext

Numbness sensation in left side neck and arm in nerve that runs across top of shoulder and down backside of left arm. Tingling sensation, numbness, and weakness had begun about a week after shot and has persisted still to this day 4 months later. It?s not getting worse nor is it getting better. Never experienced anything like this in 56 years of life

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: None.
Aktuelle Erkrankungen: None
Vorgeschichte: None prior to shot. About a week after receiving vax my left arm, same arm as shot given in, has a nerve numbness sensation in the nerve that runs across top of shoulder and down backside of arm.
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1931908

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge 201A21A

moderat

Staat: IL
Alter: 22,0
Geschlecht: M
Eingang: 08.12.2021
Impfdatum: 30.11.2021
Beginn: 30.11.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood test normal Chest pain Confusional state Diarrhoea Dyspnoea Eructation Fatigue Feeling abnormal Heart rate increased Pain

Symptomtext

Symptoms: fatigue, shortness of breath, high heart rate, confusion/cloudy head, aches, chest pain, burping, diarrhea. Treatment: probiotics, Nexium, inhaler, hydration

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: Prompt care on 12/2, no results. ER on 12/3, hydration through IV bag and blood results. No findings in blood results.
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: Multivitamin
Allergien: seasonal pollen allergies
Vorherige Impfungen: Flu-like symptoms for 24 hours after first J&J covid vaccination.

VAERS 2565372

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: -
Alter: 60,0
Geschlecht: F
Eingang: 04.12.2021
Impfdatum: 20.08.2021
Beginn: 20.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chest pain Hypertension Respiratory depression Swelling of eyelid

Symptomtext

RespDepression, HYPERtension, Chest Pain, swollen eye lids Narrative:

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2566425

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: -
Alter: 36,0
Geschlecht: F
Eingang: 01.12.2021
Impfdatum: 16.08.2021
Beginn: 13.08.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Feeling abnormal Flushing Hypertension Tachycardia Tachypnoea

Symptomtext

Narrative: Patient became hypertensive, flushed, felt "weird", tachypnic, tachycardic within minutes of vaccine administration. Received EpiPen dose and sent to emergency room. Per patient (no outside records)no further intervention was done and was not admitted.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hypertension
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1920000

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: -
Alter: 51,0
Geschlecht: M
Eingang: 01.12.2021
Impfdatum: 05.08.2021
Beginn: 02.10.2021
Tage bis Beginn: 58,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

COVID-19 Chills Cough Dyspnoea Oropharyngeal pain Pain Productive cough Pyrexia SARS-CoV-2 test positive

Symptomtext

Narrative: COVID infection following COVID vaccine series 08/05 COVID vaccine dose #1 of 1 09/29 reports sore throat, cough, dyspnea 10/02 COVID positive, seen in ED due to productive cough x 2 weeks, no nausea/vomiting but spits up when coughing, fever 1 week ago w/ chills, body aches; rx'd albuterol, Tessalon, guaifenesin DM, discharged home 10/05 COVID positive (re-tested due to work), no symptoms 10/06 clinically resolved

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: LAB RESULTS: Date TEst Name Result 10/05/2021@13:40 COVID-19 SCR (ORL) DETECTED 10/02/2021@16:18:01 COVID-19 DIAG (BIOFIRE) DETECTED 08/01/2021@15:05 COVID-19 DIAG (ORL) NotDetected
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1909250

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201a21a

moderat

Staat: KY
Alter: 80,0
Geschlecht: F
Eingang: 30.11.2021
Impfdatum: 06.04.2021
Beginn: 24.11.2021
Tage bis Beginn: 232,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Body temperature increased Bronchiectasis COVID-19 Dyspnoea SARS-CoV-2 test positive

Symptomtext

Patient is a 80 y.o. female with PMH of CKDIII, COPD (3LNC at home), Afib RVR, HFpEF, CAD (s/p CABG 2005), HTN, HLD osteoarthritis. She was recently admitted 11/15 to 11/20 for exacerbation of bronchiectasis. She was treated with Ceftriaxone/doxycycline that admission and went home on her usual 3L of oxygen. However, over the last few days her dyspnea has gradually worsened. She called EMS and was found to have oxygen sat of 85% on her usual 3L oxygen. In the ED, her temp was over 101. She was placed on nonrebreather mask. She tested positive for COVID-19 on 11/15 and 11/24.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2571861

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: -
Alter: 69,0
Geschlecht: M
Eingang: 29.11.2021
Impfdatum: 18.06.2021
Beginn: 04.10.2021
Tage bis Beginn: 108,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Angiogram pulmonary normal Blood bicarbonate decreased Blood fibrinogen increased Blood lactic acid Blood pH decreased Blood pH increased Brain natriuretic peptide normal COVID-19 COVID-19 pneumonia Chest X-ray abnormal Diarrhoea Fibrin D dimer International normalised ratio increased Interstitial lung disease Lung consolidation Lung opacity Mental status changes PCO2 decreased

Symptomtext

Narrative: COVID infection following COVID vaccine series 06/18 Janssen, dose #1 10/04 pt admit to medicine cc: "altered mental status and diarrhea" dx: COVID pneumonia LOS: 18 10/04 COVID swab, result, detected 10/04 CXR Impression: No acute cardiopulmonary disease. Please note that subtle groundglass opacities associated with viral pneumonia may not be visible on plain radiography 10/05 CXR Impression: Low lung volumes with bibasilar streaky densities and diffuse prominence of pulmonary interstitial markings, increased compared to 10/04/2021. This could represent atelectasis and vascular crowding related to low lung volumes although infectious/inflammatory process or other process not excluded by radiography. 10/06 CXR Impression: Stable bilateral patchy consolidation and groundglass densities (history of Covid). 10/07 US EXTREMITY Impression: Negative examination for thrombosis in the bilateral lower extremity veins listed above. 10/09 i-pH 7.53, i-PCo2 28.1, i-PO2 61, i-HCO3 23.7 08/03 pt cc: exposure: unknown 10/05 i-pH 7.38, i-PCo2 26.6, i-PO2 67, i-HCO3 15.9 10/06 BNP: 30.3 10/08 CXR impression: 1. Patchy bilateral airspace opacities have decreased. 10/09 DDIMER: 1.73 10/09 PROCALCITONIN: 0.24 10/09 CXR impression: 1. Obscuration of the left hemidiaphragm suggestive of left lower lobe consolidation. Findings may be related to atelectasis though superimposed infectious process is not excluded. 10/09 CTA PE impression: No evidence of pulmonary embolism. 10/11 CXR impression: Interval worsening of mixed interstitial and airspace opacities, consistent with COVID pneumonia. 10/13 FIBRNOGEN: 440 10/13 DDIMER: 1.04 10/15 FIBRINOGEN: 515 10/15 i-pH 7.44, i-PCo2 37.8, i-PO2 70, i-HCO3 26.4 10/15 DDIMER: 1.08 10/15 PT/INR 12.9/1.15 10/16 FIBRINOGEN: 515 10/16 DDIMER: 1.43 10/17 i-pH 7.25, i-PCo2 67.7, i-PO2 89, i-HCO3 29.8 10/17 FIBRINOGEN: 638 10/17 DDIMER: 1.34 10/17 i-pH 7.28, i-PCo2 63.3, i-PO2 87, i-HCO3 29.4 10/18 PROCALCITONIN: 0.33 10/18 FIBRINOGEN: 586 10/18 DDIMER: 1.79 10/18 LACTIC ACID: 2.39 10/18 i-pH 7.36, i-PCo2 56.5, i-PO2 79, i-HCO3 31.7 10/19 LACTIC ACID: 2.88 10/19 i-pH 7.22, i-PCo2 80.4, i-PO2 66, i-HCO3 33.3, 10/20 FIBRINOGEN: 658 10/20 DDIMER: 2.42 1020 LACTIC ACID: 2.32 10/21 i-pH 7.28, i-PCo2 70.3, i-PO2 58, i-HCO3 33.1 10/21 i-pH 7.31, i-PCo2 63.9, i-PO2 48, i-HCO3 32.5 10/22 PROCALCITONIN 2.94 10/22 FIBRINOGEN: 638 10/22 DDIMER: 14.31 10/22 LACTIC ACID 2.13 10/22 i-pH 7.19, i-PCo2 85.7, i-PO2 42, i-HCO3 32.7 10/22 pt deceased

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19 pneumonia
Hospital-Tage: -
Labordaten: 10/04 COVID swab, result: detected 10/04 CXR Impression: No acute cardiopulmonary disease. Please note that subtle groundglass opacities associated with viral pneumonia may not be visible on plain radiography 10/05 CXR Impression: Low lung volumes with bibasilar streaky densities and diffuse prominence of pulmonary interstitial markings, increased compared to 10/4/2021. This could represent atelectasis and vascular crowding related to low lung volumes although infectious/inflammatory process or other process not excluded by radiography. 10/06 CXR impression: Stable bilateral patchy consolidation and groundglass densities (history of Covid). 10/07 US EXTREMITY Impression: Negative examination for thrombosis in the bilateral lower extremity veins listed above. 10/09 i-pH 7.53, i-PCo2 28.1, i-PO2 61, i-HCO3 23.7 10/05 i-pH 7.38, i-PCo2 26.6, i-PO2 67, i-HCO3 15.9 10/06 BNP: 30.3 10/08 CXR impression: 1. Patchy bilateral airspace opacities have decreased. 10/09 DDIMER: 1.73 10/09 PROCALCITONIN: 0.24 10/09 CXR impression: 1. Obscuration of the left hemidiaphragm suggestive of left lower lobe consolidation. Findings may be related to atelectasis though superimposed infectious process is not excluded. 10/09 CTA PE impression: No evidence of pulmonary embolism. 10/11 CXR impression: Interval worsening of mixed interstitial airspace opacities, consistent with COVID pneumonia. 10/13 FIBRINOGEN: 440 10/13 DDIMER: 1.04 10/15 FIBRINOGEN: 515 10/15 i-pH 7.44, i-PCo2 37.8, i-PO2 70, i-HCO3 26.4 10/15 DDIMER: 1.08 10/15 PT/INR 12.9/1.15 10/16 FIBRINOGEN: 515 10/16 DDIMER: 1.43 10/17 i-pH 7.25, i-PCo2 67.7, i-PO2 89, i-HCO3 29.8 10/17 FIBRINOGEN: 638 10/17 DDIMER: 1.34 10/17 i-pH 7.28, i-PCo2 63.3, i-PO2 87, i-HCO3 29.4 10/18 PROCALCITONIN: 0.33 10/18 FIBRINOGEN: 586 10/18 DDIMER: 1.79 10/18 LACTIC ACID: 2.39 10/18 i-pH 7.36, i-PCo2 56.5, i-PO2 79, i-HCO3 31.7 10/19 LACTIC ACID: 2.88 10/19 i-pH 7.22, i-PCo2 80.4, i-PO2 66, i-HCO3 33.3, 10/20 FIBRINOGEN: 658 10/20 DDIMER: 2.42 1020 LACTIC ACID: 2.32 10/21 i-pH 7.28, i-PCo2 70.3, i-PO2 58, i-HCO3 33.1 10/21 i-pH 7.31, i-PCo2 63.9, i-PO2 48, i-HCO3 32.5 10/22 PROCALCITONIN 2.94 10/22 FIBRINOGEN: 638 10/22 DDIMER: 14.31 10/22 LACTIC ACID 2.13 10/22 i-pH 7.19, i-PCo2 85.7, i-PO2 42, i-HCO3 32.7
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1171366

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: KY
Alter: 44,0
Geschlecht: F
Eingang: 15.11.2021
Impfdatum: 06.04.2021
Beginn: 09.11.2021
Tage bis Beginn: 217,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Eye swelling Paraesthesia Throat irritation Throat tightness Tongue disorder

Symptomtext

Tested Positive for Covid

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1863377

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: HI
Alter: -
Geschlecht: F
Eingang: 12.11.2021
Impfdatum: -
Beginn: 22.06.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Body temperature Hot flush Influenza like illness Malaise Migraine Nausea

Symptomtext

HOT FLASHES; FELT LIKE 'CRAP'; NAUSEA; HEADACHES OR MIGRAINES; FLU LIKE SYMPTOMS; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: Patient had severe allergies to many substances so had to have the vaccine administered by allergy specialist. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, expiry: UNKNOWN) dose was not reported, administered on 22-JUN-2021 for prophylactic vaccination. No concomitant medications were reported. On JUN-2021, Laboratory data included: Body temperature (NR: not provided) slightly elevated but no fever. On 22-JUN-2021, the patient experienced flu like symptoms. On 23-JUN-2021, the patient experienced headaches or migraines. On 23-JUN-2021, the patient experienced felt like 'crap'. On 23-JUN-2021, the patient experienced nausea. On 24-JUN-2021, the patient experienced hot flashes. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from nausea, was recovering from hot flashes, flu like symptoms, and felt like 'crap', and had not recovered from headaches or migraines. This report was non-serious. This case, from the same reporter is linked to 20211124550.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Migraine
Hospital-Tage: -
Labordaten: Test Date: 202106; Test Name: Body temperature; Result Unstructured Data: slightly elevated but no fever
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Patient had severe allergies to many substances so had to have the vaccine administered by allergy specialist.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1854625

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201a21a

moderat

Staat: KY
Alter: 54,0
Geschlecht: M
Eingang: 09.11.2021
Impfdatum: 16.09.2021
Beginn: 17.09.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chest discomfort Chest pain Cough Hypoaesthesia Injection site erythema Injection site inflammation Injection site pain Injection site pruritus Injection site reaction Neuralgia Paraesthesia Sleep disorder

Symptomtext

Day two cough begins and tendon below deltoid(4 inces below vaccination site) red, very tender, itches and shows some inflammation burning to nerve pain at surface with clothes rubbing on it hurting. Continued for four days Day three all the above but increased cough that night dramatically effecting sleep. Chest pain and tightness. Day four still all above checked blood pressure twice 158/90 and 148/78 post med Day five cough subsiding, taking 800mg of advil and double dose of lisinopril for relief and stabilization. Day 6 began numbness and tingling in left toes and left fingers. Worsened two days later adding bottom of left foot, back of calf(lft) and side and left elbow. Faded by day 13 and as of report date 11/9 continued tingling in middle three left toes and ring and middle finger left hand.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: Told it should subside and come in if worsens
Aktuelle Erkrankungen: N/A
Vorgeschichte: Mild asthma, mild elevation in blood pressure
Andere Medikamente: Fish oil, testosterone, lisinopril, calcium,magnesium,zinc,glucosamine
Allergien: Beef
Vorherige Impfungen: -

VAERS 1853140

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: CA
Alter: 74,0
Geschlecht: F
Eingang: 09.11.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Dyspnoea Fatigue Gait disturbance Impaired work ability Malaise Mobility decreased Palpitations Paraesthesia Rash

Symptomtext

INTENSE INCREASED HEART PALPITATIONS; SHORTNESS OF BREATH (SOMETIMES); DIFFICULTY WALKING (HARD TO WALK FROM ROOM TO ROOM IN APARTMENT)/SHUFFLES FEET (ALSO USES A WALKER); REDUCED MOBILITY; INTERFERENCE WITH WORK DAY (TRIES TO WORK AT DESK BUT HAS TO LAY DOWN AND REST) / NOT ABLE TO FUNCTION; RASH ON LOWER BACK; NOT FEELING WELL; TIREDNESS; TINGLING IN THE LEFT CHEEK; This spontaneous report received from a patient concerned a 74 year old female. The patient's height, and weight were not reported. The patient's past medical history included: heart palpitations, and concurrent conditions included: advanced arthritis in the lower back and in the knee, sinus mass on left cheek cavity, existential tremor, aneurysm (stable), bad night vision, and irregular blood pressure. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, and expiry: UNKNOWN) dose was not reported, administered on 29-JUL-2021 for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the patient experienced intense increased heart palpitations, shortness of breath (sometimes), difficulty walking (hard to walk from room to room in apartment) /shuffles feet (also uses a walker), reduced mobility, interference with work day (tries to work at desk but has to lay down and rest) / not able to function, rash on lower back, not feeling well, tiredness, and tingling in the left cheek. Treatment medications (dates unspecified) included: ibuprofen, acetylsalicylic acid, and paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from shortness of breath (sometimes), tingling in the left cheek, difficulty walking (hard to walk from room to room in apartment)/shuffles feet (also uses a walker), intense increased heart palpitations, not feeling well, reduced mobility, rash on lower back, tiredness, and interference with work day (tries to work at desk but has to lay down and rest) / not able to function. This report was non-serious.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Aneurysm; Arthritis; Blood pressure abnormal; Decreased night vision; Paranasal sinus mass; Tremor
Vorgeschichte: Medical History/Concurrent Conditions: Palpitations
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1850877

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: TX
Alter: 44,0
Geschlecht: F
Eingang: 08.11.2021
Impfdatum: 07.04.2021
Beginn: 10.04.2021
Tage bis Beginn: 3,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Asthenia Blood pressure fluctuation Chills Dizziness Dysstasia Electrocardiogram normal Full blood count normal Pain in extremity Paraesthesia Pyrexia

Symptomtext

After the vaccine on 4/7/21 I had the normal pain in the arm, fever and chills but then starting on Saturday 4/10/21 I was experiencing tingling in my arms and legs. I felt as if I was going to faint for about an hour. It also felt like my blood pressure was maybe going up and down. I felt weak and could barely stand the rest of the night. My whole body felt weak for the following 4 days then on 4/14/21 I had another episode where my arms and legs were tingling and I could feel it in my chest as well. I felt like I was going to faint again so I went to urgent care. They did an EKG and CBC and they all came back normal. The doctor said it was probably normal reaction to the vaccine even this many days out. I felt weak for the next 3-4 days but then better.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: 4/14/21- EKG & CBC at Urgent Care all came back normal
Aktuelle Erkrankungen: No
Vorgeschichte: No
Andere Medikamente: Progesterone Vitamin D Vitamin B
Allergien: Wellbutrin and Diflucan
Vorherige Impfungen: -

VAERS 2570383

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: -
Alter: 42,0
Geschlecht: F
Eingang: 07.11.2021
Impfdatum: 21.05.2021
Beginn: 21.05.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Dyspnoea

Symptomtext

Narrative: Patient developed difficulty breathing approximately 3 minutes after administration of Janseen covid vaccine. Nurse administered Epi-Pen with patient reporting respiratory relief. Nurse did not report hives or tongue swelling. Patient was taken to the ER for further evaluation.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2581266

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: -
Alter: 65,0
Geschlecht: M
Eingang: 06.11.2021
Impfdatum: 12.04.2021
Beginn: 08.08.2021
Tage bis Beginn: 118,0
Dosis: UNK
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

COVID-19 Chest X-ray abnormal Computerised tomogram thorax abnormal Cough Decreased appetite Dyspnoea Fatigue Headache Lung opacity Myalgia Pyrexia SARS-CoV-2 test positive

Symptomtext

Narrative: COVID infection following COVID vaccine series 04/12 Janssen, dose #1 08/08 pt cc: cough, fatigue, fever, myalgias, lack of appetite, headache, exposure: unknown 08/13 Pt admit ED (outside facility) cc: SOB dx: unknown LOC: 1 day 08/13 CXR impression: New spiculated 1 cm opacity projecting over the right upper lobe. This could be further characterized with chest CT. 08/13 SARS-COV-2 LINEAGE AY.3 0/13 SARS-COV-2 CLADE 21A DELTA 08/13 COVID swab, result: detected 08/14- 08/23 pt symptoms continue 08/24 COVID swab, result: detected 08/24 clinically resolved 09/20 CT chest impression: 1. Pleural based pulmonary opacities bilaterally may represent thickening/scarring, recommend follow-up with FULL INSPIRATION chest CT scan in 6 months. Alternatively if prior CT scans become available, comparison may preclude the necessity for further evaluation. Other findings as above.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: 08/13 SARS-COV-2 LINEAGE AY.3 0/13 SARS-COV-2 CLADE 21A DELTA 08/13 CXR impression: New spiculated 1 projecting over the right upper lobe. This could be further characterized with chest CT. 08/13 COVID swab, result: detected 08/24 COVID swab, result: detected 09/20 CT chest impression: 1. Pleural based pulmonary opacities bilaterally may represent thickening/scarring, recommend follow-up with FULL INSPIRATION chest CT scan in 6 months. Alternatively if prior CT scans become available, comparison may preclude the necessity for further evaluation. Other findings as above.
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2596653

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: -
Alter: 67,0
Geschlecht: M
Eingang: 04.11.2021
Impfdatum: 07.06.2021
Beginn: 28.08.2021
Tage bis Beginn: 82,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

COVID-19 Chills Cough Dyspnoea Fatigue Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

Narrative: COVID infection following COVID vaccine series 06/07 Janssen, dose #1 08/30 COVID swab, result: detected 08/28 pt cc: chills cough, fatigue, rhinorrhea, dyspnea exposure: wife

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2576984

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: -
Alter: 41,0
Geschlecht: F
Eingang: 04.11.2021
Impfdatum: 21.09.2021
Beginn: 21.09.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Anxiety Chest pain Dysgeusia Pain in extremity Throat irritation

Symptomtext

ARM PAIN, ANXIETY, CHEST & THROAT BURNING, BITTER TASTE Narrative:

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1843044

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201a21a

moderat

Staat: PA
Alter: 23,0
Geschlecht: M
Eingang: 04.11.2021
Impfdatum: 01.04.2021
Beginn: 01.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Asthenia Chills Confusional state Delirium Dizziness Dyspnoea Fatigue Feeling abnormal Muscular weakness Pyrexia Tremor

Symptomtext

Around 2 hours after receiving the shot I began to feel dizzy, confused, out of it, lightheaded, delirious. Then I became incredibly weak and fatigued, possibly the most I've ever felt it in my life. I then experienced a rapid onset of a fever, chills, shakes, and became even more weak. My girlfriend had to take care of me and at one point even feed me water because I was too weak to lift my arms. At the worst my fever reached about 103-104 degrees. I then tried to sleep it off while bundled in 5 blankets. In the morning I felt better for a bit, and then immediately after felt all the same symptoms again. My breathing was short. I believe I took Motrin to deal with the fever, and eventually that worked out. My legs were incredibly weak. I never fully got my strength back in my legs, or my whole body for that matter, not to say I'm like permanently crippled or anything but my strength is not what it was. It took maybe a full month or two before my legs felt anywhere close to normal, and my lung/heart strength took months to get back to normal as well. I've recovered for the most part, but this was such a drastic reaction that I felt gaslit by the scores of people telling me there were no major reactions to this.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None at the time, possibly sinus infection or the plague around a month prior
Vorgeschichte: -
Andere Medikamente: Wellbutrin
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 1842386

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: CA
Alter: 34,0
Geschlecht: M
Eingang: 04.11.2021
Impfdatum: 19.08.2021
Beginn: 23.08.2021
Tage bis Beginn: 4,0
Dosis: 1
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: ja Erholt: nein

Disturbance in attention Dizziness Migraine Tinnitus

Symptomtext

Tinnitus very strong and getting worse month by month. Migrains, lack of concentration and dizziness after 3 mo. from shot

Weitere VAERSDATA-Felder

Praegender Schweregrund: Migraine
Hospital-Tage: -
Labordaten: not yet
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1840237

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: IL
Alter: 55,0
Geschlecht: F
Eingang: 03.11.2021
Impfdatum: 28.06.2021
Beginn: 29.10.2021
Tage bis Beginn: 123,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Chest X-ray abnormal Cough Dyspnoea Infection Lung opacity Nausea SARS-CoV-2 test positive

Symptomtext

11/1/21 ED note by Doctor: "Patient is a 55 y.o. female with PMH significant for asthma, chronic angle-closure glaucoma, hypothyroidism, chronic constipation and depression who comes to the hospital due to SOB after testing positive for COVID-19. Pt states that she has had an ongoing non-productive cough for the past month. States that she got the cough "after receiving my flu vaccine". On Friday 10/29, Pt went to clinic for appointment for cough. She was tested via rapid and PCR for COVID-19. The test results came back positive and she was informed of the results on Friday. Since Friday, pt has been feeling nauseous w/o any emesis. Pt has not had anything to eat for the past 36 hours. Pt was at home yesterday when she began to feel short of breath. She used her inhaler and nebulizer with no improvement. Pt decided to come to the ED today because she felt as though she could not breath. Pt denies any HA, CP, edema, fever/chills, diarrhea". Treatment: Remdesivir, Decadron , O2. Pt is currently hospitalized.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: Chest xray: Focal opacities in the lingula and lateral right mid lung are suspicious for multifocal infection.
Aktuelle Erkrankungen: -
Vorgeschichte: PMH significant for asthma, chronic angle-closure glaucoma, hypothyroidism, chronic constipation and depression
Andere Medikamente: -
Allergien: NKA
Vorherige Impfungen: -

VAERS 2599949

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: -
Alter: 72,0
Geschlecht: M
Eingang: 02.11.2021
Impfdatum: 14.05.2021
Beginn: 06.09.2021
Tage bis Beginn: 115,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

COVID-19 Chest pain Dyspnoea Haematemesis Nausea Neck pain Pain Retching Vaccine breakthrough infection Vomiting

Symptomtext

Narrative: c/o SOB + 8/10 CP that radiates up left side of neck. pt unable to give specific time frames of onset of SOB + CP, but thinks they have started on friday after his second covid shot. endorsing nausea with dry heaves at home, in triage he vomtted coffee ground emesis, ~325ml. Breakthrough COVID infection requiring hospitalization

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2600535

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: -
Alter: 34,0
Geschlecht: M
Eingang: 01.11.2021
Impfdatum: 25.08.2021
Beginn: 08.09.2021
Tage bis Beginn: 14,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Hypoaesthesia Pain in extremity Paraesthesia Peripheral swelling

Symptomtext

Narrative: Patient received COVID-19 vaccine (Janseen) on 8/25/21. About 2 weeks after receiving the vaccine he reports left calf pain (~9/8/21). A few days after the pain started, he reports numbness/tingling plantar surface of the foot and heel. He states the calf fees swollen. Was seen in the ED on 9/15/21. No family history of VTE, no other risk factors for DVT, no long distance travel. He is ambulatory, was given an outpt rx for rivaroxaban and discharged from the ED.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1825466

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: MD
Alter: 69,0
Geschlecht: M
Eingang: 28.10.2021
Impfdatum: 06.04.2021
Beginn: 21.10.2021
Tage bis Beginn: 198,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Chest pain SARS-CoV-2 test positive

Symptomtext

Patient was admitted from the ED with Chest pain on 10/21/2021 which he tested positive for COVID-19

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: 1,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1818631

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: TX
Alter: 26,0
Geschlecht: M
Eingang: 26.10.2021
Impfdatum: 10.08.2021
Beginn: 05.09.2021
Tage bis Beginn: 26,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Angiogram normal Antinuclear antibody Anxiety Asthenia Balance disorder Blood folate Blood test normal C-reactive protein Cardiac monitoring normal Cognitive disorder Discomfort Dizziness Dyspnoea EGFR status assay Echocardiogram normal Electroencephalogram normal Full blood count Glycosylated haemoglobin

Symptomtext

Onset 3 weeks after shot. have been ongoing without break since onset. 24/7 feelings of uneasiness and weakness/ altered cognitive function. More extreme symptoms that come and go, last anywhere from a few seconds to days at a time are pressure in the head, brain/head/ face/ extremity numbness and tingling. Includes the feeling of not being able to breathe. Feels that I am not getting adequate O2 even though my O2 levels stay over 95%. Very heavy feelings of fainting (no known loss of consciousness fully). Also include unsteadiness, altered vision (more like extreme tunnel vision/ feels like things are moving in slow motion). Have seen primary care Dr, Cardiologist, and Neurologist, all who have not found any diagnosable problems.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: MRI - With and without contrast. No issues found 10/6/2021 MRA - No issues found 10/6/2021 Echo - No major issues found. 10/13/2021 Multiple EKGs - No issues found 9/9, 10/5,2021 Multiple rounds of blood work - No issues found 9/5, 9/9, and 10/8/2021 Urine Test - No issues found 9/5/2021 EEG - Minor disturbances but Neurologist said it was too minor to be relevant 10/4/2021 7 Day heart monitor ? No issues found 10/6-10/13/2021 Blood work: CBC, eGFR. chem panel, Hgb A1C, thyroid function, ANA, respiratory panel, CRP, ESR, lipids, B12, folate, RPR, Vit D.
Aktuelle Erkrankungen: N/A
Vorgeschichte: mild motor tics
Andere Medikamente: N/A
Allergien: Amoxicillin, Ancef, Omnicef
Vorherige Impfungen: -

VAERS 1815209

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: KY
Alter: 53,0
Geschlecht: F
Eingang: 25.10.2021
Impfdatum: 07.04.2021
Beginn: 02.09.2021
Tage bis Beginn: 148,0
Dosis: N/A
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Anosmia COVID-19 Cough Diarrhoea Dyspnoea Exposure to SARS-CoV-2 Fatigue Nausea Pain SARS-CoV-2 test positive Vomiting

Symptomtext

SEE BELOW

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: POSITIVE COVID ANTIGEN TEST ON9/13/21- AFTER BEING FULLY VACCINATED. HOUSEHOLD EXPOSURE TO COVID. SYMPTOMS- ACHES, OLFACTORY D/O, FATIGUE, COUGH, SOA, AND N/V/D.
Aktuelle Erkrankungen: HTN
Vorgeschichte: UNK
Andere Medikamente: UNK
Allergien: UNK
Vorherige Impfungen: -

VAERS 1815022

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: KY
Alter: 40,0
Geschlecht: U
Eingang: 25.10.2021
Impfdatum: 06.08.2021
Beginn: 22.08.2021
Tage bis Beginn: 16,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Chills Cough Diarrhoea Dyspnoea Fatigue Headache Nausea Pain Pyrexia SARS-CoV-2 test positive Vomiting

Symptomtext

POSITIVE COVID TEST AFTER BEING FULLY VACCINATED.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: POSITIVE COVID ANTIGEN TEST ON 8/23/21. SYMPTOMS INCLUDED FEVER, CHILLS, ACHES, H/A, FATIGUE, COUGH, SOA, DIARRHEA, N/V
Aktuelle Erkrankungen: UNK
Vorgeschichte: UNK
Andere Medikamente: UNK
Allergien: UNK
Vorherige Impfungen: -

VAERS 1813196

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: MS
Alter: 54,0
Geschlecht: F
Eingang: 23.10.2021
Impfdatum: 21.09.2021
Beginn: 22.09.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cough Dyspnoea Fatigue Lymph node pain Lymphadenopathy Malaise

Symptomtext

Swelling of lymph nodes on the left side of my body that were very tender and lasted about 2 weeks, extreme fatigue began day 2 and has continued, SOB began day 2 and has continued with Spo2 dropping from my normal of 98-100% to now staying 93-95%, I have developed a "smokers cough", and generally "feel sick" all th time.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: I am a nurse and have continued to work as I do not have time or staff to take off to be seen at a clinic.
Aktuelle Erkrankungen: None
Vorgeschichte: GERD, hypothyroid, migraine, HTN, anxiety
Andere Medikamente: Metoprolol, pantoprozole, zoloft, LEVOTHYROXINE, EMGALITY
Allergien: None
Vorherige Impfungen: -

VAERS 1809829

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: AK
Alter: 39,0
Geschlecht: M
Eingang: 23.10.2021
Impfdatum: 15.09.2021
Beginn: 15.09.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood test normal Chest X-ray normal Chills Dizziness Dyspnoea Electrocardiogram normal Headache Heart rate increased Hypertension Nausea Nucleic acid test Pain Palpitations Pyrexia Urine analysis normal Vertigo Vision blurred

Symptomtext

~8 hours after injection, and for the next 2 days: -Severe chills (fever of 103 degrees) -Severe shortness of breath -Racing heart (140 bpm) and High Blood Pressure -Body Aches -Blurry vision in both eyes -Nausea/vertigo/dizziness/headache Most of the symptoms dissipated after a few days, but the shortness of breath and vision issues persisted for about a month. After about a month's time, the vision issues went away, but the shortness of breath continues to this day. I've been to the ER twice for the shortness of breath, and have been tested for C-19 SEVERAL times since the shot, all of which have been negative. My primary care Doc prescribed me a rescue inhaler to help with the breathing difficulty, which only slightly helps.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: On my first ER/Urgent Care Visit (Sep 17, 2021), no tests outside of a C-19 Nucleic Acid Amplification Test (NAAT) were performed. BP, heart rate, and temperature were all high, and I was still experiencing all of the symptoms listed above. On my second ER visit (1 Oct, 2021), my blood and urine was tested, and an EKG was performed. All came back normal. On Sep 30, 2021, my primary care Doc had a chest X-Ray done to rule out pneumonia, which showed no signs of any lung issues. I am still experiencing the shortness of breath, and am scheduled to see a host of specialists in the upcoming weeks to undergo cardio/pulmonary testing. More to follow on this...
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Daily Multi-Vitamin
Allergien: None
Vorherige Impfungen: -

VAERS 1800906

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: IL
Alter: 76,0
Geschlecht: F
Eingang: 20.10.2021
Impfdatum: 01.09.2021
Beginn: 18.10.2021
Tage bis Beginn: 47,0
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Chest X-ray normal Dyspnoea

Symptomtext

SHORTNESS OF BREATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: CEST X-RAY NO SIGNIFICANT FINDING
Aktuelle Erkrankungen: N/A
Vorgeschichte: Idiopathic pulmonary fibrosis, CRF on 3L home O2, HTN and DM
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 1798209

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: UT
Alter: 73,0
Geschlecht: M
Eingang: 19.10.2021
Impfdatum: 08.04.2021
Beginn: 10.07.2021
Tage bis Beginn: 93,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blood test Chest X-ray Computerised tomogram Dyspnoea Electrocardiogram Fatigue Pain

Symptomtext

Fatigue, shortness of breath and aches and pain.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: Bloodwork EKG Chest X-rays CT Scan
Aktuelle Erkrankungen: N/A
Vorgeschichte: Cholesterol
Andere Medikamente: Cholesterol Medicine
Allergien: Cortisone Cataphlax
Vorherige Impfungen: -

VAERS 1795290

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: CA
Alter: 63,0
Geschlecht: F
Eingang: 18.10.2021
Impfdatum: 05.09.2021
Beginn: 05.09.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Paraesthesia Pruritus

Symptomtext

Within 15 minutes of receiving the injection I began to feel itching in my chest and tingling in my legs. I had my husband purchase a Benadryl from the store and I took that. My chest itchiness resolved but the tingling in my legs has continued without ceasing for the last 6 weeks.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: I have an appointment to see the doctor but since they are very busy it is mot until November.
Aktuelle Erkrankungen: none
Vorgeschichte: Paroxysmal A-Fib Hypothyroid
Andere Medikamente: Levothyroxine Zertec Flecanide Alive vitamin
Allergien: ASA Latex Banana Avocado Kiwi Papaya Shell Fish
Vorherige Impfungen: -

VAERS 1779582

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: CA
Alter: 41,0
Geschlecht: F
Eingang: 12.10.2021
Impfdatum: 10.09.2021
Beginn: 11.09.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Abortion spontaneous Chills Condition aggravated Exposure during pregnancy Haemorrhage Joint range of motion decreased Muscle spasms Pyrexia Ultrasound antenatal screen abnormal Uterine spasm

Symptomtext

The night when I got the vaccine I felt a lot of spams on my neck all the way to my lower back. I could not turn my neck from left to right. I took Tylenol. I had the common side effects like fever and chills but I also had a lot of cramping and spasms in my lower pelvic area, I felt like it was my uterus. I started having bleeding. Even if I got up soon or put on force on those muscles to walk I would get spasms in that area. The bleeding kept going. I called the advised line and they said it was normal to bleed a little. I called back. I had an ultrasound because the bleeding continued and I ended up losing that pregnancy. I had my last ultrasound today and everything is cleared. Pregnancy history: I have 2 babies and I had a previous miscarriage prior to this. Estimated date of delivery: 05/04/2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: Ultrasound, miscarriage. Ultrasound, normal.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Prenatal vitamin
Allergien: Latex
Vorherige Impfungen: Flu vaccine, similar spasms

VAERS 1779242

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: TX
Alter: 62,0
Geschlecht: F
Eingang: 12.10.2021
Impfdatum: 12.04.2021
Beginn: 01.08.2021
Tage bis Beginn: 111,0
Dosis: 1
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Malaise Pneumonia viral

Symptomtext

Presented with worsening covid symptoms, diagnosed 4 days pta. Dx with viral PNA. Treated with abx, remdesivir, vit c and d. D/C home

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pneumonia viral
Hospital-Tage: 10,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1778805

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: KY
Alter: 34,0
Geschlecht: F
Eingang: 12.10.2021
Impfdatum: 23.08.2021
Beginn: 22.09.2021
Tage bis Beginn: 30,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Blood culture COVID-19 Chest X-ray normal Chills Cough Fatigue Hypotension Inflammatory marker decreased Lethargy Malaise Myalgia Pneumonia Pyrexia SARS-CoV-2 test positive Sepsis Tachycardia Urinary tract infection

Symptomtext

Pt is a 34 y.o. female with PMH significant for HIV not on treatment, bipolar disorder, schizoaffective disorder presented to hospital due to generalized lethargy/myagia with fever and cough. Noted to be hypotensive on initial presentation and was started on empiric antibiotics coverage for potential sepsis. COVID-19 Positive Constitutional: Positive for chills, fatigue and fever. HENT: Negative for congestion. Eyes: Negative for visual disturbance. Respiratory: Positive for cough. Negative for shortness of breath. #COVID-19 infection - Febrile and tachycardic on presentation with cough, fever and general malaise, but not hypoxic, good saturation on room air. - Unknown onset date of symptoms. - COVID PCR 9/22/21. - Blood cultures in lab. -Inflammatory markers are low. - Per chart reviewed, patient received J-J vaccine a month before. - Chest X ray without consolidations. - Not a Candidate for remdesivir or dexamethasone at the time. - Not a candidate for Barcitinib at this time. Discharge Disposition/Condition Disposition: Homeless, tentatively temporary shelter arranged Condition: Stable (s/sx potential problems absent or manageable)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hypotension
Hospital-Tage: 9,0
Labordaten: COVID PCR confirmed positive on 09/22/21
Aktuelle Erkrankungen: admitted to 9/4 to 9/6/21 for sepsis 2/2 UTI vs LLL PNA
Vorgeschichte: ? Anxiety disorder, unspecified Anxiety ? Asthma ? Bipolar 1 disorder ? Crohn disease ? Encounter for full-term uncomplicated delivery SVD (spontaneous vaginal delivery) ? Genital herpes ? GERD (gastroesophageal reflux disease) ? HIV disease ? Homeless ? OCD (obsessive compulsive disorder) ? Personal history of other mental and behavioral disorders History of depression ? Psychosis ? PTSD (post-traumatic stress disorder) ? Schizoaffective disorder ? Tobacco abuse disorder 9/22/2021
Andere Medikamente: olanzapine
Allergien: haloperidol ibuprofen trazodone
Vorherige Impfungen: -

VAERS 1771781

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: TX
Alter: 43,0
Geschlecht: M
Eingang: 08.10.2021
Impfdatum: 11.04.2021
Beginn: 28.07.2021
Tage bis Beginn: 108,0
Dosis: 1
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 pneumonia Malaise

Symptomtext

Presented with covid symptoms X 5 days, admitted with Covid PNA. J&J vaccine 3 months prior. Required O2 by nasal cannula. D/C home with oxygen. No PMH

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19 pneumonia
Hospital-Tage: 6,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1768617

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: KY
Alter: 55,0
Geschlecht: F
Eingang: 07.10.2021
Impfdatum: 09.04.2021
Beginn: 15.09.2021
Tage bis Beginn: 159,0
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Dyspnoea Fatigue Myalgia Nausea Pyrexia SARS-CoV-2 test positive Vaccine breakthrough infection Vomiting

Symptomtext

Breakthrough case after Covid vaccination. Dose # 1 4/9/2021. C/O fever, muscle aches, fatigue, cough , SOA, and nausea/vomiting/ onset 9/15/21

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: SARS CoV 2 Antigen Positive 9/15/2021
Aktuelle Erkrankungen: -
Vorgeschichte: COPD
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1768479

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: CA
Alter: 32,0
Geschlecht: M
Eingang: 07.10.2021
Impfdatum: 01.06.2021
Beginn: 01.06.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: unbekannt Erholt: nein

Amnesia Arrhythmia Cognitive linguistic deficit Dizziness Fatigue Feeling abnormal Gait disturbance Head discomfort Impaired work ability Mental impairment Motion sickness Muscle twitching Stress Vertigo

Symptomtext

Morning following injection, I experienced extreme dizziness and brain discomfort. Dizziness was bad enough to make walking difficult and even created motion sickness. 5 months later the dizziness has eased but still present, flying, driving, elevators, anything seems to trigger some form of dizziness. Hights of about 10 feet give bad vertigo, I am a pilot and aircraft mechanic and this creates an issue working on jets and I do not want to possibly loose my pilots medical. Brain fog is also long lasting still and makes mental clarity difficult which was never an issue until the day after the shot. My heart has created irregular heart rhythms, I have physical stress and tire easily and my muscles will shake and twitch after minimal effort. Biggest concern is dizziness and clarity and loss of short term memory, talking in front of large audiences for work has become difficult since my cognitive skills seem to have diminished from the lasting brain fog.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arrhythmia
Hospital-Tage: -
Labordaten: None yet
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1767779

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: KY
Alter: 46,0
Geschlecht: F
Eingang: 07.10.2021
Impfdatum: 31.08.2021
Beginn: 01.09.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chills Cough Dyspnoea Fatigue Feeling abnormal Headache Impaired work ability Insomnia Loss of personal independence in daily activities Myalgia Rash Urticaria

Symptomtext

Symptoms within a few hours to 1 day of receiving vaccine: Hives, chills, muscle pain, cough, shortness of breath, headache, sleeplessness/trouble sleeping, chronic fatigue, brain fog. Benadryl for the hives; rash went away after 2 days. Chills, muscle pain and cough went away after 3 days. I took ibuprofen for the muscle pain and headache.The shortness of breath persisted for 7 days and is still noticeable occasionally, even when just sitting. The headache, sleeplessness, chronic fatigue and brain fog have persisted from onset and I've had no relief. I continue to take ibuprofen or acetaminophen and started an OTC sleep aid the second week of symptoms. Nothing is helping. These symptoms are causing issues with job performance and in daily life.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: Eggs, Morphine
Vorherige Impfungen: Flu Vaccine, hives and trouble breathing.

VAERS 1761470

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: GA
Alter: 50,0
Geschlecht: M
Eingang: 05.10.2021
Impfdatum: 16.09.2021
Beginn: 18.09.2021
Tage bis Beginn: 2,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Chest pain Influenza like illness Pain in extremity Pyrexia

Symptomtext

chest pain, sore left arm, fever, flu-like symptoms

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Cancer
Andere Medikamente: Pegasis
Allergien: -
Vorherige Impfungen: -

VAERS 1753820

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201a21a

moderat

Staat: CA
Alter: 43,0
Geschlecht: F
Eingang: 01.10.2021
Impfdatum: 27.07.2021
Beginn: 28.07.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Condition aggravated Dizziness Fatigue Feeling abnormal Heart rate irregular Hypoaesthesia Memory impairment Palpitations Paraesthesia Tremor

Symptomtext

The night of the vaccine I started experiencing joint pain, but then severe brain fog. I literally did not know how to get home from work.I had to pull over and plan my route. This was a route I took daily. I continued to experience the brain fog and joint pain, coupled with extreme exhaustion for the next several days. I couldn't remember how to work basic equipment at work, nor how to get to very familiar destinations. The following Monday I was at work and began to feel very shaky and light headed and started getting numbness and tingling in my arms and hands. Extreme exhaustion came over me. I went home and just went to bed. I was awakened with severe heart pounding and an irregular heart rhythm, while still having the numbness and tingling. I contacted my dr. I just continued to hydrate and take aspirin and tylenol and sleep. My doctor encouraged me to report my symptoms to VAERS. I have since continued to have irregular heart rhythms . I also was exhausted for about 7 weeks post vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: fibromyalgia, hashimotos thyroid ,pcos
Andere Medikamente: LDN, topamax, synthroid, cytomel, occasional xanax & ambien for sleep
Allergien: morphine, hepatitis B vaccine - previous reaction
Vorherige Impfungen: Hepatitis B - approximately 2015. I woke up in the middle of the night on the day of the vaccine with severe chest pain and tri

VAERS 1745018

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: CA
Alter: 35,0
Geschlecht: M
Eingang: 29.09.2021
Impfdatum: 28.09.2021
Beginn: 28.09.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chills Dyspnoea Headache Hyperhidrosis Insomnia Nausea Pain Pyrexia Tremor

Symptomtext

Severe headache, fever, chills, shaking, sweating, lack of sleep, nausea, achy body, and difficulty breathing.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1708271

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: KY
Alter: 67,0
Geschlecht: F
Eingang: 29.09.2021
Impfdatum: 07.04.2021
Beginn: 28.09.2021
Tage bis Beginn: 174,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Angiogram pulmonary abnormal Arthralgia COVID-19 COVID-19 pneumonia Chills Dyspnoea Headache Lung infiltration Nausea Pyrexia SARS-CoV-2 test positive Staphylococcal bacteraemia Unevaluable event

Symptomtext

Hospitalized 9/28/21 - Recent hospitalization at outside hospital where symptoms initially started on 9/10/2021 it was noted to be COVID-19 positive on 9/15/2021. Patient did receive Johnson & Johnson vaccine in April 2021. Patient completed 5 days of remdesivir on 9/21/2021 along with 8 out of 10 days of Decadron. Her hospital course was complicated by staph hominis bacteremia and concerns for port infection. Her port was removed on 9/22/2021. Patient was discharged to complete dexamethasone. Patient states that she had been doing well up until 9/27. She began having joint pain in which she thought was secondary to the weather but then shortly after she had chills, nausea headache and a fever of 102. 9/28 she reports waking up and feeling more short of breath therefore she checked her O2 saturation and it was noted to be 77%. CTA of chest shows extensive bilateral infiltrates consistent with COVID-19 pneumonia. No evidence of pulmonary embolus

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19 pneumonia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1723108

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: MD
Alter: 47,0
Geschlecht: F
Eingang: 22.09.2021
Impfdatum: 04.05.2021
Beginn: 01.06.2021
Tage bis Beginn: 28,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia Blood test normal Carpal tunnel syndrome Hypoaesthesia Magnetic resonance imaging normal Mobility decreased Movement disorder Muscular weakness Nerve conduction studies Neurological examination abnormal Paraesthesia

Symptomtext

I have experienced numbness and loss of function on my left extremities. Both my arm and leg have loss of strength and "pins and needles" sensation. Some of all symptoms were present on my right side but have since largely resolved. My left side persists.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mobility decreased
Hospital-Tage: -
Labordaten: I had blood work done, it revealed no known issues. I had a Nerve Conduction Study performed on my left arm, leg and neck. The neurologist did not see anything of major concern but did say I had carpel tunnel syndrome on my left side, but I am right hand dominant. I had an MRI after the NCS and no major issues were revealed. I continue to have symptoms on my left side, a loss of strength and agility.
Aktuelle Erkrankungen: none
Vorgeschichte: None
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 1721503

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: KY
Alter: 48,0
Geschlecht: M
Eingang: 22.09.2021
Impfdatum: -
Beginn: 18.08.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia Fatigue Myalgia Paraesthesia Pyrexia

Symptomtext

TINGLING OF THE LOWER EXTREMITIES; WEAKNESS FELT ALL OVER THE BODY; BODY/MUSCLE ACHES; FEVER; TIREDNESS FELT ALL OVER THE BODY; This spontaneous report received from a consumer concerned a 48 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included: non-alcohol user, and non-smoker, and other pre-existing medical conditions included: The patient had no medical history. The patient had no known allergies. The patient had no history of drug abuse or illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, and batch number: 201A21A expiry: UNKNOWN) dose was not reported, administered on 18-AUG-2021 for prophylactic vaccination. No concomitant medications were reported. On 18-AUG-2021, the patient experienced tingling of the lower extremities. On 18-AUG-2021, the patient experienced weakness felt all over the body. On 18-AUG-2021, the patient experienced body/muscle aches. On 18-AUG-2021, the patient experienced fever. On 18-AUG-2021, the patient experienced tiredness felt all over the body. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever, and had not recovered from weakness felt all over the body, body/muscle aches, tingling of the lower extremities, and tiredness felt all over the body. This report was non-serious. This case, from the same reporter is linked to 20210938412.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Abstains from alcohol; Non-smoker
Vorgeschichte: Comments: The patient had no medical history. The patient had no known allergies. The patient had no history of drug abuse or illicit drug use.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1720542

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: CA
Alter: 32,0
Geschlecht: M
Eingang: 21.09.2021
Impfdatum: 21.09.2021
Beginn: 21.09.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Axillary pain Diarrhoea Musculoskeletal chest pain Pain in extremity

Symptomtext

Diarrhea, Left arm pain, Left side rib cage and armpit pain.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Musculoskeletal chest pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1718767

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: NE
Alter: 68,0
Geschlecht: F
Eingang: 21.09.2021
Impfdatum: 27.07.2021
Beginn: 28.07.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Burning sensation Condition aggravated Pain Pruritus Urticaria

Symptomtext

Severe hives from neck to upper thighs, severe burning and itching, occuring more than 24 hours after injection. Applied ice packs to relieve pain. Hives lasted over 13 hours. I had no over the counter remedy available. No other after effects. Resolved in time. This incident was extremely painful and I was not able to get to a medical facility for care. No other vaccines in the past several years or medical conditions at this time. I am on no medications for health issues and am perfectly healthy aside from allergies from antibiotics, dust mites and molds.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: penicillin, sulfa, augmentin, doxycycline
Vorherige Impfungen: hives from seasonal flu shot, last one received was in 2014 (approx)

VAERS 1718752

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: IL
Alter: 48,0
Geschlecht: F
Eingang: 21.09.2021
Impfdatum: 20.09.2021
Beginn: 20.09.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chills Dyspnoea Fatigue Mobility decreased Pain in extremity

Symptomtext

Patient reported that her left arm is in pain and can barely left it... she has chills and feels very short winded... also very tired

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: no
Aktuelle Erkrankungen: no
Vorgeschichte: no
Andere Medikamente: Ferous Sulfate Acetaminophen
Allergien: no
Vorherige Impfungen: -

VAERS 1716559

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: FL
Alter: 20,0
Geschlecht: M
Eingang: 20.09.2021
Impfdatum: 02.09.2021
Beginn: 12.09.2021
Tage bis Beginn: 10,0
Dosis: 1
Route/Site: SYR / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chest X-ray normal Chest pain Hypertension Productive cough

Symptomtext

Chest pains and violent pflemy cough, tachycardia, high blood pressure.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: Chest X-ray clear, given IV fluids to hydrate and Tylenol.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1715331

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: NY
Alter: 43,0
Geschlecht: F
Eingang: 20.09.2021
Impfdatum: 10.09.2021
Beginn: 10.09.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Arthralgia Asthenia Back pain Blood pressure increased Chest pain Computerised tomogram normal Ear discomfort Fatigue Feeling cold Gait disturbance Headache Hot flush Hypoaesthesia Inflammation Limb discomfort Mobility decreased Myalgia Nausea

Symptomtext

Received Vax 9.10.21 at 4:30pm. Immediately I felt pain/heaviness in my arm. Slight nauseous Within an hour, the forehead started tingling and gradually moved across the entire face and into the neck. Started flushing with water and started walking and moving my face and lips constantly. a cooling sensation began on both sides of my kidney area- from middle of back down to hips. shortly after my ears started plugging. Had a video dr visit around 7:00pm- was told as long as its on both sides of body, that she thought it was an inflammatory response to the vaccine. Told me to take ibuprofen and tylenol at the same time, then alternate them through the weekend, to eat a healthy meal and drink lots of water. face tingling subsided later that evening. Had extreme hot and cold flashes along with extreme body aches in joints and muscles. Eating and drinking were no problem. Saturday late afternoon to late evening was the worst for body aches. Very difficult to move or do anything. My left arm was extremely sore to the point that I couldn't touch or move it. Sunday morning I woke up and my entire left arm was tingling. Extremely tired and body aches were pretty high. Hot and cold flashes were slightly better. Around 3:00 in the afternoon, the whole left side of my face started going numb. Took my blood pressure which was 170s-/high 80/low 90. After 30-45 minutes, I decided to get checked out at ED as the tingling was severe only on my left arm and left face. A Cat scan confirmed no sign of stroke. Tingling lasted until Monday late morning and afternoon. Monday-Deep chest/back pain only on the left side. Extreme exhaustion and body aches. Hard to do much of anything. Tuesday aches were mostly gone along - had some mild hot and cold flashes, extremely fatigued, and slight headache all day. No relief from ibuprofen or nurtec. Wednesday tried walking with patient- Very difficult, extreme hot flashes and very exhausted. Mild headache persisted all of wednesday. Thursday- pain in both hips, low energy, arm still feels heavy, but pain is gone to touch and can move without pain.all other symptoms gone. Friday- woke up feeling normal again

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: Cat Scan09/12/21
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: Junel Fe Vit D Vit C
Allergien: Sulfa Amoxicillin
Vorherige Impfungen: -

VAERS 1715257

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: -
Alter: 60,0
Geschlecht: F
Eingang: 20.09.2021
Impfdatum: 03.05.2021
Beginn: 22.08.2021
Tage bis Beginn: 111,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Brain natriuretic peptide increased COVID-19 Chills Dyspnoea Orthopnoea Pyrexia SARS-CoV-2 test positive

Symptomtext

60 yo female pt s/p J&J COVID vaccination on 5/3. PMH significant for COPD, Bipolar, Hepatitis C, HTN, hx osteomyelitis s/p 2nd toe amputation, and polysubstance use disorder coming in with shortness of breath, fever, chills and found to have COVID 19. No evidence of PNA on imaging or exam. However, did have orthopnea and elevated BNP so concern there may have been component of CHF exacerbation on admit. Pt was started on remdesivir given comorbid risk factors. At discharge patient was hemodynamically stable and on room air.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: 3,0
Labordaten: SARS-COV-2 RAPID: Detected (8/22/2021)
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1710192

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: GA
Alter: 44,0
Geschlecht: M
Eingang: 18.09.2021
Impfdatum: 26.08.2021
Beginn: 26.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Bone disorder Chills Decreased appetite Dyspnoea Fatigue Feeling cold Hot flush Hypopnoea Joint noise Musculoskeletal discomfort Pain Pain in extremity Sleep disorder Temperature intolerance

Symptomtext

Around 8PM I started having chills. Within an hour I was achy and the chills were terrible. I wore freezing winter weather clothing under 4 blankets and was still freezing. I experienced shortness of breath and started using my CPAP even when awake about half the time. I walked with a hunch very slowly and my knees and feet crunched. I couldn't sleep for more than about 30 minutes at a time and it took a lot of energy to roll over or get up. By 6AM, I couldn't even try to sleep anymore and started drinking constant hot black tea with a splash of milk. I had lost my appetite and only ate small amounts until Tuesday, July 31. The extreme chills started alternating between bad chills and burning up for about 12 hours but most of the time I was chilly and wore layers. My joints and bones felt loose and I still walked with a hunch and around 4PM on Aug 27 I was walking on a hardwood floor when I felt a crunch in the instep of my right foot and it started hurting bad. To this day (Sept 17) it still hurts although not as bad but occasionally I'll be walking normally and I'll feel a pop and it hurts like crazy for a few seconds. The chills started to die down slowly and the hot flashes became less often for the next two days and by dinner time on Sunday, Aug 29 I was only slightly chilly and no longer walked with a hunch but did walk slightly slower than normal. Normally I feel fine in temperatures between about 60 and 80 degrees Fahrenheit but by this point I wasn't comfortable outside of about 70-75. Over the past 3 weeks my comfortable temperature range has widened a bit and as I write this my house is 68 degrees and I'm slightly cold when I normally wouldn't be. My appetite restored by Tuesday and the only night I had a hard time sleeping thru was the first night. As of Wednesday, Sept 15 I'd say I felt close enough to my pre-vaccination self to say I've fully recovered. I'm not achy anymore but my energy level is only about 85%-90% of what it was pre-vaccination and my right foot still hurts sometimes when I walk. I've noticed that I still get winded quicker than I did pre-vaccination and fatigue quicker when walking but I'm no longer shallow breathing and haven't since the day after my vaccination. I think that's about as thorough as I can be.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Men's one a day vitamin, zinc supplement and turmeric with black pepper supplement
Allergien: None
Vorherige Impfungen: -

VAERS 1708460

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: -
Alter: 29,0
Geschlecht: M
Eingang: 17.09.2021
Impfdatum: 16.09.2021
Beginn: 16.09.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Altered visual depth perception Arthralgia Chills Fatigue Headache Impaired work ability Migraine Myalgia Neuralgia Pain Sleep disorder

Symptomtext

About 35-40 minutes after the vaccine I started to experience altered sensory perception and fatigue. It became significant enough I went to bed early. I woke up in the middle of the night with a migraine type headache, full body fatigue, myalgias, neuralgias, and arthralgias. I called out of work and spent the rest of the day shivering and in full body aches. I took 600mg ibuprofen in the morning and again in the evening.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Migraine
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: IBS - Mixed type
Andere Medikamente: None
Allergien: No known food or drug allergies
Vorherige Impfungen: -

VAERS 1706569

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: GA
Alter: 32,0
Geschlecht: M
Eingang: 17.09.2021
Impfdatum: -
Beginn: 08.09.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Blood pressure measurement Body temperature Cardiac flutter Chills Dysgeusia Dyspnoea Fatigue Flushing Headache Heart rate Hot flush Hyperhidrosis Hypoaesthesia Injection site pain Injection site warmth Lethargy Pain

Symptomtext

HEART FLUTTERING; HOT FLASH; PROFUSELY SWEATING; LETHARGIC; SPEAKING SLOWER THAN USUAL AND NOT IN COMPLETE SENTENCES; SHAKINESS; BODY ACHES; WEIRD, INDESCRIBABLE TASTE IN HIS MOUTH; HEAVY AND LABORED BREATHING; FLUSHED FACE; SLIGHTLY SWOLLEN TONGUE; INJECTION SITE ARM WAS WARM TO TOUCH; LEFT ARM PAIN; SEVERE CHILLS; SEVERE JOINT PAIN; EAR RINGING; HIGH FEVER; TINGLING SENSATION IN BOTH LEGS AND ARMS WHILE SITTING UPRIGHT; INJECTION SITE ARM WAS EXTREMELY TENDER; SEVERE HEADACHE; NUMBNESS IN BOTH LEG AND ARM ON SITTING; BECAME EXHAUSTED AGAIN; This spontaneous report received from a patient concerned a 32-year-old white male of unknown ethnicity. The patient's height, and weight were not reported. The patient's past medical history included: covid-19 infection, and concurrent conditions included: alcohol use, and non-smoker, conditions included: The patient had no known drug allergy and no drug abuse or illicit drug use. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: 201A21A, expiry: 21-SEP-2021) dose was not reported, 1 total administered on 08-SEP-2021 on left arm for prophylactic vaccination. No concomitant medications were reported. On 08-SEP-2021, in afternoon patient began to experience a severe headache, shortly after headache he had severe chills (felt like freezing in winter with no clothes on). Within 20 minutes of chills, he had a hot flash and began to profusely sweat. By 14:00 patient had a high fever at 102.6 Fahrenheit (F). Patient felt that his heart was fluttering. He went to the clinic, and he had a high heart rate with no beats per minute number. The healthcare professional at the base sent him home to rest. Patient wished to be seen by a healthcare professional due to these unforeseen side effects, because the fever should not have been that high. At approximately 15:30 to 16:00 was soaking in pool bath in Epsom salt. He was lethargic, speaking slower than usual and not in complete sentences. The nurse recommended him not go to urgent care and continue home therapy with over the counter Motrin for fever. At 16:30 he was lethargic, had heavy and labored breathing (respiration rate 12), face was flushed even though he washed with cool water. Patient vital signs were taken body temperature was still 102.6 Fahrenheit (F) although he was soaking in the pool bath for an hour. Heart rate was 118 beats per minute, blood pressure was 128/62 mmHg. This was all while patient was sitting and resting on the chair, with no exertion. Given 400mg of Motrin at 17:15. At 18:00, patient complained of ear's ringing for the past 2 hours, which may have started at 16:00. Only reported of ear ringing, because the ringing was unbearable. An hour after taking Motrin, body temperature was 101.4 Fahrenheit (F) and heart rate was 84 beats per minute. headache was still persistent, but felt like it was moving from one area to another. Patient stated that headache was painful by the frontal lobe area of his head. Complained of shakiness. He took a nap. At about 19:00, he woke up and ate a few snacks, then became exhausted again and fell asleep. Body temperature was 98.9 Fahrenheit (F) and heart rate 82 beats per minute. Temperature was decreasing, but heart rate was not normal at about 60 beats per minute. Patient complained that headache was still constant and now had left arm pain, body aches and severe joint pain in his entire body. He experienced a weird, indescribable taste in his mouth. His tongue was slightly swollen, but was not affecting his swallowing very much. Injection site on left arm was extremely tender and warm to touch. Nurse advised that him to seek treatment as soon as possible within 24 hours. Patient was not sure if he wanted to go to emergency room. At 22:00, patient woke up and ate a bit of homemade chicken and rice soup. He fell back to sleep after that. At 22:40, he was still complaining of headache and joint pain throughout body, and pain at injection site was a 5 out of 10. Sensation of tingling in both legs and arm started, while sitting upright. Tingling went away when he laid flat on his back and when he stood up, with mild improvement from the tingling sensation. Every time he sat, the sensation in both his legs and arms would go numb again. Body temperature was 97.4 Fahrenheit (F) and heart rate was 69 beats per minute. Patient went to bed for the night and at 2 AM. Vital signs were checked again. Body temperature dropped to 96.3 Fahrenheit (F) and heart rate was 74 beats per minute. Patient went back to sleep and woke up at 6:00 AM, body temperature was at 96.1 Fahrenheit (F) and heart rate was 65 beats per minute. Left arm pain decreased to a 4 out of 10. Patient went again to medical clinic at 9:30 AM on 10-SEP-2021. Patient looked fine that morning. The action taken with covid-19 vaccine was not applicable. The patient recovered from heart fluttering, hot flash, profusely sweating, lethargic, speaking slower than usual and not in complete sentences, shakiness, body aches, weird, indescribable taste in his mouth, heavy and labored breathing, flushed face, slightly swollen tongue, severe chills, severe joint pain, ear ringing, high fever, and tingling sensation in both legs and arms while sitting upright on 10-SEP-2021, recovered with sequelae from severe headache on 10-SEP-2021, was recovering from injection site arm was extremely tender, and left arm pain, and the outcome of injection site arm was warm to touch, numbness in both leg and arm on sitting and became exhausted again was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20210925879-COVID-19 VACCINE-Heart fluttering. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: Test Date: 20210908; Test Name: Body temperature; Result Unstructured Data: 102.6 F; Test Date: 20210908; Test Name: Heart rate; Result Unstructured Data: 60 {beats}/min; Test Date: 20210908; Test Name: Blood pressure; Result Unstructured Data: 128/62 mmHg; Test Date: 20210908; Test Name: Body temperature; Result Unstructured Data: 101.4 F; Comments: an hour after taking motrin body temperature decreased; Test Date: 20210908; Test Name: Heart rate; Result Unstructured Data: 84 {beats}/min; Comments: an hour after taking motrin heart rate decreased; Test Date: 20210908; Test Name: Body temperature; Result Unstructured Data: 98.9 F; Test Date: 20210908; Test Name: Heart rate; Result Unstructured Data: 82 {beats}/min; Comments: Temperature was decreasing, but heart rate was not normal at about 60 beats per minute; Test Date: 20210908; Test Name: Pain scale; Result Unstructured Data: 5 out of 10; Test Date: 20210908; Test Name: Body temperature; Result Unstructured Data: 97.4 F; Test Date: 20210908; Test Name: Heart rate; Result Unstructured Data: 69 {beats}/min; Test Date: 20210908; Test Name: Heart rate; Result Unstructured Data: 118 {beats}/min; Test Date: 20210908; Test Name: Respiratory rate; Result Unstructured Data: 12 {beats}/min; Test Date: 20210909; Test Name: Body temperature; Result Unstructured Data: 96.1 F; Test Date: 20210909; Test Name: Heart rate; Result Unstructured Data: 65 {beats}/min; Test Date: 20210909; Test Name: Pain scale; Result Unstructured Data: 4 out of 10; Test Date: 20210909; Test Name: Heart rate; Result Unstructured Data: 74 {beats}/min; Test Date: 20210909; Test Name: Body temperature; Result Unstructured Data: 96.3 F
Aktuelle Erkrankungen: Alcohol use (1 BEER IN EVERY 6 MONTH); Non-smoker
Vorgeschichte: Medical History/Concurrent Conditions: COVID-19; Comments: The patient had no known drug allergies and no drug abuse or illicit drug use
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1706531

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: IL
Alter: -
Geschlecht: F
Eingang: 17.09.2021
Impfdatum: -
Beginn: 01.09.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Back pain Fatigue Feeling abnormal Headache Injection site pain Migraine Muscle twitching Pain assessment Pain in extremity SARS-CoV-2 test Vital signs measurement

Symptomtext

SEVER MIGRAINE; ARMS WERE HURTING SO MUCH / ARM PAIN; HEADACHES; EXHAUSTED; PAIN AT SITE OF INJECTION; LOWER BACK PAIN; TWITCHING ON LOWER RIGHT HIP OR AS IF SOMETHING WAS KICKING HER; BODY WAS IN A FIGHT MODE; This spontaneous report received from a patient concerned a 51 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, expiry: 05-SEP-2021) dose was not reported, administered on 03-SEP-2021 09:30 for prophylactic vaccination. No concomitant medications were reported. On SEP-2021, the patient experienced lower back pain. On SEP-2021, the patient experienced twitching on lower right hip or as if something was kicking her. On SEP-2021, the patient experienced body was in a fight mode. On SEP-2021, the patient experienced pain at site of injection. On 03-SEP-2021, the patient experienced headaches. On 03-SEP-2021, the patient experienced exhausted. On 04-SEP-2021, the patient experienced arms were hurting so much / arm pain. On 12-SEP-2021, the patient experienced sever migraine. Laboratory data included: COVID-19 virus test (not provided) Negative, and Pain scale (not provided) 8/10, and Vital signs measurement (not provided) stable. Treatment medications included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sever migraine on SEP-2021, lower back pain, arms were hurting so much / arm pain, and exhausted, and headaches on 03-SEP-2021, and the outcome of twitching on lower right hip or as if something was kicking her, pain at site of injection and body was in a fight mode was not reported. This report was non-serious. This case, from the same reporter is linked to 20210924029.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Migraine
Hospital-Tage: -
Labordaten: Test Date: 20210912; Test Name: COVID-19 virus test; Result Unstructured Data: Negative; Test Date: 20210912; Test Name: Vital signs measurement; Result Unstructured Data: stable; Test Date: 20210912; Test Name: Pain scale; Result Unstructured Data: 8/10
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1705269

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: -
Alter: 36,0
Geschlecht: F
Eingang: 16.09.2021
Impfdatum: 16.09.2021
Beginn: 16.09.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Feeling hot Posture abnormal Tremor

Symptomtext

36 year old female airport employee with medical history signficant for chronic focal seizure (diagnosed for 15 years, taking lamotrigine, gabapentin, and pregabilin daily), transient hypertension, and food allergies who presents for Johnson and Johnson vaccine.. She was given vaccine to her left arm and was sent to the observation area. Approximately 10 minutes after vaccination, patient was seen slouched over and slightly shaking. She was responsive with nods and simple yes/no questions. Pt reported ?feeling hot?, ice pack applied to back of neck until she felt more comfortable. No loss of consciousness.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Tremor
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: -
Vorgeschichte: Epilepsy
Andere Medikamente: Lamotrigine, pre-gabalin, and gabapentin
Allergien: Tropical fruits and "a plethora of things" (carries epi-pens)
Vorherige Impfungen: -

VAERS 1704831

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: WA
Alter: 32,0
Geschlecht: F
Eingang: 16.09.2021
Impfdatum: 15.09.2021
Beginn: 15.09.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chills Decreased appetite Migraine Pain Pyrexia Tremor

Symptomtext

Fever, chills, uncontrollable shaking. Migraine, extreme body aches, lasting over 24 hours. Loss of appetite.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Migraine
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Covid positive 30 days prior to vaccination
Vorgeschichte: None
Andere Medikamente: Vitamin D daily supplement
Allergien: None
Vorherige Impfungen: -

VAERS 1700758

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: CA
Alter: 32,0
Geschlecht: M
Eingang: 15.09.2021
Impfdatum: 25.06.2021
Beginn: 04.07.2021
Tage bis Beginn: 9,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Computerised tomogram head Electrocardiogram Fatigue Laboratory test Migraine Vomiting

Symptomtext

I experienced migraine headaches after my vaccine. I went to the ER got a lab work, EKG test, CT scan of the head on 07-0-2021. On 07-05-2021 I went to urgent care I got IV because I was vomiting a lot. My symptoms of vomiting and migraines stopped around 07-17-2021. I also had extreme fatigue that kicked in after that and that fully subsided on 07-31-2021. I have no symptoms today.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Migraine
Hospital-Tage: -
Labordaten: EKG CT scan of the head EKG lab work
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1700274

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: CO
Alter: 35,0
Geschlecht: F
Eingang: 15.09.2021
Impfdatum: 20.08.2021
Beginn: 21.08.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: unbekannt Erholt: nein

Abdominal pain upper Acoustic stimulation tests abnormal Anxiety Arthralgia Balance disorder Balance test Cold sweat Cough Deafness Decreased appetite Diarrhoea Dizziness Dizziness postural Dyskinesia Dysmenorrhoea Ear discomfort Fall Fatigue

Symptomtext

Immediate ache in Left arm with some nerve tingling into fingertips 2-4. 8/21/21 woke with full body ache and fatigue. Aching pain in all joints predominantly settling in both hips and SI joints. Fatigue progressed all day. headache developed by 6 pm. Experienced mild nausea with each meal. 8/22/21 - Ache at injection sight persisted. Mild stomach ache with first meal. 4 pm notice involuntary mild flexor contraction (UMN lesion) of Left shoulder, elbow and wrist with internal rotation. 6pm mild constriction in throat leading to cough when eating. Insomnia. 8/23/21 Mild nausea with all meals. Light headed and dizzy when moving from sitting to standing. Warm/ clammy - temperature 99.1. Left shoulder contraction continues. 8/24/21 Moderate anxiety, continued "hot flashes" of 99.1 throughout the day. Left shoulder contraction. Loss of hearing due to feeling of fullness in both ears. 8/25/21 No sensation of hunger or desire to eat. Difficulty with focusing eyes. Left neck contracture, continued Left shoulder contracture. Continued hot flashes (99.4), IBS- like stomach flare with diarrhea. 8/26/21 No sensation of hunger or desire to eat. Period began 3 days early with severe cramping (atypical for me). 8/27/21 No sensation of hunger or desire to eat. Increased constriction in throat and irritation on tongue. Uncontrolled left cervical rotation. Neck pain and imbalance. Began leaning and falling to the left. Symptoms continued as above until 9/5/21 Severe Nausea and IBS. No sensation of hunger or desire to eat. 9/8/21 Complete drop of Vestibular Ocular reflex in all directions. I experience quick bouts of dizziness every 5-10 min in any direction independent of movement or body position. Motion sickness (I have no history of motion sickness prior), fatigue, No sensation of hunger or desire to eat.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: Sought care from Doctor of Chiropractic with a Diplomate in Functional Neurology. 8/27/21 Tested cerebellar functioning, Cranial nerve function. Functional tests of coordination and balance demonstrated inability to stand with eyes closed without falling.Hearing test with auditory app demonstrated 15% reduced hearing in each ear. 9/8/21 Eye movement reflexes with body movement - this showed no VOR reflex in any direction. Functional tests of coordination and balance demonstrated inability to stand with eyes closed without falling.
Aktuelle Erkrankungen: None
Vorgeschichte: History of neurologic injury due to H. Flu meningitis at 7 mo of age. All symptoms resolved as of January 2021
Andere Medikamente: Magnesium, Vitamin D, Vitamin B complex, Multivitamin
Allergien: Allergies to Codine, gluten and nickle
Vorherige Impfungen: -

VAERS 1699118

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: MI
Alter: 27,0
Geschlecht: M
Eingang: 15.09.2021
Impfdatum: 01.05.2021
Beginn: 25.08.2021
Tage bis Beginn: 116,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Dyspnoea N-terminal prohormone brain natriuretic peptide increased

Symptomtext

Difficulty breathing, persistent for three weeks

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: Blood test showed >600 pg/mL nt-probnp levels
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1697185

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: IL
Alter: 68,0
Geschlecht: F
Eingang: 14.09.2021
Impfdatum: 13.09.2021
Beginn: 13.09.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Confusional state Dyspnoea Nausea Palpitations Pharyngeal swelling Thirst

Symptomtext

Client became nauseous,felt like throat was swelling,dyspneic,palpitatipns,thirsty,confused as to location. Oxygen started at 4liters, epinephrine 0.3mg given right lateral thigh at 1139. Placed on mat in supine position with legs elevated. BP 166/95,HR 112,R22 at 1138. Client was able to speak without difficulty,reports feeling as if is running,leg tremors noted. Pulse ox range from 95 to99%. 911 called at 1136,arrived at 1150. Client reported feeling A little better at 1145, VS 140/82,p 111,resp18 at this time. 1147 ambulance here,started saline lock at 1150,Benadryl 50 mg given IVP by EMT. Client placed on g,urney and taken to hospital ER.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: unknown
Aktuelle Erkrankungen: unknown
Vorgeschichte: unknown
Andere Medikamente: Unknown
Allergien: Morphine,unknown other allergies
Vorherige Impfungen: -

VAERS 1696488

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201a21a

moderat

Staat: CA
Alter: 55,0
Geschlecht: F
Eingang: 14.09.2021
Impfdatum: 12.09.2021
Beginn: 13.09.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Chest pain Dizziness Fatigue Injection site pain Lymphadenopathy Pain in extremity Paraesthesia Pyrexia

Symptomtext

Fever of 101 degrees Tingling in left arm from shoulder to fingers Swollen lymph nodes under left arm Severe aching pain from left shoulder across chest and under the left arm Extreme fatigue Dizziness, light headedness Arm tenderness at injection site

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: Erythromycin
Vorherige Impfungen: -

VAERS 1695525

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: MO
Alter: 75,0
Geschlecht: M
Eingang: 13.09.2021
Impfdatum: 20.07.2021
Beginn: 20.07.2021
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Arthritis Condition aggravated Peripheral swelling

Symptomtext

Janssen COVID-19 Vaccine EUA. I could not possibly fill out all the questions in 15 minutes. My usual arthritis joints were affected to an extent more painful than usual especially my right arm. The pain was akin to when both my rotator cuffs were torn. Some swelling in my hands. It lasted six weeks winding down as time went by.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1694941

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: -
Alter: 72,0
Geschlecht: M
Eingang: 13.09.2021
Impfdatum: 07.04.2021
Beginn: 03.09.2021
Tage bis Beginn: 149,0
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 pneumonia

Symptomtext

Hospitalization for COVID pneumonia.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19 pneumonia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1693150

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: CA
Alter: 58,0
Geschlecht: M
Eingang: 11.09.2021
Impfdatum: 19.06.2021
Beginn: 20.06.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Aggression Chills Condition aggravated Feeling cold Headache Personality change Sleep disorder

Symptomtext

Three, maybe four: 1. Sleep pattern, almost right away, I had a sleep pattern I had not had before. I would sleep maybe ten or fifteen minutes, wake, be awake for a few minutes, then wake again ten or fifteen minutes later. Eventually, a month or so, this went away. 2. Headache, I have headaches since I was maybe three our four, fell down a set of stairs. Usually, when I feel a headache starting, I had maybe a minute or two to take some over-the-counter medication. After the shot, that changed to maybe ten to fifteen seconds, the headache came much faster and with sharp pain. Eventually, a month or so, this went away. 3. Chills, I get cold, shoulders mostly, a lot, after shot, this, even in the Summer, happens more often and this continues, even into early September 2021. 4. This one is much harder to understand, for me, but the immediate weeks after the shot, I had a really bad attitude. I was mean to at least one person and this is not my usual behavior. This has caused me a lot of grief and I really can only say an expression, such and such (person's name) is a mean drunk. I guess I became somehow mean after the shot. I really have no idea of what happened. This has gone now, but some of the outcome of being mean still persist. Once you are mean to someone, it is hard to repair. I do not believe this would have happened but for the shot.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None known
Vorgeschichte: None known
Andere Medikamente: Vitamins: B, C, D; Magnesium
Allergien: None known
Vorherige Impfungen: Flu shot, right arm, I lost much of the strength in my right arm. Age 57, this happened or three months, I started to recover,

VAERS 1692876

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: VA
Alter: 36,0
Geschlecht: M
Eingang: 11.09.2021
Impfdatum: 16.05.2021
Beginn: 21.05.2021
Tage bis Beginn: 5,0
Dosis: UNK
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood test normal Cardiac function test normal Chest discomfort Chest pain Ear discomfort Headache Hypoaesthesia Pain Pain in jaw Paraesthesia Visual impairment

Symptomtext

After five days, the left side of my body (foot, arm, face) started going numb, my chest tightened, and my vision started to narrow. The numbness did not show noticeable drooping but the tingling lasted over two weeks. The pain in the left side of my chest lasted for over a month. My ears popped constantly for about over 2 months and had a headache impacting my right temple and the back right side of my head. I had some sharp pain to my chest that radiated to my jaw at about the 2+ month mark. I went in to the emergency clinic at the deployed hospital to get a heart reading. Results looked normal.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: Received blood test from Hospital on 5/24/21. There were no signs of blood clots.
Aktuelle Erkrankungen: N/A
Vorgeschichte: -
Andere Medikamente: Multi-vitamin and fish oil
Allergien: No known allergies
Vorherige Impfungen: -

VAERS 1691342

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: IL
Alter: 20,0
Geschlecht: F
Eingang: 11.09.2021
Impfdatum: -
Beginn: 08.09.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chest pain Paraesthesia Pruritus

Symptomtext

ITCHINESS OVER THE ENTIRE BODY; CHEST PAIN FELT LIKE PINS AND NEEDLES; PINS AND NEEDLES FEELING OVER THE LEFT SIDE OF THE BODY; This spontaneous report received from a patient concerned a 20 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient had no change in lifestyle. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: 201A21A, and expiry: 21-SEP-2021) dose was not reported, administered on 08-SEP-2021 08:50 for prophylactic vaccination. No concomitant medications were reported. On 08-SEP-2021, the patient experienced itchiness over the entire body. On 08-SEP-2021, the patient experienced chest pain felt like pins and needles. On 08-SEP-2021, the patient experienced pins and needles feeling over the left side of the body. The action taken with covid-19 vaccine was not applicable. The patient had not recovered from itchiness over the entire body, pins and needles feeling over the left side of the body, and chest pain felt like pins and needles. This report was non-serious.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: The patient had no change in lifestyle.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1691304

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: HI
Alter: 72,0
Geschlecht: F
Eingang: 11.09.2021
Impfdatum: -
Beginn: 23.08.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Abdominal pain Body temperature Chest pain Chills Diarrhoea Fatigue Gastrointestinal disorder Headache Laryngitis Myalgia Nasal congestion Pharyngeal ulceration Pyrexia Rash erythematous Rhinorrhoea Skin discolouration Tachycardia

Symptomtext

LARYNGITIS/ HOARSE VOICE; CONGESTION; RUNNY NOSE; DIARRHEA; 15 BRIGHT RED DOTS AROUND YELLOW CIRCLE, LATER DOTS WERE BROWN; YELLOW RING ON LEFT FOREARM SIZE OF A QUARTER; ERYTHEMA AND SORES ON THROAT, APPEARED BRIGHT RED WITH 3 INCH AREAS WITH LITTLE BLISTER IN BACK OF MOUTH; GASTROINTESTINAL SYMPTOMS; BAD ABDOMINAL CRAMPING AFTER EATING AND ABDOMINAL PAIN; CHILLS; MUSCLE PAIN; FEVER; TIREDNESS- FALLS ASLEEP WHILE SITTING, WORKING, NOT NORMAL; HEADACHE; RAPID HEART BEAT/ TACHYCARDIA SHORTLY AFTER VACCINATION; CHEST PAIN; This spontaneous report received from a patient concerned a 72 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: arrhythmias, urinary tract infection, low blood pressure, biliary disease, alcoholic, non smoker, and red spots over body, and other pre-existing medical conditions included: Patient had no drug abuse or illicit drug usage. The patient experienced drug allergy when treated with clindamycin, cyproheptadine hydrochloride, benzylpenicillin, sulfacetamide sodium/sulfadiazine/sulfadimidine/sulfamerazine, tetracycline, and vancomycin. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported and batch number: 201A21A expiry: UNKNOWN) dose was not reported, administered on 23-AUG-2021 for prophylactic vaccination. Concomitant medications included bnt 162 for prophylactic vaccination. On 23-AUG-2021, the patient experienced rapid heart beat/ tachycardia shortly after vaccination. On 23-AUG-2021, the patient experienced chest pain. On 23-AUG-2021, the patient experienced headache. On 24-AUG-2021, the patient experienced erythema and sores on throat, appeared bright red with 3 inch areas with little blister in back of mouth. On 24-AUG-2021, the patient experienced gastrointestinal symptoms. On 24-AUG-2021, the patient experienced bad abdominal cramping after eating and abdominal pain. On 24-AUG-2021, the patient experienced chills. On 24-AUG-2021, the patient experienced muscle pain. On 24-AUG-2021, the patient experienced fever. On 24-AUG-2021, the patient experienced tiredness- falls asleep while sitting, working, not normal. Laboratory data included: Body temperature (NR: not provided) 99.8 F. On 02-SEP-2021, the patient experienced yellow ring on left forearm size of a quarter. On 02-SEP-2021, the patient experienced 15 bright red dots around yellow circle, later dots were brown. On an unspecified date, the patient experienced laryngitis/ hoarse voice, congestion, runny nose, and diarrhea. Treatment medications (dates unspecified) included: ibuprofen, acetylsalicylic acid, and paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from rapid heart beat/ tachycardia shortly after vaccination on 23-AUG-2021, chest pain on 24-AUG-2021, gastrointestinal symptoms, bad abdominal cramping after eating and abdominal pain, diarrhea, chills, and muscle pain, headache on AUG-2021, and fever on 01-SEP-2021, was recovering from tiredness- falls asleep while sitting, working, not normal, and erythema and sores on throat, appeared bright red with 3 inch areas with little blister in back of mouth, had not recovered from laryngitis/ hoarse voice, yellow ring on left forearm size of a quarter, and 15 bright red dots around yellow circle, later dots were brown, and the outcome of congestion and runny nose was not reported. This report was non-serious.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: Test Date: 20210824; Test Name: Body temperature; Result Unstructured Data: 99.8 F
Aktuelle Erkrankungen: Alcohol use (1 glass, couple of ounces of red wine 3 times a week.); Arrhythmia (arrhythmias after Pfizer COVID-19 hormone cream / ointment.); Generalized rash (Patient had red spots over body for years and HCP following up.); Hepatobiliary disease (Biliary disease, controlled with diet.); Low blood pressure; Non-smoker; Urinary tract infection (hormone cream/oint, UTIs (once a year).)
Vorgeschichte: Comments: Patient had no drug abuse or illicit drug usage.
Andere Medikamente: BNT 162
Allergien: -
Vorherige Impfungen: -

VAERS 1659249

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: TX
Alter: -
Geschlecht: F
Eingang: 11.09.2021
Impfdatum: -
Beginn: 21.08.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Body temperature Fatigue Feeling abnormal Frustration tolerance decreased Hallucination Chills Cough Dehydration Heart rate increased Monoclonal antibody unconjugated therapy Laboratory test Nausea Pyrexia X-ray Pain

Symptomtext

FRUSTRATED; NAUSEA; HALLUCINATION; VERY EXHAUSTED; FEELING BAD; FEVER; This spontaneous report received from a patient concerned a 56 year old female and unspecified ethnic origin. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient reported no prior contact/ exposure to anyone infected with COVID-19. The patient was not pregnant at the time of vaccination. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration not reported, batch number: 201A21A, expiry: 21-SEP-2021) dose was not reported, 1 total administered to left arm on 18-AUG-2021 for prophylactic vaccination. No concomitant medications were reported. On AUG-2021, Laboratory data included: Body temperature (NR: not provided) 100 Fahrenheit (F). On 21-AUG-2021, 3 days after receiving the COVID-19 vaccine, she started feeling bad. She began to have a fever that maybe reached 102 F. On AUG-2021, she took treatment medication: Day/Nyquil (dextromethorphan hydrobromide/paracetamol/pseudoephedrine hydrochloride) for fever which brought her fever down to around 100 F. On 26-AUG-2021, after about 5 days of feeling bad, she was very exhausted and visited urgent care. MD did Laboratory data included: Lab test (NR: not provided) not reported, and X-ray (NR: not provided) not reported and while she did not specify breakthrough COVID-19 infection, she was treated with antibody infusions. On 31-AUG-2021, (for the last 3 days when she was reporting) she stated that she was feeling a little better since her fever went down, but she was still generally feeling bad, like she was poisoned and has been experiencing nausea and hallucinations. She describes the hallucinations as feeling really weird like she was in another world. It has been 15 days since she received her vaccination and on 03-SEP-2021, she was frustrated that she was still feeling this bad. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from fever, had not recovered from hallucination, feeling bad, frustrated, nausea, and the outcome of very exhausted was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20210908135- Covid-19 vaccine ad26.cov2.s- Hallucination, feeling bad, frustrated. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). 20210908135- Covid-19 vaccine ad26.cov2.s- Nausea, fever, very exhausted. This event(s) is labeled per Agency and is therefore considered potentially related.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dehydration
Hospital-Tage: -
Labordaten: Test Date: 202108; Test Name: Body temperature; Result Unstructured Data: 100 F; Test Date: 20210821; Test Name: Body temperature; Result Unstructured Data: 102 F; Test Date: 20210826; Test Name: Lab test; Result Unstructured Data: not reported; Test Date: 20210826; Test Name: X-ray; Result Unstructured Data: not reported
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: The patient reported no prior contact/ exposure to anyone infected with COVID-19.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1659249

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: TX
Alter: -
Geschlecht: F
Eingang: 11.09.2021
Impfdatum: -
Beginn: 21.08.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Body temperature Fatigue Feeling abnormal Frustration tolerance decreased Hallucination Chills Cough Dehydration Heart rate increased Monoclonal antibody unconjugated therapy Laboratory test Nausea Pyrexia X-ray Pain

Symptomtext

FRUSTRATED; NAUSEA; HALLUCINATION; VERY EXHAUSTED; FEELING BAD; FEVER; This spontaneous report received from a patient concerned a 56 year old female and unspecified ethnic origin. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient reported no prior contact/ exposure to anyone infected with COVID-19. The patient was not pregnant at the time of vaccination. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration not reported, batch number: 201A21A, expiry: 21-SEP-2021) dose was not reported, 1 total administered to left arm on 18-AUG-2021 for prophylactic vaccination. No concomitant medications were reported. On AUG-2021, Laboratory data included: Body temperature (NR: not provided) 100 Fahrenheit (F). On 21-AUG-2021, 3 days after receiving the COVID-19 vaccine, she started feeling bad. She began to have a fever that maybe reached 102 F. On AUG-2021, she took treatment medication: Day/Nyquil (dextromethorphan hydrobromide/paracetamol/pseudoephedrine hydrochloride) for fever which brought her fever down to around 100 F. On 26-AUG-2021, after about 5 days of feeling bad, she was very exhausted and visited urgent care. MD did Laboratory data included: Lab test (NR: not provided) not reported, and X-ray (NR: not provided) not reported and while she did not specify breakthrough COVID-19 infection, she was treated with antibody infusions. On 31-AUG-2021, (for the last 3 days when she was reporting) she stated that she was feeling a little better since her fever went down, but she was still generally feeling bad, like she was poisoned and has been experiencing nausea and hallucinations. She describes the hallucinations as feeling really weird like she was in another world. It has been 15 days since she received her vaccination and on 03-SEP-2021, she was frustrated that she was still feeling this bad. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from fever, had not recovered from hallucination, feeling bad, frustrated, nausea, and the outcome of very exhausted was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20210908135- Covid-19 vaccine ad26.cov2.s- Hallucination, feeling bad, frustrated. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). 20210908135- Covid-19 vaccine ad26.cov2.s- Nausea, fever, very exhausted. This event(s) is labeled per Agency and is therefore considered potentially related.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dehydration
Hospital-Tage: -
Labordaten: Test Date: 202108; Test Name: Body temperature; Result Unstructured Data: 100 F; Test Date: 20210821; Test Name: Body temperature; Result Unstructured Data: 102 F; Test Date: 20210826; Test Name: Lab test; Result Unstructured Data: not reported; Test Date: 20210826; Test Name: X-ray; Result Unstructured Data: not reported
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: The patient reported no prior contact/ exposure to anyone infected with COVID-19.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1689144

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: OH
Alter: 53,0
Geschlecht: F
Eingang: 10.09.2021
Impfdatum: 10.09.2021
Beginn: 10.09.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Cough Dyspnoea Throat irritation Wheezing

Symptomtext

wheezing, SOB, cough, scratchy throat benadryl 50 mg po at 10:28am VS obtained 10:38 am 204/130, HR 100, SpO2 98% 10:48 am 204/112, HR 86, SpO2 96% 10:55 am 170/98 and advised to go to stat care or ER for BP only. Breathing issues resolved at time of last VS obtained. Pt drove by husband.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: n/a
Vorgeschichte: asthma
Andere Medikamente: Albuterol inhaler, MVI, Claritin
Allergien: bees, IVP dye, shellfish, tramadol, toradol
Vorherige Impfungen: MMR Vaccine in 2019 ER visit

VAERS 1686748

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: CA
Alter: 44,0
Geschlecht: F
Eingang: 10.09.2021
Impfdatum: 09.09.2021
Beginn: 09.09.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chest discomfort Chest pain Dyspnoea Heart rate increased Heart rate irregular Palpitations

Symptomtext

Chest pain chest tightness. Irregular heartbeat. Sharp pain in chest. Fast and hard beating. Feels like someone is sitting on my chest heavy and hard to breathe.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: None yet
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1685245

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: CA
Alter: 46,0
Geschlecht: M
Eingang: 09.09.2021
Impfdatum: 03.08.2021
Beginn: 06.08.2021
Tage bis Beginn: 3,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Diarrhoea Fatigue Pain Paraesthesia

Symptomtext

3 days after the vaccination, I developed tingling of my arm and hand but only the right side. I got the vaccine on my left arm.. I also had diarrhea , body ache and fatigue for several days.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: none but messaged my PCP regarding the symptoms..
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: Fish oil, garlic supplement and Cinnamon supplements
Allergien: Erythromycin
Vorherige Impfungen: -

VAERS 1685046

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: CT
Alter: 36,0
Geschlecht: M
Eingang: 09.09.2021
Impfdatum: 04.09.2021
Beginn: 05.09.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Injection site pain Insomnia Migraine

Symptomtext

Migraines and insomnia, soreness at the injection site, still ongoing at this time of reporting

Weitere VAERSDATA-Felder

Praegender Schweregrund: Migraine
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1678647

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: NC
Alter: 46,0
Geschlecht: M
Eingang: 07.09.2021
Impfdatum: 08.06.2021
Beginn: 08.06.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Cardiac pacemaker insertion Chest pain Condition aggravated Diarrhoea Dizziness Fatigue Influenza like illness Nausea Sinus node dysfunction Vertigo Vomiting

Symptomtext

Visit date 02 SEP 21:- The patient is a 46 yo male with a history of HTN and obesity developed natural COVID infection in APRIL and continued prolonged dyspnea and fatigue. He received Janssen COVID vaccine #1 08 JUN 21 followed by severe flulike symptoms with n/v/d dizziness and vertigo and CP for at least several days. He continued with fatigue, dizziness and vertigo symptoms and was ultimately diagnosed SSS and received a pacemaker in AUG 2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: 5,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Hypertension
Andere Medikamente: ZALEPLON, 10 MG, ALPRAZOLAM, 0.5 MG CITALOPRAM HBR , 40 MG TOPIRAMATE , 25 MG Multivitamin
Allergien: -
Vorherige Impfungen: -

VAERS 1675704

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: FL
Alter: 44,0
Geschlecht: F
Eingang: 06.09.2021
Impfdatum: 02.09.2021
Beginn: 03.09.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Body temperature increased Headache Heart rate increased Migraine Thirst

Symptomtext

Within an hour of the shot, elevated heart rate recorded on smart watch and continued for 24 hours. Resting heart rate is usually 85; after shot it was sustained at 120 bpm, spiking as high as 145 bpm at times. No physical activity was recorded after the shot. Occasionally, heart rate increases to 120 at rest, even 96 hours later. Extreme thirst noted at 1am, woke up from sleep. Dehydration continues 96 hours later. Also, bad taste in mouth has been noted since the shot. Nothing has helped. Headache, migraine like, began at 2am, continued for 72 hours. Anacin used but did not help much. Elevated temperature 100.2 noted at 8pm, continued for 24 hours.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Migraine
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: none
Vorgeschichte: allergies, headaches
Andere Medikamente: Pantoprazole, claritin, anacin
Allergien: codeine, environmental allergies (grass, ragweed, oak, dust)
Vorherige Impfungen: -

VAERS 1666368

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: KY
Alter: 39,0
Geschlecht: F
Eingang: 06.09.2021
Impfdatum: 30.08.2021
Beginn: 30.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Full blood count Hypersensitivity Metabolic function test Pain Paraesthesia Peripheral swelling Swelling face Pruritus Treponema test Urticaria

Symptomtext

Significant allergy reaction. Almost full body Hives, including itching and painful tingling all over.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: CBC, Comp Chem, RPR,
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None prior to Vaccine, several prescriptions prescribed due to adverse reaction.
Allergien: None
Vorherige Impfungen: -

VAERS 1675276

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: CA
Alter: 35,0
Geschlecht: F
Eingang: 05.09.2021
Impfdatum: 30.08.2021
Beginn: 31.08.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chest pain Dyspnoea Head discomfort Injection site pain Migraine Neck pain Pain in extremity Photophobia

Symptomtext

Chest pains, heavy breathing, speratically through the day, back of neck pain, the injection pain sensation through my whole body. Eyes sensitive to light. Migraines with pressure in the middle of forehead through the day every 45 minutes that last for 30 min longest until Tylenol kicked in for pain. Today is Sept 5th, Arm still in pain and can still see where the injection was. Still having speratic migraines with pressure in the middle of forehead, eyes sensitive to sun light still. On CDC site it say J&J effects should take up to 2 days tomorrow will be a full week. I've naturally had covid beginning of December in 2020 and was tested positive at a facility. The shot definitely different feeling than naturally having covid. And I am not gona be taking boosters.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1675102

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: CA
Alter: 31,0
Geschlecht: F
Eingang: 05.09.2021
Impfdatum: 03.09.2021
Beginn: 03.09.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Erythema Fatigue Paraesthesia Pyrexia Rash

Symptomtext

9/3/21 Fever 100.9 F. tingling of the extremites, extreme tireness 9/4/21 Joint pain, few red spot on the body (resolved within 4 hours) 9/5/21 Rash on one side of the upper body, tingling sensation on extremities

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: NONE
Allergien: Pollen
Vorherige Impfungen: Flu

VAERS 1666693

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: FL
Alter: 45,0
Geschlecht: F
Eingang: 02.09.2021
Impfdatum: 24.06.2021
Beginn: 08.07.2021
Tage bis Beginn: 14,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood test Confusional state Dizziness Eyelid function disorder Fatigue Hypoaesthesia Laboratory test Magnetic resonance imaging head Mental impairment Mobility decreased Paraesthesia oral Scan thyroid gland Speech disorder

Symptomtext

July 8th, extreme tiredness, July 9th, dizziness, affected speech, confusion, difficulty thinking, July 10th, in bed, unable to open my eyes, tingling in the mouth and tongue, and then for 2 weeks symptoms getting worse, I was unable to be out of bed, extremely tired, face, numbness in the faced, confusion, difficult understanding speech and talking

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mobility decreased
Hospital-Tage: -
Labordaten: Brain MMR, neurological tests, blood tests, thyroid scan
Aktuelle Erkrankungen: None apart from Hashimoto and hypothyroidism
Vorgeschichte: Hashimoto and hypothyroidism
Andere Medikamente: Levothyroxine 75, Daflon 1000, PAUSAFREN
Allergien: No.
Vorherige Impfungen: -

VAERS 1666683

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: CA
Alter: 45,0
Geschlecht: F
Eingang: 02.09.2021
Impfdatum: 08.04.2021
Beginn: 29.08.2021
Tage bis Beginn: 143,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Ageusia Anosmia C-reactive protein increased COVID-19 Chest discomfort Cough Dyspnoea Dyspnoea exertional Fibrin D dimer normal Hypoxia Oxygen saturation decreased Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

45 woman with depression, presented to ED on 8/29/21 with symptoms of congestion, loss of sense of taste and smell starting on 8/25.she later developed mild shortness of breath, worse with exertion and had adry cough but no fevers. Had J&J vaccine 4/2021. Patient tested COVID positive and came to ED, while in ED, desat to 91 while doing squats in her room and later 88% when walking and was admitted and started on decadron and remdesivir. She received a few days of decadron and remdesivir, her CRP normalized, her DDimer remained normal. She was only hypoxic with activity and the hypoxia resolved in about 2 days but she continued to have some symptoms of DOE and chest congestion or pressure. She was monitored another day and was tried on an albuterol inhaler which significantly helped her chest symptoms. On the day of discharge, her O2 sat was 97 on RA and she feels overall improved. She is not continued on steroids since her hypoxia has fully resolved. She is instructed to monitor her O2 sats at home and isolate. She is ordered for a prn albuterol inhaler for home.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: 2,0
Labordaten: Results for patient as of 9/2/2021 12:32 4/3/2019 17:31 CRP, SER QL: 0.4 4/11/2019 08:44 12/5/2019 17:43 12/5/2019 17:45 12/7/2019 11:43 CRP, SER QL: 0.9 (H) 11/3/2020 17:05 11/3/2020 17:09 11/5/2020 19:55 11/10/2020 17:48 11/21/2020 11:27 1/26/2021 16:58 1/26/2021 17:00 6/30/2021 12:10 8/28/2021 21:22 8/28/2021 22:41 8/28/2021 22:50 CRP, SER QL: 1.6 (H) 8/28/2021 22:52 8/29/2021 03:06 8/30/2021 06:10 CRP, SER QL: 0.6 8/31/2021 06:10
Aktuelle Erkrankungen: None
Vorgeschichte: Depression, Obesity
Andere Medikamente: None
Allergien: Allergies Allergen Reactions ? Hydrocodone Nausea/Vomiting
Vorherige Impfungen: -

VAERS 1665970

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: FL
Alter: 63,0
Geschlecht: M
Eingang: 02.09.2021
Impfdatum: 06.04.2021
Beginn: 24.06.2021
Tage bis Beginn: 79,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: unbekannt Erholt: nein

Arthralgia Balance disorder Fall Gait disturbance Magnetic resonance imaging Muscle atrophy Muscular weakness Pain in extremity Paraesthesia

Symptomtext

Weak left leg muscles inability to walk correctly falling for lack of balance. Muscle wasting and muscle tingling. Soreness and pain in the left leg both above and below it in the knee.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: MRI
Aktuelle Erkrankungen: Diabetes
Vorgeschichte: Diabetes
Andere Medikamente: Insulin
Allergien: None
Vorherige Impfungen: -

VAERS 1662843

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: KY
Alter: 62,0
Geschlecht: M
Eingang: 01.09.2021
Impfdatum: 29.04.2021
Beginn: 14.08.2021
Tage bis Beginn: 107,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Anticoagulant therapy Blood culture negative Blood lactate dehydrogenase C-reactive protein COVID-19 COVID-19 pneumonia Chest X-ray abnormal Computerised tomogram abnormal Cough Decreased appetite Dyspnoea Fibrin D dimer Full blood count Hypoxia Lung infiltration Lung opacity Metabolic function test Myalgia

Symptomtext

Patient received COVID vaccine 4/29/21, tested positive for COVID 8/14/21 8/14/21: patient is a 62 y.o. male with no significant past medical history presents with mild shortness of breath, myalgias, cough, somnolence and poor appetite. He was found to be significantly hypoxic while in the waiting room in the emergency department when his pulse ox was found to be 74%. He was put on supplemental oxygen of 6 liters/minute by nasal cannula and his pulse ox improved to about 92%. Currently he is on 60% FiO2 with high-flow nasal cannula an oxygen flow of 30 liters/minute. Patient is a 62 y.o. obese male with no significant past medical history presenting with shortness of breath, cough, myalgias for 6 days and severe hypoxemia. Principal problem: Hypoxia Viral pneumonia with severe hypoxemia: 62-year-old male presenting with 6 day history of shortness of breath, myalgias, cough and severe hypoxemia likely due to viral pneumonia caused by COVID 19 infection. COVID-19 pneumonia chest x-ray shows diffuse bilateral infiltrates most likely due to COVID-19 pneumonia Intravenous dexamethasone 6 mg daily started in the emergency department COVID-19 PCR test is pending The patient is a candidate for intravenous remdesivir because of severe new onset hypoxemia Check CBC, CMP, CRP, LDH, ferritin, D-dimer with morning labs Discharge Summary 9/1/21: Hospitalization Admit Date/Time: 8/14/2021 10:57 AM Admitting Attending: Discharge Date: 8/28/21 Discharge Attending Physician: medical doctor PCP name and Address: Referring provider name and address: No referring provider defined for this encounter. Chief Concern, Brief History of Present Illness, and Hospital Course Patient is a 62 y.o. male with a history of diabetes that presented with a 6 day history of myalgias, cough and poor po intake with new reports of shortness of breath. Patient Received the Johnson and Johnson vaccine in April of 2021. Upon arrival to ED was found to have an SpO2 of 74% on room air, and was placed on 6 liters nasal cannula. His O2 requirements continued to increase requiring high flow nasal cannula. As a result he was started on Dexamethasone and remdesivir. He continued to have increasing O2 requirements and was transferred to the ICU for closer monitoring. He did not require intubation. Ultimately he completed a five day course of remdesivir as well as a ten day course of dexamethasone. He was able to tolerate wean of his supplemental O2 and tolerated 2 liters NC on the day of his discharge. His room air SPO2 was 88% with improvement to 93% on 2 liters NC. He will be provided with home O2 at the time of his discharge. His hospitalization was complicated by a PE (CT scan 8/28/21) for which anticoagulation was started. He was started on Apixaban 10mg po BID with plan to continue for ten days (last dose will be the evening dose on 9/4/21) prior to beginning Apixaban 5 mg BID for at least 3 months. Additionally his hospitalization was complicated by Enterobacter Cloacae. (blood cultures on 8/27/21). He was started on Cefepime with plan to continue for seven days total. His repeat blood cultures have remained negative. Given his he is medically appropriate for discharge otherwise we will transition to oral antibiotic therapy today and continue Bactrim for two more days to complete the total antibiotic course. The patient's blood sugars were poorly controlled on admission (HgbA1C was 14). Insulin adjustments were made. His blood pressure was also poorly controlled on admission but with medication adjustments improved. The patient declined insulin plus Metformin ER recommendations at discharge. Given this he will be discharged on Metformin ER plus trulicity (PA was obtained by pharmacy). Diabetes educators were consulted for assistance with diabetic teaching. It is strongly recommended that the patient follow up with primary care for ongoing management. Lastly, the patient was noted to have incidental findings of thyroid and pancreatic masses on CT imaging. Given his COVID positive status and other acute medical conditions MRI was not obtained as an outpatient. It is strongly recommended that he follow up with his PCP for ongoing workup in addition to all age appropriate cancer screenings. The patient was evaluated by PT/OT and deemed appropriate for home with assistance. He was evaluated by internal medicine on am rounds and deemed appropriate for discharge home. He will be provided a referral for a PCP at discharge (order placed in system). The patient is aware of his upcoming discharge and is agreeable with the discharge plan of care.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19 pneumonia
Hospital-Tage: 19,0
Labordaten: 8/14/21: XR Chest 1 View Result Date: 8/14/2021 Narrative: Exam/Procedure: XR CHEST 1 VIEW ordered by ordering provider, CLINICAL INDICATION: hypoxia TECHNIQUE: Frontal view of the chest. COMPARISON: None. FINDINGS: Diffuse bilateral airspace disease. The cardiac silhouette, mediastinum and pulmonary vascularity are unremarkable. No evidence of pneumothorax or pleural effusion. The osseous structures are unremarkable
Aktuelle Erkrankungen: -
Vorgeschichte: No past medical history
Andere Medikamente: None
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1662676

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: FL
Alter: 67,0
Geschlecht: F
Eingang: 01.09.2021
Impfdatum: 27.08.2021
Beginn: 27.08.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Fatigue Headache Muscle spasms Paraesthesia Tinnitus

Symptomtext

Headache Leg cramps Fingers tingling Ocean sound in ears/head Fatigue

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Asthma
Andere Medikamente: D3. B12 Biotin Vit C
Allergien: Penicillin. Amoxicillin Tetracycline Fish (not shellfish) salmon
Vorherige Impfungen: Yellow Fever/2010/57years/fever

VAERS 1654155

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: CA
Alter: 73,0
Geschlecht: F
Eingang: 29.08.2021
Impfdatum: 26.08.2021
Beginn: 26.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Anxiety Condition aggravated Feeling abnormal Hypertension Paraesthesia Pruritus Somnolence Urticaria

Symptomtext

At about 1:43PM RN overheard the client stating "I'm feeling weird" to her husband and noted the client placing her hand over her chest. The client was seated in a wheelchair. RN approached the client and asked what symptoms she was currently experiencing. The client again stated "I feel weird." RN asked the client to explain her symptoms. The client stated "I feel like my blood pressure is getting high." The client reported a history of hypertension. The client stated that she takes her blood pressure medication at night and confirmed she did take her medication last night. Vitals obtained at 1:46PM were as follows: automatic BP 156/67, HR 64, O2 98%. The client reported feeling "anxiety" then she stated "it's coming down." The client stated her systolic blood pressure was at 176 last night. The client said "when my blood pressure goes up, I take my medication." Repeat vitals obtained at 1:52PM were as follows: automatic 172/80, O2 96%, and HR 62. The client denied any other s/s of anaphylaxis. The client has a history of anaphylaxis and does own an Epinephrine injection. The client states she has not used Epinephrine in several years. Allergies include Methotrexate, Darvon, and Cipro. The client reports swelling and diarrhea after taking Methotrexate. The client reports a history of a "big brown rash" on her back during her other allergic reactions. The client states that she takes Benedryl when she experiences allergic reactions, which provides relief of her symptoms. Client has a history of hypertension and polymyositis. Client takes Metoprolol, Tramadol, Meclizine, Levothyroxine, magnesium, and vitamins. The client was alert and oriented to person, place, time, and situation. The client stated "I feel like my pressure is going up." RN recommended repeat manual BP on the other arm. Repeat vitals obtained at 1:56PM were as follows: manual BP 152/78, HR 62, and O2 96%. The client stated when her blood pressure goes up she takes her blood pressure medication. RN educated the client that we cannot provide advice regarding personal medications. The client voiced understanding of this education. Client decided to take her personal Metoprolol 50mg PO at 1:57PM with water. The client subsequently reported "its starting to feel like pins in the back." RN evaluated the client's back where the client reported itching and noted to evidence of urticaria or hives. The client denied any other s/s of anaphylaxis. RN offered the client Diphenhydramine. The client denied the medication. Repeat vitals obtained at 2:02PM were as follows: BP 158/82, HR 64, and O2 96%. The client reported itching on her back along the band of her bra. RN noted mild urticaria on the right lower side of the client's back. RN recommended administration of Diphenhydramine 50mg PO. The client elected to proceed. RN educated the client regarding Diphenhydramine including drowsiness. The client voiced understanding of this education. The client denied any shortness of breath, itchiness in the throat or tongue, or swelling of the throat or tongue. The client consumed 50mg Diphenhydramine in oral solution PO at 2:09PM with water. Vitals obtained at 2:10PM were as follows: BP 160/89, HR 63, and O2 98%. The client reported "itchiness just on my back a little bit and no symptoms of increased blood pressure." The client subsequently reported "pressure in my chest that comes and goes." RN activated EMS at 2:13PM. Repeat vitals obtained at 2:19PM were as follows: manual BP 165/86, O2 97%, HR 60. The client reports feeling "sleepy." The client denied any other s/s of anaphylaxis. EMS assumed care at 2:21PM. The client denied EMS transport AMA at 2:25PM. The client left the vaccination site in a wheelchair with her husband. The client stated she was going to seek care at the hospital. The client did not state which hospital.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: Unknown
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Polymyocitis and hypertension.
Andere Medikamente: Metoprolol, Tramadol, Meclizine, Levothyroxine, magnesium, and vitamins
Allergien: Methotrexate, Darvon, and Cipro.
Vorherige Impfungen: -

VAERS 1651611

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: CO
Alter: 45,0
Geschlecht: M
Eingang: 28.08.2021
Impfdatum: 26.08.2021
Beginn: 26.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Anxiety Arthralgia Headache Insomnia Myalgia Neck pain Pain in extremity Peripheral swelling Swelling Tachycardia

Symptomtext

I experienced a sore and swollen arm that immediately traveled to my neck and head. It only took a matter of an hour to feel the joint and pain intense discomfort after the injection. I had a headache for more than 12 hours through the night, with insomnia, tachycardia, and anxiety. Systemic pain and discomfort of my joints and muscles with a headache have remained 48 hours after vaccination.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Tachycardia
Hospital-Tage: -
Labordaten: Vital signs
Aktuelle Erkrankungen: E. coli, strep throat
Vorgeschichte: Asthma
Andere Medikamente: Advair, singular, trazodone, aspirin ,
Allergien: None
Vorherige Impfungen: -

VAERS 1641181

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: IL
Alter: 49,0
Geschlecht: F
Eingang: 27.08.2021
Impfdatum: 24.08.2021
Beginn: 26.08.2021
Tage bis Beginn: 2,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Arthritis Condition aggravated Feeling abnormal Peripheral swelling

Symptomtext

Joint pains, hands and knuckles are swollen, arthritis flair, feels bad

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: Psoriatic Arthritis Psoriasis Interstitial Cystitis Peritus
Andere Medikamente: Effexor 150 mg (once daily)
Allergien: Macrobid
Vorherige Impfungen: -

VAERS 1637387

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: CA
Alter: 39,0
Geschlecht: M
Eingang: 26.08.2021
Impfdatum: 25.08.2021
Beginn: 25.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Asthenia Balance disorder Dizziness Dyspnoea Feeling abnormal Head discomfort Immediate post-injection reaction Ocular hyperaemia Somnolence Swollen tongue Tremor Unresponsive to stimuli

Symptomtext

Client reported feeling dizzy immediately after administration of the COVID vaccine Janssen. Noted the client was rubbing his forehead and eyes. The client's eyes were closed. When the client opened his eyes. Noted the client's eyes appeared red. Noted that this redness was not present prior to receiving the vaccine. The client was deliberately shaking his hands bilaterally and squeezing his hands into fists. Asked the client what his current symptoms were and he did not verbally respond. Repeated the question. A few seconds later the client stated he felt "dizzy and weird." The client stated that he felt something in his right leg, but RN was unable to discern what the client said. RN noted shaking of the client's right leg. The client stood up with the assistance of his cane and support of the arm of the anti-gravity chair and transferred into the anti-gravity chair. The client appeared unsteady on his feet to RN. The anti-gravity chair was reclined. The client was verbally unresponsive for a few seconds. RN noted the client's head leaned against the anti-gravity chair and the client's eyes were closed. The client then opened his eyes. The client was alert and oriented to person, place, and time. The client reported feeling "dizzy, weak, and sleepy, like when you have surgery." The client denied any chest pain or shortness of breath. Vitals obtained at 1:39PM were as follows: BP 147/94 and HR 84. The client stated he felt thirsty, RN offered the client water. The client did not drink the water. At 1:43PM the client reported "my tongue feels like when you take medicine." The client subsequently clarified that his tongue felt "swollen." RN assessed the client's tongue and did not note any swelling and noted the client's tongue was pink. The client has a history of seizures and takes Dilantin. The client states he took his Dilantin this morning as prescribed. The client stated his current status feels different than his seizures. The client states that when he has a seizure he "shakes a lot and then I can't talk." Vitals obtained at 1:46PM were as follows: BP 134/90 and HR 90. The client stated that his tongue still felt "swollen." The client stated that he took the trolley to the vaccination site and does not have anyone who could come and pick him up. The client stated his throat felt "itchy." Offered the client Diphenhydramine IM. The client reported a history of an allergy to Keppra where he developed a rash. The client denied any history of anaphylaxis. Oxygenation status obtained via pulse oximeter at 1:52PM was 97%. The client stated that he would like to receive Diphenhydramine IM. RN educated the client regarding Diphenhydramine including risk of drowsiness. The client voiced understanding of this education and gave verbal consent to receive Diphenhydramine IM. The client stated his dizziness was improving and that he still felt tired at 1:52PM. RN administered 50mg/1ml Diphenhydramine (Lot# 020020 exp 02/2022) in the right deltoid muscle at 1:53PM. The client was verbally non-responsive for a several seconds after receiving the Diphenhydramine. RN noted shaking of the client's right leg. The client's head was heavy on the anti-gravity chair. The client then attempted to sit up quickly. RNs reassured the client of the situation and the client relaxed in the chair. RN activated EMS at 1:55PM. The client stated "I can't breathe". RN noted the client clutching his chest. The client reported repeated difficulty with respirations. Prepared to administer Ephinephrine by removing the cap and safety release. RN prepared to administer the Epinephrine when the client moved quickly and stated "no." RN did not administer Ephinephrine. RN educated the client regarding Ephinephrine and continued to question the client regarding his respiratory symptoms. The client appeared more alert to RN and began to respond to questions more clearly. RN noted no pallor or use of accessory muscles. The client stated that his breathing was improving. Vitals obtained at 2:00PM were as follows: BP 146/88 and HR 84. The client denied any persistent weakness. The client appeared disoriented to RN. The client stated that his right arm hurt. RN explained that was likely related to the Diphenhydramine administered IM into the right deltoid. The client asked RN, "I received another injection?" RNs educated the client regarding the administration of Diphenhydramine IM. The client voiced understanding of this education. EMS assumed care at approximately 2:03 PM. The client was transported to ER 2:09PM.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: Unknown
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Seizures
Andere Medikamente: Dilantin
Allergien: -
Vorherige Impfungen: -

VAERS 1636530

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201a21a

moderat

Staat: CO
Alter: 43,0
Geschlecht: F
Eingang: 26.08.2021
Impfdatum: 16.08.2021
Beginn: 16.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Chest X-ray Chest discomfort Chills Cough Discomfort Dyspnoea Electrocardiogram normal Fatigue Fibrin D dimer Headache Human chorionic gonadotropin Hyperhidrosis Laboratory test normal Menstruation irregular Pain Pyrexia Troponin

Symptomtext

At 9pm of the day of the vaccination (Monday August 16) I came down with a fever, body aches, chills, headache, extreme fatigue, pain, shortness of breath, and pressure in my chest/heart/lungs/upper back area. On Thursday the symptoms resolved EXCEPT for a continued headache, shortness of breath, unproductive cough, and pressure in my chest/heart/lungs/upper back area and they continue even today, August 26. I started my menstral cycle a week early, The Thursday after vaccination instead of the following week. I bled for 6 days instead of 3 days and before this, my periods have been consistent to the exact day for a solid 12+ years, since after my last pregancy, every 28 days. Every day since the vaccination, multiple times a day, I break into a sweat as if I have a fever for no apparent reason and then it passes. The pressure in my chest is still present as I am typing now, it has not subsided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: d-dimer, troponin 1, hcg, serum, qualitative istat 8 profile: Normal ecg 12 lead, x ray chest 1 view: Normal poct troponin, poct, istat chem 8: Normal Normal the doctor told me.
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: latex
Vorherige Impfungen: -

VAERS 1634872

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: OH
Alter: 47,0
Geschlecht: F
Eingang: 26.08.2021
Impfdatum: -
Beginn: 01.08.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Cardiac stress test Chest X-ray Chest discomfort Chills Computerised tomogram Dyspnoea Electrocardiogram Fibrin D dimer Headache Heart rate Hyperhidrosis Injection site pain Myalgia Oxygen saturation Oxygen saturation decreased Pain in extremity Pyrexia SARS-CoV-2 test

Symptomtext

CHRONIC CHEST TIGHTNESS; LABORED BREATHING UPON MOVEMENT; WITH MOVEMENT OXYGEN LEVEL WENT DOWN TO 70 TO 80 PERCENTAGE; SWEATS; CHILLS; SORE ARM FOR 1 WEEK; BURNED INTENSELY AT THE TIME OF INJECTION; HEADACHE; MUSCLE ACHES ALL OVER THE BODY; LOW GRADE FEVER; This spontaneous report received from a patient concerned a 47 year old female. The patient's weight was 155 pounds, and height was 67 inches. The patient's past medical history included chest infection and ended up with bronchitis in her late 30s. When the patient was a teenager and was active in sports sometimes would get short of breath. The patient's concurrent conditions included non smoker, and abstains from alcohol, and other pre-existing medical conditions included no known prior history and did not have any drug abuse/illicit drug use. The patient was previously treated with salbutamol for bronchitis and with nebulizer for short of breath. The patient experienced hives all over body when treated with amoxicillin. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 201A21A expiry: 21-SEP-2021) dose was not reported, 1 total, administered on 09-AUG-2021 at around 15:30 to left arm for prophylactic vaccination. No concomitant medications were reported. On 09-AUG-2021, the patient experienced intense burning at the time of injection and had sore arms for one week. Half an hour later the patient had a headache and 2 hours later had muscle aches all over her body, low grade fever, chills and sweating which all were resolved in morning after 48 hours. The next morning on 10-AUG-2021 the patient felt tight chest, something that had not gone away and she had chronic chest tightness and labored breathing. The patient visited ER (emergency room) twice. On 14-AUG-2021, the patient visited ER for second time and got admitted. The patient underwent lab tests such as blood clots (negative for pulmonary embolism), troponin, D-Dimer, COVID (rapid tests), 5 times EKGs (electrocardiogram), 2 times CT (computerised tomogram) scans, 2 times chest X-Rays, Stress test with lexiscan (because the patient could not perform on treadmill) and they all were negative. They ruled out myocarditis or pericarditis and did ultrasound for the possibility of fluid around the lung which was negative. They found mitral valve thickening which were told it was not significant. They also pointed out to anxiety but the reporter said that she knew that was not anxiety. The patient's main concern was that she had labored breathing with any movement or positioning and she had chronic chest tightness that she said she had been in intermittent ambulatory distress. The patient's oxygen level at rest was 100 but with movement oxygen level went down to 70 to 80 percentage and her heart rate went up to 100. They treated her with IV (intravenous) saline drip on the first day in the hospital and nothing was given orally for the tests. They offered heparin and steroids but the patient declined. She will also be seen by a pulmonary specialist. At the time of reporting the patient was in the hospital. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sweats, chills, headache, muscle aches all over the body, and low grade fever on 11-AUG-2021, and sore arm for 1 week, and burned intensely at the time of injection on 16-AUG-2021, had not recovered from chronic chest tightness, and labored breathing upon movement, and the outcome of with movement oxygen level went down to 70 to 80 percentage was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0: 20210846641 -covid-19 vaccine ad26.cov2.s- chronic chest tightness, labored breathing upon movement, with movement oxygen level went down to 70 to 80 percentage. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: Test Date: 202108; Test Name: SARS-CoV-2 rapid diagnostic test; Result Unstructured Data: negative; Test Date: 202108; Test Name: Troponin; Result Unstructured Data: negative; Test Date: 202108; Test Name: CT scan; Result Unstructured Data: negative; Comments: 2 times; Test Date: 202108; Test Name: EKG; Result Unstructured Data: negative; Comments: 5 times; Test Date: 202108; Test Name: Fibrin D dimer; Result Unstructured Data: negative; Test Date: 202108; Test Name: Chest X-ray; Result Unstructured Data: negative; Comments: 2 times; Test Date: 202108; Test Name: Stress test; Result Unstructured Data: negative; Test Date: 202108; Test Name: Oxygen saturation; Result Unstructured Data: 100 but with movement it goes down to 70-80%; Test Date: 202108; Test Name: Heart rate; Result Unstructured Data: 100; Test Date: 202108; Test Name: Diagnostic ultrasound; Result Unstructured Data: negative; Comments: Did ultrasound for the possibility of fluid around the lung which was negative.
Aktuelle Erkrankungen: Abstains from alcohol; Non-smoker
Vorgeschichte: Medical History/Concurrent Conditions: Bronchitis (The patient had a chest infection and ended up with bronchitis in her late 30s and was treated with Albuterol.); Chest infection; Short of breath (When the patient was a teenager and was active in sports sometimes would get short of breath and was treated with nebulizer.); Comments: The patient had no known prior history and did not have any drug abuse/illicit drug use.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1629301

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21a

moderat

Staat: CA
Alter: -
Geschlecht: F
Eingang: 24.08.2021
Impfdatum: 24.08.2021
Beginn: 24.08.2021
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Asthenia Bradycardia Condition aggravated Dizziness Fall Hyperhidrosis Hypotension Nausea

Symptomtext

Patient fell out of observation chair and become diaphoretic, weak, dizzy, and nauseated post vaccination. Assisted to chair and assessed blood pressure of being hypotensive at 74/40 and bradycardic at 54. Gave Zofran ODT and Benadryl PO w/ resolve to condition after monitoring for approx 30 min. Discharged to self under supervision of family member.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: Hypotension
Vorgeschichte: None
Andere Medikamente: NKDA
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1628607

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: IL
Alter: 32,0
Geschlecht: F
Eingang: 24.08.2021
Impfdatum: 19.08.2021
Beginn: 19.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chest discomfort Feeling abnormal Palpitations Tremor

Symptomtext

5:35 pm- Patient c/o heart racing, not feeling so good. Patient place in reclined position. Fingertip pulse ox 99%. Heart rate 99-105. Client hands shaky. Patient has good color, lips pink, talking. No respiratory distress noted. 5:37 pm B/P unable to get reading, client requested cuff be removed and said it was making her feel worse. Cool moist cloth applied to forehead. Bilateral radial pulse present and equal. No wheezing noted. Calm talk with client, encouraged her to take slow deep breaths, talked about general things, weather, Grandma being with her, etc. Heart rate slowed to 85, client sat up a little more. Visual monitoring continued. 6:05 pm- Patient stated she felt response returning. Pulse rate increased to 105, pulse ox 99%, shakiness returned. Patient returned to reclining position. Patient refused to allow B/P pressure to be checked. Radial pulse equal bilaterally, lungs clear to auscultation, no wheezing noted. No respiratory distress noted. Patient color good, lips pink. Client continued with increased heartrate, c/o not feeling better. Patient c/o some chest tightness, but denied pain. Due to return of symptoms and c/o chest tightness. *EMS notified at 6:09 pm. EMS arrived approximately 6:25pm. (LISTED as Other Healthcare professional in Item 21 below.)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Palpitations
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: ---
Vorgeschichte: Patient stated had previous diagnosis of adrenal reaction to Hep B vaccination.
Andere Medikamente: Paxal
Allergien: Anaphylaxis to bee stings.
Vorherige Impfungen: Reported similar response to Hep B vaccination, lightheadedness and increased heartrate.

VAERS 1627935

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: NY
Alter: 29,0
Geschlecht: F
Eingang: 24.08.2021
Impfdatum: 23.08.2021
Beginn: 23.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Body temperature increased Chest discomfort Discomfort Dry throat Dyspnoea Eye pain Feeling abnormal Feeling cold Headache Myalgia Oropharyngeal pain Pain Paraesthesia Sleep disorder Tremor Vomiting

Symptomtext

I felt okay after getting it and went to bed about 9:30pm. Then I woke up around 11pm so cold and shaking uncontrollably and my head was pounding and my whole body was uncomfortable like pins and needles with goosebumps and I was in so much pain with muscle aches and icy head was pounding and I couldn?t stay still I was like rocking in discomfort. And then I put on long sweat pants and socks and a sweater and got water. My throat was so dry and also hurt. A sore throat. And then I threw up a ton and it was awful me hard to clear and hard to breath and I had this pressure in my chest. My temp was 101.5F and I didn?t even have patients to let it keep going under my young so I think it was higher. And then I called my mom and tried to rest and tried hard to get comfy on my bed prolong myself up with pillows and I fell back asleep. Then woke up again at 2am and felt the same and rechecked my temp and it was 101.2F. I took Tylenol. Then I fell back asleep until almost 7 but with lots of tossing and turning and lots of waking up uncomfortable again. Then in the morning I checked my temp again an fit was 99.2. And I still really hurt all over and my right eye is throbbing along with the headache and still gods bumps but not shaking anymore but still very uncomfortable. I took a warm shower and more Tylenol at 8:20. I didn?t retake my temp bc I didn?t want to move but I know it got really hot again with a fever. And I still feel really yucky.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: No.
Aktuelle Erkrankungen: No.
Vorgeschichte: No.
Andere Medikamente: Xulane Birth control patch
Allergien: No.
Vorherige Impfungen: -

VAERS 1905117

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: TX
Alter: 70,0
Geschlecht: F
Eingang: 23.08.2021
Impfdatum: 18.08.2021
Beginn: 18.08.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Abdominal pain upper Headache Hypoaesthesia Pruritus Rash Taste disorder Tremor

Symptomtext

Sudden headache, uncontrollable shaking, numbness in face, upper gastric pain, altered taste in mouth, severe itching, followed by skin rash Took 50 mg Benadryl, tylenol, drank water, Continued Benadryl 50 mg rested for several hours I am tiring easily and still have rash.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Tremor
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: Psoriasis, Osteoarthritis Knees
Andere Medikamente: amLODIPINE 5 mg OTL Multivitamin TUM VIT d Tylenol
Allergien: Aleve, Nickel, HepB Vaccine
Vorherige Impfungen: -

VAERS 1594457

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: AZ
Alter: 75,0
Geschlecht: M
Eingang: 21.08.2021
Impfdatum: -
Beginn: 15.08.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Asthenia Chest pain Fatigue SARS-CoV-2 test Scan Upper-airway cough syndrome

Symptomtext

CHEST PAIN; FATIGUE; FEELS WEAK; POST NASAL DRIP; This spontaneous report received from a consumer concerned a 75 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: exercise induced asthma, gout, blood pressure, anxiety, alcohol user, asthma, alcohol user, and non-smoker, and other pre-existing medical conditions included: The patient was not a drug abuse or illicit drug user. The patient experienced drug allergy when treated with acetylsalicylic acid. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, and expiry: UNKNOWN) dose was not reported, 1 total administered on 09-AUG-2021 for prophylactic vaccination. Concomitant medications included lorazepam for anxiety, mometasone furoate for asthma, salmeterol xinafoate for asthma, verapamil for blood pressure, and allopurinol for gout. On 15-AUG-2021, after receiving the vaccine, the patient started having post nasal drip from the nose. It was clear, but it was very heavy and everywhere then there was mucus. On 16-AUG-2021, the patient experienced chest pain and the patient thought it was because of anxiety and took lorazepam which did not work, and was hospitalized and had to stay in emergency room for observation. The patient stated that lots of scans were done, received IV and then was released on 17-Aug-2021. The laboratory result for lots of scan was unknown. The Consumer stated that they tested him for Covid-19 and it came back negative. . On an unspecified date, the patient experienced fatigue, and feels weak, the patient was asked if the symptoms were gone the patient stated that the patient was feeling weak. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chest pain and post nasal drip on 17-AUG-2021, the patient had not recovered from feels weak, and the outcome of fatigue was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0: 20210837701-covid-19 vaccine ad26.cov2.s -Chest pain. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: 1,0
Labordaten: Test Date: 20210816; Test Name: Scan; Result Unstructured Data: Unknown; Test Name: COVID-19 virus test; Result Unstructured Data: Negative
Aktuelle Erkrankungen: Alcohol use (Couple of wine glasses every night); Anxiety; Asthma (Use serevent inhaler and twist inhaler Flonase for nose, 2 sprays in each nostril once a day.); Blood pressure; Exercise induced asthma; Gout; Non-smoker
Vorgeschichte: Comments: The patient was not a drug abuse or illicit drug user.
Andere Medikamente: FLONASE [MOMETASONE FUROATE]; ALLOPURINOL; VERAPAMIL; LORAZEPAM; SEREVENT
Allergien: -
Vorherige Impfungen: -

VAERS 1591607

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201a21a

moderat

Staat: FL
Alter: 61,0
Geschlecht: M
Eingang: 20.08.2021
Impfdatum: 29.07.2021
Beginn: 07.08.2021
Tage bis Beginn: 9,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Anxiety Bronchiolitis Chest X-ray abnormal Dyspnoea

Symptomtext

Shortness of breath. Anxiety. Both to the point I went to the ER

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: X-ray shows swelling of bronchioles. Other test ten please check with er
Aktuelle Erkrankungen: None
Vorgeschichte: C2thru c6 fused. Back issues. Overweight
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1591281

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: NC
Alter: 70,0
Geschlecht: F
Eingang: 20.08.2021
Impfdatum: 20.08.2021
Beginn: 20.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Dysphagia Lip pruritus Paraesthesia oral

Symptomtext

0930: Patient reporting "tingling" in tongue after J&J COVID vaccine. 0933 Patient reports difficulty swallowing. Epi 0.3mg given IM R thigh. 0937 Patient reporting continued tingling, feels as though tongue is "thick". Reports swallowing has improved. Itching on bottom lip. 0946 Patient taken to ED by ED RNs via stretcher.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia oral
Hospital-Tage: -
Labordaten: pending
Aktuelle Erkrankungen: no
Vorgeschichte: depression
Andere Medikamente: unknown
Allergien: flu vaccine, iodinated contrast, codeine
Vorherige Impfungen: Flu vaccine-hypotension and fever

VAERS 1589092

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: CA
Alter: 59,0
Geschlecht: M
Eingang: 20.08.2021
Impfdatum: 21.07.2021
Beginn: 28.07.2021
Tage bis Beginn: 7,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Dizziness Fatigue Gait disturbance Hypoaesthesia Pain in extremity Paraesthesia Vomiting

Symptomtext

Numbness in lower right leg and foot. Numbness in left toes. occasional fingers tinkling and pain. Can't walk normal. fels like my foot fell asleep and I've twisted ankle because I didn't feel the step. Major pain after wearing work boots more than a few hours. occasional throwing up. Fatiguing. Dizziness and faint feeling

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: neurology test and blood test scheduled ASAP
Aktuelle Erkrankungen: -
Vorgeschichte: knee replacement. Bariatric gastric bypass. kidney stones.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1588724

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: CA
Alter: 30,0
Geschlecht: M
Eingang: 19.08.2021
Impfdatum: 16.08.2021
Beginn: 16.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Auditory disorder Chills Fatigue Injection site pain Injection site swelling Insomnia Migraine Pain Pyrexia

Symptomtext

Chill, fever, insomnia, body aches, migraine, pain at site of injection, tiredness, auditory anomalies, swollen injection site

Weitere VAERSDATA-Felder

Praegender Schweregrund: Migraine
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None.
Vorgeschichte: None.
Andere Medikamente: None.
Allergien: None.
Vorherige Impfungen: -

VAERS 1587390

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: CA
Alter: 58,0
Geschlecht: F
Eingang: 19.08.2021
Impfdatum: 18.08.2021
Beginn: 18.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Dizziness Dysphagia Lip pruritus Paraesthesia oral Pruritus Throat irritation

Symptomtext

1649 Pt received dose of Janssen (Johnson & Johnson) vaccine today approximately around 1440. Pt states she is "feels like I'm going to throw up". Pt brought back to AR triage for observation. Pt states feeling lightheaded and feels tingling and itching around lips. Vital signs at 1652: BP: 160/103 (Map: 133) HR: 73 SPO2: 99% Temp: 98.2 F RR: 21 1658: Spoke with emergency department Dr. about patients situation. Dr. advises that 911 be called and patient be taken to emergency department, due to high blood pressure and itching around face. 1702: 911 called. Pt still feeling itching around lips and face. Vital Signs at 1702: BP: 212/106 (Map: 139) HR: 67 SPO2: 93% Temp: 97.4 F RR: 22 1720: Pt states itching around lips, face, and now throat. Pt also states "It's hard to swallow and my tongue feels big". Paramedics arrived and administered IM epinephrine. Pt was taken to ER by paramedics

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia oral
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: HTN (HYPERTENSION) HX OF LASIK FEMALE STRESS INCONTINENCE MASTALGIA. FHX OF BREAST CANCER CHRONIC PAIN COUNSELING HX OF THYROIDECTOMY HX OF LASER REFRACTIVE SURGERY BENIGN CARCINOID TUMOR, LUNG ELEVATED H PYLORI ANTIBODY BILAT DRY EYE SYNDROME BILAT AGE RELATED CATARACT
Andere Medikamente: predniSONE (DELTASONE) 10 mg Oral Tab Famotidine (PEPCID) 20 mg Oral Tab EPINEPHrine (ADRENACLICK/EPIPEN) 0.3 mg/0.3 mL Inj AutoInjector Cetirizine (ZyrTEC) 10 mg Oral Tab
Allergien: Avocado - DietaryAnaphylaxis Dilaudid [Hydromorphone]Hives CodeineRash Covid-19 Vaccine, Ad26.cov2.s (Janssen) Flu Vaccine Ts 2015-16 (5 Yr+) Latex
Vorherige Impfungen: FLU VACCINE TS 2015-16 (5 YR+) 10/26/2015 Got facial swelling after getting flu shot.

VAERS 1584210

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: TX
Alter: 27,0
Geschlecht: F
Eingang: 19.08.2021
Impfdatum: 17.08.2021
Beginn: 18.08.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Feeling cold Hypoaesthesia Injection site hypoaesthesia Injection site paraesthesia Paraesthesia

Symptomtext

Tingling, numbness, and feeling of coldness primarily in the left arm near the injection site, but extending to other parts of the body as well including the face and shoulder.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site paraesthesia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Celiac disease
Andere Medikamente: Adderall 10mg
Allergien: None known of
Vorherige Impfungen: -

VAERS 1583189

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: HI
Alter: 44,0
Geschlecht: F
Eingang: 18.08.2021
Impfdatum: 10.04.2021
Beginn: 14.08.2021
Tage bis Beginn: 126,0
Dosis: UNK
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia Burning sensation Contusion Flushing Gait disturbance Hypoaesthesia Limb discomfort Loss of personal independence in daily activities Magnetic resonance imaging Menstruation irregular Muscular weakness Musculoskeletal stiffness Paraesthesia Peripheral venous disease

Symptomtext

I had all the symptoms they mentioned could happen plus some that started the next day and continued for months. The passing tingling and numbness is still occurring today when I sleep. Here's a list of symptoms that occurred in the following days, weeks and months after the shot: heavy legs and arms (dropping things, unable to do house work, instability, left leg felt paralyzed or weak, entire body felt week mussels went loose starting in my legs first left then right then arms one after the other then my face. Tingling, numbness, and burning sensations were occurring through out the day and at night. Had to go to urgent care for bruising on inner thigh then for a vein check they said my femoral vein was not working (venous insufficiency ). Bruising continued on the right leg inner thigh but not as big. I could not walk up stairs the heavyness in my legs was so bad. I had stabbing back pain while walking. Face, arm and leg tingling, numbness and burning continued to the point that I got an MRI with negative results. Cheeks were flushed for weeks after the shot. My period was 16 days early after the shot. The right side of my neck was often stiff and my right arm still cannot bend all the way backwards with out crippling pain that feels paralyzing (it comes and goes) .

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: MRI Venious Insufficiency tests
Aktuelle Erkrankungen: Possible pinworm infection
Vorgeschichte: None
Andere Medikamente: EnerC 1,000 mg vitamin C
Allergien: Metronytozol creme
Vorherige Impfungen: -

VAERS 1582422

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: CA
Alter: 46,0
Geschlecht: F
Eingang: 18.08.2021
Impfdatum: 06.04.2021
Beginn: 06.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Basedow's disease Chills Fatigue Hyperhidrosis Illness Malaise Pain Palpitations Pyrexia Rash SARS-CoV-2 test negative Swollen tongue Tongue discolouration

Symptomtext

The evening of the vaccination about 8:00pm, I began to feel body aches all over and my fever spiked to over 100 degrees. My heart rhythm became a bit erratic per an ECG I took with my wearable device although still sinus rhytum. I took the Tylenol as directed and went to bed. That night was the worst sickness in over a decade. My entire body was in pain, and the fever was up to 102 despite taking Tylenol every 4 hours. I was drenched in sweat, with fever and chills. My heart was palpitating. The illness continued for 5 days, with fever and fatigue, until it subsided. I took Tylenol the whole time. Around May 28, I fell ill again with almost the same symptoms. Fever, chills, fatigue, aches, and this time my tongue swelled and turned white. I had a rash on my back and chest. This continued for 2 weeks until subsiding. I tested negative for Covid. I did not seek medical care at this time. I have not had a fever in over 10 years from any illness. I now am suffering from what appears to be Graves Disease.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Palpitations
Hospital-Tage: -
Labordaten: I saw my doctor for a check up and had blood work ran on July 21, 2021. The lab results show that I am now apparently suffering from an auto immune thyroid condition called Graves Disease that was not present in the past. As recently as December 2020 I had everything checked and it was normal. Thyroid Test Name Current Reference Range Previous T3 - Triiodothyronine (ng/mL) 2.9 H 0.8~2.0 1.2 (12/11/2020) T4 - Thyroxine (?g/dL) 19.0 H 4.5~9.8 8.6 (12/11/2020) Free T3 (pg/mL) 9.3 H 2.0~4.4 3.1 (12/11/2020) Free T4 (ng/dL) 3.2 H 0.9~1.7 1.4 (12/11/2020) TSH (?IU/mL) <0.005 L 0.111~4.910 1.420 (12/11/2020) Anti-TPO (IU/mL) 7 ?34 10 (06/17/2020) Reverse T3* (ng/dL) 29 H 7~23 13 (06/17/2020) Anti-TG (IU/mL) 520.4 H ?115.0 14.8 (06/17/202
Aktuelle Erkrankungen: no
Vorgeschichte: none
Andere Medikamente: bioidentical hormone replacement, multi vitamin
Allergien: no
Vorherige Impfungen: -

VAERS 1574408

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: CA
Alter: 48,0
Geschlecht: F
Eingang: 16.08.2021
Impfdatum: 08.08.2021
Beginn: 08.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Balance disorder Body temperature increased Chills Decreased appetite Diarrhoea Disturbance in attention Dizziness Dyspnoea Dyspnoea exertional Fatigue Feeling cold Headache Hyperhidrosis Impaired driving ability Myalgia Nausea Night sweats

Symptomtext

Started feeling slightly dizzy, lightheaded at 1535. Thought it was the heat. Then at 1545, after I had been observed and seen as ok, no reaction, feeling very very tired. A little afterwards, when I got home, 1602, my throat had started to close up, had SOB, DOE, and extreme fatigue and imbalance and dizziness. I immediately took 4 liquid zyrtec (40mg total--I didn't have my epi pen) and then the throat closing started feeling better. 2 hours after the vaccine, more or less, I started to have a temp 99.8, then soon after 100.5, and then spiked at 101.8 that same night with lots of chills. I had arthralgia, myalgia, nausea, anorexia, sweats and night sweats, slight HA, and very very SOB and DOE. I had loose stool (and continued nausea) on the 3rd day, and continued to Thurs and Friday, (days 5 and 6). My fever still continued for 3 days straight, as well as my dizziness and imbalance for a week. I just barely started feeling better, and less tired yesterday, so that I can attend church. I was unable to drive much, as I couldn't concentrate, loss focus, and feeling very very Winded. Even now, Today, Monday, 8x days after the JJ, I am feeling tired with mental and physical exertion. Physical exertion is making myself a fried egg, taking out the eggs, mixing eggs, frying, and finish eating the egg and putting away the plate. I still have sweats and night sweats, when I am the one always complaining of cold and turning off the fan, now, I am sweating like a pig. I have appt with doctor scheduled this coming end of the month. Was unable to go to seek medical attention for these symptoms 2nd to s/s

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: seasonal allergies
Andere Medikamente: omega 3
Allergien: Shrimp
Vorherige Impfungen: flu vaccines 2007-2012--got sick and sicker from each subsequent injection of flu vaccine. Had to stay home from work for 2 wks

VAERS 1574116

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: TX
Alter: 53,0
Geschlecht: F
Eingang: 16.08.2021
Impfdatum: 05.05.2021
Beginn: 05.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: ja Erholt: nein

Arthralgia Burning sensation Hypoaesthesia Immediate post-injection reaction Injection site pain Joint range of motion decreased Magnetic resonance imaging Neck pain Pain in extremity Paraesthesia Peripheral swelling X-ray

Symptomtext

Immediate Severe burning with Injection, told by pharmacist normal for some...thought I was going to passout hurt so bad. Severe arm pain. Over next few days swelling rectangular shaped, showed pharmacist, again dismissed as normal reaction. Over next few weeks continued arm pain and swelling, as wll as other symptoms, numbness, tingling, burning up to shoulder with decreased range of motion. Then neck started hurting with decrease in range of motion as well. Went to Chiropractor, Xrays-assisted with neck slightly, but continued with pain and decreased range of motion in neck and right arm. Started to correlate onset of neckpain and shot as pain fromn neck down shoulder into lower arm. Went to Medical DR. CONTINUE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: XRAY 6/7/2021 MRI 06/22/2021 07/30/2021
Aktuelle Erkrankungen: None
Vorgeschichte: HTN Hypothyroidism Asthma Depression/Anxiety
Andere Medikamente: See Attached
Allergien: Latex=Contact
Vorherige Impfungen: -

VAERS 1558270

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: FL
Alter: 28,0
Geschlecht: F
Eingang: 14.08.2021
Impfdatum: 04.08.2021
Beginn: 04.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chest pain Dizziness Dysstasia Eye pain Headache Pain

Symptomtext

Initial headache and body ache occuring same day of vaccination. Above issue disappeared within 3 days. Day 4-5 post vaccination, headaches at random intervals began. Headache comes behind one eye and stays for 10-20 seconds, no longer than 30 seconds each time. The ache will then move to a new place, back of head, behind other eye, middle of cheek, and will stay only for 10-20 seconds. This happens multiple times per hour. Chest pain in mid-chest. Like above pain, will happen for 10-20 seconds and stop. The pain is dull, not sharp. It returns on the other side with the same duration. This happens multiple times per hour. Sometimes it feels like I'm struggling to stay standing and need to sit down or I may pass out.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: None yet.
Aktuelle Erkrankungen: Case of extreme pompholyx eczema on two fingers for 6 months prior to vaccination
Vorgeschichte: None
Andere Medikamente: Generic benadryl a few times per week Tylenol a few hours post vaccination to help with chills/body pain No regularly prescribed medication taken
Allergien: Lactose intolerant
Vorherige Impfungen: -

VAERS 1554082

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: CA
Alter: 38,0
Geschlecht: F
Eingang: 13.08.2021
Impfdatum: 17.07.2021
Beginn: 17.07.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia Cognitive disorder Feeling abnormal Paraesthesia

Symptomtext

Muscle weakness in arms and legs within hours of the shot (from shot to present, ongoing) Slightly impaired cognitive functioning, "brain fog" (from shot to present, ongoing) Tingling/pins and needles in lower legs (began 8/9/2021 and ongoing). Periodic at first, now nearly constant Tingling/pins and needles in fingers (began 8/12/2021 and ongoing)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: Have not seen a doctor yet
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: zoloft, 100mg daily
Allergien: none known
Vorherige Impfungen: -

VAERS 1549187

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: CA
Alter: 46,0
Geschlecht: F
Eingang: 12.08.2021
Impfdatum: 11.08.2021
Beginn: 11.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Paraesthesia oral

Symptomtext

Patient complained of tingling of lips, RN walked patient over to urgent care for further evaluation.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia oral
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1549041

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201a21a

moderat

Staat: GA
Alter: 35,0
Geschlecht: F
Eingang: 12.08.2021
Impfdatum: 09.08.2021
Beginn: 09.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chest discomfort Chills Dyspnoea Fatigue Headache Hyperhidrosis Hypoaesthesia Myalgia Nausea Pain in extremity Tachycardia Tachypnoea Vomiting

Symptomtext

Day 1: Around 10 hours post injection tachycardia and tachypnea began with chest tightness. Regardless of activity. As the evening continued severe headache, fatigue, arm pain and numbness, nausea, vomiting, severe muscle pains, chills, sweats. Day 2: Chest tightness, shortness of breath, tachycardia, tachypnea, muscle pains, nausea, vomiting, arm pain and numbness, severe headache. Day 3: Nausea, arm pain and numbness, severe fatigue

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: n/a.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: lo estrin
Allergien: sulfa, codeine
Vorherige Impfungen: -

VAERS 1548937

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: CA
Alter: 18,0
Geschlecht: M
Eingang: 12.08.2021
Impfdatum: 09.08.2021
Beginn: 09.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Chills Dyspnoea Full blood count normal Headache Metabolic function test Myalgia Nausea Pyrexia Tachycardia Tachypnoea Throat tightness

Symptomtext

Pt received Johnson & Johnson vaccine 8/9/21 @ 1000 at a pharmacy out in town. At approximately 1400, pt reported shortness of breath and throat tightness to his corpsman. Pt received unknown amount of Tylenol and Benadryl with no improvement. Pt brought to Hospital ER at 1700 c/o worsening shortness of breath, throat tightness, myalgias, nausea, headache, chills. Pt found to be tachycardic to 115bpm, mildly tachypnic at 22RR/min, and febrile with TMAX 38.6. Pt's lung sounds clear, tolerating PO secretions, speaking in full sentences, satting 100% on RA. Pt was treated with additional anti-pyretics, IV steroids and fluids with improvement. Pt discharged to home after a few hours in the ER with recommended PCM follow-up.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: CBC and CMP had no abnormal findings.
Aktuelle Erkrankungen: NONE
Vorgeschichte: NONE
Andere Medikamente: NONE
Allergien: PCN, AMOXICILLIN
Vorherige Impfungen: -

VAERS 1545747

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: CO
Alter: 40,0
Geschlecht: F
Eingang: 11.08.2021
Impfdatum: 11.08.2021
Beginn: 11.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood pressure increased Chest pain Dizziness Palpitations Respiratory rate increased

Symptomtext

Looked over patient's consent form and saw that the patient had multiple allergies such as Keflex, Amoxicillin, and Bactrim. And everything else did not prevent her from getting the vaccine. Pt did not mark that she had any health issues on the consent form. Prepped the vaccines and called both husband and the patient into the room to get their shots. Verified both patients date of birth and confirmed that they were getting the JJ vaccines. Gave the husband the first shot and went over the side effects of the JJ and the rare occurrences of GBS in men. Gave him the shot and we discussed the differences of the vaccine and why they were getting the vaccine because at their son's school nobody was masked and up in each other's faces and they wanted to get vaccinated. The husband said that a few doctors told him that the Moderna and Pfizer did not stay in one place and how the JJ does and it is like the flu shot. Then the patient got into the chair and went over the side effects and how it effects women about risk of clotting and it affects women that are smokers and on birth control. The patient confirmed that she's good and that everything will be fine. I discussed her allergies and that bc of that we ask that all patient stay and be observed for at least 30 minutes. And then gave the shot to the patient and everything seemed fine. Then the husband and I continued our discussion about how they developed the Moderna and the Pfizer vaccines and then the patient said that her heart was racing and how she was feeling dizzy. I advised the patient to stay down and sit and asked her husband to look over her and I grabbed her a cup of orange juice and rice krispy treat and she ate it and drank the orange juice and she said that she was feeling a little better, but then progressively looked worse. Staff continued to watch over her as they took her blood pressure and pulse ox and the first blood pressure reading was 144/89 and 81 pulse, then a second blood pressure reading was 151/90 and her pulse ox was 99% but she was trying to breathe in and out slowly. At that time 20 minutes had passed and I had to go to lunch and other staff members were looking over her. Staff member brought up POTS syndrome but the consent form didn't indicate any about dizziness or fainting or health condition for before and after shots. Staff member and I went over shot technique and everything was fine in our eyes. Patient experienced dizziness, rapid breathing, and chest pain

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: Blood pressure checks
Aktuelle Erkrankungen: Not disclosed at time of vaccination
Vorgeschichte: Not disclosed at time of vaccination
Andere Medikamente: No OTC
Allergien: Keflex, Penicillin, Amoxicillin, Bactrim, and Zofran
Vorherige Impfungen: -

VAERS 1540875

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: CA
Alter: 33,0
Geschlecht: M
Eingang: 10.08.2021
Impfdatum: 10.08.2021
Beginn: 10.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Dyspnoea Hyperhidrosis Hypophagia Pallor

Symptomtext

Patient received the 1st COVID vaccine (Janssen Lot #201A21A expiration date 09/21/2021) at 1035. At 1050 patient alerted PHN that he was feeling "shortness of breath and feeling dizzy." PHN responded and helped patient transfer to the zero gravity chair and raised the feet of the chair. Patients skin was pale and diaphoretic. PHN black out for about two to three seconds. I'm starting to feel normal again though." Vital signs were taken by PHN at 1052 (blood pressure 120/70, heart rate 68, oxygen 95%). At 1053, color had returned to the patients face. Patient was alert and oriented times four. Patient stated, "I haven't eaten yet today, and I had coffee this morning." At 1056 PHN offered the patient a snack which he accepted and ate. At 1056, patient said, "I'm feeling much better. I feel normal now. I have no shortness of breath." Vital signs taken at 1103 (blood pressure 128/70, heart rate 65, oxygen 97%). Vital signs taken at 1111 (blood pressure 130/80, heart rate 59, oxygen 99%). Vital signs taken at 1119 (blood pressure 130/78, heart rate 58, oxygen 99%). Patient denied any medical issues, or medications, and stated that he is allergic to penicillin. PHN provided education to patient on life threatening symptoms and advised the client to follow up with his primary care provider. At 1120, patient stated, "I feel fine," and left the building unassisted with a steady gait.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 1536330

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: TX
Alter: 45,0
Geschlecht: F
Eingang: 09.08.2021
Impfdatum: 05.07.2021
Beginn: 08.07.2021
Tage bis Beginn: 3,0
Dosis: N/A
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Fatigue Headache Nausea Palpitations Retching

Symptomtext

I started feeling extremely fatigued and had really bad headaches and heart palpitations. I also felt extremely nauseous with dry heaving. I waited until July 16th or 17th to see a doctor. I explained my symptoms to the doctor, and he gave me something for nausea and a shot for my headache. He said he was not going to test me for COVID because he thought it would be a false positive. The medication didn't help any of my symptoms. I was tired of taking the Tylenol and ibuprofen because it wasn't helping at all either. The nausea has gotten better, but the extreme fatigue, heart palpitations, and headaches are still here.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Palpitations
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Depression medication; cholesterol medication
Allergien: Penicillin
Vorherige Impfungen: For the last 4 years flu vaccine cause me to get the flu, pnuemonia, and bronchitis

VAERS 1534922

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: CO
Alter: 20,0
Geschlecht: M
Eingang: 07.08.2021
Impfdatum: 07.08.2021
Beginn: 07.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Tremor

Symptomtext

Upon arriving in observation patient parked and began shaking. Patient advises this has happened in the past when he gave blood. Patient CAD x4. He denies complaint, advises he is "fine". HR 53 SpO2 97% BP 110/60 approximate time 1156.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Tremor
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1532263

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: TX
Alter: 26,0
Geschlecht: M
Eingang: 06.08.2021
Impfdatum: 06.08.2021
Beginn: 06.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Hyperhidrosis Palpitations Vomiting

Symptomtext

Patient got super sweaty and heart racing and after we got a cold towel and water on his forehead, he threw up in the trash can. Paramedics came and took his vital and he was fine after.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Palpitations
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1530053

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: CO
Alter: 34,0
Geschlecht: F
Eingang: 06.08.2021
Impfdatum: 02.08.2021
Beginn: 04.08.2021
Tage bis Beginn: 2,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Contusion Erythema Induration Injected limb mobility decreased Nodule Pain Pruritus Skin tightness Swelling Tenderness

Symptomtext

Redness, Swelling, itchy, bruising, hard lump, tender to the touch, Upper arm feels tight when trying to raise up, throbbing. Going on 5 days since getting vaccine. No signs of improvement, very itchy on day 5. Spoke with local pharmacist for advice. She recommended this website and to go get it looked at by a doctor.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injected limb mobility decreased
Hospital-Tage: -
Labordaten: None yet
Aktuelle Erkrankungen: None
Vorgeschichte: -
Andere Medikamente: Nuva Ring Contraceptive
Allergien: None known
Vorherige Impfungen: -

VAERS 1529433

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201a21a

moderat

Staat: -
Alter: 18,0
Geschlecht: M
Eingang: 05.08.2021
Impfdatum: 03.08.2021
Beginn: 03.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Flushing Hyperhidrosis Hypotension

Symptomtext

Patient became dizzy, flushed, and visibly diaphoretic. Patient stated he felt like he was going to pass out. Patient taken to a private observation room. Patient hypotensive. All other vital signs stable. Juice offered and patient placed in recumbent position. Patient recovered within 15 minutes for a total observation period of 30 minutes. Patient walked out of clinic with mother in stable condition.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hypotension
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1525806

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: NC
Alter: 24,0
Geschlecht: M
Eingang: 04.08.2021
Impfdatum: 26.07.2021
Beginn: 26.07.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chest pain Injection site pain Pain Pain in extremity

Symptomtext

Gradual increase in soreness from injection site, spreading to top of trapezius muscle, mid upper arm, and side of chest. 7/10 pain when doing physical activity. No treatment administered.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: NKA
Vorherige Impfungen: -

VAERS 1523412

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: CA
Alter: 56,0
Geschlecht: F
Eingang: 03.08.2021
Impfdatum: 09.06.2021
Beginn: 16.06.2021
Tage bis Beginn: 7,0
Dosis: 1
Route/Site: UN / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Chest pain Rash

Symptomtext

intermittent chest pain after vaccine 6/20/21-7/12/21 skin rash on back of legs starting after vaccine 7/5/21- 7/19/21

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1519081

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 201A21A

moderat

Staat: CA
Alter: 18,0
Geschlecht: M
Eingang: 01.08.2021
Impfdatum: 01.08.2021
Beginn: 01.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Hyperhidrosis Hypotension Pallor

Symptomtext

Client requested water prior to vaccination. Client requested for a snack just after receiving vaccination. Fruit bar and gold fish crackers were provided to client as he was sitting in vaccination chair. Client appeared diaphoretic, face was becoming pale, and eyes were fixated directly to his front. Client dropped water bottle and then client was safely transferred from chair to the ground at 3:20 PM with two person patient transfer. Client was instructed to take deep breaths while client had his eyes closed. Reporter asked client if he was still present with us and client stated, "Yes, I am feeling fine now." Reporter assessed client to which he was alert and oriented to person, place, time, and situation. Client's face mask and beanie were removed to assist client with cooling down. When client was ready to get up, he stood up immediately and then sat down into the gravity chair at 3:22 PM. Client was advised to continue eating snacks and drinking water and to wait in the gravity chair for a 30 minute observation. Reporter took vitals at 3:22 PM which were the following: blood pressure of right arm 108/58, pulse 60, O2 SAT 96%. Client stated verbally, "my blood pressure always runs low, that is a regular reading for me." Client denied taking any medications and denied having any diagnosed medical conditions. Client revealed, "I've had syncope episodes in the past. Needles make me anxious and makes my blood sugar drop. I just need to eat something to feel better." Reporter recommended for client to follow up with his primary care physician and notify them of the syncope episode. Client was also referred to V-SAFE. Client called his brother at 3:29 PM to drive him home which is a 10 minute drive from the vaccination site. Second blood pressure reading at 3:45 PM on right arm 108/50. Client was escorted by reporter as a standby assist to the entrance. Client left facility safely alert and oriented x4 with steady gait at 3:46 PM.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hypotension
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -